<SEC-DOCUMENT>0001104659-25-098909.txt : 20251014
<SEC-HEADER>0001104659-25-098909.hdr.sgml : 20251014
<ACCEPTANCE-DATETIME>20251014061221
ACCESSION NUMBER:		0001104659-25-098909
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20251013
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251014
DATE AS OF CHANGE:		20251014

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TAO Synergies Inc.
		CENTRAL INDEX KEY:			0001571934
		STANDARD INDUSTRIAL CLASSIFICATION:	FINANCE SERVICES [6199]
		ORGANIZATION NAME:           	09 Crypto Assets
		EIN:				461585656
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40458
		FILM NUMBER:		251389339

	BUSINESS ADDRESS:	
		STREET 1:		1185 AVENUE OF THE AMERICAS, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		9732420005

	MAIL ADDRESS:	
		STREET 1:		1185 AVENUE OF THE AMERICAS, 3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Synaptogenix, Inc.
		DATE OF NAME CHANGE:	20201210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEUROTROPE BIOSCIENCE, INC.
		DATE OF NAME CHANGE:	20130312
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2528153d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:snpx="http://synaptogen.com/20251013">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_snpx_synaptogen.com_20251013 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20251013_20251013 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DEntityCentralIndexKey_0001571934 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000004" name="dei:EntityCentralIndexKey">0001571934</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="snpx-20251013.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-10-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001571934</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-10-13</xbrli:startDate>
        <xbrli:endDate>2025-10-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 6pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_901_edei--DocumentType_c20251013__20251013_zRrzwgxerXqj"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported): </span><span id="xdx_90F_edei--DocumentPeriodEndDate_c20251013__20251013_zYILDwksXmY"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">October
13, 2025</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityRegistrantName_c20251013__20251013_zBcql251NJIe"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000011" name="dei:EntityRegistrantName">TAO Synergies Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 30%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_907_edei--EntityIncorporationStateCountryCode_c20251013__20251013_zMYQpwrOnqXl"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></b></span></td>
    <td style="padding-bottom: 1pt; width: 2%"><b><span style="text-decoration: underline"></span></b></td>
    <td style="width: 36%; text-align: center"><span id="xdx_905_edei--EntityFileNumber_c20251013__20251013_zUagXD9CCXIf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000013" name="dei:EntityFileNumber">001-40458</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1pt; width: 2%"><b><span style="text-decoration: underline"></span></b></td>
    <td style="width: 30%; text-align: center"><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20251013__20251013_zBU2UcUsWi8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000014" name="dei:EntityTaxIdentificationNumber">48-1585656</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction of
    incorporation)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center"><span id="xdx_90C_edei--EntityAddressAddressLine1_c20251013__20251013_zJGvS5TV96gc" style="font-family: Times New Roman, Times, Serif"><b><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000015" name="dei:EntityAddressAddressLine1">1185
    Avenue of the Americas</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif">,</span> <span id="xdx_908_edei--EntityAddressAddressLine2_c20251013__20251013_zZkxWQ5hVdK7"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000016" name="dei:EntityAddressAddressLine2">3<sup>rd
    </sup>Floor</ix:nonNumeric></span></b><b><br/>
    </b><span id="xdx_90B_edei--EntityAddressCityOrTown_c20251013__20251013_z7Tpq84hwU8a"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000017" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressStateOrProvince_c20251013__20251013_ztQEgkkAsDi4"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">New
    York</ix:nonNumeric></span></td>
    <td style="padding-bottom: 1.5pt; text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><span id="xdx_900_edei--EntityAddressPostalZipCode_c20251013__20251013_zKRWu7jsURYc"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000019" name="dei:EntityAddressPostalZipCode">10036</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">(Address of Principal Executive Offices)</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip Code)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including area code: <b>(<span id="xdx_903_edei--CityAreaCode_c20251013__20251013_zEqJmozjYEOf"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000020" name="dei:CityAreaCode">973</ix:nonNumeric></span></b><b>) <span id="xdx_90C_edei--LocalPhoneNumber_c20251013__20251013_zjTJ4sgME1s2"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000021" name="dei:LocalPhoneNumber">242-0005</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">N/A</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form&#160;8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_90D_edei--WrittenCommunications_c20251013__20251013_zH8CtjQM4YPb"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_90F_edei--SolicitingMaterial_c20251013__20251013_zuAQCMZ5tsS5"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementTenderOffer_c20251013__20251013_zH0WEOZYoCUk"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20251013__20251013_zMD3mvNMxxq7"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 43%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 37%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--Security12bTitle_c20251013__20251013_zfmLMrcWmEub"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000026" name="dei:Security12bTitle">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--TradingSymbol_c20251013__20251013_zebFmgVXdpZg"><ix:nonNumeric contextRef="AsOf2025-10-13" id="Fact000027" name="dei:TradingSymbol">TAOX</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--SecurityExchangeName_c20251013__20251013_zRhoSxK7eHw7"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405
of this Chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Emerging growth company&#160;<span style="font-family: Wingdings"><span id="xdx_902_edei--EntityEmergingGrowthCompany_c20251013__20251013_zcdvgMElODCe"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt:booleantrue" id="Fact000029" name="dei:EntityEmergingGrowthCompany">x</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;</span><span style="font-family: Wingdings"><span id="xdx_90A_edei--EntityExTransitionPeriod_c20251013__20251013_zY2BfryqI48f"><ix:nonNumeric contextRef="AsOf2025-10-13" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityExTransitionPeriod">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529"><b>Item 1.01. Entry into a
Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529"><b><i><span style="text-decoration: underline">Series&#160;E Convertible
Preferred Stock Financing</span></i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On
October&#160;13, 2025, TAO Synergies Inc. (the &#8220;<b>Company</b>&#8221;) entered into a Securities Purchase Agreement (the &#8220;<b>Purchase
Agreement</b>&#8221;) with certain accredited investors (the &#8220;<b>Investors</b>&#8221;), pursuant to which it agreed to sell to the
Investors in a private placement (the &#8220;<b>Private Placement</b>&#8221;) (i)&#160;an aggregate of 11,000 shares of the Company&#8217;s
newly designated Series&#160;E convertible preferred stock, par value $0.001, with a stated value of $1,000 per share (the &#8220;<b>Preferred
Stock</b>&#8221;), initially convertible into up to 1,375,000 shares of the Company&#8217;s common stock, par value $0.0001 per share
(the &#8220;<b>Common Stock</b>&#8221;) at an initial conversion price of $8.00 and (ii)&#160;warrants to purchase up to an aggregate
of 1,375,000 shares of Common Stock (the &#8220;<b>Warrants</b>&#8221;). The shares of Common Stock issuable upon conversion of the Preferred
Stock are referred to as the &#8220;<b>Conversion Shares</b>&#8221;.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Private Placement is exempt from the registration requirements of the Securities Act of 1933, as amended (the &#8220;<b>Securities Act</b>&#8221;)
pursuant to the exemption for transactions by an issuer not involving any public offering under Section&#160;4(a)(2)&#160;of the Securities
Act and Rule&#160;506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable state laws. Each of
the Investors has represented to the Company that it is an accredited investor within the meaning of Rule&#160;501(a)&#160;of Regulation
D and that it is acquiring the securities for investment only and not with a view towards, or for resale in connection with, the public
sale or distribution thereof. The Preferred Stock and the Warrants are being offered without any general solicitation by the Company or
its representatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
closing of the Private Placement is expected to occur on October&#160;15, 2025, subject to the satisfaction of customary closing conditions.
The aggregate gross proceeds from the Private Placement are expected to be $11.0 million. The Company expects to use the net proceeds
from the Private Placement for general corporate purposes and working capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Purchase Agreement contains certain representations and warranties, covenants and indemnities customary for similar transactions. The
representations, warranties and covenants contained in the Purchase Agreement were made solely for the benefit of the parties to the Purchase
Agreement and may be subject to limitations agreed upon by the contracting parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">GP
Nurmenkari Inc. is acting as the placement agent for the Private Placement (the &#8220;<b>Placement Agent</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">In
connection with the Private Placement, pursuant to an Engagement Letter (the &#8220;<b>Engagement Letter</b>&#8221;) between the Company
and the Placement Agent, the Company has agreed to pay the Placement Agent (i)&#160;a cash fee equal to 8.0% of the gross proceeds from
any sale of securities in the Private Placement plus a due diligence fee of $10,000, and (ii)&#160;warrants to purchase shares of Common
Stock equal to 4.0% of the number of shares of common stock that the Preferred Stock are initially convertible into, with an exercise
price of $8.00 per share and a five-year term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Preferred Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
terms of the Preferred Stock are as set forth in the form of Certificate of Designations, attached as Exhibit&#160;3.1 to this Current
Report on Form&#160;8-K (the &#8220;<b>Certificate of Designations</b>&#8221;), which will be filed with the Secretary of State for the
State of Delaware prior to the closing of the Private Placement. The Preferred Stock will be convertible into Conversion Shares at the
election of the holder at any time at an initial conversion price of $8.00 (the &#8220;<b>Conversion Price</b>&#8221;). The Conversion
Price is subject to customary adjustments for stock dividends, stock splits, reclassifications and the like, and subject to price-based
adjustment in the event of any issuances of Common Stock, or securities convertible, exercisable or exchangeable for Common Stock, at
a price below the then-applicable Conversion Price (subject to certain exceptions).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
holders of the Preferred Stock will be entitled to dividends of 7% per annum, compounded quarterly, which will be payable in cash. Upon
the occurrence and during the continuance of a Triggering Event (as defined in the Certificate of Designations), the Preferred Stock will
accrue dividends at the rate of 15% per annum. The holders of Preferred Stock are entitled to vote with holders of the Common Stock as
a single class on all matters that holders of Common Stock are entitled to vote upon, with the number of votes per Preferred Share equal
to the stated value of such Preferred Share divided by the then applicable Conversion Price; provided, however that in no event shall
the then applicable Conversion Price be less than the &#8220;Minimum Price&#8221; (as defined in Nasdaq Listing Rule&#160;5635(d)) on
the date immediately prior to the date of the Purchase Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Notwithstanding
the foregoing, the Company&#8217;s ability to settle conversions is subject to certain limitations set forth in the Certificate of Designations,
including a limit on the number of shares that may be issued until the time, if any, that the Company&#8217;s stockholders have approved
the issuance of more than 19.99% of the Company&#8217;s outstanding shares of Common Stock in accordance with Nasdaq listing standards
(the &#8220;<b>Nasdaq Stockholder Approval</b>&#8221;). The Company has agreed to seek stockholder approval of these matters at a meeting
to be held no later than December 31, 2025. Further, the Certificate of Designations contains a certain beneficial ownership limitation
after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Certificate of Designations or Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Certificate of Designations includes certain Triggering Events (as defined in the Certificate of Designations), including, among other
things, the failure to file and maintain an effective registration statement covering the sale of the holder&#8217;s securities registrable
pursuant to the Registration Rights Agreement (defined below) and the Company&#8217;s failure to pay any amounts due to the holders of
the Preferred Stock when due. In connection with a Triggering Event, each holder of Preferred Stock will be able to require the Company
to redeem in cash any or all of the holder&#8217;s Preferred Stock at a premium set forth in the Certificate of Designations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company will be subject to certain affirmative and negative covenants regarding the incurrence of indebtedness, acquisition and investment
transactions, the existence of liens, the repayment of indebtedness, the payment of cash in respect of dividends (other than dividends
pursuant to the Certificate of Designations), distributions or redemptions, and the transfer of assets, among other matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">There
is no established public trading market for the Preferred Stock and the Company does not intend to list the Preferred Stock on any national
securities exchange or nationally recognized trading system.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Warrants are exercisable immediately at an exercise price of $8.00 per share (the &#8220;<b>Exercise Price</b>&#8221;) and expire five
years from the date of issuance. The Exercise Price is subject to customary adjustments for stock dividends, stock splits, reclassifications
and the like, and subject to price-based adjustment, on a &#8220;full ratchet&#8221; basis, in the event of any issuances of Common Stock,
or securities convertible, exercisable or exchangeable for Common Stock, at a price below the then-applicable Exercise Price (subject
to certain exceptions). There is no established public trading market for the Warrants and the Company does not intend to list the Warrants
on any national securities exchange or nationally recognized trading system.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><i>Registration Rights</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Preferred Stock, the Warrants, the Conversion Shares and shares of Common Stock issuable upon exercise of the Warrants (the &#8220;<b>Warrant
Shares</b>&#8221;) have not been registered under the Securities Act. In connection with the Purchase Agreement, on October&#160;13, 2025,
the Company and the Investors entered into a Registration Rights Agreement (the &#8220;<b>Registration Rights Agreement</b>&#8221;), pursuant
to which the Company will be required to file a resale registration statement (the &#8220;<b>Registration Statement</b>&#8221;) with the
SEC to register for resale 150% of the Conversion Shares and 150% of the Warrant Shares promptly following the Closing Date, but in no
event later than 30 calendar days after the effective date of the Registration Rights Agreement, and to have such Registration Statement
declared effective by the Effectiveness Deadline (as defined in the Registration Rights Agreement). The Company will be obligated to pay
certain liquidated damages to the investors if the Company fails to file the Registration Statement when required, fails to file or cause
the Registration Statement to be declared effective by the SEC when required, or fails to maintain the effectiveness of the Registration
Statement pursuant to the terms of the Registration Rights Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
foregoing descriptions of the Purchase Agreement, the Warrants, the Certificate of Designations, the Registration Rights Agreement and
the Engagement Letter do not purport to be complete and are qualified in their entirety by reference to the full texts of the Purchase
Agreement, the Warrants, the Certificate of Designations, the Registration Rights Agreement and the Engagement Letter, forms of which
are filed as Exhibits 10.1, 4.1, 3.1, 10.2 and 10.3, respectively, to this Current Report on Form&#160;8-K and incorporated herein by
reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529"><b>Item 3.02. Unregistered
Sales of Equity Securities.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">The
matters described in Section&#160;1.01 of this Current Report on Form&#160;8-K related to the Private Placement are incorporated herein
by reference. In connection with the issuance of the Preferred Stock and the Warrants in the Private Placement described in Item 1.01,
the Company relied upon the exemption from registration provided by Section&#160;4(a)(2)&#160;of the Securities Act of 1933, as amended,
and Regulation D promulgated thereunder for transactions not involving a public offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">This
report shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any
state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the
securities laws of any such state or jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">The
matters described in Section&#160;1.01 of this Current Report on Form&#160;8-K related to the Certificate of Designations under the title
&#8220;Preferred Stock&#8221; are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529"><b>Item 7.01. Regulation FD.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">On
October&#160;13, 2025, the Company issued a press release announcing the Private Placement. A copy of the press release is attached as
Exhibit&#160;99.1 hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">The
information in this Item 7.01 to this Current Report on Form&#160;8-K, and in Exhibit&#160;99.1 furnished herewith, shall not be deemed
to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;<b>Exchange Act</b>&#8221;),
or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing
under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><b>Item
8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><i>Termination
of Alkon Consulting Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">As
previously disclosed, the Company entered into a consulting agreement dated as of June&#160;4, 2025, with Dr.&#160;Daniel L. Alkon, M.D.
(the &#8220;<b>Alkon Consulting Agreement</b>&#8221;) pursuant to which Dr.&#160;Alkon provided consulting services to the Company&#8217;s
Bryostatin Development Committee and served as director of the Bryostatin Platform Development Program. The Alkon Consulting Agreement
required Dr.&#160;Alkon to work with the Bryostatin Development Committee to find and evaluate opportunities for continued development
of the Company&#8217;s Bryostatin assets. Pursuant to the Alkon Consulting Agreement, the Company reduced Dr.&#160;Alkon&#8217;s base
monthly salary to $12,500 per month and entitled him to receive incentive fees if the Company entered into certain transactions relating
to the Bryostatin assets during the term of the Alkon Consulting Agreement or during the one-year period after termination of the Alkon
Consulting Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">On
October&#160;3, 2025, the Company delivered notice of termination to Dr.&#160;Alkon pursuant to the terms of the Alkon Consulting Agreement,
effective immediately. Pursuant to the terms of the Alkon Consulting Agreement, the Company remains obligated to pay Dr.&#160;Alkon incentive
fees if the Company enters into certain transactions relating to the Bryostatin assets up to one year after the date of termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; color: #212529"><i>Appointment
of Vice-Chairman of the Board of Directors</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white; color: #212529">On
October&#160;1, 2025, the board of directors of the Company (the &#8220;<b>Board</b>&#8221;) appointed Bruce Bernstein as Vice-Chairman
of the Board, effective immediately. In connection with the appointment, Mr.&#160;William Singer will remain a member of the Board in
his capacity as an independent director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529"><b>Item 9.01. Financial Statements
and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white; color: #212529"><b>(d)&#160;Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; font-size: 10pt; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; font-size: 10pt; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></a></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Certificate of Designations of Series&#160;E Convertible Preferred Stock</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex4-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Warrant</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></a></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Purchase Agreement</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></a></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex10-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Registration Rights Agreement</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></a></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex10-3.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Engagement Letter, dated September&#160;25, 2025 by and between TAO Synergies Inc. and GP Nurmenkari Inc.</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><a href="tm2528153d1_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press
    Release dated October&#160;13, 2025</span></a></td></tr>
  <tr>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></span></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif">TAO SYNERGIES INC.</td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%">Date: October&#160;14, 2025</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%">/s/ Robert Weinstein</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">Name: Robert Weinstein</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></span></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwkAMhE/QO4R9lv4qaB8tKmKVUor4utgoi+2mZNe/I3lLty1iCIQw880IMREbWqsGGU7LMocK266RFqHECzLqMzpHtt2l4G6JV2UsS22H9wdm5Bh0zMyPE+mEwfpQBusUwkUQzoN4ClGUThMo9sLr9Yz0RdWorZINSF1DwdSxQiv5PSZU8kWa2vdQdUQ2inQKkR+O8gfiMIrhQA/5JL4ZyPNMeJNhPLFhunfOtXpZ1D0JqwZbV2dG+r/eFwqrSpM= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>tm2528153d1_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 3.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF CERTIFICATE OF DESIGNATIONS OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SERIES E CONVERTIBLE PREFERRED STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF<BR>
TAO SYNERGIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>a Delaware corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">I, Joshua Silverman, hereby
certify that I am the Executive Chairman of TAO Synergies Inc. (the &ldquo;<B>Company</B>&rdquo;), a corporation organized and existing
under the Delaware General Corporation Law (the &ldquo;<B>DGCL</B>&rdquo;), and further do hereby certify:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">That pursuant to the authority
expressly conferred upon the Board of Directors of the Company (the &ldquo;<B>Board</B>&rdquo;) by the Company&rsquo;s Amended and Restated
Certificate of Incorporation (the &ldquo;<B>Certificate of Incorporation</B>&rdquo;), and Section 151(g) of the DGCL, the Board on October
1, 2025 adopted the following resolution determining it desirable and in the best interests of the Company and its stockholders for the
Company to create a series of 11,000 (eleven thousand) shares of preferred stock designated as &ldquo;<B>Series E Convertible Preferred
Stock</B>,&rdquo; none of which shares have been issued:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RESOLVED, that pursuant to
the authority vested in the Board, in accordance with the provisions of the Certificate of Incorporation, a series of preferred stock,
par value $0.001 per share, of the Company be and hereby is created pursuant to this certificate of designations (this &ldquo;<B>Certificate
of Designations</B>&rdquo;), and that the designation and number of shares thereof and the voting and other powers, preferences and relative,
participating, optional or other rights of the shares of such series and the qualifications, limitations and restrictions thereof are
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TERMS OF SERIES E CONVERTIBLE PREFERRED STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1. <U>Designation and Number
of Shares</U>. There shall hereby be created and established a series of preferred stock of the Company designated as &ldquo;Series E
Convertible Preferred Stock&rdquo; (the &ldquo;<B>Preferred Shares</B>&rdquo;). The authorized number of Preferred Shares shall be 11,000
(eleven thousand) shares. Each Preferred Share shall have a par value of $0.001. Capitalized terms not defined herein shall have the meaning
as set forth in Section 33 below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2. <U>Ranking</U>. Except to
the extent that the holders of at least a majority of the outstanding Preferred Shares (the &ldquo;<B>Required Holders</B>&rdquo;) expressly
consent to the creation of Parity Stock (as defined below) or Senior Preferred Stock (as defined below) in accordance with Section&nbsp;18,
all shares of capital stock of the Company shall be junior in rank to all Preferred Shares with respect to the preferences as to dividends,
distributions and payments upon the liquidation, dissolution and winding up of the Company (such junior stock is referred to herein collectively
as &ldquo;<B>Junior Stock</B>&rdquo;). The rights of all such shares of capital stock of the Company shall be subject to the rights, powers,
preferences and privileges of the Preferred Shares. Without limiting any other provision of this Certificate of Designations, without
the prior express consent of the Required Holders, voting separately as a single class, the Company shall not hereafter authorize or issue
any additional or other shares of capital stock that are (i)&nbsp;of senior rank to the Preferred Shares in respect of the preferences
as to dividends, distributions and payments upon the liquidation, dissolution and winding up of the Company (collectively, the &ldquo;<B>Senior
Preferred Stock</B>&rdquo;), (ii)&nbsp;of pari passu rank to the Preferred Shares in respect of the preferences as to dividends, distributions
and payments upon the liquidation, dissolution and winding up of the Company (collectively, the &ldquo;<B>Parity Stock</B>&rdquo;) or
(iii)&nbsp;any Junior Stock having a maturity date or any other date requiring redemption or repayment of such shares of Junior Stock
that is prior to the Maturity Date. In the event of the merger or consolidation of the Company with or into another corporation, the Preferred
Shares shall maintain their relative rights, powers, designations, privileges and preferences provided for herein and no such merger or
consolidation shall be consummated if it would result in the Preferred Shares being treated in any manner inconsistently with the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3. <U>Dividends and Payments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;From and after the
first date of issuance of any Preferred Shares (the &ldquo;<B>Initial Issuance Date</B>&rdquo;), each holder of a Preferred Share (each,
a &ldquo;<B>Holder</B>&rdquo; and collectively, the &ldquo;<B>Holders</B>&rdquo;) shall be entitled to receive dividends on the Stated
Value of the Preferred Shares (&ldquo;<B>Dividends</B>&rdquo;) payable, subject to the conditions and other terms hereof, at the Dividend
Rate computed on the basis of a 360-day year and twelve 30-day months and shall be payable in arrears quarterly on each Dividend Date
and shall compound each calendar quarter and shall be payable in funds legally available therefor or in shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;On any Conversion Date
that is not also a Dividend Date, Dividends shall accrue at the Dividend Rate and be payable by way of inclusion of the Dividends in the
Conversion Amount<B>&nbsp;</B>on each Conversion Date in accordance with Section&nbsp;4(b)(i)&nbsp;or upon any redemption in accordance
with Section&nbsp;12 or any required payment upon any Triggering Event. From and after the occurrence and during the continuance of any
Triggering Event, Dividends shall accrue on the Stated Value of each Preferred Share at fifteen percent (15.0%) per annum (the &ldquo;<B>Default
Rate</B>&rdquo;) and shall be computed on the basis of a 360-day year and twelve 30-day months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) On the Maturity Date, the
Company shall pay to the Holder an amount in funds legally available therefor in an amount equal to the product of (i) the Maturity Redemption
Premium multiplied by (ii) the Conversion Amount of the Preferred Shares being redeemed, plus accrued and unpaid Dividends and unpaid
Late Charges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) In the Company&rsquo;s sole
and absolute discretion, upon not less than twenty (20) Trading Days prior written notice to the Holder (the &ldquo;<B>Prepayment Notice</B>&rdquo;),
the Company may prepay any portion of the aggregate Stated Value underlying outstanding Preferred Shares plus any Make-Whole Amount and
accrued and unpaid Dividends and applicable Late Charges (&ldquo;<B>Prepayment</B>&rdquo;); provided that the Equity Conditions are satisfied
on each Trading Day beginning on the date the Prepayment Notice is delivered to such Holder and ending on the date the Prepayment is made
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4. <U>Conversion</U>. At any
time after the Initial Issuance Date, each Preferred Share shall be convertible into validly issued, fully paid and non-assessable shares
of Common Stock (as defined below), on the terms and conditions set forth in this Section&nbsp;4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Holder&rsquo;s
Conversion Right</U>. Subject to the provisions of Section&nbsp;4(d), at any time or times on or after the Initial Issuance Date, each
Holder shall be entitled to convert any portion of the outstanding Preferred Shares held by such Holder into validly issued, fully paid
and non-assessable shares of Common Stock in accordance with Section&nbsp;4(c)&nbsp;at the Conversion Rate (as defined below). The Company
shall not issue any fraction of a share of Common Stock upon any conversion. If the issuance would result in the issuance of a fraction
of a share of Common Stock, the Company shall round such fraction of a share of Common Stock up to the nearest whole share. The Company
shall pay any and all transfer, stamp, issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses
of the Transfer Agent (as defined below)) that may be payable with respect to the issuance and delivery of Common Stock upon conversion
of any Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Conversion
Rate</U>. The number of shares of Common Stock issuable upon conversion of any Preferred Share pursuant to Section&nbsp;4(a)&nbsp;shall
be determined by dividing (x)&nbsp;the Conversion Amount of such Preferred Share by (y)&nbsp;the Conversion Price (the &ldquo;<B>Conversion
Rate</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) &ldquo;<B>Conversion
Amount</B>&rdquo; means, with respect to each Preferred Share, as of the applicable date of determination, the sum of (1) the Stated Value
thereof plus (2) the Make-Whole Amount, (3) the Additional Amount thereon and any accrued and unpaid Late Charges (as defined below in
Section 26(c)) with respect to such Stated Value and Additional Amount as of such date of determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) &ldquo;<B>Conversion
Price</B>&rdquo; means, with respect to each Preferred Share, as of any Conversion Date or other date of determination, $8.00, subject
to adjustment as provided herein and for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions
following the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Mechanics
of Conversion</U>. The conversion of each Preferred Share shall be conducted in the following manner:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Optional
Conversion</U>. To convert a Preferred Share into shares of Common Stock on any date (a &ldquo;<B>Conversion Date</B>&rdquo;), a
Holder shall deliver (whether via electronic mail or otherwise), for receipt on or prior to 11:59 p.m., New York time, on such date,
a copy of an executed notice of conversion of the share(s)&nbsp;of Preferred Shares subject to such conversion in the form attached
hereto as <B><U>Exhibit&nbsp;I</U></B> (the &ldquo;<B>Conversion Notice</B>&rdquo;) to the Company. If required by
Section&nbsp;4(c)(iii), within two (2)&nbsp;Trading Days following a conversion of any such Preferred Shares as aforesaid, such
Holder shall surrender to a nationally recognized overnight delivery service for delivery to the Company the original certificates,
if any, representing the Preferred Shares (the &ldquo;<B>Preferred Share Certificates</B>&rdquo;) so converted as aforesaid (or an
indemnification undertaking with respect to the Preferred Shares in the case of its loss, theft or destruction as contemplated by
Section&nbsp;20(b)). On or before the first (1<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>) Trading Day following the date of
receipt of a Conversion Notice, the Company shall transmit by electronic mail an acknowledgment of confirmation and representation
as to whether such shares of Common Stock may then be resold pursuant to Rule&nbsp;144 or an effective and available registration
statement, in the form attached hereto as <B><U>Exhibit&nbsp;II</U></B>, of receipt of such Conversion Notice to such Holder and the
Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;), which confirmation shall constitute an instruction to the
Transfer Agent to process such Conversion Notice in accordance with the terms herein. On or before the first (1st) Trading Day
following each date on which the Company has received a Conversion Notice (or such earlier date as required pursuant to the 1934 Act
or other applicable law, rule&nbsp;or regulation for the settlement of a trade initiated on the applicable Conversion Date of such
shares of Common Stock issuable pursuant to such Conversion Notice) (the &ldquo;<B>Share Delivery Deadline</B>&rdquo;), the Company
shall (1)&nbsp;provided that the Transfer Agent is participating in The Depository Trust Company&rsquo;s (&ldquo;<B>DTC</B>&rdquo;)
Fast Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;), credit such aggregate number of shares of Common Stock to
which such Holder shall be entitled pursuant to such conversion to such Holder&rsquo;s or its designee&rsquo;s balance account with
DTC through its Deposit/Withdrawal at Custodian system, or (2)&nbsp;if the Transfer Agent is not participating in FAST, upon the
request of such Holder, issue and deliver (via reputable overnight courier) to the address as specified in such Conversion Notice, a
certificate, registered in the name of such Holder or its designee, for the number of shares of Common Stock to which such Holder
shall be entitled. If the number of Preferred Shares represented by the Preferred Share Certificate(s)&nbsp;submitted for conversion
pursuant to Section&nbsp;4(c)(iii)&nbsp;is greater than the number of Preferred Shares being converted, then the Company shall, as
soon as practicable and in no event later than two (2)&nbsp;Trading Days after receipt of the Preferred Share
Certificate(s)&nbsp;and at its own expense, issue and deliver to such Holder (or its designee) a new Preferred Share Certificate or
a new Book-Entry (in either case, in accordance with Section&nbsp;20(d)) representing the number of Preferred Shares not converted.
The Person or Persons entitled to receive the shares of Common Stock issuable upon a conversion of Preferred Shares shall be treated
for all purposes as the record holder or holders of such shares of Common Stock on the Conversion Date. Notwithstanding the
foregoing, with respect to any Conversion Notice delivered by a Buyer (as defined in the Securities Purchase Agreement) to the
Company on or prior to 4:00 p.m.&nbsp;(New York City time) on the Trading Day immediately prior to the date of initial issuance of
such applicable Preferred Shares to be converted pursuant to such Conversion Notice (each, an &ldquo;<B>Issuance Date</B>&rdquo;),
which may be delivered at any time after the time of execution of the Securities Purchase Agreement, the Company agrees to deliver
the shares of Common Stock issuable upon conversion of such Preferred Shares to be issued on such date subject to such
notice(s)&nbsp;by 4:00 p.m.&nbsp;(New York City time) on such applicable Issuance Date and such Issuance Date shall be the Share
Delivery Deadline for purposes hereunder with respect to such Conversion Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Company&rsquo;s
Failure to Timely Convert</U>. If the Company shall fail, for any reason or for no reason, on or prior to the applicable Share Delivery
Deadline, if the Transfer Agent is not participating in FAST, to issue and deliver to such Holder (or its designee) a certificate for
the number of shares of Common Stock to which such Holder is entitled and register such shares of Common Stock on the Company&rsquo;s
share register or, if the Transfer Agent is participating in FAST, to credit such Holder&rsquo;s or its designee&rsquo;s balance account
with DTC for such number of shares of Common Stock to which such Holder is entitled upon such Holder&rsquo;s conversion of any Conversion
Amount (as the case may be) (a &ldquo;<B>Conversion Failure</B>&rdquo;), then, in addition to all other remedies available to such Holder,
(X)&nbsp;the Company shall pay in cash from funds legally available therefor to such Holder on each day after the Share Delivery Deadline
that the issuance of such shares of Common Stock is not timely effected an amount equal to 1% of the product of (A)&nbsp;the sum of the
number of shares of Common Stock not issued to such Holder on or prior to the Share Delivery Deadline and to which such Holder is entitled,
multiplied by (B)&nbsp;any trading price of the Common Stock selected by such Holder in writing as in effect at any time during the period
beginning on the applicable Conversion Date and ending on the applicable Share Delivery Deadline, and (Y)&nbsp;such Holder, upon written
notice to the Company, may void its Conversion Notice with respect to, and retain or have returned, as the case may be, all, or any portion,
of such Preferred Shares that has not been converted pursuant to such Conversion Notice; provided that the voiding of a Conversion Notice
shall not affect the Company&rsquo;s obligations to make any payments which have accrued prior to the date of such notice pursuant to
this Section&nbsp;4(c)(ii)&nbsp;or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Deadline the Transfer
Agent is not participating in FAST, the Company shall fail to issue and deliver to such Holder (or its designee) a certificate and register
such shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating in FAST, the Transfer Agent
shall fail to credit the balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for the number of shares
of Common Stock to which such Holder is entitled upon such Holder&rsquo;s conversion hereunder or pursuant to the Company&rsquo;s obligation
pursuant to clause (ii)&nbsp;below, and if on or after such Share Delivery Deadline such Holder acquires (in an open market transaction,
stock loan or otherwise) shares of Common Stock corresponding to all or any portion of the number of shares of Common Stock issuable upon
such conversion that such Holder is entitled to receive from the Company and has not received from the Company in connection with such
Conversion Failure (a &ldquo;<B>Buy-In</B>&rdquo;), then, in addition to all other remedies available to such Holder, the Company shall,
within two (2)&nbsp;Business Days after receipt of such Holder&rsquo;s request and in such Holder&rsquo;s discretion, either: (I)&nbsp;pay
cash from funds legally available therefor to such Holder in an amount equal to such Holder&rsquo;s total purchase price (including brokerage
commission, stock loan costs and other out-of-pocket expenses, if any) for the shares of Common Stock so acquired (including, without
limitation, by any other Person in respect, or on behalf, of such Holder) (the &ldquo;<B>Buy-In Price</B>&rdquo;), at which point the
Company&rsquo;s obligation to so issue and deliver such certificate (and to issue such shares of Common Stock) or credit to the balance
account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for the number of shares of Common Stock to which such
Holder is entitled upon such Holder&rsquo;s conversion hereunder (as the case may be) (and to issue such shares of Common Stock) shall
terminate, or (II)&nbsp;promptly honor its obligation to so issue and deliver to such Holder a certificate or certificates representing
such shares of Common Stock or credit the balance account of such Holder or such Holder&rsquo;s designee, as applicable, with DTC for
the number of shares of Common Stock to which such Holder is entitled upon such Holder&rsquo;s conversion hereunder (as the case may be)
and pay cash from funds legally available therefor to such Holder in an amount equal to the excess (if any) of the Buy-In Price over the
product of (x)&nbsp;such number of shares of Common Stock multiplied by (y)&nbsp;the lowest Closing Sale Price of the Common Stock on
any Trading Day during the period commencing on the date of the applicable Conversion Notice and ending on the date of such issuance and
payment under this clause (II). Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder,
at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s
failure to timely deliver certificates representing shares of Common Stock (or to electronically deliver such shares of Common Stock)
upon the conversion of the Preferred Shares as required pursuant to the terms hereof. Notwithstanding anything herein to the contrary,
with respect to any given Conversion Failure, this Section&nbsp;4(c)(ii)&nbsp;shall not apply to a Holder to the extent the Company has
already paid such amounts in full to such Holder with respect to such Conversion Failure, as applicable, pursuant to the analogous sections
of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Registration;
Book-Entry</U>. At the time of issuance of any Preferred Shares hereunder, the applicable Holder may, by written request (including by
electronic-mail) to the Company, elect to receive such Preferred Shares in the form of one or more Preferred Share Certificates or in
Book-Entry form. The Company (or the Transfer Agent, as custodian for the Preferred Shares) shall maintain a register (the &ldquo;<B>Register</B>&rdquo;)
for the recordation of the names and addresses of the Holders of each Preferred Share and the Stated Value of the Preferred Shares and
whether the Preferred Shares are held by such Holder in Preferred Share Certificates or in Book-Entry form (the &ldquo;<B>Registered Preferred
Shares</B>&rdquo;). The entries in the Register shall be conclusive and binding for all purposes absent manifest error. The Company and
each Holder of the Preferred Shares shall treat each Person whose name is recorded in the Register as the owner of a Preferred Share for
all purposes (including, without limitation, the right to receive payments and Dividends hereunder) notwithstanding notice to the contrary.
A Registered Preferred Share may be assigned, transferred or sold only by registration of such assignment or sale on the Register. Upon
its receipt of a written request to assign, transfer or sell one or more Registered Preferred Shares by such Holder thereof, the Company
shall record the information contained therein in the Register and issue one or more new Registered Preferred Shares in the same aggregate
Stated Value as the Stated Value of the surrendered Registered Preferred Shares to the designated assignee or transferee pursuant to Section&nbsp;19,
provided that if the Company does not so record an assignment, transfer or sale (as the case may be) of such Registered Preferred Shares
within two (2)&nbsp;Business Days of such a request, then the Register shall be automatically deemed updated to reflect such assignment,
transfer or sale (as the case may be). Notwithstanding anything to the contrary set forth in this Section&nbsp;4, following conversion
of any Preferred Shares in accordance with the terms hereof, the applicable Holder shall not be required to physically surrender such
Preferred Shares held in the form of a Preferred Share Certificate to the Company unless (A)&nbsp;the full or remaining number of Preferred
Shares represented by the applicable Preferred Share Certificate are being converted (in which event such certificate(s)&nbsp;shall be
delivered to the Company as contemplated by this Section&nbsp;4(c)(iii)) or (B)&nbsp;such Holder has provided the Company with prior written
notice (which notice may be included in a Conversion Notice) requesting reissuance of Preferred Shares upon physical surrender of the
applicable Preferred Share Certificate. Each Holder and the Company shall maintain records showing the Stated Value, Dividends and Late
Charges converted and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case may be) or shall use
such other method, reasonably satisfactory to such Holder and the Company, so as not to require physical surrender of a Preferred Share
Certificate upon conversion. If the Company does not update the Register to record such Stated Value, Dividends and Late Charges converted
and/or paid (as the case may be) and the dates of such conversions and/or payments (as the case may be) within two (2)&nbsp;Business Days
of such occurrence, then the Register shall be automatically deemed updated to reflect such occurrence. In the event of any dispute or
discrepancy, such records of such Holder establishing the number of Preferred Shares to which the record holder is entitled shall be controlling
and determinative in the absence of manifest error. A Holder and any transferee or assignee, by acceptance of a certificate, acknowledge
and agree that, by reason of the provisions of this paragraph, following conversion of any Preferred Shares, the number of Preferred Shares
represented by such certificate may be less than the number of Preferred Shares stated on the face thereof. Each Preferred Share Certificate
shall bear the following legend:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">ANY TRANSFEREE OR ASSIGNEE OF THIS CERTIFICATE
SHOULD CAREFULLY REVIEW THE TERMS OF THE COMPANY&rsquo;S CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES E PREFERRED STOCK
REPRESENTED BY THIS CERTIFICATE,&nbsp;INCLUDING SECTION&nbsp;4(c)(iii)&nbsp;THEREOF. THE NUMBER OF SHARES OF SERIES E PREFERRED STOCK
REPRESENTED BY THIS CERTIFICATE MAY&nbsp;BE LESS THAN THE NUMBER OF SHARES OF SERIES E PREFERRED STOCK STATED ON THE FACE HEREOF PURSUANT
TO SECTION&nbsp;4(c)(iii)&nbsp;OF THE CERTIFICATE OF DESIGNATIONS RELATING TO THE SHARES OF SERIES E PREFERRED STOCK REPRESENTED BY THIS
CERTIFICATE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;<U>Pro Rata
Conversion; Disputes</U>. In the event that the Company receives a Conversion Notice from more than one Holder for the same Conversion
Date and the Company can convert some, but not all, of such Preferred Shares submitted for conversion, the Company shall convert from
each Holder electing to have Preferred Shares converted on such date a pro rata amount of such Holder&rsquo;s Preferred Shares submitted
for conversion on such date based on the number of Preferred Shares submitted for conversion on such date by such Holder relative to the
aggregate number of Preferred Shares submitted for conversion on such date. In the event of a dispute as to the number of shares of Common
Stock issuable to a Holder in connection with a conversion of Preferred Shares, the Company shall issue to such Holder the number of shares
of Common Stock not in dispute and resolve such dispute in accordance with Section&nbsp;25.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Limitation
on Beneficial Ownership</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Beneficial
Ownership</U>. The Company shall not effect the conversion of any of the Preferred Shares held by a Holder, and such Holder shall not
have the right to convert any of the Preferred Shares held by such Holder pursuant to the terms and conditions of this Certificate of
Designations and any such conversion shall be null and void and treated as if never made, to the extent that after giving effect to such
conversion, such Holder together with the other Attribution Parties collectively would beneficially own in excess of 4.99% (the
 &ldquo;<B>Maximum Percentage</B>&rdquo;) of the shares of Common Stock outstanding immediately after giving effect to such conversion.
For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Holder and the other
Attribution Parties shall include the number of shares of Common Stock held by such Holder and all other Attribution Parties plus the
number of shares of Common Stock issuable upon conversion of the Preferred Shares with respect to which the determination of such sentence
is being made, but shall exclude shares of Common Stock which would be issuable upon (A)&nbsp;conversion of the remaining, nonconverted
Preferred Shares beneficially owned by such Holder or any of the other Attribution Parties and (B)&nbsp;exercise or conversion of the
unexercised or nonconverted portion of any other securities of the Company (including, without limitation, any convertible notes, convertible
preferred stock or warrants, including the Preferred Shares and the Warrants) beneficially owned by such Holder or any other Attribution
Party subject to a limitation on conversion or exercise analogous to the limitation contained in this Section&nbsp;4(d)(i). For purposes
of this Section&nbsp;4(d)(i), beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the 1934 Act. In
addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&nbsp;13(d)&nbsp;of
the 1934 Act and the rules&nbsp;and regulations promulgated thereunder. For purposes of determining the number of outstanding shares of
Common Stock a Holder may acquire upon the conversion of such Preferred Shares without exceeding the Maximum Percentage, such Holder may
rely on the number of outstanding shares of Common Stock as reflected in (x)&nbsp;the Company&rsquo;s most recent Annual Report on Form&nbsp;10-K,
Quarterly Report on Form&nbsp;10-Q, Current Report on Form&nbsp;8-K or other public filing with the SEC, as the case may be, (y)&nbsp;a
more recent public announcement by the Company or (z)&nbsp;any other written notice by the Company or the Transfer Agent, if any, setting
forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Company receives
a Conversion Notice from a Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding
Share Number, the Company shall notify such Holder in writing of the number of shares of Common Stock then outstanding and, to the extent
that such Conversion Notice would otherwise cause such Holder&rsquo;s beneficial ownership, as determined pursuant to this Section&nbsp;4(d)(i),
to exceed the Maximum Percentage, such Holder must notify the Company of a reduced number of shares of Common Stock to be purchased pursuant
to such Conversion Notice. For any reason at any time, upon the written or oral request of any Holder, the Company shall within one (1)&nbsp;Business
Day confirm orally and in writing or by electronic mail to such Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of
the Company, including such Preferred Shares, by such Holder and any other Attribution Party since the date as of which the Reported Outstanding
Share Number was reported. In the event that the issuance of shares of Common Stock to a Holder upon conversion of such Preferred Shares
results in such Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage
of the number of outstanding shares of Common Stock (as determined under Section&nbsp;13(d)&nbsp;of the 1934 Act), the number of shares
so issued by which such Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage
(the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and such Holder shall not have
the power to vote or to transfer the Excess Shares. Upon delivery of a written notice to the Company, any Holder may from time to time
increase (with such increase not effective until the sixty-first (61<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>) day after delivery
of such notice) or decrease the Maximum Percentage of such Holder to any other percentage not in excess of 9.99% as specified in such
notice; provided that (i)&nbsp;any such increase in the Maximum Percentage will not be effective until the sixty-first (61<FONT STYLE="font-size: 10pt"><SUP>st</SUP></FONT>)
day after such notice is delivered to the Company and (ii)&nbsp;any such increase or decrease will apply only to such Holder and the other
Attribution Parties and not to any other Holder that is not an Attribution Party of such Holder. For purposes of clarity, the shares of
Common Stock issuable to a Holder pursuant to the terms of this Certificate of Designations in excess of the Maximum Percentage shall
not be deemed to be beneficially owned by such Holder for any purpose including for purposes of Section&nbsp;13(d)&nbsp;or Rule&nbsp;16a-1(a)(1)&nbsp;of
the 1934 Act. No prior inability to convert such Preferred Shares pursuant to this paragraph shall have any effect on the applicability
of the provisions of this paragraph with respect to any subsequent determination of convertibility. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&nbsp;4(d)(i)&nbsp;to the extent
necessary to correct this paragraph (or any portion of this paragraph) which may be defective or inconsistent with the intended beneficial
ownership limitation contained in this Section&nbsp;4(d)(i)&nbsp;or to make changes or supplements necessary or desirable to properly
give effect to such limitation. The limitation contained in this paragraph may not be waived and shall apply to a successor holder of
such Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) <U>Principal
Market Regulation</U>. The Company shall not issue any shares of Common Stock upon conversion of any Preferred Shares or otherwise pursuant
to the terms of this Certificate of Designations if the issuance of such shares of Common Stock (taken together with the issuance of all
other shares of Common Stock upon exercise of the Warrants) would exceed the aggregate number of shares of Common Stock which the Company
may issue upon exercise or conversion (as the case may be) of the Preferred Shares and the Warrants without breaching the Company&rsquo;s
obligations under the rules and regulations the listing rules of the Principal Market (the number of shares which may be issued without
violating such rules and regulations, the &ldquo;<B>Exchange Cap</B>&rdquo;), except that such limitation shall not apply in the event
that the Company (A) obtains the approval of its stockholders as required by the applicable rules and regulations of the Principal Market
for issuances of shares of Common Stock in excess of such amount (&ldquo;<B>Stockholder Approval</B>&rdquo;) or (B) obtains a written
opinion from outside counsel to the Company that such approval is not required, which opinion shall be reasonably satisfactory to the
Required Holders. Until such approval or such written opinion is obtained, no Holder shall be issued in the aggregate, upon conversion
or exercise (as the case may be) of any Preferred Shares or any Warrant, shares of Common Stock in an amount greater than the product
of (i) the Exchange Cap as of the Initial Issuance Date multiplied by (ii) the quotient of (1) the aggregate number of Preferred Shares
issued to such Holder on the Initial Issuance Date divided by (2) the aggregate number of Preferred Shares issued to the Holders on the
Initial Issuance Date (with respect to each Holder, the &ldquo;<B>Exchange Cap Allocation</B>&rdquo;). In the event that any Holder shall
sell or otherwise transfer any of such Holder&rsquo;s Preferred Shares, the transferee shall be allocated a pro rata portion of such Holder&rsquo;s
Exchange Cap Allocation with respect to such portion of such Preferred Shares so transferred, and the restrictions of the prior sentence
shall apply to such transferee with respect to the portion of the Exchange Cap Allocation so allocated to such transferee. Upon conversion
in full of a holder&rsquo;s Preferred Shares, the difference (if any) between such holder&rsquo;s Exchange Cap Allocation and the number
of shares of Common Stock actually issued to such holder upon such holder&rsquo;s conversion in full of such Preferred Shares shall be
allocated, to the respective Exchange Cap Allocations of the remaining holders of Preferred Shares and/or related Warrants on a pro rata
basis in proportion to the shares of Common Stock underlying the Preferred Shares and/or related Warrants then held by each such holder
of Preferred Shares and/or related Warrants. In the event that after the date that is ninety (90) days following the Closing Date, the
Company is prohibited from issuing any shares of Common Stock pursuant to this Section 4(d)(ii)(the &ldquo;<B>Exchange Cap Shares</B>&rdquo;)
to a Holder, the Company shall pay cash from funds legally available therefor to such Holder in exchange for the redemption of such number
of Preferred Shares held by such Holder that are not convertible into such Exchange Cap Shares at a price equal to the sum of (i) the
product of (x) such number of Exchange Cap Shares and (y) the greatest Closing Sale Price of the Common Stock on any Trading Day during
the period commencing on the date such Holder delivers the applicable Conversion Notice with respect to such Exchange Cap Shares to the
Company and ending on the date of such issuance and payment under this Section 4(d)(ii) and (ii) to the extent such Holder purchases (in
an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Holder of Exchange Cap Shares,
any brokerage commissions and other out-of-pocket expenses, if any, of such Holder incurred in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Right
of Alternate Conversion</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Alternate
Conversion Upon a Triggering Event</U>. Subject to Section&nbsp;4(d), at any time during a Triggering Event Redemption Right Period (as
defined below), such Holder may, at such Holder&rsquo;s option, by delivery of a Conversion Notice to the Company (the date of any such
Conversion Notice, each an &ldquo;<B>Alternate Conversion Date</B>&rdquo;), convert all, or any number of Preferred Shares (such Conversion
Amount of the Preferred Shares to be converted pursuant to this Section&nbsp;4(e)(ii), each, an &ldquo;<B>Alternate Conversion Amount</B>&rdquo;)
into shares of Common Stock at the Alternate Conversion Price (each an &ldquo;<B>Alternate Conversion</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) <U>Mechanics
of Alternate Conversion</U>. On any Alternate Conversion Date, a Holder may voluntarily convert any Alternate Conversion Amount of Preferred
Shares pursuant to Section 4(c) (with &ldquo;Alternate Conversion Price&rdquo; replacing &ldquo;Conversion Price&rdquo; for all purposes
hereunder with respect to such Alternate Conversion and with &ldquo;Alternate Conversion Amount&rdquo; replacing &ldquo;Conversion Amount&rdquo;
in clause (x) of the definition of Conversion Rate above with respect to such Alternate Conversion) by designating in the Conversion Notice
delivered pursuant to this Section 4(e) of this Certificate of Designations that such Holder is electing to use the Alternate Conversion
Price for such conversion; provided that in the event of the Conversion Floor Price Condition, on the applicable Alternate Conversion
Date the Company shall also deliver to the Holder the applicable Alternate Conversion Floor Amount. Notwithstanding anything to the contrary
in this Section 4(e), but subject to Section 4(d), until the Company delivers shares of Common Stock representing the applicable Alternate
Conversion Amount of Preferred Shares to such Holder, such Preferred Shares may be converted by such Holder into shares of Common Stock
pursuant to Section 4(c) without regard to this Section 4(e).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">5. <U>Triggering Event Redemptions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Triggering
Event</U>. Each of the following events shall constitute a &ldquo;<B>Triggering Event</B>&rdquo; and each of the events in clauses (viii),
(ix), and (x)&nbsp;shall constitute a &ldquo;<B>Bankruptcy Triggering Event</B>&rdquo;:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the suspension
from trading or the failure of the Common Stock to be trading or listed (as applicable) on an Eligible Market for a period of five (5)&nbsp;consecutive
Trading Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;the Company&rsquo;s
(A)&nbsp;failure to cure a Conversion Failure or a Delivery Failure (as defined in the Warrants) by delivery of the required number of
shares of Common Stock within five (5)&nbsp;Trading Days after the applicable Conversion Date or exercise date (as the case may be) or
(B)&nbsp;written notice to any holder of Preferred Shares or Warrants, including, without limitation, by way of public announcement or
through any of its agents, at any time, of its intention not to comply, as required, with a request for exercise of any Warrants for Warrant
Shares in accordance with the provisions of the Warrants or a request for conversion of any Preferred Shares into shares of Common Stock
that is requested in accordance with the provisions of this Certificate of Designations, other than pursuant to Section&nbsp;4(d)&nbsp;hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;except
to the extent the Company is in compliance with Section&nbsp;11(b)&nbsp;below, at any time following the tenth (10<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>)
consecutive day that a Holder&rsquo;s Authorized Share Allocation (as defined in Section&nbsp;11(a)&nbsp;below) is less than the sum of
(A)&nbsp;150% of the number of shares of Common Stock that such Holder would be entitled to receive upon a conversion, in full, of all
of the Preferred Shares then held by such Holder (assuming a conversion at the Floor Price then in effect and without regard to any limitations
on conversion set forth in this Certificate of Designations) and (B)&nbsp;150% of the number of shares of Common Stock that such Holder
would then be entitled to receive upon exercise in full of such Holder&rsquo;s Warrants (without regard to any limitations on exercise
set forth in the Warrants);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">(iv)&nbsp;subject to the provisions of
Section&nbsp;170 of the DGCL, the Board fails to declare any Dividend to be paid on the applicable Dividend Date in accordance with Section&nbsp;3;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;the Company&rsquo;s
failure to pay to any Holder any Dividend on any Dividend Date (whether or not declared by the Board) or any other amount when and as
due under this Certificate of Designations (including, without limitation, the Company&rsquo;s failure to pay any redemption payments
or amounts hereunder), the Securities Purchase Agreement or any other Transaction Document or any other agreement, document, certificate
or other instrument delivered in connection with the transactions contemplated hereby and thereby (in each case, whether or not permitted
pursuant to the DGCL), except, in the case of a failure to pay Dividends and Late Charges when and as due, in each such case only if such
failure remains uncured for a period of at least five (5)&nbsp;Trading Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;the Company
fails to remove any restrictive legend on any certificate or any shares of Common Stock issued to the applicable Holder upon conversion
or exercise (as the case may be) of any Securities (as defined in the Securities Purchase Agreement) acquired by such Holder under the
Transaction Documents as and when required by such Securities or the Securities Purchase Agreement, as applicable, unless otherwise then
prohibited by applicable federal securities laws, and any such failure remains uncured for at least five (5)&nbsp;Trading Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;the occurrence
of any default under, redemption of or acceleration prior to maturity of at least an aggregate of $250,000 of Indebtedness (as defined
in the Securities Purchase Agreement) of the Company or any of its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(viii)&nbsp;bankruptcy,
insolvency, reorganization or liquidation proceedings or other proceedings for the relief of debtors shall be instituted by or against
the Company or any Subsidiary and, if instituted against the Company or any Subsidiary by a third party, shall not be dismissed within
thirty (30) days of their initiation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ix)&nbsp;the commencement
by the Company or any Subsidiary of a voluntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency,
reorganization or other similar law or of any other case or proceeding to be adjudicated a bankrupt or insolvent, or the consent by it
to the entry of a decree, order, judgment or other similar document in respect of the Company or any Subsidiary in an involuntary case
or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar law or to the commencement
of any bankruptcy or insolvency case or proceeding against it, or the filing by it of a petition or answer or consent seeking reorganization
or relief under any applicable federal, state or foreign law, or the consent by it to the filing of such petition or to the appointment
of or taking possession by a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company
or any Subsidiary or of any substantial part of its property, or the making by it of an assignment for the benefit of creditors, or the
execution of a composition of debts, or the occurrence of any other similar federal, state or foreign proceeding, or the admission by
it in writing of its inability to pay its debts generally as they become due, the taking of corporate action by the Company or any Subsidiary
in furtherance of any such action or the taking of any action by any Person to commence a Uniform Commercial Code foreclosure sale or
any other similar action under federal, state or foreign law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(x)&nbsp;the entry
by a court of (i)&nbsp;a decree, order, judgment or other similar document in respect of the Company or any Subsidiary of a voluntary
or involuntary case or proceeding under any applicable federal, state or foreign bankruptcy, insolvency, reorganization or other similar
law or (ii)&nbsp;a decree, order, judgment or other similar document adjudging the Company or any Subsidiary as bankrupt or insolvent,
or approving as properly filed a petition seeking liquidation, reorganization, arrangement, adjustment or composition of or in respect
of the Company or any Subsidiary under any applicable federal, state or foreign law or (iii)&nbsp;a decree, order, judgment or other similar
document appointing a custodian, receiver, liquidator, assignee, trustee, sequestrator or other similar official of the Company or any
Subsidiary or of any substantial part of its property, or ordering the winding up or liquidation of its affairs, and the continuance of
any such decree, order, judgment or other similar document or any such other decree, order, judgment or other similar document unstayed
and in effect for a period of thirty (30) consecutive days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xi)&nbsp;a final
judgment or judgments for the payment of money aggregating in excess of $250,000 are rendered against the Company and/or any of its Subsidiaries
and which judgments are not, within thirty (30) days after the entry thereof, bonded, discharged, settled or stayed pending appeal, or
are not discharged within thirty (30) days after the expiration of such stay; provided, however, any judgment which is covered by insurance
or an indemnity from a credit worthy party shall not be included in calculating the $250,000 amount set forth above so long as the Company
provides each Holder a written statement from such insurer or indemnity provider (which written statement shall be reasonably satisfactory
to each Holder) to the effect that such judgment is covered by insurance or an indemnity and the Company or such Subsidiary (as the case
may be) will receive the proceeds of such insurance or indemnity within thirty (30) days of the issuance of such judgment;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xii)&nbsp;the Company
and/or any Subsidiary, individually or in the aggregate, either (i)&nbsp;fails to pay, when due, or within any applicable grace period,
any payment with respect to any Indebtedness in excess of $250,000 due to any third party (other than, with respect to unsecured Indebtedness
only, payments contested by the Company and/or such Subsidiary (as the case may be) in good faith by proper proceedings and with respect
to which adequate reserves have been set aside for the payment thereof in accordance with GAAP) or is otherwise in breach or violation
of any agreement for monies owed or owing in an amount in excess of $250,000, which breach or violation permits the other party thereto
to declare a default or otherwise accelerate amounts due thereunder, or (ii)&nbsp;suffer to exist any other circumstance or event that
would, with or without the passage of time or the giving of notice, result in a default or event of default under any agreement binding
the Company or any Subsidiary, which default or event of default would or is likely to have a material adverse effect on the business,
assets, operations (including results thereof), liabilities, properties, condition (including financial condition) or prospects of the
Company or any of its Subsidiaries, individually or in the aggregate, but only if such failure or occurrence remains uncured for a period
of at least five (5)&nbsp;days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xiii)&nbsp;other
than as specifically set forth in another clause of this Section&nbsp;5(a), the Company or any Subsidiary breaches any representation
or warranty in any material respect (other than representations or warranties subject to material adverse effect or materiality, which
may not be breached in any respect) or any covenant or other term or condition of any Transaction Document, except, in the case of a breach
of a covenant or other term or condition that is curable, only if such breach remains uncured for a period of five (5)&nbsp;consecutive
Trading Days;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xiv)&nbsp;a false
or inaccurate certification (including a false or inaccurate deemed certification) by the Company that either (A)&nbsp;the Equity Conditions
are satisfied, (B)&nbsp;there has been no Equity Conditions Failure, or (C)&nbsp;as to whether any Triggering Event has occurred;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xv)&nbsp;any breach
or failure in any respect by the Company or any Subsidiary to comply with any provision of Section&nbsp;15(m)&nbsp;of this Certificate
of Designations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xvi)&nbsp;any Material
Adverse Effect (as defined in the Securities Purchase Agreement) occurs that has not been cured, if capable of curing, within five (5)&nbsp;Trading
Days of the occurrence; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(xvii)&nbsp;any provision
of any Transaction Document shall at any time for any reason (other than pursuant to the express terms thereof) cease to be valid and
binding on or enforceable against the Company, or the validity or enforceability thereof shall be contested, directly or indirectly, by
the Company or any Subsidiary, or a proceeding shall be commenced by the Company or any Subsidiary or any governmental authority having
jurisdiction over any of them, seeking to establish the invalidity or unenforceability thereof or the Company or any of its Subsidiaries
shall deny in writing that it has any liability or obligation purported to be created under one or more Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Notice
of a Triggering Event; Redemption Right</U>. Upon the occurrence of a Triggering Event with respect to the Preferred Shares, the Company
shall within one (1)&nbsp;Business Day deliver written notice thereof via electronic mail and overnight courier (with next day delivery
specified) (a &ldquo;<B>Triggering Event Notice</B>&rdquo;) to each Holder. At any time after the earlier of a Holder&rsquo;s receipt
of a Triggering Event Notice and such Holder becoming aware of a Triggering Event (such earlier date, the &ldquo;<B>Triggering Event Right
Commencement Date</B>&rdquo;) and ending (such ending date, the &ldquo;<B>Triggering Event Right Expiration Date</B>&rdquo; and each such
period, a &ldquo;<B>Triggering Event Redemption Right Period</B>&rdquo;) on the fifteenth (15th) Trading Day after the later of (x)&nbsp;the
later of (1)&nbsp;the date such Triggering Event is cured and (2)&nbsp;the date the Company delivers written notice to the Holders of
the cure of such Triggering Event and (y)&nbsp;such Holder&rsquo;s receipt of a Triggering Event Notice that includes (I)&nbsp;a reasonable
description of the applicable Triggering Event, (II)&nbsp;a certification as to whether, in the opinion of the Company, such Triggering
Event is capable of being cured and, if applicable, a reasonable description of any existing plans of the Company to cure such Triggering
Event and (III)&nbsp;a certification as to the date the Triggering Event occurred and, if cured on or prior to the date of such Triggering
Event Notice, the applicable Triggering Event Right Expiration Date, such Holder may require the Company to redeem (regardless of whether
such Triggering Event has been cured on or prior to the Triggering Event Right Expiration Date) all or any of the Preferred Shares by
delivering written notice thereof (the &ldquo;<B>Triggering Event Redemption Notice</B>&rdquo;) to the Company, which Triggering Event
Redemption Notice shall indicate the number of the Preferred Shares such Holder is electing to redeem. Each of the Preferred Shares subject
to redemption by the Company pursuant to this Section&nbsp;5(b)&nbsp;shall be redeemed by the Company at a price equal to the greater
of (i)&nbsp;the product of (A)&nbsp;the Conversion Amount to be redeemed multiplied by (B)&nbsp;the Redemption Premium and (ii)&nbsp;the
product of (X)&nbsp;the Conversion Rate with respect to the Conversion Amount in effect at such time as such Holder delivers a Triggering
Event Redemption Notice multiplied by (Y)&nbsp;the product of (1)&nbsp;the Redemption Premium multiplied by (2)&nbsp;the greatest Closing
Sale Price of the Common Stock on any Trading Day during the period commencing on the date immediately preceding such Triggering Event
and ending on the date the Company makes the entire payment required to be made under this Section&nbsp;5(b)&nbsp;(the &ldquo;<B>Triggering
Event Redemption Price</B>&rdquo;). Redemptions required by this Section&nbsp;5(b)&nbsp;shall be made in accordance with the provisions
of Section&nbsp;12. To the extent redemptions required by this Section&nbsp;5(b)&nbsp;are deemed or determined by a court of competent
jurisdiction to be prepayments of the Preferred Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding
anything to the contrary in this Section&nbsp;5(b), but subject to Section&nbsp;4(d), until the Triggering Event Redemption Price (together
with any Late Charges thereon) is paid in full, the Conversion Amount submitted for redemption under this Section&nbsp;5(b)&nbsp;(together
with any Late Charges thereon) may be converted, in whole or in part, by such Holder into Common Stock pursuant to the terms of this Certificate
of Designations. In the event of the Company&rsquo;s redemption of any of the Preferred Shares under this Section&nbsp;5(b), a Holder&rsquo;s
damages would be uncertain and difficult to estimate because of the parties&rsquo; inability to predict future interest rates and the
uncertainty of the availability of a suitable substitute investment opportunity for such Holder. Accordingly, any redemption premium due
under this Section&nbsp;5(b)&nbsp;is intended by the parties to be, and shall be deemed, a reasonable estimate of such Holder&rsquo;s
actual loss of its investment opportunity and not as a penalty. Any redemption upon a Triggering Event shall not constitute an election
of remedies by the applicable Holder or any other Holder, and all other rights and remedies of each Holder shall be preserved.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Mandatory
Redemption upon Bankruptcy Triggering Event</U>. Notwithstanding anything to the contrary herein, and notwithstanding any conversion that
is then required or in process, upon any Bankruptcy Triggering Event, whether occurring prior to or following the Maturity Date, the Company
shall immediately redeem, out of funds legally available therefor, each of the Preferred Shares then outstanding at a redemption price
equal to the applicable Triggering Event Redemption Price (calculated as if such Holder shall have delivered the Triggering Event Redemption
Notice immediately prior to the occurrence of such Bankruptcy Triggering Event), without the requirement for any notice or demand or other
action by any Holder or any other person or entity, provided that a Holder may, in its sole discretion, waive such right to receive payment
upon a Bankruptcy Triggering Event, in whole or in part, and any such waiver shall not affect any other rights of such Holder or any other
Holder hereunder, including any other rights in respect of such Bankruptcy Triggering Event, any right to conversion, and any right to
payment of such Triggering Event Redemption Price or any other Redemption Price, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6. <U>Rights Upon Fundamental
Transactions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Assumption</U>.
The Company shall not enter into or be party to a Fundamental Transaction unless (i)&nbsp;the Successor Entity (if the Successor Entity
is not the Company) assumes in writing all of the obligations of the Company under this Certificate of Designations and the other Transaction
Documents in accordance with the provisions of this Section&nbsp;6(a)&nbsp;pursuant to written agreements in form and substance satisfactory
to the Required Holders and approved by the Required Holders prior to such Fundamental Transaction, including agreements to deliver to
each holder of Preferred Shares in exchange for such Preferred Shares a security of the Successor Entity evidenced by a written instrument
substantially similar in form and substance to this Certificate of Designations, including, without limitation, having a stated value
and dividend rate equal to the stated value and dividend rate of the Preferred Shares held by the Holders and having similar ranking to
the Preferred Shares, and satisfactory to the Required Holders and (ii)&nbsp;the Successor Entity (including its Parent Entity) is a publicly
traded corporation whose shares of common stock are quoted on or listed for trading on an Eligible Market. Upon the occurrence of any
Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental
Transaction, the provisions of this Certificate of Designations and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Certificate of Designations and the other Transaction Documents with the same effect as if such Successor Entity
had been named as the Company herein and therein. In addition to the foregoing, upon consummation of a Fundamental Transaction, the Successor
Entity (if the Successor Entity is not the Company) shall deliver to each Holder confirmation that there shall be issued upon conversion
or redemption of the Preferred Shares at any time after the consummation of such Fundamental Transaction, in lieu of the shares of Common
Stock (or other securities, cash, assets or other property (except such items still issuable under Sections 7 and 17, which shall continue
to be receivable thereafter)) issuable upon the conversion or redemption of the Preferred Shares prior to such Fundamental Transaction,
such shares of the publicly traded common stock (or their equivalent) of the Successor Entity (including its Parent Entity) which each
Holder would have been entitled to receive upon the happening of such Fundamental Transaction had all the Preferred Shares held by each
Holder been converted immediately prior to such Fundamental Transaction (without regard to any limitations on the conversion of the Preferred
Shares contained in this Certificate of Designations), as adjusted in accordance with the provisions of this Certificate of Designations.
Notwithstanding the foregoing, such Holder may elect, at its sole option, by delivery of written notice to the Company to waive this Section&nbsp;6(a)&nbsp;to
permit the Fundamental Transaction without the assumption of the Preferred Shares. The provisions of this Section&nbsp;6 shall apply similarly
and equally to successive Fundamental Transactions and shall be applied without regard to any limitations on the conversion or redemption
of the Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Notice
of a Change of Control Redemption Right</U>. No sooner than (i)&nbsp;in the case of a Change of Control, twenty (20) Trading Days nor
later than ten (10)&nbsp;Trading Days prior to the consummation of a Change of Control or (ii)&nbsp;in the case of an Involuntary Change
of Control, as such date as reasonably practicable prior to the consummation of an Involuntary Change of Control (in each case, the &ldquo;<B>Change
of Control Date</B>&rdquo;), but not prior to the public announcement of such Change of Control or Involuntary Change of Control, as applicable,
the Company shall deliver written notice thereof via electronic mail and overnight courier to each Holder (a &ldquo;<B>Change of Control
Notice</B>&rdquo;). At any time during the period beginning after a Holder&rsquo;s receipt of a Change of Control Notice or such Holder
becoming aware of a Change of Control or an Involuntary Change of Control, as applicable, if a Change of Control Notice is not delivered
to such Holder in accordance with the immediately preceding sentence (as applicable) and ending on the later of (A)&nbsp;the date of consummation
of such Change of Control or Involuntary Change of Control, as applicable, or (B)&nbsp;twenty (20) Trading Days after the date of receipt
of such Change of Control Notice or (C)&nbsp;twenty (20) Trading Days after the date of the announcement of such Change of Control or
Involuntary Change of Control, as applicable, such Holder may require the Company to redeem all or any portion of such Holder&rsquo;s
Preferred Shares by delivering written notice thereof (&ldquo;<B>Change of Control Redemption Notice</B>&rdquo;) to the Company, which
Change of Control Redemption Notice shall indicate the number of Preferred Shares such Holder is electing to have the Company redeem.
Each Preferred Share subject to redemption pursuant to this Section&nbsp;6(b)&nbsp;shall be redeemed by the Company in funds legally available
therefor at a price equal to the greatest of (i)&nbsp;the product of (w)&nbsp;the applicable Change of Control Redemption Premium multiplied
by (y)&nbsp;the Conversion Amount of the Preferred Shares being redeemed, (ii)&nbsp;the product of (x)&nbsp;the applicable Change of Control
Redemption Premium multiplied by (y)&nbsp;the product of (A)&nbsp;the Conversion Amount of the Preferred Shares being redeemed multiplied
by (B)&nbsp;the quotient determined by dividing (I)&nbsp;the greatest Closing Sale Price of the shares of Common Stock during the period
beginning on the date immediately preceding the earlier to occur of (1)&nbsp;the consummation of the applicable Change of Control or Involuntary
Change of Control and (2)&nbsp;the public announcement of such Change of Control or Involuntary Change of Control, as applicable, and
ending on the date such Holder delivers the Change of Control Redemption Notice by (II)&nbsp;the Conversion Price then in effect and (iii)&nbsp;the
product of (y)&nbsp;the applicable Change of Control Redemption Premium multiplied by (z)&nbsp;the product of (A)&nbsp;the Conversion
Amount of the Preferred Shares being redeemed multiplied by (B)&nbsp;the quotient of (I)&nbsp;the aggregate cash consideration and the
aggregate cash value of any non-cash consideration per share of Common Stock to be paid to such holders of the shares of Common Stock
upon consummation of such Change of Control or Involuntary Change of Control, as applicable (any such non-cash consideration constituting
publicly-traded securities shall be valued at the highest of the Closing Sale Price of such securities as of the Trading Day immediately
prior to the consummation of such Change of Control or Involuntary Change of Control, as applicable, the Closing Sale Price of such securities
on the Trading Day immediately following the public announcement of such proposed Change of Control or Involuntary Change of Control,
as applicable, and the Closing Sale Price of such securities on the Trading Day immediately prior to the public announcement of such proposed
Change of Control or Involuntary Change of Control, as applicable) divided by (II)&nbsp;the Conversion Price then in effect (the &ldquo;<B>Change
of Control Redemption Price</B>&rdquo;). Redemptions required by this Section&nbsp;6(b)&nbsp;shall have priority to payments to all other
stockholders of the Company in connection with such Change of Control or Involuntary Change of Control, as applicable. To the extent redemptions
required by this Section&nbsp;6(b)&nbsp;are deemed or determined by a court of competent jurisdiction to be prepayments of the Preferred
Shares by the Company, such redemptions shall be deemed to be voluntary prepayments. Notwithstanding anything to the contrary in this
Section&nbsp;6(b), but subject to Section&nbsp;4(d), until the applicable Change of Control Redemption Price (together with any Late Charges
thereon) is paid in full to the applicable Holder, the Preferred Shares submitted by such Holder for redemption under this Section&nbsp;6(b)&nbsp;may
be converted, in whole or in part, by such Holder into Common Stock pursuant to Section&nbsp;4 or in the event the Conversion Date is
after the consummation of such Change of Control or Involuntary Change of Control, as applicable, stock or equity interests of the Successor
Entity substantially equivalent to the Company&rsquo;s shares of Common Stock pursuant to Section&nbsp;4. In the event of the Company&rsquo;s
redemption of any of the Preferred Shares under this Section&nbsp;6(b), such Holder&rsquo;s damages would be uncertain and difficult to
estimate because of the parties&rsquo; inability to predict future interest rates and the uncertainty of the availability of a suitable
substitute investment opportunity for a Holder. Accordingly, any redemption premium due under this Section&nbsp;6(b)&nbsp;is intended
by the parties to be, and shall be deemed, a reasonable estimate of such Holder&rsquo;s actual loss of its investment opportunity and
not as a penalty. The Company shall make payment of the applicable Change of Control Redemption Price concurrently with the consummation
of such Change of Control or Involuntary Change of Control, as applicable, if a Change of Control Redemption Notice is received prior
to the consummation of such Change of Control or Involuntary Change of Control, as applicable, and within two (2)&nbsp;Trading Days after
the Company&rsquo;s receipt of such notice otherwise (the &ldquo;<B>Change of Control Redemption Date</B>&rdquo;). Redemptions required
by this Section&nbsp;6 shall be made in accordance with the provisions of Section&nbsp;12.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7. <U>Rights Upon Issuance of
Purchase Rights and Other Corporate Events</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Purchase
Rights</U>. In addition to any adjustments pursuant to Section&nbsp;8 and Section&nbsp;17 below, if at any time the Company grants, issues
or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to all or substantially
all of the record holders of any class of Common Stock (the &ldquo;<B>Purchase Rights</B>&rdquo;), then each Holder will be entitled to
acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which such Holder could have acquired if such
Holder had held the number of shares of Common Stock acquirable upon complete conversion of all the Preferred Shares (without taking into
account any limitations or restrictions on the convertibility of the Preferred Shares and assuming for such purpose that all the Preferred
Shares were converted at the Alternate Conversion Price as of the applicable record date) held by such Holder immediately prior to the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of
which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, to the extent that such Holder&rsquo;s right to participate in any such Purchase Right would result in such Holder and the other
Attribution Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Purchase Right to
such extent of the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of
such Purchase Right (and beneficial ownership) to such extent of any such excess) and such Purchase Right to such extent shall be held
in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision, such term shall be extended
by such number of days held in abeyance, if applicable) for the benefit of such Holder until such time or times, if ever, as its right
thereto would not result in such Holder and the other Attribution Parties exceeding the Maximum Percentage, at which time or times such
Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase Right or on any subsequent
Purchase Right held similarly in abeyance (and, if such Purchase Right has an expiration date, maturity date or other similar provision,
such term shall be extended by such number of days held in abeyance, if applicable)) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Other
Corporate Events</U>. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental
Transaction pursuant to which holders of shares of Common Stock are entitled to receive securities or other assets with respect to or
in exchange for shares of Common Stock (a &ldquo;<B>Corporate Event</B>&rdquo;), the Company shall make appropriate provision to ensure
that each Holder will thereafter have the right, at such Holder&rsquo;s option, to receive upon a conversion of all the Preferred Shares
held by such Holder (i)&nbsp;in addition to the shares of Common Stock receivable upon such conversion, such securities or other assets
to which such Holder would have been entitled with respect to such shares of Common Stock had such shares of Common Stock been held by
such Holder upon the consummation of such Corporate Event (without taking into account any limitations or restrictions on the convertibility
of the Preferred Shares set forth in this Certificate of Designations) or (ii)&nbsp;in lieu of the shares of Common Stock otherwise receivable
upon such conversion, such securities or other assets received by the holders of shares of Common Stock in connection with the consummation
of such Corporate Event in such amounts as such Holder would have been entitled to receive had the Preferred Shares held by such Holder
initially been issued with conversion rights for the form of such consideration (as opposed to shares of Common Stock) at a conversion
rate for such consideration commensurate with the Conversion Rate. Provision made pursuant the preceding sentence shall be in a form and
substance satisfactory to the Required Holders. The provisions of this Section&nbsp;7 shall apply similarly and equally to successive
Corporate Events and shall be applied without regard to any limitations on the conversion or redemption of the Preferred Shares set forth
in this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">8. <U>Rights Upon Issuance of
Other Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Adjustment
of Conversion Price upon Issuance of Common Stock</U>. If and whenever on or after the Subscription Date the Company grants, issues or
sells (or enters into any agreement or publicly announces its intention to grant, issue or sell), or in accordance with this Section&nbsp;8(a)&nbsp;is
deemed to have granted, issued or sold, any shares of Common Stock (including the granting, issuance or sale of shares of Common Stock
owned or held by or for the account of the Company, but excluding any Excluded Securities granted, issued or sold or deemed to have been
granted, issued or sold) for a consideration per share (the &ldquo;<B>New Issuance Price</B>&rdquo;) less than a price equal to the Conversion
Price in effect immediately prior to such granting, issuance or sale or deemed granting, issuance or sale (such Conversion Price then
in effect is referred to herein as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive Issuance</B>&rdquo;),
then, immediately after such Dilutive Issuance, the Conversion Price then in effect shall be reduced to an amount equal to the New Issuance
Price. For all purposes of the foregoing (including, without limitation, determining the adjusted Conversion Price and the New Issuance
Price under this Section&nbsp;8(a)), the following shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Issuance
of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options
and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon
conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the
terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the granting, issuance or sale of such Option for such price per share. For purposes of this Section&nbsp;8(a)(i),
the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or
upon conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to
the terms thereof&rdquo; shall be equal to (1)&nbsp;the lower of (x)&nbsp;the sum of the lowest amounts of consideration (if any) received
or receivable by the Company with respect to any one share of Common Stock upon the granting, issuance or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option or otherwise
pursuant to the terms thereof and (y)&nbsp;the lowest exercise price set forth in such Option for which one share of Common Stock is issuable
(or may become issuable assuming all possible market conditions) upon the exercise of any such Options or upon conversion, exercise or
exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof, minus (2)&nbsp;the
sum of all amounts paid or payable to the holder of such Option (or any other Person) with respect to any one share of Common Stock upon
the granting, issuance or sale of such Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible
Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus the value of any other consideration received
or receivable by, or benefit conferred on, the holder of such Option (or any other Person). Except as contemplated below, no further adjustment
of the Conversion Price shall be made upon the actual issuance of such share of Common Stock or of such Convertible Securities upon the
exercise of such Options or otherwise pursuant to the terms thereof or upon the actual issuance of such shares of Common Stock upon conversion,
exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Issuance
of Convertible Securities</U>. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Convertible
Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or
exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be
deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution
of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes of this Section&nbsp;8(a)(ii),
the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or exchange
thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1)&nbsp;the lower of (x)&nbsp;the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance or sale (or
pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange of such
Convertible Security or otherwise pursuant to the terms thereof and (y)&nbsp;the lowest conversion price set forth in such Convertible
Security for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion,
exercise or exchange thereof or otherwise pursuant to the terms thereof minus (2)&nbsp;the sum of all amounts paid or payable to the holder
of such Convertible Security (or any other Person) with respect to any one share of Common Stock upon the issuance or sale (or the agreement
to issue or sell, as applicable) of such Convertible Security plus the value of any other consideration received or receivable by, or
benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment
of the Conversion Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of
such Convertible Securities or otherwise pursuant to the terms thereof, and if any such issuance or sale of such Convertible Securities
is made upon exercise of any Options for which adjustment of the Conversion Price has been or is to be made pursuant to other provisions
of this Section&nbsp;8(a), except as contemplated below, no further adjustment of the Conversion Price shall be made by reason of such
issuance or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Change
in Option Price or Rate of Conversion</U>. If the purchase or exercise price provided for in any Options, the additional consideration,
if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate at which any Convertible Securities
are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases at any time (other than proportional
changes in conversion or exercise prices, as applicable, in connection with an event referred to in Section&nbsp;8(b)&nbsp;below), the
Conversion Price in effect at the time of such increase or decrease shall be adjusted to the Conversion Price which would have been in
effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional consideration
or increased or decreased conversion rate (as the case may be) at the time initially granted, issued or sold. For purposes of this Section&nbsp;8(a)(iii),
if the terms of any Option or Convertible Security (including, without limitation, any Option or Convertible Security that was outstanding
as of the Subscription Date) are increased or decreased in the manner described in the immediately preceding sentence, then such Option
or Convertible Security and the shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to
have been issued as of the date of such increase or decrease. No adjustment pursuant to this Section&nbsp;8(a)&nbsp;shall be made if such
adjustment would result in an increase of the Conversion Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;<U>Calculation
of Consideration Received</U>. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company (as determined by the Required Holders, the &ldquo;<B>Primary
Security</B>&rdquo;, and such Option and/or Convertible Security and/or Adjustment Right, the &ldquo;<B>Secondary Securities</B>&rdquo;
and together with the Primary Security, each a &ldquo;<B>Unit</B>&rdquo;), together comprising one integrated transaction, the aggregate
consideration per share of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x)&nbsp;the purchase
price of such Unit, (y)&nbsp;if such Primary Security is an Option and/or Convertible Security, the lowest price per share for which one
share of Common Stock is at any time issuable upon the exercise or conversion of the Primary Security in accordance with Section&nbsp;8(a)(i)&nbsp;or
8(a)(ii)&nbsp;above and (z)&nbsp;the lowest VWAP of the shares of Common Stock on any Trading Day during the five (5)&nbsp;Trading Day
period (the &ldquo;<B>Adjustment Period</B>&rdquo;) immediately following the public announcement of such Dilutive Issuance (for the avoidance
of doubt, if such public announcement is released prior to the opening of the Principal Market on a Trading Day, such Trading Day shall
be the first Trading Day in such five Trading Day period and if any Preferred Shares are converted, on any given Conversion Date during
any such Adjustment Period, solely with respect to such Preferred Shares converted on such applicable Conversion Date, such applicable
Adjustment Period shall be deemed to have ended on, and included, the Trading Day immediately prior to such Conversion Date). If any shares
of Common Stock, Options or Convertible Securities are issued or sold or deemed to have been issued or sold for cash, the consideration
received therefor will be deemed to be the net amount of consideration received by the Company therefor. If any shares of Common Stock,
Options or Convertible Securities are issued or sold for a consideration other than cash, the amount of such consideration received by
the Company will be the fair value of such consideration, except where such consideration consists of publicly traded securities, in which
case the amount of consideration received by the Company for such securities will be the arithmetic average of the VWAPs of such security
for each of the five (5)&nbsp;Trading Days immediately preceding the date of receipt. If any shares of Common Stock, Options or Convertible
Securities are issued to the owners of the non-surviving entity in connection with any merger in which the Company is the surviving entity,
the amount of consideration therefor will be deemed to be the fair value of such portion of the net assets and business of the non-surviving
entity as is attributable to such shares of Common Stock, Options or Convertible Securities (as the case may be). The fair value of any
consideration other than cash or publicly traded securities will be determined jointly by the Company and the Required Holders. If such
parties are unable to reach agreement within ten (10)&nbsp;days after the occurrence of an event requiring valuation (the &ldquo;<B>Valuation
Event</B>&rdquo;), the fair value of such consideration will be determined within five (5)&nbsp;Trading Days after the tenth (10<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>)
day following such Valuation Event by an independent, reputable appraiser jointly selected by the Company and the Required Holders. The
determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and expenses of such appraiser
shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Record
Date</U>. If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A)&nbsp;to receive
a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B)&nbsp;to subscribe for
or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance
or sale of the shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other
distribution or the date of the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Adjustment
of Conversion Price upon Subdivision or Combination of Common Stock</U>. Without limiting any provision of Sections 7, 17 or 8(a), if
the Company at any time on or after the Subscription Date subdivides (by any stock split, stock dividend, stock combination, recapitalization
or other similar transaction) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Conversion
Price in effect immediately prior to such subdivision will be proportionately reduced. Without limiting any provision of Sections 7, 17
or 8(a), if the Company at any time on or after the Subscription Date combines (by any stock split, stock dividend, stock combination,
recapitalization or other similar transaction) one or more classes of its outstanding shares of Common Stock into a smaller number of
shares, the Conversion Price in effect immediately prior to such combination will be proportionately increased. Any adjustment pursuant
to this Section&nbsp;8(b)&nbsp;shall become effective immediately after the effective date of such subdivision or combination. If any
event requiring an adjustment under this Section&nbsp;8(b)&nbsp;occurs during the period that a Conversion Price is calculated hereunder,
then the calculation of such Conversion Price shall be adjusted appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Holder&rsquo;s
Right of Adjusted Conversion Price</U>. In addition to and not in limitation of the other provisions of this Section&nbsp;8(b), if the
Company in any manner issues or sells or enters into any agreement to issue or sell, any Common Stock, Options or Convertible Securities
(any such securities, &ldquo;<B>Variable Price Securities</B>&rdquo;) after the Subscription Date that are issuable pursuant to such agreement
or convertible into or exchangeable or exercisable for shares of Common Stock at a price which varies or may vary with the market price
of the shares of Common Stock, including by way of one or more reset(s)&nbsp;to a fixed price, but exclusive of such formulations reflecting
customary anti-dilution provisions (such as share splits, share combinations, share dividends and similar transactions) (each of the formulations
for such variable price being herein referred to as, the &ldquo;<B>Variable Price</B>&rdquo;), the Company shall provide written notice
thereof via electronic mail and overnight courier to each Holder on the date of such agreement and/or the issuance of such shares of Common
Stock, Convertible Securities or Options, as applicable. From and after the date the Company enters into such agreement or issues any
such Variable Price Securities, each Holder shall have the right, but not the obligation, in its sole discretion to substitute the Variable
Price for the Conversion Price upon conversion of the Preferred Shares by designating in the Conversion Notice delivered upon any conversion
of Preferred Shares that solely for purposes of such conversion such Holder is relying on the Variable Price rather than the Conversion
Price then in effect. A Holder&rsquo;s election to rely on a Variable Price for a particular conversion of Preferred Shares shall not
obligate such Holder to rely on a Variable Price for any future conversions of Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Stock
Combination Event Adjustments</U>. If at any time and from time to time on or after the Subscription Date there occurs any stock split,
stock dividend, stock combination, reverse stock split, recapitalization or other similar transaction involving the Common Stock (each,
a &ldquo;<B>Stock Combination Event</B>&rdquo;, and such date thereof, the &ldquo;<B>Stock Combination Event Date</B>&rdquo;) and the
Event Market Price is less than the Conversion Price then in effect (after giving effect to the adjustment in Section&nbsp;8(b)&nbsp;above),
then on the fifth (5th) Trading Day immediately following such Stock Combination Event Date, the Conversion Price then in effect on such
fifth (5th) Trading Day following the Stock Combination Event (after giving effect to the adjustment in Section&nbsp;8(b)&nbsp;above)
shall be reduced (but in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately
preceding sentence would otherwise result in an increase in the Conversion Price hereunder, no adjustment shall be made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Other
Events</U>. In the event that the Company (or any Subsidiary) shall take any action to which the provisions hereof are not strictly applicable,
or, if applicable, would not operate to protect any Holder from dilution or if any event occurs of the type contemplated by the provisions
of this Section&nbsp;8 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation
rights, phantom stock rights or other rights with equity features), then the Board shall in good faith determine and implement an appropriate
adjustment in the Conversion Price so as to protect the rights of such Holder, provided that no such adjustment pursuant to this Section&nbsp;8(e)&nbsp;will
increase the Conversion Price as otherwise determined pursuant to this Section&nbsp;8, provided further that if such Holder does not accept
such adjustments as appropriately protecting its interests hereunder against such dilution, then the Board and such Holder shall agree,
in good faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments, whose determination
shall be final and binding absent manifest error and whose fees and expenses shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Calculations</U>.
All calculations under this Section&nbsp;8 shall be made by rounding to the nearest cent or the nearest 1/100<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>
of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by
or for the account of the Company, and the disposition of any such shares shall be considered an issue or sale of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Voluntary
Adjustment by Company</U>. Subject to the rules&nbsp;and regulations of the Principal Market, the Company may at any time any Preferred
Shares remain outstanding, with the prior written consent of the Required Holders, reduce the then current Conversion Price to any amount
and for any period of time deemed appropriate by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9. [<U>Reserved</U>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10. <U>Noncircumvention</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation, Bylaws (as defined
in the Securities Purchase Agreement) or through any reorganization, transfer of assets, consolidation, merger, scheme of arrangement,
dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance of any of
the terms of this Certificate of Designations, and will at all times in good faith carry out all the provisions of this Certificate of
Designations and take all action as may be required to protect the rights of the Holders hereunder. Without limiting the generality of
the foregoing or any other provision of this Certificate of Designations or the other Transaction Documents, the Company (a)&nbsp;shall
not increase the par value of any shares of Common Stock receivable upon the conversion of any Preferred Shares above the Conversion Price
then in effect, (b)&nbsp;shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally
issue fully paid and non-assessable shares of Common Stock upon the conversion of Preferred Shares and (c)&nbsp;shall, so long as any
Preferred Shares are outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares of
Common Stock, solely for the purpose of effecting the conversion of the Preferred Shares, the maximum number of shares of Common Stock
as shall from time to time be necessary to effect the conversion of the Preferred Shares then outstanding (without regard to any limitations
on conversion contained herein). Notwithstanding anything herein to the contrary, if after the sixty (60) calendar day anniversary of
the Initial Issuance Date, each Holder is not permitted to convert such Holder&rsquo;s Preferred Shares in full for any reason (other
than pursuant to restrictions set forth in Section&nbsp;4(d)(i)&nbsp;hereof), the Company shall use its best efforts to promptly remedy
such failure, including, without limitation, obtaining such consents or approvals as necessary to effect such conversion into shares of
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11. <U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Reservation</U>.
So long as any Preferred Shares remain outstanding, the Company shall at all times reserve out of its authorized and unissued Common Stock
a number of shares of Common Stock equal to at least 150% of the aggregate number of shares of Common Stock as shall from time to time
be necessary to effect the conversion, including without limitation, Alternate Conversions, of all of the Preferred Shares then outstanding
at the Floor Price then in effect (without regard to any limitations on conversions and assuming the Preferred Shares remain outstanding
until the Maturity Date) (the &ldquo;<B>Required Reserve Amount</B>&rdquo;). The Required Reserve Amount (including, without limitation,
each increase in the number of shares so reserved) shall be allocated pro rata among the Holders based on the number of the Preferred
Shares held by each Holder on the Initial Issuance Date or increase in the number of reserved shares, as the case may be (the &ldquo;<B>Authorized
Share Allocation</B>&rdquo;). In the event that a Holder shall sell or otherwise transfer any of such Holder&rsquo;s Preferred Shares,
each transferee shall be allocated a pro rata portion of such Holder&rsquo;s Authorized Share Allocation. Any shares of Common Stock reserved
and allocated to any Person which ceases to hold any Preferred Shares shall be allocated to the remaining Holders of Preferred Shares,
pro rata based on the number of the Preferred Shares then held by the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Insufficient
Authorized Shares</U>. If, notwithstanding Section&nbsp;11(a)&nbsp;and not in limitation thereof, at any time while any of the Preferred
Shares remain outstanding the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy
its obligation to reserve for issuance upon conversion of the Preferred Shares at least a number of shares of Common Stock equal to the
Required Reserve Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall immediately take all action necessary
to increase the Company&rsquo;s authorized shares of Common Stock to an amount sufficient to allow the Company to reserve the Required
Reserve Amount for the Preferred Shares then outstanding (or deemed outstanding pursuant to Section&nbsp;11(a)&nbsp;above). Without limiting
the generality of the foregoing sentence, as soon as practicable after the date of the occurrence of an Authorized Share Failure, but
in no event later than sixty (60) days after the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its
stockholders for the approval of an increase in the number of authorized shares of Common Stock. In connection with such meeting, the
Company shall provide each stockholder with a proxy statement and shall use its best efforts to solicit its stockholders&rsquo; approval
of such increase in authorized shares of Common Stock and to cause its board of directors to recommend to the stockholders that they approve
such proposal (or, if a majority of the voting power then in effect of the capital stock of the Company consents to such increase, in
lieu of such proxy statement, deliver to the stockholders of the Company an information statement that has been filed with (and either
approved by or not subject to comments from) the SEC with respect thereto). In the event that the Company is prohibited from issuing shares
of Common Stock to a Holder upon any conversion due to the failure by the Company to have sufficient shares of Common Stock available
out of the authorized but unissued shares of Common Stock (such unavailable number of shares of Common Stock, the &ldquo;<B>Authorized
Failure Shares</B>&rdquo;), in lieu of delivering such Authorized Failure Shares to such Holder, the Company shall pay legally available
funds in exchange for the redemption of such portion of the Conversion Amount of the Preferred Shares convertible into such Authorized
Failure Shares at a price equal to the sum of (i)&nbsp;the product of (x)&nbsp;such number of Authorized Failure Shares and (y)&nbsp;the
greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date such Holder delivers the applicable
Conversion Notice with respect to such Authorized Failure Shares to the Company and ending on the date of such issuance and payment under
this Section&nbsp;11(a); and (ii)&nbsp;to the extent such Holder purchases (in an open market transaction or otherwise) shares of Common
Stock to deliver in satisfaction of a sale by such Holder of Authorized Failure Shares, any brokerage commissions and other out-of-pocket
expenses, if any, of such Holder incurred in connection therewith. Nothing contained in Section&nbsp;11(a)&nbsp;or this Section&nbsp;11(b)&nbsp;shall
limit any obligations of the Company under any provision of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12. <U>Redemptions.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>General</U>.
If a Holder has submitted a Triggering Event Redemption Notice in accordance with Section&nbsp;5(b), the Company shall deliver the applicable
Triggering Event Redemption Price to such Holder in legally available funds within five (5)&nbsp;Business Days after the Company&rsquo;s
receipt of such Holder&rsquo;s Triggering Event Redemption Notice. If a Holder has submitted a Change of Control Redemption Notice in
accordance with Section&nbsp;6(b), the Company shall deliver the applicable Change of Control Redemption Price to such Holder in legally
available funds concurrently with the consummation of such Change of Control or Involuntary Change of Control, as applicable, if such
notice is received prior to the consummation of such Change of Control or Involuntary Change of Control, as applicable, and within five
(5)&nbsp;Business Days after the Company&rsquo;s receipt of such notice otherwise. Notwithstanding anything herein to the contrary, in
connection with any redemption hereunder at a time a Holder is entitled to receive a cash payment under any of the other Transaction Documents,
at the option of such Holder delivered in writing to the Company, the applicable Redemption Price hereunder shall be increased by the
amount of such cash payment owed to such Holder under such other Transaction Document and, upon payment in full or conversion in accordance
herewith, shall satisfy the Company&rsquo;s payment obligation under such other Transaction Document. In the event of a redemption of
less than all of the Preferred Shares, the Company shall promptly cause to be issued and delivered to such Holder a new Preferred Share
Certificate (in accordance with Section&nbsp;20) (or evidence of the creation of a new Book-Entry) representing the number of Preferred
Shares which have not been redeemed. In the event that the Company does not pay the applicable Redemption Price to a Holder within the
time period required for any reason (including, without limitation, to the extent such payment is prohibited pursuant to the DGCL), at
any time thereafter and until the Company pays such unpaid Redemption Price in full, such Holder shall have the option, in lieu of redemption,
to require the Company to promptly return to such Holder all or any of the Preferred Shares that were submitted for redemption and for
which the applicable Redemption Price (together with any Late Charges thereon) has not been paid. Upon the Company&rsquo;s receipt of
such notice, (x)&nbsp;the applicable Redemption Notice shall be null and void with respect to such Preferred Shares, (y)&nbsp;the Company
shall immediately return the applicable Preferred Share Certificate, or issue a new Preferred Share Certificate (in accordance with Section&nbsp;20(d)),
to such Holder (unless the Preferred Shares are held in Book-Entry form, in which case the Company shall deliver evidence to such Holder
that a Book-Entry for such Preferred Shares then exists), and in each case the Additional Amount of such Preferred Shares shall be increased
by an amount equal to the difference between (1)&nbsp;the applicable Redemption Price (as the case may be, and as adjusted pursuant to
this Section&nbsp;12, if applicable) minus (2)&nbsp;the Stated Value portion of the Conversion Amount submitted for redemption and (z)&nbsp;the
Conversion Price of such Preferred Shares shall be automatically adjusted with respect to each conversion effected thereafter by such
Holder to the lowest of (A)&nbsp;the Conversion Price as in effect on the date on which the applicable Redemption Notice is voided, (B)&nbsp;the
greater of (x)&nbsp;the Floor Price and (y)&nbsp;75% of the lowest Closing Bid Price of the Common Stock during the period beginning on
and including the date on which the applicable Redemption Notice is delivered to the Company and ending on and including the date on which
the applicable Redemption Notice is voided and (C)&nbsp;the greater of (x)&nbsp;the Floor Price and (y)&nbsp;75% of the quotient of (I)&nbsp;the
sum of the five (5)&nbsp;lowest VWAPs of the Common Stock during the twenty (20) consecutive Trading Day period ending and including the
Trading Day immediately preceding the applicable Conversion Date divided by (II)&nbsp;five (5)&nbsp;(it being understood and agreed that
all such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction
during such period). A Holder&rsquo;s delivery of a notice voiding a Redemption Notice and exercise of its rights following such notice
shall not affect the Company&rsquo;s obligations to make any payments of Late Charges which have accrued prior to the date of such notice
with respect to the Preferred Shares subject to such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Redemption
by Multiple Holders</U>. Upon the Company&rsquo;s receipt of a Redemption Notice from any Holder for redemption or repayment as a result
of an event or occurrence substantially similar to the events or occurrences described in Section&nbsp;5(b)&nbsp;or Section&nbsp;6(b),
the Company shall immediately, but no later than one (1)&nbsp;Business Day of its receipt thereof, forward to each other Holder by electronic
mail a copy of such notice. If the Company receives one or more Redemption Notices, during the seven (7)&nbsp;Business Day period beginning
on and including the date which is two (2)&nbsp;Business Days prior to the Company&rsquo;s receipt of the initial Redemption Notice and
ending on and including the date which is two (2)&nbsp;Business Days after the Company&rsquo;s receipt of the initial Redemption Notice
and the Company is unable to redeem all of the Conversion Amount of such Preferred Shares designated in such initial Redemption Notice
and such other Redemption Notices received during such seven (7)&nbsp;Business Day period, then the Company shall redeem a pro rata amount
from each Holder based on the Stated Value of the Preferred Shares submitted for redemption pursuant to such Redemption Notices received
by the Company during such seven (7)&nbsp;Business Day period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13. <U>[Reserved]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14. <U>Voting Rights</U>.
Except as otherwise provided herein or as required by applicable law and subject to the provisions of Section 4(d) hereof, Holders of
Preferred Shares shall be entitled to vote with the holders of Common Stock on all matters that such holders of Common Stock are entitled
to vote upon, in the same manner and with the same effect as the holders of Common Stock, voting together with the holders of Common Stock
as a single class. Subject to the provisions of Section 4(d) hereof, each Preferred Share shall entitle the Holder thereof to cast that
number of votes per Preferred Share as is equal to the Stated Value of such Preferred Share divided by the then applicable Conversion
Price; provided, however that in no event shall the then applicable Conversion Price for purposes of this Section 14 be less than the
 &ldquo;Minimum Price&rdquo; (as defined in Nasdaq Listing Rule 5635(d)) on the date immediately preceding the Subscription Date (or $7.31
per share, as of the date of this Certificate of Designations, and subject to adjustments for any stock splits, stock dividends, stock
combinations, recapitalizations or other similar transactions following the Subscription Date). For purposes of clarity, this Nasdaq Minimum
Price shall apply only for purposes of this Section 14 of the Certificate of Designations and not apply to any other section of the Certificate
of Designations or any Transaction Document. Notwithstanding the foregoing, to the extent that under the DGCL the vote of the holders
of the Preferred Shares, voting separately as a class or series, as applicable, is required to authorize a given action of the Company,
the affirmative vote or consent of the Required Holders of the shares of the Preferred Shares, voting together in the aggregate and not
in separate series unless required under the DGCL, represented at a duly held meeting at which a quorum is present or by written consent
of the Required Holders (except as otherwise may be required under the DGCL), voting together in the aggregate and not in separate series
unless required under the DGCL, shall constitute the approval of such action by both the class or the series, as applicable. For the avoidance
of doubt, for purposes of determining the presence of a quorum at any meeting of the stockholders of the Company at which the Preferred
Shares are entitled to vote, the number of Preferred Shares and votes represented by such shares shall be counted on an as converted to
Common Stock basis, subject to any limitations on conversion set forth herein. Holders of the Preferred Shares shall be entitled to written
notice of all stockholder meetings or written consents (and copies of proxy materials and other information sent to stockholders) with
respect to which they would be entitled to vote, which notice would be provided pursuant to the Company&rsquo;s bylaws and the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15. <U>Covenants</U>. For
so long as any Preferred Shares are outstanding, without the prior written consent of the Required Holders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Incurrence
of Indebtedness</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, incur
or guarantee, assume or suffer to exist any Indebtedness (other than Permitted Indebtedness).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Existence
of Liens</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, allow or suffer
to exist any mortgage, lien, pledge, charge, security interest or other encumbrance upon or in any property or assets (including accounts
and contract rights) owned by the Company or any of its Subsidiaries (collectively, &ldquo;<B>Liens</B>&rdquo;) other than Permitted Liens.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Restricted
Payments and Investments</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
redeem, defease, repurchase, repay or make any payments in respect of, by the payment of cash or cash equivalents (in whole or in part,
whether by way of open market purchases, tender offers, private transactions or otherwise), all or any portion of any Indebtedness (other
pursuant to this Certificate of Designations) whether by way of payment in respect of principal of (or premium, if any) or interest on,
such Indebtedness or make any Investment, as applicable, if at the time such payment with respect to such Indebtedness and/or Investment,
as applicable, is due or is otherwise made or, after giving effect to such payment, (i)&nbsp;an event constituting a Triggering Event
has occurred and is continuing or (ii)&nbsp;an event that with the passage of time and without being cured would constitute a Triggering
Event has occurred and is continuing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Restriction
on Redemption and Cash Dividends</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or
indirectly, redeem, repurchase or declare or pay any cash dividend or distribution on any of its capital stock (other than as required
by this Certificate of Designations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Restriction
on Transfer of Assets</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly,
sell, lease, license, assign, transfer, spin-off, split-off, close, convey or otherwise dispose of any assets or rights of the Company
or any Subsidiary owned or hereafter acquired whether in a single transaction or a series of related transactions, other than (i)&nbsp;sales,
leases, licenses, assignments, transfers, conveyances and other dispositions of such assets or rights by the Company and its Subsidiaries
in the ordinary course of business consistent with its past practice, or (ii)&nbsp;sales of inventory and product in the ordinary course
of business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Maturity
of Indebtedness</U>. The Company shall not, and the Company shall cause each of its Subsidiaries to not, directly or indirectly, permit
any Indebtedness of the Company or any of its Subsidiaries to mature or accelerate prior to the Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>[Reserved]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Preservation
of Existence, Etc</U>. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, its existence,
rights and privileges, and become or remain, and cause each of its Subsidiaries to become or remain, duly qualified and in good standing
in each jurisdiction in which the character of the properties owned or leased by it or in which the transaction of its business makes
such qualification necessary; provided, however, that the Company shall have the right to merge or combine wholly-owned Subsidiaries hereunder,
or eliminate or dissolve foreign Subsidiaries, in each case where such restructuring does not have a material impact on the Company&rsquo;s
assets or ability to comply with the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Maintenance
of Properties, Etc</U>. The Company shall maintain and preserve, and cause each of its Subsidiaries to maintain and preserve, all of its
properties which are necessary or useful in the proper conduct of its business in good working order and condition, ordinary wear and
tear excepted, and comply, and cause each of its Subsidiaries to comply, at all times with the provisions of all leases to which it is
a party as lessee or under which it occupies property, so as to prevent any loss or forfeiture thereof or thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Maintenance
of Intellectual Property</U>. The Company will, and will cause each of its Subsidiaries to, take all action necessary or advisable to
maintain all of the Intellectual Property Rights of the Company and/or any of its Subsidiaries that are necessary or material to the conduct
of its business in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Maintenance
of Insurance</U>. The Company shall use reasonable best efforts to maintain, and cause each of its Subsidiaries to maintain, insurance
with responsible and reputable insurance companies or associations (including, without limitation, comprehensive general liability, hazard,
rent and business interruption insurance) with respect to its properties (including all real properties leased or owned by it) and business,
in such amounts and covering such risks as are generally consistent with the coverage held by the Company on the Initial Issuance Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Transactions
with Affiliates</U>. The Company shall not, nor shall it permit any of its Subsidiaries to, enter into, renew, extend or be a party to,
any transaction or series of related transactions (including, without limitation, the purchase, sale, lease, transfer or exchange of property
or assets of any kind or the rendering of services of any kind) with any affiliate, except transactions in the ordinary course of business
in a manner and to an extent, if applicable, consistent with past practice and necessary or desirable for the prudent operation of its
business, for fair consideration and on terms no less favorable to it or its Subsidiaries than would be reasonably expected to be obtained
in a comparable arm&rsquo;s length transaction with a Person that is not an affiliate thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Restricted
Issuances</U>. The Company shall not, directly or indirectly, without the prior written consent of the Required Holders, (i)&nbsp;issue
any Preferred Shares (other than as contemplated by the Securities Purchase Agreement and this Certificate of Designations) or (ii)&nbsp;issue
any other securities that would cause a breach or default under this Certificate of Designations or the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Stay,
Extension and Usury Laws</U>. To the extent that it may lawfully do so, the Company (A)&nbsp;agrees that it will not at any time insist
upon, plead, or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law (wherever or whenever
enacted or in force) that may affect the covenants or the performance of this Certificate of Designations; and (B)&nbsp;expressly waives
all benefits or advantages of any such law and agrees that it will not, by resort to any such law, hinder, delay or impede the execution
of any power granted to the Holders by this Certificate of Designations, but will suffer and permit the execution of every such power
as though no such law has been enacted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Taxes</U>.
The Company and its Subsidiaries shall pay when due all taxes, fees or other charges of any nature whatsoever (together with any related
interest or penalties) now or hereafter imposed or assessed against the Company and its Subsidiaries or their respective assets or upon
their ownership, possession, use, operation or disposition thereof or upon their rents, receipts or earnings arising therefrom (except
where the failure to pay would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries).
The Company and its Subsidiaries shall file on or before the due date therefor all personal property tax returns (except where the failure
to file would not, individually or in the aggregate, have a material effect on the Company or any of its Subsidiaries). Notwithstanding
the foregoing, the Company and its Subsidiaries may contest, in good faith and by appropriate proceedings, taxes for which they maintain
adequate reserves therefor in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p) <U>Cash Minimum</U>.
From the Closing Date until no shares of Preferred Shares are outstanding, the Company shall, at all times, maintain unencumbered, unrestricted
cash, cash equivalents, TAO tokens and investments in the Bittensor ecosystem, in an amount equal to at least the aggregate Stated Value
of Preferred Shares then outstanding. Such cash shall be maintained in one or more domestic deposit accounts, money market accounts or
certificates of deposit (with a maturity of no more than three months) with one or more Eligible Banks, or, with respect to TAO tokens
and investments in the Bittensor ecosystem, with a Qualified Custodian. For purposes hereof, an &ldquo;Eligible Bank&rdquo; is a U.S.
chartered commercial bank with total assets in excess of $300 billion and &ldquo;Qualified Custodian&rdquo; is Bitgo Trust Company, Inc.,
Wells Fargo Bank, N.A. (and any affiliates thereof), or any suitable bank licensed as a qualified custodian of digital assets, approved
in writing by the Required Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Independent
Investigation</U>. At the request of any Holder either (x)&nbsp;at any time when a Triggering Event has occurred and is continuing, (y)&nbsp;upon
the occurrence of an event that with the passage of time or giving of notice would constitute a Triggering Event or (z)&nbsp;at any time
such Holder reasonably believes a Triggering Event may have occurred or be continuing, the Company shall hire an independent, reputable
investment bank selected by the Company and approved by such Holder to investigate as to whether any breach of the Certificate of Designations
has occurred (the &ldquo;<B>Independent Investigator</B>&rdquo;). If the Independent Investigator determines that such breach of the Certificate
of Designations has occurred, the Independent Investigator shall notify the Company of such breach and the Company shall deliver written
notice to each Holder of such breach. In connection with such investigation, the Independent Investigator may, during normal business
hours, inspect all contracts, books, records, personnel, offices and other facilities and properties of the Company and its Subsidiaries
and, to the extent available to the Company after the Company uses reasonable efforts to obtain them, the records of its legal advisors
and accountants (including the accountants&rsquo; work papers) and any books of account, records, reports and other papers not contractually
required of the Company to be confidential or secret, or subject to attorney-client or other evidentiary privilege, and the Independent
Investigator may make such copies and inspections thereof as the Independent Investigator may reasonably request. The Company shall furnish
the Independent Investigator with such financial and operating data and other information with respect to the business and properties
of the Company as the Independent Investigator may reasonably request. The Company shall permit the Independent Investigator to discuss
the affairs, finances and accounts of the Company with, and to make proposals and furnish advice with respect thereto to, the Company&rsquo;s
officers, directors, key employees and independent public accountants or any of them (and by this provision the Company authorizes said
accountants to discuss with such Independent Investigator the finances and affairs of the Company and any Subsidiaries), all at such reasonable
times, upon reasonable notice, and as often as may be reasonably requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16. <U>Liquidation, Dissolution,
Winding-Up</U>. In the event of a Liquidation Event, the Holders shall be entitled to receive in cash out of the assets of the Company,
whether from capital or from earnings available for distribution to its stockholders (the &ldquo;<B>Liquidation Funds</B>&rdquo;), before
any amount shall be paid to the holders of any of shares of Junior Stock, but pari passu with any Parity Stock then outstanding, an amount
per Preferred Share equal to the greater of (A)&nbsp;125% of the Conversion Amount of such Preferred Share on the date of such payment
and (B)&nbsp;the amount per share such Holder would receive if such Holder converted such Preferred Share into Common Stock immediately
prior to the date of such payment, provided that if the Liquidation Funds are insufficient to pay the full amount due to the Holders and
holders of shares of Parity Stock, then each Holder and each holder of Parity Stock shall receive a percentage of the Liquidation Funds
equal to the full amount of Liquidation Funds payable to such Holder and such holder of Parity Stock as a liquidation preference, in accordance
with their respective certificate of designations (or equivalent), as a percentage of the full amount of Liquidation Funds payable to
all holders of Preferred Shares and all holders of shares of Parity Stock. To the extent necessary, the Company shall cause such actions
to be taken by each of its Subsidiaries so as to enable, to the maximum extent permitted by law, the proceeds of a Liquidation Event to
be distributed to the Holders in accordance with this Section&nbsp;16. All the preferential amounts to be paid to the Holders under this
Section&nbsp;16 shall be paid or set apart for payment before the payment or setting apart for payment of any amount for, or the distribution
of any Liquidation Funds of the Company to the holders of shares of Junior Stock in connection with a Liquidation Event as to which this
Section&nbsp;16 applies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17. <U>Distribution of Assets</U>.
In addition to any adjustments pursuant to Section&nbsp;7(a)&nbsp;and Section&nbsp;8, if the Company shall declare or make any dividend
or other distributions of its assets (or rights to acquire its assets) to any or all holders of shares of Common Stock, by way of return
of capital or otherwise (including without limitation, any distribution of cash, stock or other securities, property or options by way
of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (the &ldquo;<B>Distributions</B>&rdquo;),
then each Holder, as holders of Preferred Shares, will be entitled to such Distributions as if such Holder had held the number of shares
of Common Stock acquirable upon complete conversion of the Preferred Shares (without taking into account any limitations or restrictions
on the convertibility of the Preferred Shares and assuming for such purpose that the Preferred Share was converted at the Alternate Conversion
Price as of the applicable record date)immediately prior to the date on which a record is taken for such Distribution or, if no such record
is taken, the date as of which the record holders of Common Stock are to be determined for such Distributions (provided, however, that
to the extent that such Holder&rsquo;s right to participate in any such Distribution would result in such Holder and the other Attribution
Parties exceeding the Maximum Percentage, then such Holder shall not be entitled to participate in such Distribution to such extent of
the Maximum Percentage (and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution
(and beneficial ownership) to such extent of any such excess) and the portion of such Distribution shall be held in abeyance for the benefit
of such Holder until such time or times as its right thereto would not result in such Holder and the other Attribution Parties exceeding
the Maximum Percentage, at which time or times, if any, such Holder shall be granted such Distribution (and any Distributions declared
or made on such initial Distribution or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had
been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18. <U>Vote to Change the
Terms of or Issue Preferred Shares</U>. In addition to any other rights provided by law, except where the vote or written consent of the
holders of a greater number of shares is required by law or by another provision of the Certificate of Incorporation, without first obtaining
the affirmative vote at a meeting duly called for such purpose or the written consent without a meeting of the Required Holders, voting
together as a single class, the Company shall not (in any case, whether by amendment, modification, recapitalization, merger, consolidation
or otherwise): (a)&nbsp;amend or repeal any provision of, or add any provision to, its Certificate of Incorporation or bylaws, or file
any certificate of designations or articles of amendment of any series of shares of preferred stock, if such action would adversely alter
or change in any respect the preferences, rights, privileges or powers, or restrictions provided for the benefit of the Preferred Shares
hereunder, regardless of whether any such action shall be by means of amendment to the Certificate of Incorporation or by merger, consolidation
or otherwise; (b)&nbsp;increase or decrease (other than by conversion) the authorized number of Preferred Shares; (c)&nbsp;without limiting
any provision of Section&nbsp;2, create or authorize (by reclassification or otherwise) any new class or series of Senior Preferred Stock
or Parity Stock; (d)&nbsp;purchase, repurchase or redeem any shares of Junior Stock (other than pursuant to the terms of the Company&rsquo;s
equity incentive plans and options and other equity awards granted under such plans (that have in good faith been approved by the Board));
(e)&nbsp;without limiting any provision of Section&nbsp;2, pay dividends or make any other distribution on any shares of any Junior Stock;
(f)&nbsp;issue any Preferred Shares other than as contemplated hereby or pursuant to the Securities Purchase Agreement; or (g)&nbsp;without
limiting any provision of Section&nbsp;10, whether or not prohibited by the terms of the Preferred Shares, circumvent a right of the Preferred
Shares hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19. <U>Transfer of Preferred
Shares</U>. A Holder may transfer some or all of its Preferred Shares without the consent of the Company, but any such transfer shall
be in compliance with all applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">20. <U>Reissuance of Preferred
Share Certificates and Book Entries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Transfer</U>.
If any Preferred Shares are to be transferred, the applicable Holder shall surrender the applicable Preferred Share Certificate to the
Company (or, if the Preferred Shares are held in Book-Entry form, a written instruction letter to the Company), whereupon the Company
will forthwith issue and deliver upon the order of such Holder a new Preferred Share Certificate (in accordance with Section&nbsp;20(d))
(or evidence of the transfer of such Book-Entry), registered as such Holder may request, representing the outstanding number of Preferred
Shares being transferred by such Holder and, if less than the entire outstanding number of Preferred Shares is being transferred, a new
Preferred Share Certificate (in accordance with Section&nbsp;20(d)) to such Holder representing the outstanding number of Preferred Shares
not being transferred (or evidence of such remaining Preferred Shares in a Book-Entry for such Holder). Such Holder and any assignee,
by acceptance of the Preferred Share Certificate or evidence of Book-Entry issuance, as applicable, acknowledge and agree that, by reason
of the provisions of Section&nbsp;4(c)(i)&nbsp;following conversion or redemption of any of the Preferred Shares, the outstanding number
of Preferred Shares represented by the Preferred Shares may be less than the number of Preferred Shares stated on the face of the Preferred
Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Lost,
Stolen or Mutilated Preferred Share Certificate</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of a Preferred Share Certificate (as to which a written certification and the indemnification
contemplated below shall suffice as such evidence), and, in the case of loss, theft or destruction, of any indemnification undertaking
by the applicable Holder to the Company in customary and reasonable form and, in the case of mutilation, upon surrender and cancellation
of such Preferred Share Certificate, the Company shall execute and deliver to such Holder a new Preferred Share Certificate (in accordance
with Section&nbsp;20(d)) representing the applicable outstanding number of Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Preferred
Share Certificate and Book-Entries Exchangeable for Different Denominations and Forms</U>. Each Preferred Share Certificate is exchangeable,
upon the surrender hereof by the applicable Holder at the principal office of the Company, for a new Preferred Share Certificate or Preferred
Share Certificate(s)&nbsp;or new Book-Entry (in accordance with Section&nbsp;20(d)) representing, in the aggregate, the outstanding number
of the Preferred Shares in the original Preferred Share Certificate, and each such new Preferred Share Certificate and/or new Book-Entry,
as applicable, will represent such portion of such outstanding number of Preferred Shares from the original Preferred Share Certificate
as is designated in writing by such Holder at the time of such surrender. Each Book-Entry may be exchanged into one or more new Preferred
Share Certificates or split by the applicable Holder by delivery of a written notice to the Company into two or more new Book-Entries
(in accordance with Section&nbsp;20(d)) representing, in the aggregate, the outstanding number of the Preferred Shares in the original
Book-Entry, and each such new Book-Entry and/or new Preferred Share Certificate, as applicable, will represent such portion of such outstanding
number of Preferred Shares from the original Book-Entry as is designated in writing by such Holder at the time of such surrender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Issuance
of New Preferred Share Certificate or Book-Entry</U>. Whenever the Company is required to issue a new Preferred Share Certificate or a
new Book-Entry pursuant to the terms of this Certificate of Designations, such new Preferred Share Certificate or new Book-Entry (i)&nbsp;shall
represent, as indicated on the face of such Preferred Share Certificate or in such Book-Entry, as applicable, the number of Preferred
Shares remaining outstanding (or in the case of a new Preferred Share Certificate or new Book-Entry being issued pursuant to Section&nbsp;20(a)&nbsp;or
Section&nbsp;20(c), the number of Preferred Shares designated by such Holder) which, when added to the number of Preferred Shares represented
by the other new Preferred Share Certificates or other new Book-Entry, as applicable, issued in connection with such issuance, does not
exceed the number of Preferred Shares remaining outstanding under the original Preferred Share Certificate or original Book-Entry, as
applicable, immediately prior to such issuance of new Preferred Share Certificate or new Book-Entry, as applicable, and (ii)&nbsp;shall
have an issuance date, as indicated on the face of such new Preferred Share Certificate or in such new Book-Entry, as applicable, which
is the same as the issuance date of the original Preferred Share Certificate or in such original Book-Entry, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">21. <U>Remedies, Characterizations,
Other Obligations, Breaches and Injunctive Relief. </U>The remedies provided in this Certificate of Designations shall be cumulative and
in addition to all other remedies available under this Certificate of Designations and any of the other Transaction Documents, at law
or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit any Holder&rsquo;s
right to pursue actual and consequential damages for any failure by the Company to comply with the terms of this Certificate of Designations.
No failure on the part of a Holder to exercise, and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver
thereof; nor shall any single or partial exercise by such Holder of any right, power or remedy preclude any other or further exercise
thereof or the exercise of any other right, power or remedy. In addition, the exercise of any right or remedy of a Holder at law or equity
or under this Certificate of Designations or any of the documents shall not be deemed to be an election of such Holder&rsquo;s rights
or remedies under such documents or at law or equity. The Company covenants to each Holder that there shall be no characterization concerning
this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments, conversion
and the like (and the computation thereof) shall be the amounts to be received by a Holder and shall not, except as expressly provided
herein, be subject to any other obligation of the Company (or the performance thereof). No failure on the part of a Holder to exercise,
and no delay in exercising, any right, power or remedy hereunder shall operate as a waiver thereof; nor shall any single or partial exercise
by such Holder of any right, power or remedy preclude any other or further exercise thereof or the exercise of any other right, power
or remedy. In addition, the exercise of any right or remedy of any Holder at law or equity or under Preferred Shares or any of the documents
shall not be deemed to be an election of such Holder&rsquo;s rights or remedies under such documents or at law or equity. The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holders and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, each Holder
shall be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary and permanent injunctive
or other equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and
without posting a bond or other security. The Company shall provide all information and documentation to a Holder that is requested by
such Holder to enable such Holder to confirm the Company&rsquo;s compliance with the terms and conditions of this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">22. <U>Payment of Collection,
Enforcement and Other Costs</U>. If (a)&nbsp;any Preferred Shares are placed in the hands of an attorney for collection or enforcement
or is collected or enforced through any legal proceeding or a Holder otherwise takes action to collect amounts due under this Certificate
of Designations with respect to the Preferred Shares or to enforce the provisions of this Certificate of Designations or (b)&nbsp;there
occurs any bankruptcy, reorganization, receivership of the Company or other proceedings affecting Company creditors&rsquo; rights and
involving a claim under this Certificate of Designations, then the Company shall pay the costs incurred by such Holder for such collection,
enforcement or action or in connection with such bankruptcy, reorganization, receivership or other proceeding, including, without limitation,
attorneys&rsquo; fees and disbursements. The Company expressly acknowledges and agrees that no amounts due under this Certificate of Designations
with respect to any Preferred Shares shall be affected, or limited, by the fact that the purchase price paid for each Preferred Share
was less than the original Stated Value thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">23. <U>Construction; Headings</U>.
This Certificate of Designations shall be deemed to be jointly drafted by the Company and the Holders and shall not be construed against
any such Person as the drafter hereof. The headings of this Certificate of Designations are for convenience of reference and shall not
form part of, or affect the interpretation of, this Certificate of Designations. Unless the context clearly indicates otherwise, each
pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof. The terms &ldquo;including,&rdquo;
 &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed broadly as if followed by the words &ldquo;without
limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo; and words of like import refer to this
entire Certificate of Designations instead of just the provision in which they are found. Unless expressly indicated otherwise, all section
references are to sections of this Certificate of Designations. Terms used in this Certificate of Designations and not otherwise defined
herein, but defined in the other Transaction Documents, shall have the meanings ascribed to such terms on the Initial Issuance Date in
such other Transaction Documents unless otherwise consented to in writing by the Required Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">24. <U>Failure or Indulgence
Not Waiver</U>. No failure or delay on the part of a Holder in the exercise of any power, right or privilege hereunder shall operate as
a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof
or of any other right, power or privilege. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party. This Certificate of Designations shall be deemed to be jointly drafted by the Company and all Holders and shall
not be construed against any Person as the drafter hereof. Notwithstanding the foregoing, nothing contained in this Section&nbsp;24 shall
permit any waiver of any provision of Section&nbsp;4(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">25. <U>Dispute Resolution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Submission
to Dispute Resolution.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;In the case
of a dispute relating to a Closing Bid Price, a Closing Sale Price, a Conversion Price, an Alternate Conversion Price, a VWAP or a fair
market value or the arithmetic calculation of a Conversion Rate, or the applicable Redemption Price (as the case may be) (including, without
limitation, a dispute relating to the determination of any of the foregoing), the Company or the applicable Holder (as the case may be)
shall submit the dispute to the other party via electronic mail (A)&nbsp;if by the Company, within two (2)&nbsp;Business Days after the
occurrence of the circumstances giving rise to such dispute or (B)&nbsp;if by such Holder at any time after such Holder learned of the
circumstances giving rise to such dispute. If such Holder and the Company are unable to promptly resolve such dispute relating to such
Closing Bid Price, such Closing Sale Price, such Conversion Price, such Alternate Conversion Price, such VWAP or such fair market value,
or the arithmetic calculation of such Conversion Rate or such applicable Redemption Price (as the case may be), at any time after the
second (2<FONT STYLE="font-size: 10pt"><SUP>nd</SUP></FONT>) Business Day following such initial notice by the Company or such Holder
(as the case may be) of such dispute to the Company or such Holder (as the case may be), then such Holder may, at its sole option, select
an independent, reputable investment bank to resolve such dispute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;Such Holder
and the Company shall each deliver to such investment bank (A)&nbsp;a copy of the initial dispute submission so delivered in accordance
with the first sentence of this Section&nbsp;25 and (B)&nbsp;written documentation supporting its position with respect to such dispute,
in each case, no later than 5:00 p.m.&nbsp;(New York time) by the fifth (5<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>) Business
Day immediately following the date on which such Holder selected such investment bank (the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;)
(the documents referred to in the immediately preceding clauses (A)&nbsp;and (B)&nbsp;are collectively referred to herein as the &ldquo;<B>Required
Dispute Documentation</B>&rdquo;) (it being understood and agreed that if either such Holder or the Company fails to so deliver all of
the Required Dispute Documentation by the Dispute Submission Deadline, then the party who fails to so submit all of the Required Dispute
Documentation shall no longer be entitled to (and hereby waives its right to) deliver or submit any written documentation or other support
to such investment bank with respect to such dispute and such investment bank shall resolve such dispute based solely on the Required
Dispute Documentation that was delivered to such investment bank prior to the Dispute Submission Deadline). Unless otherwise agreed to
in writing by both the Company and such Holder or otherwise requested by such investment bank, neither the Company nor such Holder shall
be entitled to deliver or submit any written documentation or other support to such investment bank in connection with such dispute (other
than the Required Dispute Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;The Company
and such Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and such Holder of
such resolution no later than ten (10)&nbsp;Business Days immediately following the Dispute Submission Deadline. The fees and expenses
of such investment bank shall be borne solely by the Company, and such investment bank&rsquo;s resolution of such dispute shall be final
and binding upon all parties absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Miscellaneous</U>.
The Company expressly acknowledges and agrees that (i)&nbsp;this Section&nbsp;25 constitutes an agreement to arbitrate between the Company
and each Holder (and constitutes an arbitration agreement) under &sect; 7501, et seq. of the New York Civil Practice Law and Rules&nbsp;(&ldquo;<B>CPLR</B>&rdquo;)
and that any Holder is authorized to apply for an order to compel arbitration pursuant to CPLR &sect; 7503(a)&nbsp;in order to compel
compliance with this Section&nbsp;25, (ii)&nbsp;a dispute relating to a Conversion Price includes, without limitation, disputes as to
(A)&nbsp;whether an issuance or sale or deemed issuance or sale of Common Stock occurred under Section&nbsp;8(a), (B)&nbsp;the consideration
per share at which an issuance or deemed issuance of Common Stock occurred, (C)&nbsp;whether any issuance or sale or deemed issuance or
sale of Common Stock was an issuance or sale or deemed issuance or sale of Excluded Securities, (D)&nbsp;whether an agreement, instrument,
security or the like constitutes and Option or Convertible Security and (E)&nbsp;whether a Dilutive Issuance occurred, (iii)&nbsp;the
terms of this Certificate of Designations and each other applicable Transaction Document shall serve as the basis for the selected investment
bank&rsquo;s resolution of the applicable dispute, such investment bank shall be entitled (and is hereby expressly authorized) to make
all findings, determinations and the like that such investment bank determines are required to be made by such investment bank in connection
with its resolution of such dispute and in resolving such dispute such investment bank shall apply such findings, determinations and the
like to the terms of this Certificate of Designations and any other applicable Transaction Documents, (iv)&nbsp;the applicable Holder
(and only such Holder with respect to disputes solely relating to such Holder), in its sole discretion, shall have the right to submit
any dispute described in this Section&nbsp;25 to any state or federal court sitting in The City of New York, Borough of Manhattan, New
York, in lieu of utilizing the procedures set forth in this Section&nbsp;25 and (v)&nbsp;nothing in this Section&nbsp;25 shall limit such
Holder from obtaining any injunctive relief or other equitable remedies (including, without limitation, with respect to any matters described
in this Section&nbsp;25).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">26. <U>Notices; Currency; Payments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Notices</U>.
The Company shall provide each Holder of Preferred Shares with prompt written notice of all actions taken pursuant to the terms of this
Certificate of Designations, including in reasonable detail a description of such action and the reason therefor. Whenever notice is required
to be given under this Certificate of Designations, unless otherwise provided herein, such notice must be in writing and shall be given
in accordance with Section&nbsp;9(f)&nbsp;of the Securities Purchase Agreement. The Company shall provide each Holder with prompt written
notice of all actions taken pursuant to this Certificate of Designations, including in reasonable detail a description of such action
and the reason therefore. Without limiting the generality of the foregoing, the Company shall give written notice to each Holder (i)&nbsp;immediately
upon any adjustment of the Conversion Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and
(ii)&nbsp;at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A)&nbsp;with respect to
any dividend or distribution upon the Common Stock, (B)&nbsp;with respect to any grant, issuances, or sales of any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property to holders of shares of Common Stock or (C)&nbsp;for determining
rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information shall
be made known to the public prior to or in conjunction with such notice being provided to such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Currency</U>.
All dollar amounts referred to in this Certificate of Designations are in United States Dollars (&ldquo;<B>U.S. Dollars</B>&rdquo;), and
all amounts owing under this Certificate of Designations shall be paid in U.S. Dollars. All amounts denominated in other currencies (if
any) shall be converted into the U.S. Dollar equivalent amount in accordance with the Exchange Rate on the date of calculation. &ldquo;<B>Exchange
Rate</B>&rdquo; means, in relation to any amount of currency to be converted into U.S. Dollars pursuant to this Certificate of Designations,
the U.S. Dollar exchange rate as published in the Wall Street Journal on the relevant date of calculation (it being understood and agreed
that where an amount is calculated with reference to, or over, a period of time, the date of calculation shall be the final date of such
period of time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Payments</U>.
Whenever any payment of cash is to be made by the Company to any Person pursuant to this Certificate of Designations, unless otherwise
expressly set forth herein, such payment shall be made in lawful money of the United States of America by wire transfer of immediately
available funds pursuant to wire transfer instructions that Holder shall provide to the Company in writing from time to time. Whenever
any amount expressed to be due by the terms of this Certificate of Designations is due on any day which is not a Business Day, the same
shall instead be due on the next succeeding day which is a Business Day. Any amount due under the Transaction Documents which is not paid
when due (except to the extent such amount is simultaneously accruing Dividends at the Default Rate hereunder) shall result in a late
charge being incurred and payable by the Company in an amount equal to interest on such amount at the rate of fifteen percent (15%) per
annum from the date such amount was due until the same is paid in full (&ldquo;<B>Late Charge</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">27. <U>Waiver of Notice</U>.
To the extent permitted by law, the Company hereby irrevocably waives demand, notice, presentment, protest and all other demands and notices
in connection with the delivery, acceptance, performance, default or enforcement of this Certificate of Designations and the Securities
Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">28. <U>Governing Law</U>.
This Certificate of Designations shall be construed and enforced in accordance with, and all questions concerning the construction, validity,
interpretation and performance of this Certificate of Designations shall be governed by, the internal laws of the State of Delaware, without
giving effect to any choice of law or conflict of law provision or rule&nbsp;(whether of the State of Delaware or any other jurisdictions)
that would cause the application of the laws of any jurisdictions other than the State of Delaware. Except as otherwise required by Section&nbsp;25
above, the Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New
York, Borough of Manhattan, New York, for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any
claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any
right to serve process in any manner permitted by law. Nothing contained herein shall be deemed to limit in any way any right to serve
process in any manner permitted by law. Nothing contained herein (i)&nbsp;shall be deemed or operate to preclude any Holder from bringing
suit or taking other legal action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations to such
Holder, to realize on any collateral or any other security for such obligations, or to enforce a judgment or other court ruling in favor
of such Holder or (ii)&nbsp;shall limit, or shall be deemed or construed to limit, any provision of Section&nbsp;25 above. <B>THE COMPANY
HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY&nbsp;HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER
OR IN CONNECTION WITH OR ARISING OUT OF THIS CERTIFICATE OF DESIGNATIONS OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">29. <U>Judgment Currency</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;If for
the purpose of obtaining or enforcing judgment against the Company in any court in any jurisdiction it becomes necessary to convert into
any other currency (such other currency being hereinafter in this Section&nbsp;29 referred to as the &ldquo;<B>Judgment Currency</B>&rdquo;)
an amount due in U.S. dollars under this Certificate of Designations, the conversion shall be made at the Exchange Rate prevailing on
the Trading Day immediately preceding:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the date
actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction that
will give effect to such conversion being made on such date: or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;the date
on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which such
conversion is made pursuant to this Section&nbsp;29(a)(ii)&nbsp;being hereinafter referred to as the &ldquo;<B>Judgment Conversion Date</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;If in the
case of any proceeding in the court of any jurisdiction referred to in Section&nbsp;29(a)(ii)&nbsp;above, there is a change in the Exchange
Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall pay
such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate
prevailing on the date of payment, will produce the amount of US dollars which could have been purchased with the amount of Judgment Currency
stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;Any amount
due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained for any
other amounts due under or in respect of this Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">30. <U>Severability</U>. If
any provision of this Certificate of Designations is prohibited by law or otherwise determined to be invalid or unenforceable by a court
of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply
to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect
the validity of the remaining provisions of this Certificate of Designations so long as this Certificate of Designations as so modified
continues to express, without material change, the original intentions of the parties as to the subject matter hereof and the prohibited
nature, invalidity or unenforceability of the provision(s)&nbsp;in question does not substantially impair the respective expectations
or reciprocal obligations of the parties or the practical realization of the benefits that would otherwise be conferred upon the parties.
The parties will endeavor in good faith negotiations to replace the prohibited, invalid or unenforceable provision(s)&nbsp;with a valid
provision(s), the effect of which comes as close as possible to that of the prohibited, invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">31. <U>Maximum Payments</U>.
Without limiting Section&nbsp;9(c)&nbsp;of the Securities Purchase Agreement, nothing contained herein shall be deemed to establish or
require the payment of a rate of interest or other charges in excess of the maximum permitted by applicable law. In the event that the
rate of interest required to be paid or other charges hereunder exceed the maximum permitted by such law, any payments in excess of such
maximum shall be credited against amounts owed by the Company to the applicable Holder and thus refunded to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">32. <U>Stockholder Matters;
Amendment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Stockholder
Matters</U>. Any stockholder action, approval or consent required, desired or otherwise sought by the Company pursuant to the DGCL, the
Certificate of Incorporation, this Certificate of Designations or otherwise with respect to the issuance of Preferred Shares may be effected
by written consent of the Company&rsquo;s stockholders or at a duly called meeting of the Company&rsquo;s stockholders, all in accordance
with the applicable rules&nbsp;and regulations of the DGCL. This provision is intended to comply with the applicable sections of the DGCL
permitting stockholder action, approval and consent affected by written consent in lieu of a meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Amendment</U>.
Except for Section&nbsp;4(d)(i), which may not be amended or waived hereunder, this Certificate of Designations or any provision hereof
may be amended by obtaining the affirmative vote at a meeting duly called for such purpose, or written consent without a meeting in accordance
with the DGCL, of the Required Holders, voting separately as a single class, and with such other stockholder approval, if any, as may
then be required pursuant to the DGCL and the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">33. <U>Certain Defined Terms</U>.
For purposes of this Certificate of Designations, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&ldquo;<B>1933 Act</B>&rdquo;
means the Securities Act of 1933, as amended, and the rules&nbsp;and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&ldquo;<B>1934 Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&ldquo;<B>Additional
Amount</B>&rdquo; means, as of the applicable date of determination, with respect to each Preferred Share, all accrued and unpaid Dividends
on such Preferred Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&ldquo;<B>Adjustment
Right</B>&rdquo; means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or
sale (or deemed issuance or sale in accordance with Section&nbsp;8(a)) of shares of Common Stock (other than rights of the type described
in Section&nbsp;7(a)&nbsp;hereof) that could result in a decrease in the net consideration received by the Company in connection with,
or with respect to, such securities (including, without limitation, any cash settlement rights, cash adjustment or other similar rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&ldquo;<B>Affiliate</B>&rdquo;
or &ldquo;<B>Affiliated</B>&rdquo; means, with respect to any Person, any other Person that directly or indirectly controls, is controlled
by, or is under common control with, such Person, it being understood for purposes of this definition that &ldquo;control&rdquo; of a
Person means the power directly or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of
directors of such Person or direct or cause the direction of the management and policies of such Person whether by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&ldquo;<B>Alternate
Conversion Floor Amount</B>&rdquo; means an amount in cash, to be delivered by wire transfer of immediately available funds pursuant to
wire instructions delivered to the Company by the Holder in writing, equal to the product obtained by multiplying (A)&nbsp;the higher
of (I)&nbsp;the highest price that the Common Stock trades at on the Trading Day immediately preceding the relevant Alternate Conversion
Date and (II)&nbsp;the applicable Alternate Conversion Price and (B)&nbsp;the difference obtained by subtracting (I)&nbsp;the number of
shares of Common Stock delivered (or to be delivered) to the Holder on the applicable Share Delivery Deadline with respect to such Alternate
Conversion from (II)&nbsp;the quotient obtained by dividing (x)&nbsp;the applicable Conversion Amount that the Holder has elected to be
the subject of the applicable Alternate Conversion, by (y)&nbsp;the applicable Alternate Conversion Price without giving effect to clause
(x)&nbsp;of such definition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&ldquo;<B>Alternate
Conversion Price</B>&rdquo; means, with respect to any Alternate Conversion that price which shall be the lowest of (i)&nbsp;the applicable
Conversion Price as in effect on the applicable Conversion Date of the applicable Alternate Conversion, and (ii)&nbsp;the greater of (x)&nbsp;the
Floor Price and (y)&nbsp;80% of the lowest VWAP of the Common Stock of any Trading Day during the twenty (20) consecutive Trading Day
period ending and including the Trading Day immediately preceding the delivery or deemed delivery of the applicable Conversion Notice
(such period, the &ldquo;Alternate Conversion Measuring Period&rdquo;). All such determinations to be appropriately adjusted for any stock
dividend, stock split, stock combination, reclassification or similar transaction that proportionately decreases or increases the Common
Stock during such Alternate Conversion Measuring Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&ldquo;<B>Approved
Stock Plan</B>&rdquo; means any employee benefit plan or agreement which has been approved by the Board prior to or subsequent to the
Subscription Date pursuant to which shares of Common Stock and standard options to purchase Common Stock may be issued to any employee,
officer, consultant or director for services provided to the Company in their capacity as such.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons and entities: (i)&nbsp;any investment vehicle, including, any funds, feeder
funds or managed accounts, currently, or from time to time after the Initial Issuance Date, directly or indirectly managed or advised
by a Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii)&nbsp;any direct or indirect Affiliates of such Holder
or any of the foregoing, (iii)&nbsp;any Person acting or who could be deemed to be acting as a Group together with such Holder or any
of the foregoing and (iv)&nbsp;any other Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated
with such Holder&rsquo;s and the other Attribution Parties for purposes of Section&nbsp;13(d)&nbsp;of the 1934 Act. For clarity, the purpose
of the foregoing is to subject collectively such Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&ldquo;<B>Book-Entry</B>&rdquo;
means each entry on the Register evidencing one or more Preferred Shares held by a Holder in lieu of a Preferred Share Certificate issuable
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; provided, however, for clarification, commercial banks shall not be deemed to be authorized or required
by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any
other similar orders or restrictions or the closure of any physical branch locations at the direction of any governmental authority so
long as the electronic funds transfer systems (including for wire transfers) of commercial banks in The City of New York generally are
open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&ldquo;<B>Change of
Control</B>&rdquo; means (a)&nbsp;any Fundamental Transaction other than (i)&nbsp;any merger of the Company or any of its, direct or indirect,
wholly-owned Subsidiaries with or into any of the foregoing Persons, (ii)&nbsp;any reorganization, recapitalization or reclassification
of the Common Stock in which holders of the Company&rsquo;s voting power immediately prior to such reorganization, recapitalization or
reclassification continue after such reorganization, recapitalization or reclassification to hold publicly traded securities and, directly
or indirectly, are, in all material respects, the holders of the voting power of the surviving entity (or entities with the authority
or voting power to elect the members of the board of directors (or their equivalent if other than a corporation) of such entity or entities)
after such reorganization, recapitalization or reclassification, (iii)&nbsp;pursuant to a migratory merger effected solely for the purpose
of changing the jurisdiction of incorporation of the Company or any of its Subsidiaries or (iv)&nbsp;bona fide arm&rsquo;s length sales
or acquisitions by the Company (including, without limitation, the sale by the Company of its Computex business) with one or more third
parties as long as holders of the Company&rsquo;s voting power as of the Issuance Date continue after such sale or acquisition to hold
publicly traded securities and, directly or indirectly, are, in all material respects, the holders of at least 51% of the voting power
of the surviving entity (or entities with the authority or voting power to elect the members of the board of directors (or their equivalent
if other than a corporation) of such entity or entities) after such sale or acquisition or (b)&nbsp;individuals who constitute the Continuing
Directors, taken together, ceasing for any reason to constitute at least a majority of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;&ldquo;<B>Change of
Control Redemption Premium</B>&rdquo; means 125%; provided that, in the case of an Involuntary Change of Control, the Change of Control
Redemption Premium means 300%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)&nbsp;&ldquo;<B>Closing Bid
Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing bid price and last
closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins
to operate on an extended hours basis and does not designate the closing bid price or the closing trade price (as the case may be) then
the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg,
or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing bid price or
last trade price, respectively, of such security on the principal securities exchange or trading market where such security is listed
or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of
such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing
bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices,
respectively, of any market makers for such security as reported in The Pink Open Market (or a similar organization or agency succeeding
to its functions of reporting prices). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular
date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security on such date
shall be the fair market value as mutually determined by the Company and the Required Holder. If the Company and the Required Holders
are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures
in Section&nbsp;25. All such determinations shall be appropriately adjusted for any stock splits, stock dividends, stock combinations,
recapitalizations or other similar transactions during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)&nbsp;&ldquo;<B>Closing Date</B>&rdquo;
shall have the meaning set forth in the Securities Purchase Agreement, which date is the date the Company initially issued the Preferred
Shares and the Warrants pursuant to the terms of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)&nbsp;&ldquo;<B>Common Stock</B>&rdquo;
means (i)&nbsp;the Company&rsquo;s shares of common stock, $0.0001 par value per share, and (ii)&nbsp;any capital stock into which such
common stock shall have been changed or any share capital resulting from a reclassification of such common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)&nbsp;&ldquo;<B>Contingent
Obligation</B>&rdquo; means, as to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect
to any Indebtedness, lease, dividend or other obligation of another Person if the primary purpose or intent of the Person incurring such
liability, or the primary effect thereof, is to provide assurance to the obligee of such liability that such liability will be paid or
discharged, or that any agreements relating thereto will be complied with, or that the holders of such liability will be protected (in
whole or in part) against loss with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s) &ldquo;<B>Continuing Directors</B>&rdquo;
means the directors of the Company on the Closing Date and each other director, if, in each case, such other director is nominated for
election by the Board a majority of whom are directors on the Closing Date or whose election or nomination for election was approved by
one or more of such directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)&nbsp;&ldquo;<B>Conversion
Floor Price Condition</B>&rdquo; means that the relevant Alternate Conversion Price is being determined based on clause (x)&nbsp;of such
definition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)&nbsp;&ldquo;<B>Convertible
Securities</B>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any shares
of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)&nbsp;&ldquo;<B>Dividend
Date</B>&rdquo; means January&nbsp;1, April&nbsp;1, July&nbsp;1 and October&nbsp;1 of each calendar year, with the first Dividend Date
being January&nbsp;1, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w)&nbsp;&ldquo;<B>Dividend
Rate</B>&rdquo; means seven percent (7.0%) per annum, as may be adjusted from time to time in accordance with Section&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)&nbsp;&ldquo;<B>Eligible
Market</B>&rdquo; means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the
Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y)&nbsp;&ldquo;<B>Equity Conditions</B>&rdquo;
means, with respect to a given date of determination: (i)&nbsp;on each day during the period beginning thirty Trading Days prior to such
applicable date of determination and ending on and including such applicable date of determination all shares of Common Stock issuable
upon conversion of the Preferred Shares shall be eligible to be resold by the Holders without restriction or any legend under any applicable
federal or state securities laws (in each case, disregarding any limitation on conversion of the Preferred Shares, other issuance of securities
with respect to the Preferred Shares); (ii)&nbsp;on each day during the period beginning thirty Trading Days prior to the applicable date
of determination and ending on and including the applicable date of determination (the &ldquo;Equity Conditions Measuring Period&rdquo;),
the Common Stock (including all shares of Common Stock issued or issuable upon conversion of the Preferred Shares and exercise of the
Warrants) is listed or designated for quotation (as applicable) on an Eligible Market and shall not have been suspended from trading on
an Eligible Market (other than suspensions of not more than two (2)&nbsp;days and occurring prior to the applicable date of determination
due to business announcements by the Company) nor shall delisting or suspension by an Eligible Market have been threatened (with a reasonable
prospect of delisting occurring after giving effect to all applicable notice, appeal, compliance and hearing periods) or reasonably likely
to occur or pending as evidenced by (A)&nbsp;a writing by such Eligible Market or (B)&nbsp;the Company falling below the minimum listing
maintenance requirements of the Eligible Market on which the Common Stock is then listed or designated for quotation, as applicable; (iii)&nbsp;during
the Equity Conditions Measuring Period, the Company shall have delivered all shares of Common Stock issuable upon conversion of the Preferred
Shares on a timely basis as set forth in Section&nbsp;4 hereof and all other shares of capital stock required to be delivered by the Company
on a timely basis as set forth in the other Transaction Documents; (iv)&nbsp;any shares of Common Stock to be issued in connection with
the event requiring determination (or issuable upon conversion of the Conversion Amount being redeemed in the event requiring this determination)
may be issued in full without violating Section&nbsp;4(d)&nbsp;hereof; (v)&nbsp;any shares of Common Stock to be issued in connection
with the event requiring determination (or issuable upon conversion of the Conversion Amount being redeemed in the event requiring this
determination (without regards to any limitations on conversion set forth herein)) may be issued in full without violating the rules&nbsp;or
regulations of the Eligible Market on which the Common Stock is then listed or designated for quotation (as applicable); (vi)&nbsp;on
each day during the Equity Conditions Measuring Period, no public announcement of a pending, proposed or intended Fundamental Transaction
shall have occurred which has not been abandoned, terminated or consummated; (vii)&nbsp;none of the Holders shall be in possession of
any material, non-public information provided to any of them by the Company, any of its Subsidiaries or any of their respective affiliates,
employees, officers, representatives, agents or the like; (viii)&nbsp;on each day during the Equity Conditions Measuring Period, the Company
otherwise shall have been in compliance with each, and shall not have breached any representation or warranty in any material respect
(other than representations or warranties subject to material adverse effect or materiality, which may not be breached in any respect)
or any covenant or other term or condition of any Transaction Document, including, without limitation, the Company shall not have failed
to timely make any payment pursuant to any Transaction Document; (ix)&nbsp;on each Trading Day during the Equity Conditions Measuring
Period, there shall not have occurred any Volume Failure or Price Failure as of such applicable date of determination; (x)&nbsp;on the
applicable date of determination (A)&nbsp;no Authorized Share Failure shall exist or be continuing and the applicable Required Reserve
Amount of shares of Common Stock are available under the Certificate of Incorporation of the Company and reserved by the Company to be
issued pursuant to this Articles of Designations and the Warrants and (B)&nbsp;all shares of Common Stock to be issued in connection with
the event requiring this determination may be issued in full without resulting in an Authorized Share Failure; (xi)&nbsp;on each day during
the Equity Conditions Measuring Period, there shall not have occurred and there shall not exist a Triggering Event or an event that with
the passage of time or giving of notice would constitute a Triggering Event; or (xii)&nbsp;the shares of Common Stock issuable pursuant
to the event requiring the satisfaction of the Equity Conditions are duly authorized and listed and eligible for trading without restriction
on an Eligible Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z)&nbsp;&ldquo;<B>Equity Conditions
Failure</B>&rdquo; means that with respect to any date of determination, on any day during the thirty Trading Day period ending on, and
including, such date of determination, the Equity Conditions have not been satisfied (or waived in writing by the applicable Holder).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aa) &ldquo;<B>Event Market
Price</B>&rdquo; means, with respect to any Stock Combination Event Date, the lower of (i) the Conversion Price in effect immediately
after such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following such Stock Combination Event Date as set
forth herein), and (ii) the lowest VWAP of the Common Stock during the eleven (11) consecutive Trading Day period commencing on the fifth
(5th) Trading Day immediately preceding the date of such Stock Combination Event Date and ending on the fifth (5th) Trading Day immediately
following the Stock Combination Event Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bb) &ldquo;<B>Excluded Securities</B>&rdquo;
means (i) shares of Common Stock or standard options to purchase Common Stock issued to directors, officers or employees of the Company
for services rendered to the Company in their capacity as such pursuant to an Approved Stock Plan (as defined above); provided that (A)
all such issuances (taking into account the shares of Common Stock issuable upon exercise of such options) after the Subscription Date
pursuant to this clause (i) do not, in the aggregate, exceed more than 10.0% of the sum of (1) the shares of Common Stock issued and outstanding
immediately prior to the Subscription Date, (2) the shares of Common Stock issuable upon conversion in full of the Preferred Shares (assuming
for purposes hereof that (x) the Preferred Shares are convertible at the Conversion Price (as defined in the Certificate of Designations)
as of the Closing Date, and (y) any such conversion shall not take into account any limitations on the conversion of the Preferred Shares
as set forth herein) issued and outstanding as of the Closing Date, and (3) the shares of Common Stock issuable upon conversion in full
of the Series D Convertible Preferred Stock, par value $0.0001 per share, of the Company (&ldquo;Series D Preferred Stock&rdquo;) (assuming
for purposes hereof that (x) the shares of Series D Preferred Stock are convertible at the Conversion Price (as defined in the certificate
of designations of the Series D Convertible Preferred Stock of the Company (&ldquo;Series D Certificate of Designations&rdquo;)) as of
the Closing Date, and (y) any such conversion shall not take into account any limitations on the conversion of the shares of the Series
D Preferred Stock set forth in the Series D Certificate of Designations) issued and outstanding as of the Closing Date, and (B) the exercise
price of any such options is not lowered, none of such options are amended to increase the number of shares issuable thereunder and none
of the terms or conditions of any such options are otherwise materially changed in any manner that adversely affects any of the Buyers
(as defined in the Securities Purchase Agreement), (ii) shares of Common Stock issued upon the conversion or exercise of Convertible Securities
(other than standard options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above)
issued prior to the Subscription Date, provided that the conversion price of any such Convertible Securities (other than standard options
to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) is not lowered (other than in
accordance with the terms thereof in effect as of the Subscription Date) from the conversion price in effect as of the Subscription Date
(whether pursuant to the terms of such Convertible Securities or otherwise), none of such Convertible Securities (other than standard
options to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are amended to increase
the number of shares issuable thereunder and none of the terms or conditions of any such Convertible Securities (other than standard options
to purchase Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) are otherwise materially changed
in any manner that adversely affects any of the Buyers; (iii) the shares of Common Stock issuable upon conversion of the Preferred Shares
or otherwise pursuant to the terms of this Certificate of Designations; provided, that the terms of this Certificate of Designations are
not amended, modified or changed on or after the Subscription Date (other than in accordance with the terms thereof, including antidilution
adjustments pursuant to the terms thereof in effect as of the Subscription Date), and (iv) the shares of Common Stock issuable upon exercise
of the Warrants; provided, that the terms of the Warrants are not amended, modified or changed on or after the Subscription Date (other
than antidilution adjustments pursuant to the terms thereof in effect as of the Subscription Date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(cc) &ldquo;<B>Floor Price</B>&rdquo;
means the lower of (i) $1.46 (or such lower amount as permitted, from time to time, by the Principal Market) and (ii) 20% of the &ldquo;Minimum
Price&rdquo; (as defined in Rule 5635 of the Rule of the Nasdaq Stock Market) on the Stockholder Approval Date (as defined in the Securities
Purchase Agreement) (or such lower amount as permitted, from time to time, by the Principal Market); in each case, subject to adjustment
for stock splits, stock dividends, stock combinations, recapitalizations or other similar events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(dd) &ldquo;<B>Fundamental Transaction</B>&rdquo;
means (A)&nbsp;that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more
related transactions, (i)&nbsp;consolidate or merge with or into (whether or not the Company is the surviving corporation) another Subject
Entity, or (ii)&nbsp;sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of the
Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule&nbsp;1-02 of Regulation S-X) to one or more Subject Entities,
or (iii)&nbsp;make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its Common Stock be subject
to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders of at least either
(x)&nbsp;50% of the outstanding shares of Common Stock, (y)&nbsp;50% of the outstanding shares of Common Stock calculated as if any shares
of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities making or party to, such purchase,
tender or exchange offer were not outstanding; or (z)&nbsp;such number of shares of Common Stock such that all Subject Entities making
or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer, become collectively the
beneficial owners (as defined in Rule&nbsp;13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (iv)&nbsp;consummate
a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate,
in any transaction or series or related transactions, acquire, either (x)&nbsp;at least 50% of the outstanding shares of Common Stock,
(y)&nbsp;at least 50% of the outstanding shares of Common Stock calculated as if any shares of Common Stock held by all the Subject Entities
making or party to, or Affiliated with any Subject Entity making or party to, such stock purchase agreement or other business combination
were not outstanding; or (z)&nbsp;such number of shares of Common Stock such that the Subject Entities become collectively the beneficial
owners (as defined in Rule&nbsp;13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v)&nbsp;reorganize,
recapitalize or reclassify its Common Stock, (B)&nbsp;that the Company shall, directly or indirectly, including through subsidiaries,
Affiliates or otherwise, in one or more related transactions, allow any Subject Entity individually or the Subject Entities in the aggregate
to be or become the &ldquo;beneficial owner&rdquo; (as defined in Rule&nbsp;13d-3 under the 1934 Act), directly or indirectly, whether
through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock,
merger, consolidation, business combination, reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization
or reclassification or otherwise in any manner whatsoever, of either (x)&nbsp;at least 50% of the aggregate ordinary voting power represented
by issued and outstanding Common Stock, (y)&nbsp;at least 50% of the aggregate ordinary voting power represented by issued and outstanding
Common Stock not held by all such Subject Entities as of the date of this Certificate of Designations calculated as if any shares of Common
Stock held by all such Subject Entities were not outstanding, or (z)&nbsp;a percentage of the aggregate ordinary voting power represented
by issued and outstanding shares of Common Stock or other equity securities of the Company sufficient to allow such Subject Entities to
effect a statutory short form merger or other transaction requiring other stockholders of the Company to surrender their shares of Common
Stock without approval of the stockholders of the Company or (C)&nbsp;directly or indirectly, including through subsidiaries, Affiliates
or otherwise, in one or more related transactions, the issuance of or the entering into any other instrument or transaction structured
in a manner to circumvent, or that circumvents, the intent of this definition in which case this definition shall be construed and implemented
in a manner otherwise than in strict conformity with the terms of this definition to the extent necessary to correct this definition or
any portion of this definition which may be defective or inconsistent with the intended treatment of such instrument or transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ee) &ldquo;<B>GAAP</B>&rdquo;
means United States generally accepted accounting principles, consistently applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ff) &ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section&nbsp;13(d)&nbsp;of the 1934 Act and as defined in Rule&nbsp;13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(gg) [Reserved].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hh) &ldquo;<B>Indebtedness</B>&rdquo;
means of any Person means, without duplication (A)&nbsp;all indebtedness for borrowed money, (B)&nbsp;all obligations issued, undertaken
or assumed as the deferred purchase price of property or services, including, without limitation, &ldquo;capital leases&rdquo; in accordance
with United States generally accepted accounting principles consistently applied for the periods covered thereby (other than trade payables
entered into in the ordinary course of business consistent with past practice), (C)&nbsp;all reimbursement or payment obligations with
respect to letters of credit, surety bonds and other similar instruments, (D)&nbsp;all obligations evidenced by notes, bonds, debentures
or similar instruments, including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses,
(E)&nbsp;all indebtedness created or arising under any conditional sale or other title retention agreement, or incurred as financing,
in either case with respect to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies
of the seller or bank under such agreement in the event of default are limited to repossession or sale of such property), (F)&nbsp;all
monetary obligations under any leasing or similar arrangement which, in connection with United States generally accepted accounting principles,
consistently applied for the periods covered thereby, is classified as a capital lease, (G)&nbsp;all indebtedness referred to in clauses
(A)&nbsp;through (F)&nbsp;above secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise,
to be secured by) any mortgage, deed of trust, lien, pledge, charge, security interest or other encumbrance of any nature whatsoever in
or upon any property or assets (including accounts and contract rights) with respect to any asset or property owned by any Person, even
though the Person which owns such assets or property has not assumed or become liable for the payment of such indebtedness, and (H)&nbsp;all
Contingent Obligations in respect of indebtedness or obligations of others of the kinds referred to in clauses (A)&nbsp;through (G)&nbsp;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&nbsp;&ldquo;<B>Intellectual
Property Rights</B>&rdquo; means, with respect to the Company and its Subsidiaries, all of their rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, original works of authorship, patents, patent rights, copyrights,
inventions, licenses, approvals, governmental authorizations, trade secrets and other intellectual property rights and all applications
and registrations therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jj) &ldquo;<B>Investment</B>&rdquo;
means any beneficial ownership (including stock, partnership or limited liability company interests) of or in any Person, or any loan,
advance or capital contribution to any Person or the acquisition of all, or substantially all, of the assets of another Person or the
purchase of any assets of another Person for greater than the fair market value of such assets.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kk) &ldquo;<B>Involuntary Change
of Control</B>&rdquo; means a Change of Control that is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s
Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ll) &ldquo;<B>Liquidation Event</B>&rdquo;
means, whether in a single transaction or series of transactions, the voluntary or involuntary liquidation, dissolution or winding up
of the Company or such Subsidiaries the assets of which constitute all or substantially all of the assets of the business of the Company
and its Subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(mm) &ldquo;<B>Make-Whole Amount</B>&rdquo;
means, as of any given date and as applicable, in connection with any redemption or other repayment hereunder, an amount equal to the
amount of additional Dividends that would accrue under this Certificate of Designations at the Dividend Rate then in effect assuming for
calculation purposes that the aggregate Stated Value of the Preferred Shares as of the Closing Date remained outstanding through and including
the Maturity Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(nn) &#8239;[Reserved].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(oo) &ldquo;<B>Maturity Date</B>&rdquo;
shall mean April 13, 2027; provided, however, the Maturity Date may be extended upon the mutual consent of a Holder and the Company with
respect to such Holder; and provided further, however, the Maturity Date may be extended at the option of a Holder with respect to such
Holder (i) in the event that, and for so long as, a Triggering Event shall have occurred and be continuing or any event shall have occurred
and be continuing that with the passage of time and the failure to cure would result in a Triggering Event or (ii) through the date that
is twenty (20) Business Days after the consummation of a Fundamental Transaction in the event that a Fundamental Transaction is publicly
announced or a Change of Control Notice is delivered prior to the Maturity Date, provided further that if a Holder elects to convert some
or all of its Preferred Shares pursuant to Section 4 hereof, and the Conversion Amount would be limited pursuant to Section 4(d) hereunder,
the Maturity Date shall automatically be extended until such time as such provision shall not limit the conversion of such Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(pp) &ldquo;<B>Maturity Redemption
Premium</B>&rdquo; means 106%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(qq) &ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(rr) &ldquo;<B>Parent Entity</B>&rdquo;
of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security
is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with
the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ss) &ldquo;<B>Permitted Indebtedness</B>&rdquo;
means (i) Indebtedness existing on June 30, 2025, and reflected on the Company&rsquo;s balance sheet included in the Company&rsquo;s Quarterly
Report on Form 10-Q filed with the SEC on August 14, 2025, (ii) Indebtedness secured by Permitted Liens or unsecured but as described
in clauses (iv) and (v) of the definition of Permitted Liens, (iii) Indebtedness assumed by the Company in connection with any strategic
merger transaction, including, without limitation, a reverse merger, and (iv) if (x) the Stockholder Approval Date has occurred, and (y)
less than 1,100 Preferred Shares remain outstanding, the Permitted Senior Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(tt) &ldquo;<B>Permitted Liens</B>&rdquo;
means (i)&nbsp;any Lien for taxes not yet due or delinquent or being contested in good faith by appropriate proceedings for which adequate
reserves have been established in accordance with GAAP, (ii)&nbsp;any statutory Lien arising in the ordinary course of business by operation
of law with respect to a liability that is not yet due or delinquent, (iii)&nbsp;any Lien created by operation of law, such as materialmen&rsquo;s
liens, mechanics&rsquo; liens and other similar liens, arising in the ordinary course of business with respect to a liability that is
not yet due or delinquent or that are being contested in good faith by appropriate proceedings, (iv)&nbsp;Liens (A)&nbsp;upon or in any
equipment acquired or held by the Company or any of its Subsidiaries to secure the purchase price of such equipment or Indebtedness incurred
solely for the purpose of financing the acquisition or lease of such equipment, or (B)&nbsp;existing on such equipment at the time of
its acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon, and the proceeds of such
equipment, in either case, with respect to Indebtedness in an aggregate amount not to exceed $150,000, (v)&nbsp;Liens incurred in connection
with the extension, renewal or refinancing of the Indebtedness secured by Liens of the type described in clause (iv)&nbsp;above, provided
that any extension, renewal or replacement Lien shall be limited to the property encumbered by the existing Lien and the principal amount
of the Indebtedness being extended, renewed or refinanced does not increase, (vi)&nbsp;Liens in favor of customs and revenue authorities
arising as a matter of law to secure payments of custom duties in connection with the importation of goods, (vii)&nbsp;Liens arising from
judgments, decrees or attachments in circumstances not constituting a Triggering Event under Section&nbsp;5(a)(vii)&nbsp;and (viii)&nbsp;Liens
with respect to the Permitted Senior Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(uu) &ldquo;<B>Permitted Senior
Indebtedness</B>&rdquo; means non-convertible Indebtedness issued pursuant to a credit facility with a bank or similar financial institution
with no principal payments required prior to the 91st calendar day after the Maturity Date, provided, however, that the aggregate outstanding
principal amount of such Indebtedness permitted hereunder does not at any time exceed $10 million; provided, further, however, no Permitted
Senior Indebtedness shall permit the lender to accelerate such Permitted Senior Indebtedness as a result of the occurrence of any Triggering
Event hereunder or the Holder&rsquo;s delivery of a Triggering Event Redemption Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vv) &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ww) <B>&ldquo;Price Failure</B>&rdquo;
means, with respect to a particular date of determination, the VWAP of the Common Stock on any Trading Day during the twenty (20) Trading
Day period ending on the Trading Day immediately preceding such date of determination fails to exceed the Floor Price (as adjusted for
stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions occurring after the Subscription Date).
All such determinations to be appropriately adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other
similar transactions during any such measuring period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xx)&nbsp;&ldquo;<B>Principal
Market</B>&rdquo; means the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(yy) &ldquo;<B>Redemption Notices</B>&rdquo;
means, collectively, the Triggering Events Redemption Notices and the Change of Control Redemption Notices, and each of the foregoing,
individually, a &ldquo;Redemption Notice.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(zz) &ldquo;<B>Redemption Premium</B>&rdquo;
means 130%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aaa) &ldquo;<B>Redemption Prices</B>&rdquo;
means, collectively, any Triggering Event Redemption Price and Change of Control Redemption Price and each of the foregoing, individually,
a &ldquo;Redemption Price.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(bbb) &ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission or the successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ccc) &ldquo;<B>Securities Purchase
Agreement</B>&rdquo; means that certain securities purchase agreement by and among the Company and the initial holders of Preferred Shares,
dated as of the Subscription Date, as may be amended from time in accordance with the terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ddd) &ldquo;<B>Stated Value</B>&rdquo;
shall mean $1,000 per share, subject to adjustment for stock splits, stock dividends, recapitalizations, reorganizations, reclassifications,
combinations, subdivisions or other similar events occurring after the Initial Issuance Date with respect to the Preferred Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(eee) &ldquo;<B>Subscription
Date</B>&rdquo; means October 13, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(fff) &ldquo;<B>Subject Entity</B>&rdquo;
means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ggg) &ldquo;<B>Subsidiaries</B>&rdquo;
shall have the meaning as set forth in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(hhh) &ldquo;<B>Successor Entity</B>&rdquo;
means the Person (or, if so elected by the Required Holders, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Required Holders, the Parent Entity) with which such Fundamental Transaction shall
have been entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)&nbsp;&ldquo;<B>Trading
Day</B>&rdquo; means, as applicable, (x)&nbsp;with respect to all price or trading volume determinations relating to the Common Stock,
any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for
the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that
 &ldquo;Trading Day&rdquo; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less
than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market
(or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour
ending at 4:00:00 p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the applicable Holder or
(y)&nbsp;with respect to all determinations other than price determinations relating to the Common Stock, any day on which The New York
Stock Exchange (or any successor thereto) is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(jjj) &ldquo;<B>Transaction
Documents</B>&rdquo; means the Securities Purchase Agreement, this Certificate of Designations, the Warrants and each of the other agreements
and instruments entered into or delivered by the Company or any of the Holders in connection with the transactions contemplated by the
Securities Purchase Agreement, all as may be amended from time to time in accordance with the terms thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(kkk) &ldquo;<B>Volume Failure</B>&rdquo;
means, with respect to a particular date of determination, the aggregate daily dollar trading volume (as reported on Bloomberg) of the
Common Stock on the Principal Market on any Trading Day during the twenty (20) Trading Day period ending on the Trading Day immediately
preceding such date of determination (such period, the &ldquo;Volume Failure Measuring Period&rdquo;), is less than $1,000,000 (as adjusted
for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions occurring after the Subscription
Date).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(lll) &ldquo;<B>VWAP</B>&rdquo;
means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the
Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market
on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time,
as reported by Bloomberg through its &ldquo;VAP&rdquo; function (set to 09:30 start time and 16:00 end time) or, if the foregoing does
not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for
such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg,
or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing
bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such security on such date
on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company
and the Required Holders. If the Company and the Required Holders are unable to agree upon the fair market value of such security, then
such dispute shall be resolved in accordance with the procedures in Section&nbsp;25. All such determinations shall be appropriately adjusted
for any stock dividend, stock split, stock combination, recapitalization or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(mmm) &ldquo;<B>Warrants</B>&rdquo;
has the meaning ascribed to such term in the Securities Purchase Agreement, and shall include all warrants issued in exchange therefor
or replacement thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(nnn) &ldquo;<B>Warrant Shares</B>&rdquo;
means, collectively, the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">34. <U>Disclosure</U>. Upon
receipt or delivery by the Company of any notice in accordance with the terms of this Certificate of Designations, unless the Company
has in good faith determined that the matters relating to such notice do not constitute material, non-public information relating to the
Company or any of its Subsidiaries, the Company shall on or prior to 9:00 a.m., New York city time on the Business Day immediately following
such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form&nbsp;8-K or otherwise.
In the event that the Company believes that a notice contains material, non-public information relating to the Company or any of its Subsidiaries,
the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt of notice from such Holder,
as applicable), and in the absence of any such written indication in such notice (or notification from the Company immediately upon receipt
of notice from such Holder), such Holder shall be entitled to presume that information contained in the notice does not constitute material,
non-public information relating to the Company or any of its Subsidiaries. Nothing contained in this Section&nbsp;34 shall limit any obligations
of the Company, or any rights of any Holder, under Section&nbsp;4(l)&nbsp;of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">35. <U>Absence of Trading
and Disclosure Restrictions</U>. The Company acknowledges and agrees that no Holder is a fiduciary or agent of the Company and that each
Holder shall have no obligation to (a)&nbsp;maintain the confidentiality of any information provided by the Company or (b)&nbsp;refrain
from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an
officer of such Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,
written non-disclosure agreement, the Company acknowledges that each Holder may freely trade in any securities issued by the Company,
may possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information
to any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* * * * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Company
has caused this Certificate of Designations of Series E Convertible Preferred Stock of TAO Synergies Inc. to be signed by its Executive
Chairman on this 13th day of October, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TAO SYNERGIES INC.</B></FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 3%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 50%; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: Joshua N. Silverman</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: Executive Chairman</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TAO SYNERGIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONVERSION NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is made to the Certificate
of Designations of the Series&nbsp;E Convertible Preferred Stock of TAO Synergies Inc. (the &ldquo;<B>Certificate of Designations</B>&rdquo;).
In accordance with and pursuant to the Certificate of Designations, the undersigned hereby elects to convert the number of shares of Series&nbsp;E
Convertible Preferred Stock, $0.001 par value per share (the &ldquo;<B>Preferred Shares</B>&rdquo;), of TAO Synergies Inc. a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), indicated below into shares of common stock, $0.0001 value per share (the &ldquo;<B>Common
Stock</B>&rdquo;), of the Company, as of the date specified below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt; width: 69%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date of Conversion:</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-bottom: black 1pt solid; width: 31%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate number of Preferred Shares to be converted</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate Stated Value of such Preferred Shares to be converted:</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Aggregate accrued and unpaid Dividends and accrued and unpaid Late Charges with respect to such Preferred Shares and such Aggregate Dividends to be converted:</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">AGGREGATE CONVERSION AMOUNT TO BE CONVERTED:</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Please confirm the following information:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conversion Price:</FONT></TD>
    <TD STYLE="padding-right: 5pt; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number of shares of Common Stock to be issued:</FONT></TD>
    <TD STYLE="padding-right: 5pt; vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If this Conversion Notice is being delivered
    with respect to an Alternate Conversion, check here if Holder is electing to use the following Alternate Conversion Price:____________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please issue the Common Stock into which the applicable Preferred
Shares are being converted to Holder, or for its benefit, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Check here if requesting delivery as a certificate
    to the following name and to the following address:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issue to:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 30%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Wingdings">&uml;</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif">Check here
    if requesting delivery by Deposit/Withdrawal at Custodian as follows:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Participant:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">DTC Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 70%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Account Number:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 30%">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date: _____________ __, ____</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name of Registered Holder</FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 45%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Tax ID:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; width: 40%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 38%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby (a)&nbsp;acknowledges
this Conversion Notice, (b)&nbsp;certifies that the above indicated number of shares of Common Stock are eligible to be resold by the
Holder without restriction or any legend and (c)&nbsp;hereby directs _________________ to issue the above indicated number of shares of
Common Stock in accordance with the Transfer Agent Instructions dated __________, 2025 from the Company and acknowledged and agreed to
by ________________________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>TAO SYNERGIES INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 47%">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>tm2528153d1_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.1</B></P>

<P STYLE="margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM OF WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED
(I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B)
AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS
NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED
BY THE SECURITIES. THE NUMBER OF SHARES OF COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY BE LESS THAN THE AMOUNTS SET FORTH
ON THE FACE HEREOF PURSUANT TO SECTION 1(a) OF THIS WARRANT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TAO SYNERGIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrant To Purchase Common Stock</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrant No.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date of Issuance: October 15, 2025 (&ldquo;<B>Issuance
Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">TAO Synergies Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, [BUYER], the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is
entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,
upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or
replacement hereof, the &ldquo;<B>Warrant</B>&rdquo;), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New
York time, on the Expiration Date (as defined below), ______________ (subject to adjustment as provided herein) fully paid and non-assessable
shares of Common Stock (as defined below)<B>&nbsp;</B>(the &ldquo;<B>Warrant Shares</B>&rdquo;, and such number of Warrant Shares, the
 &ldquo;<B>Warrant Number</B>&rdquo;). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set
forth in Section 17 or in the Securities Purchase Agreement (as defined below). This Warrant is one of the Warrants to Purchase Common
Stock (the &ldquo;<B>SPA Warrants</B>&rdquo;) issued pursuant to Section 1 of that certain Securities Purchase Agreement, dated as of
October 13, 2025 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the Company and the investors (the &ldquo;<B>Buyers</B>&rdquo;)
referred to therein, as amended from time to time (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>EXERCISE
OF WARRANT.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Mechanics of Exercise</U>.
Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(f)), this Warrant may
be exercised by the Holder on any day on or after the Issuance Date (an &ldquo;<B>Exercise Date</B>&rdquo;), in whole or in part, by delivery
(whether via facsimile or otherwise) of a written notice, in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise
Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading Day (or any other settlement cycle
as may be in effect pursuant to Rule 15c6-1 under the Exchange Act from time to time) following an exercise of this Warrant as aforesaid,
the Holder shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied
by the number of Warrant Shares as to which this Warrant was so exercised (the &ldquo;<B>Aggregate Exercise Price</B>&rdquo;) in cash
or via wire transfer of immediately available funds if the Holder did not notify the Company in such Exercise Notice that such exercise
was made pursuant to a Cashless Exercise (as defined in Section 1(d)). The Holder shall not be required to deliver the original of this
Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect to less than all of the Warrant
Shares shall have the same effect as cancellation of the original of this Warrant and issuance of a new Warrant evidencing the right to
purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise Notice for all of the then-remaining Warrant Shares
shall have the same effect as cancellation of the original of this Warrant after delivery of the Warrant Shares in accordance with the
terms hereof. On or before the first (1st) Trading Day following the date on which the Company has received an Exercise Notice, the Company
shall transmit by facsimile or electronic mail an acknowledgment of confirmation of receipt of such Exercise Notice, in the form attached
hereto as <B><U>Exhibit B</U></B>, to the Holder and the Company&rsquo;s transfer agent (the &ldquo;<B>Transfer Agent</B>&rdquo;), which
confirmation shall constitute an instruction to the Transfer Agent to process such Exercise Notice in accordance with the terms herein.
On or before the first (1st) Trading Day following the date on which the Company has received such Exercise Notice (or such earlier date
as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade of such Warrant Shares
initiated on the applicable Exercise Date), the Company shall (X) provided that the Transfer Agent is participating in The Depository
Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;), upon the request of the
Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s
or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal at Custodian system, or (Y) if the Transfer Agent is not
participating in the DTC FAST, upon the request of the Holder, issue and deliver (via reputable overnight courier) to the address as specified
in the Exercise Notice, a certificate, registered in the name of the Holder or its designee, for the number of shares of Common Stock
to which the Holder shall be entitled pursuant to such exercise. Upon delivery of an Exercise Notice, the Holder shall be deemed for all
corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date such Warrant Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the certificates evidencing
such Warrant Shares (as the case may be). If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and
the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired
upon an exercise and upon surrender of this Warrant to the Company by the Holder, then, at the request of the Holder, the Company shall
as soon as practicable and in no event later than two (2) Business Days after any exercise and at its own expense, issue and deliver to
the Holder (or its designee) a new Warrant (in accordance with Section 7(d)) representing the right to purchase the number of Warrant
Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this
Warrant is exercised. No fractional shares of Common Stock are to be issued upon the exercise of this Warrant, but rather the number of
shares of Common Stock to be issued shall be rounded up to the nearest whole number. The Company shall pay any and all transfer, stamp,
issuance and similar taxes, costs and expenses (including, without limitation, fees and expenses of the Transfer Agent) that may be payable
with respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant. Notwithstanding the foregoing, except in the
case where an exercise of this Warrant is validly made pursuant to a Cashless Exercise, the Company&rsquo;s failure to deliver Warrant
Shares to the Holder on or prior to the later of (i) two (2) Trading Days after receipt of the applicable Exercise Notice (or such earlier
date as required pursuant to the 1934 Act or other applicable law, rule or regulation for the settlement of a trade of such Warrant Shares
initiated on the applicable Exercise Date) and (ii) one (1) Trading Day after the Company&rsquo;s receipt of the Aggregate Exercise Price
(or valid notice of a Cashless Exercise if permissible) (such later date, the &ldquo;<B>Share Delivery Date</B>&rdquo;) shall not be deemed
to be a breach of this Warrant. Notwithstanding anything to the contrary contained in this Warrant or the Registration Rights Agreement,
after the effective date of the Registration Statement (as defined in the Registration Rights Agreement) and prior to the Holder&rsquo;s
receipt of the notice of a Grace Period (as defined in the Registration Rights Agreement), the Company shall cause the Transfer Agent
to deliver unlegended shares of Common Stock to the Holder (or its designee) in connection with any sale of Registrable Securities (as
defined in the Registration Rights Agreement) with respect to which the Holder has entered into a contract for sale, and delivered a copy
of the prospectus included as part of the particular Registration Statement to the extent applicable, and for which the Holder has not
yet settled. From the Issuance Date through and including the Expiration Date, the Company shall maintain a transfer agent that participates
in FAST.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b) <U>Exercise Price</U>. For purposes of this
Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $8.00, subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Company&rsquo;s Failure
to Timely Deliver Securities</U>. If the Company shall fail, for any reason or for no reason, on or prior to the Share Delivery Date,
either (I) if the Transfer Agent is not participating in FAST, to issue and deliver to the Holder (or its designee) a certificate for
the number of Warrant Shares to which the Holder is entitled and register such Warrant Shares on the Company&rsquo;s share register or,
if the Transfer Agent is participating in FAST, to credit the balance account of the Holder or the Holder&rsquo;s designee with DTC for
such number of Warrant Shares to which the Holder is entitled upon the Holder&rsquo;s exercise of this Warrant (as the case may be) or
(II) if a Registration Statement covering the resale of the Warrant Shares that are the subject of the Exercise Notice (the &ldquo;<B>Unavailable
Warrant Shares</B>&rdquo;) is not available for the resale of such Unavailable Warrant Shares and the Company fails to promptly, but in
no event later than as required pursuant to the Registration Rights Agreement (x) so notify the Holder and (y) deliver the Warrant Shares
electronically without any restrictive legend by crediting such aggregate number of Warrant Shares to which the Holder is entitled pursuant
to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit/Withdrawal At Custodian system
(the event described in the immediately foregoing clause (II) is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo; and together
with the event described in clause (I) above, a &ldquo;<B>Delivery Failure</B>&rdquo;), then, in addition to all other remedies available
to the Holder, (X) the Company shall pay in cash to the Holder on each day after the Share Delivery Date and during such Delivery Failure
an amount equal to 2% of the product of (A) the sum of the number of shares of Common Stock not issued to the Holder on or prior to the
Share Delivery Date and to which the Holder is entitled, multiplied by (B) any trading price of the Common Stock selected by the Holder
in writing as in effect at any time during the period beginning on the applicable Exercise Date and ending on the applicable Share Delivery
Date, and (Y) the Holder, upon written notice to the Company, may void its Exercise Notice with respect to, and retain or have returned,
as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the voiding
of an Exercise Notice shall not affect the Company&rsquo;s obligations to make any payments which have accrued prior to the date of such
notice pursuant to this Section 1(c) or otherwise. In addition to the foregoing, if on or prior to the Share Delivery Date either (I)
the Transfer Agent is not participating in the DTC FAST, the Company shall fail to issue and deliver to the Holder (or its designee) a
certificate and register such shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is participating
in the DTC FAST, the Transfer Agent shall fail to credit the balance account of the Holder or the Holder&rsquo;s designee with DTC for
the number of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder or pursuant to the Company&rsquo;s
obligation pursuant to clause (ii) below or (II) a Notice Failure occurs, and if on or after such Share Delivery Date the Holder acquires
(in an open market transaction, stock loan or otherwise) shares of Common Stock corresponding to all or any portion of the number of shares
of Common Stock issuable upon such exercise that the Holder is entitled to receive from the Company and has not received from the Company
in connection with such Delivery Failure or Notice Failure, as applicable (a &ldquo;<B>Buy-In</B>&rdquo;), then, in addition to all other
remedies available to the Holder, the Company shall, within two (2) Business Days after the Holder&rsquo;s request and in the Holder&rsquo;s
discretion, either (i) pay cash to the Holder in an amount equal to the Holder&rsquo;s total purchase price (including brokerage commissions,
stock loan costs and other out-of-pocket expenses, if any) for the shares of Common Stock so acquired (including, without limitation,
by any other Person in respect, or on behalf, of the Holder) (the &ldquo;<B>Buy-In Price</B>&rdquo;), at which point the Company&rsquo;s
obligation to so issue and deliver such certificate (and to issue such shares of Common Stock) or credit the balance account of such Holder
or such Holder&rsquo;s designee, as applicable, with DTC for the number of Warrant Shares to which the Holder is entitled upon the Holder&rsquo;s
exercise hereunder (as the case may be) (and to issue such Warrant Shares) shall terminate, or (ii) promptly honor its obligation to so
issue and deliver to the Holder a certificate or certificates representing such Warrant Shares or credit the balance account of such Holder
or such Holder&rsquo;s designee, as applicable, with DTC for the number of Warrant Shares to which the Holder is entitled upon the Holder&rsquo;s
exercise hereunder (as the case may be) and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over
the product of (A) such number of Warrant Shares multiplied by (B) the lowest Closing Sale Price of the Common Stock on any Trading Day
during the period commencing on the date of the applicable Exercise Notice and ending on the date of such issuance and payment under this
clause (ii) (the &ldquo;<B>Buy-In Payment Amount</B>&rdquo;). Nothing shall limit the Holder&rsquo;s right to pursue any other remedies
available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief
with respect to the Company&rsquo;s failure to timely deliver certificates representing shares of Common Stock (or to electronically deliver
such shares of Common Stock) upon the exercise of this Warrant as required pursuant to the terms hereof. While this Warrant is outstanding,
the Company shall cause its transfer agent to participate in FAST. In addition to the foregoing rights, (i) if the Company fails to deliver
the applicable number of Warrant Shares upon an exercise pursuant to Section 1 by the applicable Share Delivery Date, then the Holder
shall have the right to rescind such exercise in whole or in part and retain and/or have the Company return, as the case may be, any portion
of this Warrant that has not been exercised pursuant to such Exercise Notice; provided that the rescission of an exercise shall not affect
the Company&rsquo;s obligation to make any payments that have accrued prior to the date of such notice pursuant to this Section 1(c) or
otherwise, and (ii) if a registration statement (which may be the Registration Statement) covering the issuance or resale of the Warrant
Shares that are subject to an Exercise Notice is not available for the issuance or resale, as applicable, of such Warrant Shares, as required
by and in accordance with the terms of the Registration Rights Agreement, and the Holder has submitted an Exercise Notice prior to receiving
notice of the non-availability of such registration statement and the Company has not already delivered the Warrant Shares underlying
such Exercise Notice electronically without any restrictive legend by crediting such aggregate number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal
At Custodian system, the Holder shall have the option, by delivery of notice to the Company, to (x) rescind such Exercise Notice in whole
or in part and retain or have returned, as the case may be, any portion of this Warrant that has not been exercised pursuant to such Exercise
Notice; provided that the rescission of an Exercise Notice shall not affect the Company&rsquo;s obligation to make any payments that have
accrued prior to the date of such notice pursuant to this Section 1(c) or otherwise, and/or (y) switch some or all of such Exercise Notice
from a cash exercise to a Cashless Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Cashless Exercise</U>.
Notwithstanding anything contained herein to the contrary (other than Section 1(f) below), if at the time of exercise hereof a Registration
Statement (as defined in the Registration Rights Agreement) is not effective (or the prospectus contained therein is not available for
use) for the resale by the Holder of all of the Warrant Shares, then the Holder may, in its sole discretion, exercise this Warrant in
whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment
of the Aggregate Exercise Price, elect instead to receive upon such exercise the &ldquo;Net Number&rdquo; of Warrant Shares determined
according to the following formula (a &ldquo;<B>Cashless Exercise</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Net Number = <U>(A x B) - (A x C)</U></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;B</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.25in">For purposes of the foregoing
formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A= the total number of shares with respect to
which this Warrant is then being exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">B = as elected by the Holder: (i) the VWAP of
the Common Stock on the Trading Day immediately preceding the date of the applicable Exercise Notice if such Exercise Notice is (1) both
executed and delivered pursuant to Section 1(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 1(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(64) of
Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP
on the Trading Day immediately preceding the date of the applicable Exercise Notice or (z) the Bid Price of the Common Stock as of the
time of the Holder&rsquo;s execution of the applicable Exercise Notice if such Exercise Notice is executed during &ldquo;regular trading
hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter pursuant to Section 1(a) hereof, or (iii) the Closing Sale
Price of the Common Stock on the date of the applicable Exercise Notice if the date of such Exercise Notice is a Trading Day and such
Exercise Notice is both executed and delivered pursuant to Section 1(a) hereof after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">C = the Exercise
Price then in effect for the applicable Warrant Shares at the time of such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Warrant Shares are
issued in a Cashless Exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the 1933 Act, the Warrant
Shares take on the registered characteristics of the Warrants being exercised. For purposes of Rule 144(d) promulgated under the 1933
Act, as in effect on the Subscription Date, it is intended that the Warrant Shares issued in a Cashless Exercise shall be deemed to have
been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant
was originally issued pursuant to the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Disputes</U>. In the
case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to be issued
pursuant to the terms hereof, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve
such dispute in accordance with Section 15.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Limitations on Exercises</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Beneficial
Ownership</U>. The Company shall not effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise
any portion of this Warrant, pursuant to the terms and conditions of this Warrant and any such exercise shall be null and void and treated
as if never made, to the extent that after giving effect to such exercise, the Holder together with the other Attribution Parties collectively
would beneficially own in excess of [4.99][9.99]% (the &ldquo;<B>Maximum Percentage</B>&rdquo;) of the Common Stock outstanding immediately
after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially
owned by the Holder and the other Attribution Parties shall include the number of shares of Common Stock held by the Holder and all other
Attribution Parties plus the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which the determination
of such sentence is being made, but shall exclude shares of Common Stock which would be issuable upon (A) exercise of the remaining, unexercised
portion of this Warrant beneficially owned by the Holder or any of the other Attribution Parties and (B) exercise or conversion of the
unexercised or unconverted portion of any other securities of the Company (including, without limitation, any convertible notes or convertible
preferred stock or warrants, including other SPA Warrants) beneficially owned by the Holder or any other Attribution Party subject to
a limitation on conversion or exercise analogous to the limitation contained in this Section 1(f)(i). For purposes of this Section 1(f)(i),
beneficial ownership shall be calculated in accordance with Section 13(d) of the 1934 Act. In addition, a determination as to any group
status as contemplated above shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated
thereunder. For purposes of determining the number of outstanding shares of Common Stock the Holder may acquire upon the exercise of this
Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected
in (x) the Company&rsquo;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other
public filing with the SEC, as the case may be, (y) a more recent public announcement by the Company or (z) any other written notice by
the Company or the Transfer Agent, if any, setting forth the number of shares of Common Stock outstanding (the &ldquo;<B>Reported Outstanding
Share Number</B>&rdquo;). If the Company receives an Exercise Notice from the Holder at a time when the actual number of outstanding shares
of Common Stock is less than the Reported Outstanding Share Number, the Company shall (i) notify the Holder in writing of the number of
shares of Common Stock then outstanding and, to the extent that such Exercise Notice would otherwise cause the Holder&rsquo;s beneficial
ownership, as determined pursuant to this Section 1(f)(i), to exceed the Maximum Percentage, the Holder must notify the Company of a reduced
number of Warrant Shares to be acquired pursuant to such Exercise Notice (the number of shares by which such purchase is reduced, the
 &ldquo;<B>Reduction Shares</B>&rdquo;) and (ii) as soon as reasonably practicable, the Company shall return to the Holder any exercise
price paid by the Holder for the Reduction Shares. For any reason at any time, upon the written or oral request of the Holder, the Company
shall within one (1) Business Day confirm orally and in writing or by electronic mail to the Holder the number of shares of Common Stock
then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder and any other Attribution Party since the date as of which
the Reported Outstanding Share Number was reported. In the event that the issuance of shares of Common Stock to the Holder upon exercise
of this Warrant results in the Holder and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than
the Maximum Percentage of the number of outstanding shares of Common Stock (as determined under Section 13(d) of the 1934 Act), the number
of shares so issued by which the Holder&rsquo;s and the other Attribution Parties&rsquo; aggregate beneficial ownership exceeds the Maximum
Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed null and void and shall be cancelled ab initio, and the Holder shall
not have the power to vote or to transfer the Excess Shares. As soon as reasonably practicable after the issuance of the Excess Shares
has been deemed null and void, the Company shall return to the Holder the exercise price paid by the Holder for the Excess Shares. Upon
delivery of a written notice to the Company, the Holder may from time to time increase (with such increase not effective until the sixty-first
(61st) day after delivery of such notice) or decrease the Maximum Percentage to any other percentage not in excess of 9.99% as specified
in such notice; provided that (i) any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after
such notice is delivered to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution
Parties and not to any other holder of SPA Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the shares
of Common Stock issuable pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially
owned by the Holder for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to
exercise this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect
to any subsequent determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 1(f)(i) to the extent necessary to correct this paragraph or any portion of this
paragraph which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 1(f)(i) or
to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph
may not be waived and shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Principal
Market Regulation</U>. The Company shall not issue any shares of Common Stock upon the exercise of this Warrant if the issuance of such
shares of Common Stock (taken together with the issuance of such shares upon the conversion of the Preferred Shares or otherwise pursuant
to the terms of the Certificate of Designations) would exceed the aggregate number of shares of Common Stock which the Company may issue
upon exercise or conversion or otherwise pursuant to the terms of the Certificate of Designations and the SPA Warrants without breaching
the Company&rsquo;s obligations under the rules or regulations of the Principal Market (the number of shares which may be issued without
violating such rules and regulations, the &ldquo;<B>Exchange Cap</B>&rdquo;), except that such limitation shall not apply in the event
that the Company (A) obtains the approval of its stockholders as required by the applicable rules of the Principal Market for issuances
of shares of Common Stock in excess of such amount or (B) obtains a written opinion from outside counsel to the Company that such approval
is not required, which opinion shall be reasonably satisfactory to the Holder. Until such approval or such written opinion is obtained,
no Buyer shall be issued in the aggregate, upon conversion or exercise (as the case may be) of any Preferred Shares or any of the SPA
Warrants or otherwise pursuant to the terms of the Certificate of Designations or the SPA Warrants, shares of Common Stock in an amount
greater than the product of (i) the Exchange Cap as of the Issuance Date multiplied by (ii) the quotient of (1) the aggregate number of
Preferred Shares issued to such Buyer pursuant to the Securities Purchase Agreement on the Closing Date (as defined in the Securities
Purchase Agreement) divided by (2) the aggregate stated value of all Preferred Shares issued to the Buyers pursuant to the Securities
Purchase Agreement on the Closing Date (with respect to each Buyer, the &ldquo;<B>Exchange Cap Allocation</B>&rdquo;). In the event that
any Buyer shall sell or otherwise transfer any of such Buyer&rsquo;s SPA Warrants, the transferee shall be allocated a pro rata portion
of such Buyer&rsquo;s Exchange Cap Allocation with respect to such portion of such SPA Warrants so transferred, and the restrictions of
the prior sentence shall apply to such transferee with respect to the portion of the Exchange Cap Allocation so allocated to such transferee.
Upon conversion and exercise in full of a holder&rsquo;s Preferred Shares and SPA Warrants, the difference (if any) between such holder&rsquo;s
Exchange Cap Allocation and the number of shares of Common Stock actually issued to such holder upon such holder&rsquo;s conversion in
full of such Preferred Shares and such holder&rsquo;s exercise in full of such SPA Warrants shall be allocated, to the respective Exchange
Cap Allocations of the remaining holders of Preferred Shares and related SPA Warrants on a pro rata basis in proportion to the shares
of Common Stock underlying the Preferred Shares and related SPA Warrants then held by each such holder of Preferred Shares and related
SPA Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Reservation of Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Required
Reserve Amount</U>. So long as this Warrant remains outstanding, the Company shall at all times keep reserved for issuance under this
Warrant a number of shares of Common Stock at least equal to 150% of the maximum number of shares of Common Stock as shall be necessary
to satisfy the Company&rsquo;s obligation to issue shares of Common Stock under the SPA Warrants then outstanding (without regard to any
limitations on exercise) (the &ldquo;<B>Required Reserve Amount</B>&rdquo;); provided that at no time shall the number of shares of Common
Stock reserved pursuant to this Section 1(g)(i) be reduced other than proportionally in connection with any exercise or redemption of
SPA Warrants or such other event covered by Section 2(a) below. The Required Reserve Amount (including, without limitation, each increase
in the number of shares so reserved) shall be allocated pro rata among the holders of the SPA Warrants based on the number of shares of
Common Stock issuable upon exercise of SPA Warrants held by each holder on the Closing Date (as defined in the Securities Purchase Agreement)
(without regard to any limitations on exercise) or increase in the number of reserved shares, as the case may be (the &ldquo;<B>Authorized
Share Allocation</B>&rdquo;). In the event that a holder shall sell or otherwise transfer any of such holder&rsquo;s SPA Warrants, each
transferee shall be allocated a pro rata portion of such holder&rsquo;s Authorized Share Allocation. Any shares of Common Stock reserved
and allocated to any Person which ceases to hold any SPA Warrants shall be allocated to the remaining holders of SPA Warrants, pro rata
based on the number of shares of Common Stock issuable upon exercise of the SPA Warrants then held by such holders (without regard to
any limitations on exercise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Insufficient
Authorized Shares</U>. If, notwithstanding Section 1(g)(i) above, and not in limitation thereof, at any time while any of the SPA Warrants
remain outstanding, the Company does not have a sufficient number of authorized and unreserved shares of Common Stock to satisfy its obligation
to reserve the Required Reserve Amount (an &ldquo;<B>Authorized Share Failure</B>&rdquo;), then the Company shall use its best efforts
to take all action necessary to increase the Company&rsquo;s authorized shares of Common Stock to an amount sufficient to allow the Company
to reserve the Required Reserve Amount for all the SPA Warrants then outstanding. Without limiting the generality of the foregoing sentence,
as soon as practicable after the date of the occurrence of an Authorized Share Failure, but in no event later than sixty (60) days after
the occurrence of such Authorized Share Failure, the Company shall hold a meeting of its stockholders for the approval of an increase
in the number of authorized shares of Common Stock. In connection with such meeting, the Company shall provide each stockholder with a
proxy statement and shall use its best efforts to solicit its stockholders&rsquo; approval of such increase in authorized shares of Common
Stock and to cause its board of directors to recommend to the stockholders that they approve such proposal. Notwithstanding the foregoing,
if at any such time of an Authorized Share Failure, the Company is able to obtain the written consent of a majority of the shares of its
issued and outstanding shares of Common Stock to approve the increase in the number of authorized shares of Common Stock, the Company
may satisfy this obligation by obtaining such consent and submitting for filing with the SEC an Information Statement on Schedule 14C.
In the event that the Company is prohibited from issuing shares of Common Stock upon an exercise of this Warrant due to the failure by
the Company to have sufficient shares of Common Stock available out of the authorized but unissued shares of Common Stock (such unavailable
number of shares of Common Stock, the &ldquo;<B>Authorization Failure Shares</B>&rdquo;), in lieu of delivering such Authorization Failure
Shares to the Holder, the Company shall pay cash in exchange for the cancellation of such portion of this Warrant exercisable into such
Authorization Failure Shares at a price equal to the sum of (i) the product of (x) such number of Authorization Failure Shares and (y)
the greatest Closing Sale Price of the Common Stock on any Trading Day during the period commencing on the date the Holder delivers the
applicable Exercise Notice with respect to such Authorization Failure Shares to the Company and ending on the date of such issuance and
payment under this Section 1(g); and (ii) to the extent the Holder purchases (in an open market transaction or otherwise) shares of Common
Stock to deliver in satisfaction of a sale by the Holder of Authorization Failure Shares, any Buy-In Payment Amount, brokerage commissions
and other out-of-pocket expenses, if any, of the Holder incurred in connection therewith. Nothing contained in this Section 1(g) shall
limit any obligations of the Company under any provision of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant
are subject to adjustment from time to time as set forth in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Stock Dividends and
Splits</U>. Without limiting any provision of Section 2(b), Section 3 or Section 4, if the Company, at any time on or after the Subscription
Date, (i) pays a stock dividend on one or more classes of its then outstanding shares of Common Stock or otherwise makes a distribution
on any class of capital stock that is payable in shares of Common Stock, other than Excluded Securities (as defined in the Securities
Purchase Agreement), (ii) subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its then
outstanding shares of Common Stock into a larger number of shares or (iii) combines (by combination, reverse stock split or otherwise)
one or more classes of its then outstanding shares of Common Stock into a smaller number of shares then in each such case the Exercise
Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock outstanding immediately before
such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment
made pursuant to clause (i) of this paragraph shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become
effective immediately after the effective date of such subdivision or combination. If any event requiring an adjustment under this paragraph
occurs during the period that an Exercise Price is calculated hereunder, then the calculation of such Exercise Price shall be adjusted
appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Adjustment Upon Issuance
of Shares of Common Stock</U>. If and whenever on or after the Subscription Date, the Company shall sell, enter into an agreement to sell
or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or announce any offer, sale,
grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents (but excluding any Excluded Securities),
at an effective price per share less than the Exercise Price then in effect (such lower price, the &ldquo;<B>Base Share Price</B>&rdquo;
and such issuances collectively, a &ldquo;<B>Dilutive Issuance</B>&rdquo;) (it being understood and agreed that if the holder of the Common
Stock or Common Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating
conversion, exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with
such issuance, be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such
issuance shall be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective price),
then simultaneously with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall be reduced
and only reduced to equal the Base Share Price. Notwithstanding the foregoing, no adjustments shall be made, paid or issued under this
Section 2(b) in respect of the issuance of Excluded Securities. The Company shall notify the Holder, in writing, no later than the Trading
Day following the issuance or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 2(b), indicating
therein the applicable issuance price, or applicable reset price, exchange price, conversion price and other pricing terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Issuance
of Options</U>. If the Company in any manner grants, issues or sells (or enters into any agreement to grant, issue or sell) any Options
and the lowest price per share for which one share of Common Stock is at any time issuable upon the exercise of any such Option or upon
conversion, exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the
terms thereof is less than the Applicable Price, then such share of Common Stock shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the granting, issuance or sale (or the time of execution of such agreement to grant, issue or sell,
as applicable) of such Option for such price per share. For purposes of this Section 2(b)(i), the &ldquo;lowest price per share for which
one share of Common Stock is at any time issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any
Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1)
the lower of (x) the sum of the lowest amounts of consideration (if any) received or receivable by the Company with respect to any one
share of Common Stock upon the granting, issuance or sale (or pursuant to the agreement to grant, issue or sell, as applicable) of such
Option, upon exercise of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such
Option or otherwise pursuant to the terms thereof and (y) the lowest exercise price set forth in such Option for which one share of Common
Stock is issuable (or may become issuable assuming all possible market conditions) upon the exercise of any such Options or upon conversion,
exercise or exchange of any Convertible Securities issuable upon exercise of any such Option or otherwise pursuant to the terms thereof
minus (2) the sum of all amounts paid or payable to the holder of such Option (or any other Person) upon the granting, issuance or sale
(or the agreement to grant, issue or sell, as applicable) of such Option, upon exercise of such Option and upon conversion, exercise or
exchange of any Convertible Security issuable upon exercise of such Option or otherwise pursuant to the terms thereof plus the value of
any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other Person). Except as
contemplated below, no further adjustment of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock
or of such Convertible Securities upon the exercise of such Options or otherwise pursuant to the terms of or upon the actual issuance
of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <U>Issuance
of Convertible Securities</U>. If the Company in any manner issues or sells (or enters into any agreement to issue or sell) any Convertible
Securities and the lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise or
exchange thereof or otherwise pursuant to the terms thereof is less than the Applicable Price, then such share of Common Stock shall be
deemed to be outstanding and to have been issued and sold by the Company at the time of the issuance or sale (or the time of execution
of such agreement to issue or sell, as applicable) of such Convertible Securities for such price per share. For the purposes of this Section
2(b)(ii), the &ldquo;lowest price per share for which one share of Common Stock is at any time issuable upon the conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof&rdquo; shall be equal to (1) the lower of (x) the sum of the lowest amounts
of consideration (if any) received or receivable by the Company with respect to one share of Common Stock upon the issuance or sale (or
pursuant to the agreement to issue or sell, as applicable) of the Convertible Security and upon conversion, exercise or exchange of such
Convertible Security or otherwise pursuant to the terms thereof and (y) the lowest conversion price set forth in such Convertible Security
for which one share of Common Stock is issuable (or may become issuable assuming all possible market conditions) upon conversion, exercise
or exchange thereof or otherwise pursuant to the terms thereof minus (2) the sum of all amounts paid or payable to the holder of such
Convertible Security (or any other Person) upon the issuance or sale (or the agreement to issue or sell, as applicable) of such Convertible
Security plus the value of any other consideration received or receivable by, or benefit conferred on, the holder of such Convertible
Security (or any other Person). Except as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual
issuance of such shares of Common Stock upon conversion, exercise or exchange of such Convertible Securities or otherwise pursuant to
the terms thereof, and if any such issuance or sale of such Convertible Securities is made upon exercise of any Options for which adjustment
of this Warrant has been or is to be made pursuant to other provisions of this Section 2(b), except as contemplated below, no further
adjustment of the Exercise Price shall be made by reason of such issuance or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii) <U>Calculation
of Consideration Received</U>. If any Option and/or Convertible Security and/or Adjustment Right is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company (as determined by the Holder, the &ldquo;<B>Primary Security</B>&rdquo;,
and such Option and/or Convertible Security and/or Adjustment Right, the &ldquo;<B>Secondary Securities</B>&rdquo; and together with the
Primary Security, each a &ldquo;<B>Unit</B>&rdquo;), together comprising one integrated transaction, the aggregate consideration per share
of Common Stock with respect to such Primary Security shall be deemed to be the lower of (x) the purchase price of such Unit, (y) if such
Primary Security is an Option and/or Convertible Security, the lowest price per share for which one share of Common Stock is at any time
issuable upon the exercise or conversion of the Primary Security in accordance with Sections 2(b)(i) or 2(b)(ii) above and (z) the lowest
VWAP of the shares of Common Stock on any Trading Day during the five (5) Trading Day period (the &ldquo;<B>Adjustment Period</B>&rdquo;)
immediately following the public announcement of such Dilutive Issuance (for the avoidance of doubt, if such public announcement is released
prior to the opening of the Principal Market on a Trading Day, such Trading Day shall be the first Trading Day in such five Trading Day
period and if this Warrant is exercised, on any given Exercise Date during any such Adjustment Period, solely with respect to such portion
of this Warrant exercised on such applicable Exercise Date, such applicable Adjustment Period shall be deemed to have ended on, and included,
the Trading Day immediately prior to such Exercise Date). If any shares of Common Stock, Options or Convertible Securities are issued
or sold or deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be the net amount of consideration
received by the Company therefor. If any shares of Common Stock, Options or Convertible Securities are issued or sold for a consideration
other than cash, the amount of such consideration received by the Company will be the fair value of such consideration, except where such
consideration consists of publicly traded securities, in which case the amount of consideration received by the Company for such securities
will be the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding the date of receipt.
If any shares of Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with
any merger in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such
portion of the net assets and business of the non-surviving entity as is attributable to such shares of Common Stock, Options or Convertible
Securities (as the case may be). The fair value of any consideration other than cash or publicly traded securities will be determined
jointly by the Company and the Holder. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event
requiring valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair value of such consideration will be determined within five (5)
Trading Days after the tenth (10<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>) day following such Valuation Event by an independent,
reputable appraiser jointly selected by the Company and the Holder. The determination of such appraiser shall be final and binding upon
all parties absent manifest error and the fees and expenses of such appraiser shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv) <U>Record Date</U>.
If the Company takes a record of the holders of shares of Common Stock for the purpose of entitling them (A) to receive a dividend or
other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe for or purchase shares
of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the issuance or sale of the
shares of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution
or the date of the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Number of Warrant Shares</U>.
Simultaneously with any adjustment to the Exercise Price pursuant to Section 2, the number of Warrant Shares that may be purchased upon
exercise of this Warrant shall be increased or decreased proportionately, so that after such adjustment the aggregate Exercise Price payable
hereunder for the adjusted number of Warrant Shares shall be the same as the aggregate Exercise Price in effect immediately prior to such
adjustment (without regard to any limitations on exercise contained herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Reserved</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Stock Combination Event
Adjustment</U>.<B>&nbsp;</B>If at any time and from time to time on or after the Issuance Date there occurs any stock split, stock dividend,
stock combination, reverse stock split, recapitalization or other similar transaction involving the outstanding Common Stock (each, a
 &ldquo;<B>Stock Combination Event</B>&rdquo;, and such date thereof, the &ldquo;<B>Stock Combination Event Date</B>&rdquo;) and the Event
Market Price is less than the Exercise Price then in effect (after giving effect to the adjustment in clause 2(a) above), then on the
fifth (5th) Trading Day immediately following such Stock Combination Event (&ldquo;<B>Stock Combination Event Adjustment Date</B>&rdquo;),
the Exercise Price then in effect on the Stock Combination Event Adjustment Date (after giving effect to the adjustment in clause 2(a)
above) shall be reduced (but in no event increased) to the Event Market Price. For the avoidance of doubt, if the adjustment in the immediately
preceding sentence would otherwise result in an increase in the Exercise Price hereunder, no adjustment shall be made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) <U>Other Events</U>. In
the event that the Company (or any Subsidiary (as defined in the Securities Purchase Agreement)) shall take any action to which the provisions
hereof are not strictly applicable, or, if applicable, would not operate to protect the Holder from dilution or if any event occurs of
the type contemplated by the provisions of this Section 2 but not expressly provided for by such provisions (including, without limitation,
the granting of stock appreciation rights, phantom stock rights or other rights with equity features), then the Company&rsquo;s board
of directors shall in good faith determine and implement an appropriate adjustment in the Exercise Price and the number of Warrant Shares
(if applicable) so as to protect the rights of the Holder, provided that no such adjustment pursuant to this Section 2(f) will increase
the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 2, provided further that
if the Holder does not accept such adjustments as appropriately protecting its interests hereunder against such dilution, then the Company&rsquo;s
board of directors and the Holder shall agree, in good faith, upon an independent investment bank of nationally recognized standing to
make such appropriate adjustments, whose determination shall be final and binding absent manifest error and whose fees and expenses shall
be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) <U>Calculations</U>. All
calculations under this Section 2 shall be made by rounding to the nearest cent or the nearest 1/100th of a share, as applicable. The
number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company,
and the disposition of any such shares shall be considered an issuance or sale of shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) <U>Voluntary Adjustment
By Company</U>. Subject to the rules and regulations of the Principal Market, the Company may at any time during the term of this Warrant,
with the prior written consent of the Required Holders (as defined in the Securities Purchase Agreement), reduce the then current Exercise
Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. In addition to any adjustments pursuant to Section 2 above or Section 4(a) below, if the Company shall
declare or make any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock,
by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property,
options, evidence of indebtedness or any other assets by way of a dividend, spin off, reclassification, corporate rearrangement, scheme
of arrangement or other similar transaction) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this Warrant, then,
in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated
therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately before
the date on which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of
shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that to the extent that the
Holder&rsquo;s right to participate in any such Distribution would result in the Holder and the other Attribution Parties exceeding the
Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to the extent of the Maximum Percentage
(and shall not be entitled to beneficial ownership of such shares of Common Stock as a result of such Distribution (and beneficial ownership)
to the extent of any such excess) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such
time or times, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,
at which time or times the Holder shall be granted such Distribution (and any Distributions declared or made on such initial Distribution
or on any subsequent Distribution held similarly in abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>PURCHASE
RIGHTS; FUNDAMENTAL TRANSACTIONS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Purchase Rights</U>.
In addition to any adjustments pursuant to Sections 2 or 3 above, if at any time the Company grants, issues or sells any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common Stock
(the &ldquo;<B>Purchase Rights</B>&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights,
the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations or restrictions on exercise of this Warrant, including without
limitation, the Maximum Percentage) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase
Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the
grant, issuance or sale of such Purchase Rights (<U>provided</U>, <U>however</U>, that to the extent that the Holder&rsquo;s right to
participate in any such Purchase Right would result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,
then the Holder shall not be entitled to participate in such Purchase Right to the extent of the Maximum Percentage (and shall not be
entitled to beneficial ownership of such shares of Common Stock as a result of such Purchase Right (and beneficial ownership) to the extent
of any such excess) and such Purchase Right to such extent shall be held in abeyance for the benefit of the Holder until such time or
times, if ever, as its right thereto would not result in the Holder and the other Attribution Parties exceeding the Maximum Percentage,
at which time or times the Holder shall be granted such right (and any Purchase Right granted, issued or sold on such initial Purchase
Right or on any subsequent Purchase Right held similarly in abeyance) to the same extent as if there had been no such limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;(b )<U>Fundamental
Transactions</U>. The Company shall not enter into or be party to a Fundamental Transaction unless (i) the Successor Entity assumes in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents (as defined in the Securities Purchase
Agreement) in accordance with the provisions of this Section 4(b) pursuant to written agreements in form and substance satisfactory to
the Holder and approved by the Holder prior to such Fundamental Transaction, including agreements to deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this
Warrant, including, without limitation, which is exercisable for a corresponding number of shares of capital stock equivalent to the shares
of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant)
prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital
stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value
of such shares of capital stock, such adjustments to the number of shares of capital stock and such exercise price being for the purpose
of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction) and (ii) the Successor
Entity (including its Parent Entity) is a publicly traded corporation whose common stock is quoted on or listed for trading on an Eligible
Market. Upon the consummation of each Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that
from and after the date of the applicable Fundamental Transaction, the provisions of this Warrant and the other Transaction Documents
referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power of the Company
and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the same effect as
if such Successor Entity had been named as the Company herein. Upon consummation of each Fundamental Transaction, the Successor Entity
shall deliver to the Holder confirmation that there shall be issued upon exercise of this Warrant at any time after the consummation of
the applicable Fundamental Transaction, in lieu of the shares of Common Stock (or other securities, cash, assets or other property (except
such items still issuable under Sections 3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise
of this Warrant prior to the applicable Fundamental Transaction, such shares of publicly traded common stock (or its equivalent) of the
Successor Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the happening of the applicable
Fundamental Transaction had this Warrant been exercised immediately prior to the applicable Fundamental Transaction (without regard to
any limitations on the exercise of this Warrant), as adjusted in accordance with the provisions of this Warrant. Notwithstanding the foregoing,
and without limiting Section 1(f) hereof, the Holder may elect, at its sole option, by delivery of written notice to the Company to waive
this Section 4(b) to permit the Fundamental Transaction without the assumption of this Warrant. In addition to and not in substitution
for any other rights hereunder, prior to the consummation of each Fundamental Transaction pursuant to which holders of shares of Common
Stock are entitled to receive securities or other assets with respect to or in exchange for shares of Common Stock (a &ldquo;<B>Corporate
Event</B>&rdquo;), the Company shall make appropriate provision to insure that the Holder will thereafter have the right to receive upon
an exercise of this Warrant at any time after the consummation of the applicable Fundamental Transaction but prior to the Expiration Date,
in lieu of the shares of the Common Stock (or other securities, cash, assets or other property (except such items still issuable under
Sections 3 and 4(a) above, which shall continue to be receivable thereafter)) issuable upon the exercise of the Warrant prior to such
Fundamental Transaction, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other
purchase or subscription rights) which the Holder would have been entitled to receive upon the happening of the applicable Fundamental
Transaction had this Warrant been exercised immediately prior to the applicable Fundamental Transaction (without regard to any limitations
on the exercise of this Warrant). Provision made pursuant to the preceding sentence shall be in a form and substance reasonably satisfactory
to the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Black Scholes Value</U>.
Notwithstanding the foregoing and the provisions of Section 4(b) above, at the request of the Holder delivered at any time commencing
on the earliest to occur of (x) the public disclosure of any Fundamental Transaction, (y) the consummation of any Fundamental Transaction
and (z) the Holder first becoming aware of any Fundamental Transaction through the date that is ninety (90) days after the public disclosure
of the consummation of such Fundamental Transaction by the Company pursuant to a Current Report on Form 8-K filed with the SEC, the Company
or the Successor Entity (as the case may be) shall purchase this Warrant from the Holder on the date of such request by paying to the
Holder cash in an amount equal to the Black Scholes Value of the remaining unexercised portion of this Warrant. Payment of such amounts
shall be made by the Company (or at the Company&rsquo;s direction) to the Holder on or prior to the later of (x) the second (2nd) Trading
Day after the date of such request and (y) the date of consummation of such Fundamental Transaction; provided, however, that if the Fundamental
Transaction is not within the Company&rsquo;s control, including in the event that such Fundamental Transaction is not approved by the
board of directors of the Company, the Holder shall only be entitled to receive from the Company or any Successor Entity the same type
or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is
being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction, whether that consideration
be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given the choice to receive from
among alternative forms of consideration in connection with the Fundamental Transaction; provided, further, that if holders of Common
Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed
to have received common stock of the Successor Entity (which such Successor Entity may be the Company following such Fundamental Transaction)
in such Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) <U>Application</U>. The
provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and Corporate Events and shall be
applied as if this Warrant (and any such subsequent warrants) were fully exercisable and without regard to any limitations on the exercise
of this Warrant (provided that the Holder shall continue to be entitled to the benefit of the Maximum Percentage, applied however with
respect to shares of capital stock registered under the 1934 Act and thereafter receivable upon exercise of this Warrant (or any such
other warrant)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation (as defined in the
Securities Purchase Agreement), Bylaws (as defined in the Securities Purchase Agreement) or through any reorganization, transfer of assets,
consolidation, merger, scheme of arrangement, dissolution, issuance or sale of securities, or any other voluntary action, avoid or seek
to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all the provisions
of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing,
the Company (a) shall not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the
Exercise Price then in effect, and (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and non-assessable shares of Common Stock upon the exercise of this Warrant. Notwithstanding anything herein
to the contrary, if after the sixty (60) calendar day anniversary of the Issuance Date, the Holder is not permitted to exercise this Warrant
in full for any reason (other than pursuant to restrictions set forth in Section 1(f) hereof), the Company shall use its best efforts
to promptly remedy such failure, including, without limitation, obtaining such consents or approvals as necessary to permit such exercise
into shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>WARRANT
HOLDER NOT DEEMED A STOCKHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of capital stock of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the
Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with
the giving thereof to the stockholders; provided that the Company shall have no such obligation to the extent such information is filed
with the SEC through EDGAR and are available to the public through the EDGAR system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REISSUANCE
OF WARRANTS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Transfer of Warrant</U>.
If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will forthwith issue
and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may request, representing
the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares
then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing the right
to purchase the number of Warrant Shares not being transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Lost, Stolen or Mutilated
Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation
of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence), and,
in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) <U>Exchangeable for Multiple
Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new
Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant Shares
then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is
designated by the Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall be
given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;(d) <U>Issuance of New Warrants</U>.
Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor
with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying
this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares designated by
the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued in connection with such
issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as indicated
on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) <U>Representation by the
Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise hereof,
will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or reselling
such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant to
sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with Section 9(f) of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions
taken pursuant to this Warrant (other than the issuance of shares of Common Stock upon exercise in accordance with the terms hereof),
including in reasonable detail a description of such action and the reason therefor. Without limiting the generality of the foregoing,
the Company will give written notice to the Holder (i) immediately upon each adjustment of the Exercise Price and the number of Warrant
Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s), (ii) at least fifteen (15) days prior
to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common Stock,
(B) with respect to any grants, issuances or sales of any Options, Convertible Securities or rights to purchase stock, warrants, securities
or other property to holders of Common Stock or (C) for determining rights to vote with respect to any Fundamental Transaction, dissolution
or liquidation, provided in each case that such information shall be made known to the public prior to or in conjunction with such notice
being provided to the Holder, and (iii) at least ten (10) Trading Days prior to the consummation of any Fundamental Transaction. To the
extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Company or any of its
Subsidiaries, the Company shall simultaneously file such notice with the SEC (as defined in the Securities Purchase Agreement) pursuant
to a Current Report on Form 8-K. If the Company or any of its Subsidiaries provides material non-public information to the Holder that
is not simultaneously filed in a Current Report on Form 8-K and the Holder has not agreed to receive such material non-public information,
the Company hereby covenants and agrees that the Holder shall not have any duty of confidentiality to the Company, any of its Subsidiaries
or any of their respective officers, directors, employees, affiliates or agents with respect to, or a duty to any of the foregoing not
to trade on the basis of, such material non-public information. It is expressly understood and agreed that the time of execution specified
by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>DISCLOSURE</U>.
Upon delivery by the Company to the Holder (or receipt by the Company from the Holder) of any notice in accordance with the terms of this
Warrant, unless the Company has in good faith determined that the matters relating to such notice do not constitute material, non-public
information relating to the Company or any of its Subsidiaries, the Company shall on or prior to 9:00 am, New York City time on the Business
Day immediately following such notice delivery date, publicly disclose such material, non-public information on a Current Report on Form
8-K or otherwise. In the event that the Company believes that a notice contains material, non-public information relating to the Company
or any of its Subsidiaries, the Company so shall indicate to the Holder explicitly in writing in such notice (or immediately upon receipt
of notice from the Holder, as applicable), and in the absence of any such written indication in such notice (or notification from the
Company immediately upon receipt of notice from the Holder), the Holder shall be entitled to presume that information contained in the
notice does not constitute material, non-public information relating to the Company or any of its Subsidiaries. Nothing contained in this
Section 9 shall limit any obligations of the Company, or any rights of the Holder, under Section 4(i) of the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;10.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>ABSENCE
OF TRADING AND DISCLOSURE RESTRICTIONS</U>. The Company acknowledges and agrees that the Holder is not a fiduciary or agent of the Company
and that the Holder shall have no obligation to (a) maintain the confidentiality of any information provided by the Company or (b) refrain
from trading any securities while in possession of such information in the absence of a written non-disclosure agreement signed by an
officer of the Holder that explicitly provides for such confidentiality and trading restrictions. In the absence of such an executed,
written non-disclosure agreement, the Company acknowledges that the Holder may freely trade in any securities issued by the Company, may
possess and use any information provided by the Company in connection with such trading activity, and may disclose any such information
to any third party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">11.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>AMENDMENT
AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant (other than Section 1(f)) may be amended and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Required Holders (as defined in the Securities Purchase Agreement). No waiver shall be effective unless it
is in writing and signed by an authorized representative of the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>SEVERABILITY</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">13.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>GOVERNING
LAW</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably waives personal
service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to the Company
at the address set forth in Section 9(f) of the Securities Purchase Agreement and agrees that such service shall constitute good and sufficient
service of process and notice thereof. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or
proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is
brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to
preclude the Holder from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company&rsquo;s
obligations to the Holder, to realize on any collateral or any other security for such obligations, or to enforce a judgment or other
court ruling in favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY
TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED
HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CONSTRUCTION;
HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any
Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed
to such terms on the Closing Date (as defined in the Securities Purchase Agreement) in such other Transaction Documents unless otherwise
consented to in writing by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">15.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>DISPUTE
RESOLUTION</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) <U>Submission to Dispute
Resolution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) In the case of a dispute
relating to the Exercise Price, the Closing Sale Price, the Bid Price, Black Scholes Consideration Value, Black Scholes Value or fair
market value or the arithmetic calculation of the number of Warrant Shares (as the case may be) (including, without limitation, a dispute
relating to the determination of any of the foregoing), the Company or the Holder (as the case may be) shall submit the dispute to the
other party via facsimile (A) if by the Company, within two (2) Business Days after the occurrence of the circumstances giving rise to
such dispute or (B) if by the Holder, at any time after the Holder learned of the circumstances giving rise to such dispute. If the Holder
and the Company are unable to promptly resolve such dispute relating to such Exercise Price, such Closing Sale Price, such Bid Price,
such Black Scholes Consideration Value, Black Scholes Value or such fair market value or such arithmetic calculation of the number of
Warrant Shares (as the case may be), at any time after the second (2nd) Business Day following such initial notice by the Company or the
Holder (as the case may be) of such dispute to the Company or the Holder (as the case may be), then the Holder may, at its sole option,
select an independent, reputable investment bank to resolve such dispute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) The Holder and the Company
shall each deliver to such investment bank (A) a copy of the initial dispute submission so delivered in accordance with the first sentence
of this Section 15 and (B) written documentation supporting its position with respect to such dispute, in each case, no later than 5:00
p.m. (New York time) by the fifth (5th) Business Day immediately following the date on which the Holder selected such investment bank
(the &ldquo;<B>Dispute Submission Deadline</B>&rdquo;) (the documents referred to in the immediately preceding clauses (A) and (B) are
collectively referred to herein as the &ldquo;<B>Required Dispute Documentation</B>&rdquo;) (it being understood and agreed that if either
the Holder or the Company fails to so deliver all of the Required Dispute Documentation by the Dispute Submission Deadline, then the party
who fails to so submit all of the Required Dispute Documentation shall no longer be entitled to (and hereby waives its right to) deliver
or submit any written documentation or other support to such investment bank with respect to such dispute and such investment bank shall
resolve such dispute based solely on the Required Dispute Documentation that was delivered to such investment bank prior to the Dispute
Submission Deadline). Unless otherwise agreed to in writing by both the Company and the Holder or otherwise requested by such investment
bank, neither the Company nor the Holder shall be entitled to deliver or submit any written documentation or other support to such investment
bank in connection with such dispute (other than the Required Dispute Documentation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) The Company and the
Holder shall cause such investment bank to determine the resolution of such dispute and notify the Company and the Holder of such resolution
no later than ten (10) Business Days immediately following the Dispute Submission Deadline. The fees and expenses of such investment bank
shall be borne solely by the Company, and such investment bank&rsquo;s resolution of such dispute shall be final and binding upon all
parties absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) <U>Miscellaneous</U>.
The Company expressly acknowledges and agrees that (i) this Section 15 constitutes an agreement to arbitrate between the Company and the
Holder (and constitutes an arbitration agreement) under the rules then in effect under &sect; 7501, et seq. of the New York Civil Practice
Law and Rules (&ldquo;<B>CPLR</B>&rdquo;) and that the Holder is authorized to apply for an order to compel arbitration pursuant to CPLR
 &sect; 7503(a) in order to compel compliance with this Section 15, (ii) the terms of this Warrant and each other applicable Transaction
Document shall serve as the basis for the selected investment bank&rsquo;s resolution of the applicable dispute, such investment bank
shall be entitled (and is hereby expressly authorized) to make all findings, determinations and the like that such investment bank determines
are required to be made by such investment bank in connection with its resolution of such dispute, (iii) the Holder (and only the Holder),
in its sole discretion, shall have the right to submit any dispute described in this Section 15 to any state or federal court sitting
in The City of New York, Borough of Manhattan in lieu of utilizing the procedures set forth in this Section 15 and (iv) nothing in this
Section 15 shall limit the Holder from obtaining any injunctive relief or other equitable remedies (including, without limitation, with
respect to any matters described in this Section 15).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">16.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>REMEDIES,
CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual and consequential
damages for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall
be no characterization concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with
respect to payments, exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall
not, except as expressly provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder
of this Warrant shall be entitled, in addition to all other available remedies, to specific performance and/or temporary, preliminary
and permanent injunctive or other equitable relief from any court of competent jurisdiction in any such case without the necessity of
proving actual damages and without posting a bond or other security. The Company shall provide all information and documentation to the
Holder that is requested by the Holder to enable the Holder to confirm the Company&rsquo;s compliance with the terms and conditions of
this Warrant (including, without limitation, compliance with Section 2 hereof). The issuance of shares and certificates for shares as
contemplated hereby upon the exercise of this Warrant shall be made without charge to the Holder or such shares for any issuance tax or
other costs in respect thereof, provided that the Company shall not be required to pay any tax which may be payable in respect of any
transfer involved in the issuance and delivery of any certificate in a name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">17.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>PAYMENT
OF COLLECTION, ENFORCEMENT AND OTHER COSTS</U>. If (a) this Warrant is placed in the hands of an attorney for collection or enforcement
or is collected or enforced through any legal proceeding or the holder otherwise takes action to collect amounts due under this Warrant
or to enforce the provisions of this Warrant or (b) there occurs any bankruptcy, reorganization, receivership of the company or other
proceedings affecting company creditors&rsquo; rights and involving a claim under this Warrant, then the Company shall pay the costs incurred
by the Holder for such collection, enforcement or action or in connection with such bankruptcy, reorganization, receivership or other
proceeding, including, without limitation, attorneys&rsquo; fees and disbursements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">18.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>TRANSFER</U>.
This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company, except as may otherwise be required
by Section 2(g) of the Securities Purchase Agreement and applicable securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">19.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &ldquo;<B>1933 Act</B>&rdquo;
means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) &ldquo;<B>1934 Act</B>&rdquo;
means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) &ldquo;<B>Adjustment Right</B>&rdquo;
means any right granted with respect to any securities issued in connection with, or with respect to, any issuance or sale (or deemed
issuance or sale in accordance with Section 2) of Common Stock (other than rights of the type described in Section 3 and 4 hereof) that
could result in a decrease in the net consideration received by the Company in connection with, or with respect to, such securities (including,
without limitation, any cash settlement rights, cash adjustment or other similar rights).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d) &ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control
with, such Person, it being understood for purposes of this definition that &ldquo;control&rdquo; of a Person means the power directly
or indirectly either to vote 10% or more of the stock having ordinary voting power for the election of directors of such Person or direct
or cause the direction of the management and policies of such Person whether by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) &ldquo;<B>Attribution
Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle, including, any funds, feeder funds
or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed or advised by the Holder&rsquo;s
investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of the Holder or any of the foregoing,
(iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or any of the foregoing and (iv) any other
Persons whose beneficial ownership of the Company&rsquo;s Common Stock would or could be aggregated with the Holder&rsquo;s and the other
Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the foregoing is to subject collectively
the Holder and all other Attribution Parties to the Maximum Percentage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) &ldquo;<B>Bid Price</B>&rdquo;
means, for any security as of the particular time of determination, the bid price for such security on the Principal Market as reported
by Bloomberg as of such time of determination, or, if the Principal Market is not the principal securities exchange or trading market
for such security, the bid price of such security on the principal securities exchange or trading market where such security is listed
or traded as reported by Bloomberg as of such time of determination, or if the foregoing does not apply, the bid price of such security
in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg as of such time of determination,
or, if no bid price is reported for such security by Bloomberg as of such time of determination, the average of the bid prices of any
market makers for such security as reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of
reporting prices) as of such time of determination. If the Bid Price cannot be calculated for a security as of the particular time of
determination on any of the foregoing bases, the Bid Price of such security as of such time of determination shall be the fair market
value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value
of such security, then such dispute shall be resolved in accordance with the procedures in Section 15. All such determinations shall be
appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g) &ldquo;<B>Black Scholes
Consideration Value</B>&rdquo; means the value of the applicable Option, Convertible Security or Adjustment Right (as the case may be)
as of the date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function
on Bloomberg utilizing (i) an underlying price per share equal to the Closing Sale Price of the Common Stock on the Trading Day immediately
preceding the public announcement of the execution of definitive documents with respect to the issuance of such Option or Convertible
Security (as the case may be), (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining
term of such Option, Convertible Security or Adjustment Right (as the case may be) as of the date of issuance of such Option, Convertible
Security or Adjustment Right (as the case may be), (iii) a zero cost of borrow and (iv) an expected volatility equal to the 30 day volatility
obtained from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day
immediately following the date of issuance of such Option, Convertible Security or Adjustment Right (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h) &ldquo;<B>Black Scholes
Value</B>&rdquo; means the value of the unexercised portion of this Warrant remaining on the date of the Holder&rsquo;s request pursuant
to Section 4(c)(i), which value is calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function
on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest Closing Sale Price of the Common Stock
during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction (or the
consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant
to Section 4(c)(i) and (2) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if any) plus
the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price equal to
the Exercise Price in effect on the date of the Holder&rsquo;s request pursuant to Section 4(c)(i), (iii) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the greater of (1) the remaining term of this Warrant as of the date of the Holder&rsquo;s
request pursuant to Section 4(c)(i) and (2) the remaining term of this Warrant as of the date of consummation of the applicable Fundamental
Transaction or as of the date of the Holder&rsquo;s request pursuant to Section 4(c)(i) if such request is prior to the date of the consummation
of the applicable Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility equal to the 30 day volatility obtained
from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately
following the earliest to occur of (A) the public disclosure of the applicable Fundamental Transaction and (B) the date of the Holder&rsquo;s
request pursuant to Section 4(c)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) &ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) &ldquo;<B>Business Day</B>&rdquo;
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized or required by
law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial banks shall
not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
 &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) &ldquo;<B>Closing Sale
Price</B>&rdquo; means, for any security as of any date, the last closing trade price for such security on the Principal Market, as reported
by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing trade price,
then the last trade price of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the Principal Market
is not the principal securities exchange or trading market for such security, the last trade price of such security on the principal securities
exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing does not apply, the last
trade price of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg,
or, if no last trade price is reported for such security by Bloomberg, the average of the ask prices of any market makers for such security
as reported in The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices). If the Closing
Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Sale Price of such security
on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable
to agree upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section
15. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction
during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;(l) &ldquo;<B>Common
Stock</B>&rdquo; means (i) the Company&rsquo;s shares of common stock, $0.0001 par value per share, and (ii) any capital stock into which
such common stock shall have been changed or any capital stock resulting from a reclassification of such common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m) &ldquo;<B>Convertible
Securities</B>&rdquo; means any stock or other security (other than Options) that is at any time and under any circumstances, directly
or indirectly, convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any Common
Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n) &ldquo;<B>Eligible Market</B>&rdquo;
means The New York Stock Exchange, the NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market or the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) <B>[Reserved]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p) &ldquo;<B>Event Market
Price</B>&rdquo; means, with respect to any Stock Combination Event Date, the lower of (i) the Exercise Price in effect immediately after
such Stock Combination Event Date (and, for the avoidance of doubt, as adjusted following such Stock Combination Event Date as set forth
herein), and (ii) the lowest VWAP of the Common Stock for any Trading Day during the eleven (11) consecutive Trading Day period commencing
on the fifth (5th) Trading Day immediately preceding the Stock Combination Event Date and ending on the fifth (5th) Trading Day immediately
following the Stock Combination Event Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o) &ldquo;<B>Expiration Date</B>&rdquo;
means the date that is the fifth (5th) anniversary of the Issuance Date or, if such date falls on a day other than a Trading Day or on
which trading does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;), the next date that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q) &ldquo;<B>Fundamental
Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through subsidiaries, Affiliates or otherwise,
in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the surviving corporation) another
Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all of the properties or assets of
the Company or any of its &ldquo;significant subsidiaries&rdquo; (as defined in Rule 1-02 of Regulation S-X) to one or more Subject Entities,
or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be subject to or have its Common Stock be subject
to or party to one or more Subject Entities making, a purchase, tender or exchange offer that is accepted by the holders of at least either
(x) 50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares of Common Stock calculated as if any shares of Common
Stock held by all Subject Entities making or party to, or Affiliated with any Subject Entities making or party to, such purchase, tender
or exchange offer were not outstanding; or (z) such number of shares of Common Stock such that all Subject Entities making or party to,
or Affiliated with any Subject Entity making or party to, such purchase, tender or exchange offer, become collectively the beneficial
owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (iv) consummate a stock
or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off
or scheme of arrangement) with one or more Subject Entities whereby all such Subject Entities, individually or in the aggregate, acquire,
either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the outstanding shares of Common Stock calculated
as if any shares of Common Stock held by all the Subject Entities making or party to, or Affiliated with any Subject Entity making or
party to, such stock purchase agreement or other business combination were not outstanding; or (z) such number of shares of Common Stock
such that the Subject Entities become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50%
of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify its Common Stock, (B) that the Company shall,
directly or indirectly, including through subsidiaries, Affiliates or otherwise, in one or more related transactions, allow any Subject
Entity individually or the Subject Entities in the aggregate to be or become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3
under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment, conveyance, tender, tender offer, exchange,
reduction in outstanding shares of Common Stock, merger, consolidation, business combination, reorganization, recapitalization, spin-off,
scheme of arrangement, reorganization, recapitalization or reclassification or otherwise in any manner whatsoever, of either (x) at least
50% of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock, (y) at least 50% of the aggregate
ordinary voting power represented by issued and outstanding shares of Common Stock not held by all such Subject Entities as of the date
of this Warrant calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding, or (z) a percentage
of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity securities of the
Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring other stockholders
of the Company to surrender their shares of Common Stock without approval of the stockholders of the Company or (C) directly or indirectly,
including through subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of or the entering into any
other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this definition in which case
this definition shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this definition to
the extent necessary to correct this definition or any portion of this definition which may be defective or inconsistent with the intended
treatment of such instrument or transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r) &ldquo;<B>Group</B>&rdquo;
means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5 thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s) <B>[Reserved]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t) <B>[Reserved]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u) &ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase shares of Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v) &ldquo;<B>Parent Entity</B>&rdquo;
of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security
is quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with
the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w) &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)&#8239;&ldquo;<B>Principal
Market</B>&rdquo; means the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)&#8239;&ldquo;<B>Registration
Rights Agreement</B>&rdquo; means that certain registration rights agreement, dated as of the Closing Date, by and among the Company and
the Buyers of the Preferred Shares and SPA Warrants relating to, among other things, the registration of the resale of the shares of Common
Stock issuable upon conversion of the Preferred Shares or otherwise pursuant to the terms of the Certificate of Designations and exercise
of the SPA Warrants, as may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z)&#8239;&ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission or the successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) &ldquo;<B>Subject Entity</B>&rdquo;
means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ab)&#8239;&ldquo;<B>Successor
Entity</B>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been
entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ac) &ldquo;<B>Trading Day</B>&rdquo;
means, as applicable, (x) with respect to all price or trading volume determinations relating to the Common Stock, any day on which the
Common Stock is traded on the Principal Market, or, if the Principal Market is not the principal trading market for the Common Stock,
then on the principal securities exchange or securities market on which the Common Stock is then traded, provided that &ldquo;Trading
Day&rdquo; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours
or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange
or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00
p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder or (y) with respect to all determinations
other than price or trading volume determinations relating to the Common Stock, any day on which The New York Stock Exchange (or any successor
thereto) is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;(ad) <B>[Reserved]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ae) &ldquo;<B>VWAP</B>&rdquo;
means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market (or, if the
Principal Market is not the principal trading market for such security, then on the principal securities exchange or securities market
on which such security is then traded), during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time,
as reported by Bloomberg through its &ldquo;VAP&rdquo; function (set to 09:30 start time and 16:00 end time) or, if the foregoing does
not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for
such security during the period beginning at 9:30 a.m., New York time, and ending at 4:00 p.m., New York time, as reported by Bloomberg,
or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the highest closing
bid price and the lowest closing ask price of any of the market makers for such security as reported in The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices). If the VWAP cannot be calculated for such security on such date
on any of the foregoing bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company
and the Holder. If the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall
be resolved in accordance with the procedures in Section 15. All such determinations shall be appropriately adjusted for any stock dividend,
stock split, stock combination, recapitalization or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>signature page follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF,</B> the Company has caused
this Warrant to Purchase Common Stock to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><B>TAO SYNERGIES INC.</B></TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:</TD>
    <TD STYLE="width: 42%">Joshua Silverman</TD>
    <TD STYLE="width: 50%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>Executive Chairman</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#8239;&#8239;&#8239;<B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXERCISE NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE
THIS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WARRANT TO PURCHASE COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TAO SYNERGIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned holder hereby
elects to exercise the Warrant to Purchase Common Stock No. _______ (the &ldquo;<B>Warrant</B>&rdquo;) of TAO SYNERGIES INC., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), as specified below. Capitalized terms used herein and not otherwise defined shall have
the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&#8239;&#8239;&#8239;&#8239;<U>Form
of Exercise Price</U>. The Holder intends that payment of the Aggregate Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT>&#8239;&#8239;&#8239;&#8239;a
 &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _________________ Warrant Shares; and/or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT>&#8239;&#8239;&#8239;&#8239;a
 &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _______________ Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Holder
has elected a Cashless Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the Holder hereby represents
and warrants that (i) this Exercise Notice was executed by the Holder at __________ [a.m.][p.m.] on the date set forth below and (ii)
if applicable, the Bid Price as of such time of execution of this Exercise Notice was $________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&#8239;&#8239;&#8239;&#8239;<U>Payment
of Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be
issued pursuant hereto, the Holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company in accordance
with the terms of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.&#8239;&#8239;&#8239;&#8239;<U>Delivery
of Warrant Shares</U>. The Company shall deliver to Holder, or its designee or agent as specified below, __________ shares of Common Stock
in accordance with the terms of the Warrant. Delivery shall be made to Holder, or for its benefit, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&uml;</FONT>&#8239;&#8239;&#8239;&#8239;Check
here if requesting delivery as a certificate to the following name and to the following address:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; width: 70%">Issue to:</TD>
    <TD STYLE="width: 30%">&nbsp;</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid">&nbsp;</TD>
    </TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="border-top: black 1pt solid; border-bottom: black 1pt solid">&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT>&#8239;&#8239;&#8239;&#8239;Check
here if requesting delivery by Deposit/Withdrawal at Custodian as follows:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 70%">DTC Participant:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 30%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>DTC Number:</TD>
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: bottom">Account Number:</TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&#8239;___________________________&#8239;__,&#8239;__</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">Name of Registered Holder</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 70%">By:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 30%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 70%">Tax ID:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 30%">&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 70%">Facsimile:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 30%">&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 70%">E-mail Address:</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 30%">&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ACKNOWLEDGMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby acknowledges
this Exercise Notice and hereby directs ______________ to issue the above indicated number of shares of Common Stock in accordance with
the Transfer Agent Instructions dated _________, 202_, from the Company and acknowledged and agreed to by _______________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">TAO SYNERGIES INC.</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Title:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>tm2528153d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF SECURITIES PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>SECURITIES PURCHASE
AGREEMENT</B> (the &ldquo;<B>Agreement</B>&rdquo;), dated as of October&nbsp;13, 2025, is by and among TAO Synergies Inc., a Delaware
corporation (the &ldquo;<B>Company</B>&rdquo;), and each of the investors listed on the Schedule of Buyers attached hereto (individually,
a &ldquo;<B>Buyer</B>&rdquo; and collectively, the &ldquo;<B>Buyers</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RECITALS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. The Company has authorized
a new series of convertible preferred stock of the Company, designated as Series&nbsp;E Convertible Preferred Stock, $0.001 par value
per share, the terms of which are set forth in the certificate of designations for such series of preferred stock (the &ldquo;<B>Certificate
of Designations</B>&rdquo;) in the form attached hereto as <B><U>Exhibit&nbsp;A</U></B> (together with any convertible preferred shares
issued in replacement thereof in accordance with the terms thereof, the &ldquo;<B>Series&nbsp;E Preferred Stock</B>&rdquo;), which Series&nbsp;E
Preferred Stock shall be convertible into shares of the Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<B>Common
Stock</B>&rdquo;), in accordance with the terms of the Certificate of Designations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. Each Buyer wishes to purchase,
and the Company wishes to sell, upon the terms and conditions stated in this Agreement, pursuant to the exemption from securities registration
afforded by Section&nbsp;4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<B>1933 Act</B>&rdquo;) and Rule&nbsp;506(b) of
Regulation D (&ldquo;<B>Regulation D</B>&rdquo;) as promulgated by the United States Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;)
under the 1933 Act, (1) such aggregate number of shares of Series&nbsp;E Preferred Stock set forth opposite such Buyer&rsquo;s name
in column (3) on the Schedule of Buyers (which aggregate amount for all Buyers shall be 11,000 Preferred Shares and shall be referred
to herein as the &ldquo;<B>Preferred Shares</B>&rdquo;) and (2) a warrant to initially acquire up to that aggregate number of additional
shares of Common Stock set forth opposite such Buyer&rsquo;s name in column (4) on the Schedule of Buyers, substantially in the form
attached hereto as <B><U>Exhibit&nbsp;B</U></B> (the &ldquo;<B>Warrants</B>&rdquo;). The shares of Common Stock issuable pursuant to the
Preferred Shares, including, without limitation, upon conversion or otherwise, are herein referred to as the &ldquo;<B>Conversion Shares</B>.&rdquo;
The shares of Common Stock issuable upon exercise of the Warrants are herein referred to as the &ldquo;<B>Warrant Shares</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. On the Closing Date, the
parties hereto shall execute and deliver a Registration Rights Agreement, in the form attached hereto as <B><U>Exhibit&nbsp;C</U></B>
(the &ldquo;<B>Registration Rights Agreement</B>&rdquo;), pursuant to which the Company has agreed to provide certain registration rights
with respect to the Registrable Securities (as defined in the Registration Rights Agreement), under the 1933 Act and the rules&nbsp;and
regulations promulgated thereunder, and applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. The Preferred Shares, the
Conversion Shares, the Warrants and the Warrant Shares are collectively referred to herein as the &ldquo;<B>Securities</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Company and each Buyer hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>1. PURCHASE AND SALE OF PREFERRED SHARES AND
WARRANTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) <U>Purchase of Preferred
Shares and Warrants</U>. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 6 and 7 below, the Company shall
issue and sell to each Buyer, and each Buyer severally, but not jointly, agrees to purchase from the Company on the Closing Date (as defined
below), such aggregate number of Preferred Shares as is set forth opposite such Buyer&rsquo;s name in column (3) on the Schedule
of Buyers along with Warrants to initially acquire up to that aggregate number of Warrant Shares as is set forth opposite such Buyer&rsquo;s
name in column (4) on the Schedule of Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) <U>Closing</U>.
The closing (the &ldquo;<B>Closing</B>&rdquo;) of the purchase of the Preferred Shares and the Warrants by the Buyers shall occur remotely
by the electronic transfer of Closing documentation. The date and time of the Closing (the &ldquo;<B>Closing Date</B>&rdquo;) shall be
10:00 a.m., New York time, on the first (1st) Business Day on which the conditions to the Closing set forth in Sections 6 and 7 below
are satisfied or waived (or such other date as is mutually agreed to by the Company and each Buyer). As used herein &ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
 &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) <U>Purchase Price</U>.
The aggregate purchase price for the Preferred Shares and the Warrants to be purchased by each Buyer (the &ldquo;<B>Purchase Price</B>&rdquo;)
shall be the amount set forth opposite such Buyer&rsquo;s name in column (5) on the Schedule of Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) <U>Form&nbsp;of
Payment</U>. On the Closing Date, (i) each Buyer shall pay its respective Purchase Price (less, in the case of Buyers affiliated
with Iroquois, the amounts withheld pursuant to Section&nbsp;4(g)) to the Company for the Preferred Shares and the Warrants to be issued
and sold to such Buyer at the Closing, by wire transfer of immediately available funds in accordance with the Company&rsquo;s written
wire instructions (less, in the case of Buyers affiliated with Iroquois, the amounts withheld pursuant to Section&nbsp;4(g)) and (ii) the
Company shall deliver to each Buyer (A) such aggregate number of Preferred Shares as is set forth opposite such Buyer&rsquo;s name
in column (3) of the Schedule of Buyers, and (B) a Warrant pursuant to which such Buyer shall have the right to initially acquire
up to such aggregate number of Warrant Shares as is set forth opposite such Buyer&rsquo;s name in column (4) of the Schedule of Buyers,
in each case, duly executed on behalf of the Company and registered in the name of such Buyer or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2. BUYER&rsquo;S REPRESENTATIONS AND WARRANTIES.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Buyer, severally and
not jointly, represents and warrants to the Company with respect to only itself that, as of the date hereof and as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) <U>Organization;
Authority</U>. Such Buyer is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
(as defined below) to which it is a party and otherwise to carry out its obligations hereunder and thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) <U>No Public Sale
or Distributio</U>n. Such Buyer (i) is acquiring its Preferred Shares and Warrants, (ii) upon conversion of its Preferred Shares
will acquire the Conversion Shares issuable upon conversion thereof, and (iii) upon exercise of its Warrants (other than pursuant
to a Cashless Exercise (as defined in the Warrants)) will acquire the Warrant Shares issuable upon exercise thereof, in each case, for
its own account and not with a view towards, or for resale in connection with, the public sale or distribution thereof in violation of
applicable securities laws, except pursuant to sales registered or exempted under the 1933 Act; provided, however, by making the representations
herein, such Buyer does not agree, or make any representation or warranty, to hold any of the Securities for any minimum or other specific
term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration statement or an
exemption from registration under the 1933 Act. Such Buyer does not presently have any agreement or understanding, directly or indirectly,
with any Person to distribute any of the Securities in violation of applicable securities laws. For purposes of this Agreement, &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity and any Governmental Entity (as defined below) or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) <U>Accredited Investor
Status; Experience</U>. Such Buyer is an &ldquo;accredited investor&rdquo; as that term is defined in Rule&nbsp;501(a) of Regulation
D. Such Buyer, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial
matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the
merits and risks of such investment. Such Buyer is able to bear the economic risk of an investment in the Securities and, at the present
time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) <U>Reliance on Exemptions</U>.
Such Buyer understands that the Securities are being offered and sold to it in reliance on specific exemptions from the registration requirements
of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and such Buyer&rsquo;s
compliance with, the representations, warranties, agreements, acknowledgments and understandings of such Buyer set forth herein in order
to determine the availability of such exemptions and the eligibility of such Buyer to acquire the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e) <U>Information</U>.
Such Buyer acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto)
and the SEC Documents (as defined below). Such Buyer and its advisors, if any, have been furnished with all materials relating to the
business, finances and operations of the Company and materials relating to the offer and sale of the Securities that have been requested
by such Buyer. Such Buyer and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries
nor any other due diligence investigations conducted by such Buyer or its advisors, if any, or its representatives shall modify, amend
or affect such Buyer&rsquo;s right to rely on the Company&rsquo;s representations and warranties contained herein. Such Buyer understands
that its investment in the Securities involves a high degree of risk. Such Buyer has sought such accounting, legal and tax advice as it
has considered necessary to make an informed investment decision with respect to its acquisition of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(f) <U>No Governmental Review</U>. Such Buyer
understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation
or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon
or endorsed the merits of the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g) <U>Transfer or Resale</U>.
Such Buyer understands that except as provided in the Registration Rights Agreement and Section&nbsp;4(h) hereof: (i) the Securities
have not been and are not being registered under the 1933 Act or any state securities laws, and may not be offered for sale, sold, assigned
or transferred unless (A) subsequently registered thereunder, (B) such Buyer shall have delivered to the Company (if requested
by the Company) an opinion of counsel, in a form reasonably acceptable to the Company, to the effect that such Securities to be sold,
assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such registration, or (C) such Buyer provides
the Company with reasonable assurance that such Securities can be sold, assigned or transferred pursuant to Rule&nbsp;144 or Rule&nbsp;144A
promulgated under the 1933 Act (or a successor rule&nbsp;thereto) (collectively, &ldquo;<B>Rule&nbsp;144</B>&rdquo;); (ii) any sale
of the Securities made in reliance on Rule&nbsp;144 may be made only in accordance with the terms of Rule&nbsp;144, and further, if Rule&nbsp;144
is not applicable, any resale of the Securities under circumstances in which the seller (or the Person through whom the sale is made)
may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the
1933 Act or the rules&nbsp;and regulations of the SEC promulgated thereunder; and (iii) neither the Company nor any other Person
is under any obligation to register the Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions
of any exemption thereunder. Notwithstanding the foregoing, the Securities may be pledged in connection with a bona fide margin account
or other loan or financing arrangement secured by the Securities and such pledge of Securities shall not be deemed to be a transfer, sale
or assignment of the Securities hereunder, and no Buyer effecting a pledge of Securities shall be required to provide the Company with
any notice thereof or otherwise make any delivery to the Company pursuant to this Agreement or any other Transaction Document (as defined
in Section&nbsp;3(b)), including, without limitation, this Section&nbsp;2(g).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(h) <U>Validity; Enforcement</U>.
This Agreement and the Registration Rights Agreement, as applicable, have been duly and validly authorized, executed and delivered on
behalf of such Buyer and shall constitute the legal, valid and binding obligations of such Buyer enforceable against such Buyer in accordance
with their respective terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy,
insolvency, reorganization, moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable
creditors&rsquo; rights and remedies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(i) <U>No Conflicts</U>.
The execution, delivery and performance by such Buyer of this Agreement and the Registration Rights Agreement and the consummation by
such Buyer of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational documents
of such Buyer, or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become
a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which such Buyer is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree
(including federal and state securities laws) applicable to such Buyer, except in the case of clauses (ii) and (iii) above,
for such conflicts, defaults, rights or violations which could not, individually or in the aggregate, reasonably be expected to have a
material adverse effect on the ability of such Buyer to perform its obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(j) <U>No Reliance on
Placement Agent</U>. Such Buyer acknowledges and agrees that neither the Placement Agent (as defined below) nor any affiliate of the Placement
Agent has provided such Buyer with any information or advice with respect to the Securities nor is such information or advice necessary
or desired. Neither the Placement Agent nor any affiliate has made or makes any representation as to the Company or the quality of the
Securities and the Placement Agent and any affiliate may have acquired non-public information with respect to the Company which such Buyer
agrees need not be provided to it. In connection with the issuance of the Securities to such Buyer, neither the Placement Agent nor any
of its affiliates has acted as a financial advisor or fiduciary to such Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(k) <U>Residency</U>. Such Buyer is a resident
of that jurisdiction specified below its address on the Schedule of Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(l) <U>General Solicitation</U>.
Buyer represents that (i) Buyer was contacted regarding the sale of the Securities by the Placement Agent or the Company (or authorized
representative thereof) and the Buyer had a prior pre-existing relationship with the Company under the U.S. securities laws and interpretations,
(ii) to the knowledge of such Buyer, no Securities were offered or sold to it by means of any form of general solicitation, and Buyer
is not, to such Buyer&rsquo;s knowledge, purchasing the Securities as a result of any advertisement, article, notice or other communication
regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or, to the knowledge of such Buyer, any other general solicitation or general advertisement. Buyer has not become interested in
the offering of the Securities as a result of any registration statement of the Company filed with the SEC or any other securities agency
or regulator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(m) <U>Certain Transactions
and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Buyer has not, nor has any Person acting
on behalf of or pursuant to any understanding with such Buyer, directly or indirectly executed any purchases or sales, including Short
Sales, of the securities of the Company during the period commencing as of the time that such Buyer first received a term sheet (written
or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated
hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Buyer that is a multi-managed
investment vehicle whereby separate portfolio managers manage separate portions of such Buyer&rsquo;s assets and the portfolio managers
have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Buyer&rsquo;s assets,
the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the
investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such
Buyer&rsquo;s representatives, including, without limitation, its officers, directors, partners, legal and other advisors, employees,
agents and affiliates, such Buyer has maintained the confidentiality of all disclosures made to it in connection with this transaction
(including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to
effect Short Sales or similar transactions in the future. &ldquo;<B>Short Sales</B>&rdquo; means all &ldquo;short sales&rdquo; as defined
in Rule&nbsp;200 of Regulation SHO under the Exchange Act (but shall not be deemed to include locating and/or borrowing shares of Common
Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(n) <U>Potential Certain
Transactions with other Buyers</U>. Such Buyer understands that there may be one or more other Buyers investing in the Securities who
are affiliated with entities (i) in which the Company may invest or (ii) with whom the Company may enter into a strategic business
relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>3. REPRESENTATIONS AND WARRANTIES OF THE COMPANY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company represents and
warrants to each of the Buyers that, as of the date hereof and as of the Closing Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a) <U>Organization
and Qualification</U>. Each of the Company and each of its Subsidiaries are entities duly organized and validly existing and in good standing
under the laws of the jurisdiction in which they are formed, and have the requisite power and authority to own their properties and to
carry on their business as described in the SEC Documents. Each of the Company and each of its Subsidiaries is duly qualified as a foreign
entity to do business and is in good standing in every jurisdiction in which its ownership of property or the nature of the business conducted
by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing would not reasonably
be expected to have a Material Adverse Effect (as defined below). As used in this Agreement, &ldquo;<B>Material Adverse Effect</B>&rdquo;
means any material adverse effect on (i) the business, properties, assets, liabilities, operations (including results thereof), condition
(financial or otherwise) or prospects of the Company and its Subsidiaries (as defined below), taken as a whole, (ii) the transactions
contemplated hereby or in any of the other Transaction Documents or any other agreements or instruments to be entered into in connection
herewith or therewith or (iii) the authority or ability of the Company or any of its Subsidiaries to perform any of their respective
obligations under any of the Transaction Documents (as defined below). &ldquo;<B>Subsidiaries</B>&rdquo; means any Person in which the
Company, directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or similar interest of such Person
or (II) controls or operates all or any part of the business, operations or administration of such Person, and each of the foregoing,
is individually referred to herein as a &ldquo;<B>Subsidiary</B>.&rdquo; If the Company has no Subsidiaries, all references to the Subsidiaries
or any of them in this Agreement or any other documents or agreements executed in connection with the transaction contemplated hereunder
shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b) <U>Authorization;
Enforcement; Validity</U>. The Company has the requisite power and authority to enter into and perform its obligations under this Agreement
and the other Transaction Documents and to issue the Securities in accordance with the terms hereof and thereof. Each Subsidiary has the
requisite power and authority to enter into and perform its obligations under the Transaction Documents to which it is a party. The execution
and delivery of this Agreement and the other Transaction Documents by the Company and its Subsidiaries, and the consummation by the Company
and its Subsidiaries of the transactions contemplated hereby and thereby (including, without limitation, the issuance by the Company of
the Preferred Shares and the reservation for issuance and issuance of the Conversion Shares issuable upon conversion of the Preferred
Shares and the issuance of the Warrants and the reservation for issuance and issuance of the Warrant Shares issuable upon exercise of
the Warrants) have been duly authorized by the Company&rsquo;s board of directors and, to the extent applicable, each of its Subsidiaries&rsquo;
board of directors or other governing body, as applicable, and (other than the filing with the SEC of one or more Registration Statements
in accordance with the requirements of the Registration Rights Agreement, the filing of the Certificate of Designations, a Form&nbsp;D
with the SEC and any other filings as may be required by any state securities agencies) no further filing, consent or authorization is
required by the Company, its Subsidiaries, their respective boards of directors or their stockholders or other governing body. This Agreement
has been, and the other Transaction Documents to which it is a party will be prior to the Closing, duly executed and delivered by the
Company, and each constitutes the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with
its respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo;
rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law. Prior
to the Closing, the Transaction Documents to which each Subsidiary is a party will be duly executed and delivered by each such Subsidiary,
and shall constitute the legal, valid and binding obligations of each such Subsidiary, enforceable against each such Subsidiary in accordance
with their respective terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors&rsquo;
rights and remedies and except as rights to indemnification and to contribution may be limited by federal or state securities law. &ldquo;<B>Transaction
Documents</B>&rdquo; means, collectively, this Agreement, the Certificate of Designations, the Warrants, the Registration Rights Agreement,
the Irrevocable Transfer Agent Instructions (as defined below) and each of the other agreements and instruments entered into or delivered
by the Company or any of its Subsidiaries in connection with the transactions contemplated hereby and thereby, as may be amended from
time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c) <U>Issuance of Securities</U>.
The issuance of the Preferred Shares and the Warrants are duly authorized and upon issuance in accordance with the terms of the Transaction
Documents shall be validly issued, fully paid and non-assessable and free from all preemptive or similar rights, mortgages, defects, claims,
liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances (collectively &ldquo;<B>Liens</B>&rdquo;)
with respect to the issuance thereof. As of the Closing, the Company shall have reserved from its duly authorized share capital not less
than the sum of (i) 150% of the maximum number of Conversion Shares issuable upon conversion of the Preferred Shares (assuming for
purposes hereof that (x) the Preferred Shares are convertible at the Floor Price (as defined in the Certificate of Designations)
in effect and without taking into account any limitations on the conversion of the Preferred Shares set forth in the Certificate of Designations),
and (ii) the maximum number of Warrant Shares initially issuable upon exercise of the Warrants (without taking into account any limitations
on the exercise of the Warrants set forth therein). Upon issuance or conversion in accordance with the Preferred Shares or exercise in
accordance with the Warrants (as the case may be), the Conversion Shares and the Warrant Shares, respectively, when issued, will be validly
issued, fully paid and nonassessable and free from all preemptive or similar rights or Liens with respect to the issue thereof, with the
holders being entitled to all rights accorded to a holder of shares of Common Stock. The Company is eligible to use Form&nbsp;S-3 under
the 1933 Act and it meets the transaction requirements as set forth in General Instruction I.B.6 of Form&nbsp;S-3. Subject to the accuracy
of the representations and warranties of the Buyers in this Agreement, the offer and issuance by the Company of the Securities is exempt
from registration under the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d) <U>No Conflicts</U>.
The execution, delivery and performance of the Transaction Documents by the Company and its Subsidiaries and the consummation by the Company
and its Subsidiaries of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Preferred
Shares, the Warrants, the Conversion Shares and the Warrant Shares and the reservation for issuance of the Conversion Shares and the Warrant
Shares) will not (i) result in a violation of the Certificate of Incorporation (as defined below), Bylaws (as defined below) or other
organizational documents of the Company or any of its Subsidiaries, or any capital stock or other securities of the Company or any of
its Subsidiaries, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become
a default) in any respect under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in a violation of any law, rule,
regulation, order, judgment or decree and including all applicable foreign, federal and state securities laws, rules&nbsp;and regulations,
and the rules&nbsp;and regulations of The Nasdaq Capital Market (the &ldquo;<B>Principal Market</B>&rdquo;) applicable to the Company
or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected; except in
the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e) <U>Consents</U>.
Neither the Company nor any Subsidiary is required to obtain any consent from, authorization or order of, or make any filing or registration
with (other than the filing with the SEC of one or more Registration Statements in accordance with the requirements of the Registration
Rights Agreement, a Form&nbsp;D with the SEC and any other filings as may be required by any state securities agencies, the notice and/or
application(s) to the Principal Market for the issuance and sale of the Securities and the listing of the Conversion Shares and Warrant
Shares for trading thereon in the time and manner required thereby), any Governmental Entity (as defined below) or any regulatory or self-regulatory
agency or any other Person in order for it to execute, deliver or perform any of its respective obligations under or contemplated by the
Transaction Documents, in each case, in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and
registrations which the Company or any Subsidiary is required to obtain prior to the Closing Date pursuant to the preceding sentence have
been or will be obtained or effected on or prior to the Closing Date, and neither the Company nor any of its Subsidiaries are aware of
any facts or circumstances which might prevent the Company or any of its Subsidiaries from obtaining or effecting any of the registration,
application or filings contemplated by the Transaction Documents. The Company is not in violation of the requirements of the Principal
Market and has no knowledge of any facts or circumstances which could reasonably lead to delisting or suspension of the Common Stock in
the foreseeable future. &ldquo;<B>Governmental Entity</B>&rdquo; means any nation, state, county, city, town, village, district, or other
political jurisdiction of any nature, federal, state, local, municipal, foreign, or other government, governmental or quasi-governmental
authority of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal),
multi-national organization or body; or body exercising, or entitled to exercise, any administrative, executive, judicial, legislative,
police, regulatory, or taxing authority or power of any nature or instrumentality of any of the foregoing, including any entity or enterprise
owned or controlled by a government or a public international organization or any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f) <U>Acknowledgment
Regarding Buyer&rsquo;s Purchase of Securities</U>. The Company acknowledges and agrees that each Buyer is acting solely in the capacity
of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby and
that no Buyer is (i) an officer or director of the Company or any of its Subsidiaries, (ii) an &ldquo;affiliate&rdquo; (as defined
in Rule&nbsp;144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a &ldquo;beneficial owner&rdquo; of more than
10% of the shares of Common Stock (as defined for purposes of Rule&nbsp;13d-3 of the Securities Exchange Act of 1934, as amended (the
 &ldquo;<B>1934 Act</B>&rdquo;)). The Company further acknowledges that no Buyer is acting as a financial advisor or fiduciary of the Company
or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby
and thereby, and any advice given by a Buyer or any of its representatives or agents in connection with the Transaction Documents and
the transactions contemplated hereby and thereby is merely incidental to such Buyer&rsquo;s purchase of the Securities. The Company further
represents to each Buyer that the Company&rsquo;s and each Subsidiary&rsquo;s decision to enter into the Transaction Documents to which
it is a party has been based solely on the independent evaluation by the Company, each Subsidiary and their respective representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g) <U>No General Solicitation;
Placement Agent&rsquo;s Fees</U>. Neither the Company, nor any of its Subsidiaries or affiliates, nor any Person acting on its or their
behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with
the offer or sale of the Securities. The Company shall be responsible for the payment of any placement agent&rsquo;s fees, financial advisory
fees, or brokers&rsquo; commissions (other than for Persons engaged by any Buyer or its investment advisor) relating to or arising out
of the transactions contemplated hereby, including, without limitation, the advisory fees payable to GP Nurmenkari Inc. (the &ldquo;<B>Placement
Agent</B>&rdquo;) in connection with the sale of the Securities. The Company shall pay, and hold each Buyer harmless against, any liability,
loss or expense (including, without limitation, attorney&rsquo;s fees and out-of-pocket expenses) arising in connection with any such
claim. The Company acknowledges that it has engaged the Placement Agent in connection with the sale of the Securities. Other than the
Placement Agent, neither the Company nor any of its Subsidiaries has engaged any placement agent or other agent in connection with the
offer or sale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(h) <U>No Integrated
Offering</U>. None of the Company, its Subsidiaries or any of their affiliates, nor any Person acting on their behalf has, directly or
indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would require
registration of the issuance of any of the Securities under the 1933 Act, whether through integration with prior offerings or otherwise,
or caused this offering of the Securities to require approval of stockholders of the Company for purposes of the 1933 Act or under any
applicable stockholder approval provisions, including, without limitation, under the rules&nbsp;and regulations of any exchange or automated
quotation system on which any of the securities of the Company are listed or designated for quotation. None of the Company, its Subsidiaries,
their affiliates nor any Person acting on their behalf will take any action or steps that would require registration of the issuance of
any of the Securities under the 1933 Act (other than pursuant to the Registration Rights Agreement) or cause the offering of any of the
Securities to be integrated with other offerings of securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(i) <U>Dilutive Effect</U>.
The Company understands and acknowledges that the number of Conversion Shares and Warrant Shares will increase in certain circumstances.
The Company further acknowledges that its obligation to issue the Conversion Shares pursuant to the terms of the Certificate of Designations
in accordance with this Agreement and Warrant Shares upon exercise of the Warrants in accordance with this Agreement, the Preferred Shares
and the Warrants is, in each case, absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership
interests of other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(j) <U>Application of
Takeover Protections; Rights Agreement</U>. The Company and its board of directors have taken all necessary action, if any, in order to
render inapplicable any control share acquisition, interested stockholder, business combination, poison pill (including, without limitation,
any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover provision under the Certificate of
Incorporation, Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise which is or
could become applicable to any Buyer as a result of the transactions contemplated by this Agreement, including, without limitation, the
Company&rsquo;s issuance of the Securities and any Buyer&rsquo;s ownership of the Securities. The Company and its board of directors have
taken all necessary action, if any, in order to render inapplicable any stockholder rights plan or similar arrangement relating to accumulations
of beneficial ownership of shares of Common Stock or a change in control of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(k) <U>SEC Documents;
Financial Statements</U>. During the two (2) years prior to the date hereof, the Company has timely filed all reports, schedules,
forms, proxy statements, statements and other documents required to be filed by it with the SEC pursuant to the reporting requirements
of the 1934 Act (all of the foregoing filed prior to the date hereof and all exhibits and appendices included therein and financial statements,
notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the &ldquo;<B>SEC Documents</B>&rdquo;).
The Company has delivered or has made available to the Buyers or their respective representatives true, correct and complete copies of
each of the SEC Documents not available on the EDGAR system. As of their respective dates, the SEC Documents complied in all material
respects with the requirements of the 1934 Act and the rules&nbsp;and regulations of the SEC promulgated thereunder applicable to the
SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained any untrue statement of a material fact
or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading. As of their respective dates, the financial statements of the Company included
in the SEC Documents complied in all material respects with applicable accounting requirements and the published rules&nbsp;and regulations
of the SEC with respect thereto as in effect as of the time of filing. Such financial statements have been prepared in accordance with
U.S. generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;), consistently applied, during the periods involved (except (i) as
may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited interim statements,
to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material respects the financial
position of the Company as of the dates thereof and the results of its operations and cash flows for the periods then ended (subject,
in the case of unaudited statements, to normal year-end audit adjustments which will not be material, either individually or in the aggregate).
No other information provided by or on behalf of the Company to any of the Buyers which is not included in the SEC Documents (including,
without limitation, information referred to in Section&nbsp;2(e) of this Agreement or in the disclosure schedules to this Agreement)
contains any untrue statement of a material fact or omits to state any material fact necessary in order to make the statements therein
not misleading, in the light of the circumstance under which they are or were made. The Company is not currently contemplating to amend
or restate any of the financial statements (including, without limitation, any notes or any letter of the independent accountants of the
Company with respect thereto) included in the SEC Documents (the &ldquo;<B>Financial Statements</B>&rdquo;), nor is the Company currently
aware of facts or circumstances which would require the Company to amend or restate any of the Financial Statements, in each case, in
order for any of the Financials Statements to be in compliance with GAAP and the rules&nbsp;and regulations of the SEC. The Company has
not been informed by its independent accountants that they recommend that the Company amend or restate any of the Financial Statements
or that there is any need for the Company to amend or restate any of the Financial Statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(l) <U>Absence of Certain
Changes</U>. Except as disclosed in the SEC Documents, since the date of the Company&rsquo;s most recent audited financial statements
contained in a Form&nbsp;10-K, there has been no material adverse change and no material adverse development in the business, assets,
liabilities, properties, operations (including results thereof), condition (financial or otherwise) or prospects of the Company or any
of its Subsidiaries. Since the date of the Company&rsquo;s most recent audited financial statements contained in a Form&nbsp;10-K, neither
the Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets, individually or in the
aggregate, outside of the ordinary course of business or (iii) made any capital expenditures, individually or in the aggregate, outside
of the ordinary course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to
any law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company or
any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy
proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company and its Subsidiaries, individually
and on a consolidated basis, are not as of the date hereof, and after giving effect to the transactions contemplated hereby to occur at
the Closing, will not be Company Insolvent (as defined below). For purposes of this Section&nbsp;3(l), &ldquo;<B>Company Insolvent</B>&rdquo;
means, with respect to the Company and its Subsidiaries, on a consolidated basis, (A) the present fair saleable value of the Company&rsquo;s
and its Subsidiaries&rsquo; assets is less than the amount required to pay the Company&rsquo;s and its Subsidiaries&rsquo; total Indebtedness
(as defined below), (B) the Company and its Subsidiaries are unable to pay their debts and liabilities, subordinated, contingent
or otherwise, as such debts and liabilities become absolute and matured or (C) the Company and its Subsidiaries intend to incur or
believe that they will incur debts that would be beyond their ability to pay as such debts mature. Neither the Company nor any of its
Subsidiaries has engaged in any business or in any transaction, and is not about to engage in any business or in any transaction, for
which the Company&rsquo;s or such Subsidiary&rsquo;s remaining assets constitute unreasonably small capital with which to conduct the
business in which it is engaged as such business is now conducted and is proposed to be conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(m) <U>No Undisclosed Events, Liabilities,
Developments or Circumstances</U>. To the Company&rsquo;s knowledge, no event, liability, development or circumstance has occurred or
exists that is reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(n) <U>Conduct of Business;
Regulatory Permits</U>. Neither the Company nor any of its Subsidiaries is in violation of any term of or in default under its Certificate
of Incorporation, organizational documents, any certificate of designations, preferences or rights of any other outstanding series of
preferred stock of the Company or any of its Subsidiaries or Bylaws, their organizational charter, certificate of formation, memorandum
of association, articles of association or certificate of incorporation or bylaws or other organizational documents, respectively. Neither
the Company nor any of its Subsidiaries is in violation of any judgment, decree or order or any statute, ordinance, rule&nbsp;or regulation
applicable to the Company or any of its Subsidiaries, and neither the Company nor any of its Subsidiaries will conduct its business in
violation of any of the foregoing, except in all cases for possible violations which could not, individually or in the aggregate, have
a Material Adverse Effect. Without limiting the generality of the foregoing, the Company is not in violation of any of the rules, regulations
or requirements of the Principal Market and has no knowledge of any facts or circumstances that could reasonably lead to delisting or
suspension of the Common Stock by the Principal Market in the foreseeable future. Since June&nbsp;7, 2021, (i) the Common Stock has
been listed or designated for quotation on the Principal Market, (ii) trading in the Common Stock has not been suspended by the SEC
or the Principal Market and (iii) except as disclosed in the SEC Documents, the Company has received no communication, written or
oral, from the SEC or the Principal Market regarding the suspension or delisting of the Common Stock from the Principal Market. The Company
and each of its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory authorities necessary
to conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would not have,
individually or in the aggregate, a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any notice of
proceedings relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement, commitment,
judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries
is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of
the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries or the conduct of business
by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or in the aggregate, which have
not had and would not reasonably be expected to have a Material Adverse Effect on the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(o) <U>Foreign Corrupt
Practices</U>. Neither the Company, the Company&rsquo;s subsidiary or any director, officer, agent, employee, nor any other person acting
for or on behalf of the foregoing (individually and collectively, a &ldquo;<B>Company Affiliate</B>&rdquo;) have violated the U.S. Foreign
Corrupt Practices Act (the &ldquo;<B>FCPA</B>&rdquo;) or any other applicable anti-bribery or anti-corruption laws, nor has any Company
Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to give, or authorized the
giving of anything of value, to any officer, employee or any other person acting in an official capacity for any Governmental Entity to
any political party or official thereof or to any candidate for political office (individually and collectively, a &ldquo;<B>Government
Official</B>&rdquo;) or to any person under circumstances where such Company Affiliate knew or was aware of a high probability that all
or a portion of such money or thing of value would be offered, given or promised, directly or indirectly, to any Government Official,
for the purpose of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">influencing any act or decision of such Government Official in his/her official capacity, (B) inducing such Government Official to do or omit to do any act in violation of his/her lawful duty, (C) securing any improper advantage, or (D) inducing such Government Official to influence or affect any act or decision of any Governmental Entity, or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">assisting the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business to, the Company or its Subsidiaries.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(p) <U>Sarbanes-Oxley
Act</U>. The Company and each Subsidiary is in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002,
as amended, and any and all applicable rules&nbsp;and regulations promulgated by the SEC thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(q) <U>Transactions
With Affiliates</U>. Except as disclosed in the SEC Documents or for which no disclosure is required in the SEC Documents, no current
or former employee, partner, director, officer or stockholder (direct or indirect) of the Company or its Subsidiaries, or any associate,
or, to the knowledge of the Company, any affiliate of any thereof, or any relative with a relationship no more remote than first cousin
of any of the foregoing, is presently, or has ever been, (i) a party to any transaction with the Company or its Subsidiaries (including
any contract, agreement or other arrangement providing for the furnishing of services by, or rental of real or personal property from,
or otherwise requiring payments to, any such director, officer or stockholder or such associate or affiliate or relative Subsidiaries
(other than for ordinary course services as employees, officers or directors of the Company or any of its Subsidiaries)) or (ii) the
direct or indirect owner of an interest in any corporation, firm, association or business organization which is a competitor, supplier
or customer of the Company or its Subsidiaries (except for a passive investment (direct or indirect) in less than 5% of the common equity
of a company whose securities are traded on or quoted through an Eligible Market (as defined in the Certificate of Designations)), nor
does any such Person receive income from any source other than the Company or its Subsidiaries which relates to the business of the Company
or its Subsidiaries or should properly accrue to the Company or its Subsidiaries. No employee, officer, stockholder or director of the
Company or any of its Subsidiaries or member of his or her immediate family is indebted to the Company or its Subsidiaries, as the case
may be, nor is the Company or any of its Subsidiaries indebted (or committed to make loans or extend or guarantee credit) to any of them,
other than (i) for payment of salary for services rendered, (ii) reimbursement for reasonable expenses incurred on behalf of
the Company, and (iii) for other standard employee benefits made generally available to all employees or executives (including stock
option agreements outstanding under any stock option plan approved by the Board of Directors of the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(r) <U>Equity Capitalization</U>. As of the date hereof, the authorized
capital stock of the Company consists solely of (i) 150,000,000 shares of Common Stock, of which, 4,922,412 shares of Common Stock are
issued and outstanding and 227,859 shares are reserved for issuance pursuant to outstanding Convertible Securities (as defined below)
(other than the Preferred Shares and the Warrants); (ii) 15,000 shares of Series B preferred stock, of which zero shares are issued and
outstanding; (iii) 5,000 shares of Series C Convertible Preferred Stock, par value $0.0001 per share (the &ldquo;Series C Preferred Stock&rdquo;),
of which zero shares are issued and outstanding; and (iv) 5,500 shares of Series D Convertible Preferred Stock, par value $0.0001 per
share (the &ldquo;Series D Preferred Stock&rdquo;), of which 5,500 shares are issued and outstanding. &ldquo;<B>Convertible Securities</B>&rdquo;
means any capital stock or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly
or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital
stock or other security of the Company (including, without limitation, Common Stock) or any of its Subsidiaries. All of such outstanding
shares are duly authorized and have been, or upon issuance will be, validly issued and are fully paid and non-assessable. Except as disclosed
in the SEC Documents, (i) none of the Company&rsquo;s or any Subsidiary&rsquo;s capital stock is subject to preemptive rights or any other
similar rights or any liens or encumbrances suffered or permitted by the Company or any Subsidiary; (ii) there are no outstanding options,
warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible
into, or exercisable or exchangeable for, any capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings
or arrangements by which the Company or any of its Subsidiaries is or may become bound to issue additional capital stock of the Company
or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities or rights convertible into, or exercisable or exchangeable for, any capital stock of the Company or any of its Subsidiaries;
(iii) there are no outstanding debt securities, notes, credit agreements, credit facilities or other agreements, documents or instruments
evidencing Indebtedness of the Company or any of its Subsidiaries or by which the Company or any of its Subsidiaries is or may become
bound; (iv) there are no financing statements securing obligations in any amounts filed in connection with the Company or any of its Subsidiaries;
(v) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any
of their securities under the 1933 Act (except pursuant to the Registration Rights Agreement); (vi) there are no outstanding securities
or instruments of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security
of the Company or any of its Subsidiaries; (vii) there are no securities or instruments containing anti-dilution or similar provisions
that will be triggered by the issuance of the Securities; (viii) neither the Company nor any Subsidiary has any stock appreciation rights
or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement; and (ix) neither the Company nor any of its Subsidiaries
have any liabilities or obligations required to be disclosed in the SEC Documents which are not so disclosed in the SEC Documents, other
than those incurred in the ordinary course of the Company&rsquo;s or its Subsidiaries&rsquo; respective businesses and which, individually
or in the aggregate, do not or could not have a Material Adverse Effect. The Company has furnished to the Buyers true, correct and complete
copies of the Company&rsquo;s Certificate of Incorporation, as amended and as in effect on the date hereof (the &ldquo;<B>Certificate
of Incorporation</B>&rdquo;), and the Company&rsquo;s amended and restated bylaws, as amended and as in effect on the date hereof (the
 &ldquo;<B>Bylaws</B>&rdquo;), and the terms of all Convertible Securities convertible into, or exercisable or exchangeable for, shares
of Common Stock and the material rights of the holders thereof in respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(s) <U>Indebtedness
and Other Contracts</U>. Neither the Company nor any of its Subsidiaries, (i) has any outstanding debt securities, notes, credit
agreements, credit facilities or other agreements, documents or instruments evidencing Indebtedness of the Company or any of its Subsidiaries
or by which the Company or any of its Subsidiaries is or may become bound, (ii) is a party to any contract, agreement or instrument,
the violation of which, or default under which, by the other party(ies) to such contract, agreement or instrument could reasonably be
expected to result in a Material Adverse Effect, (iii) has any financing statements securing obligations in any amounts filed in
connection with the Company or any of its Subsidiaries; (iv) is in violation of any term of, or in default under, any contract, agreement
or instrument relating to any Indebtedness, except where such violations and defaults would not result, individually or in the aggregate,
in a Material Adverse Effect, or (v) is a party to any contract, agreement or instrument relating to any Indebtedness, the performance
of which, in the judgment of the Company&rsquo;s officers, has or is expected to have a Material Adverse Effect. For purposes of this
Agreement: (x) &ldquo;<B>Indebtedness</B>&rdquo; of any Person means, without duplication (A) all indebtedness for borrowed
money, (B) all obligations issued, undertaken or assumed as the deferred purchase price of property or services (including, without
limitation, &ldquo;finance leases&rdquo; in accordance with GAAP) (other than trade payables entered into in the ordinary course of business
consistent with past practice), (C) all reimbursement or payment obligations, currently due and payable, with respect to letters
of credit, surety bonds and other similar instruments, (D) all obligations evidenced by notes, bonds, debentures or similar instruments,
including obligations so evidenced incurred in connection with the acquisition of property, assets or businesses, (E) all indebtedness
created or arising under any conditional sale or other title retention agreement, or incurred as financing, in either case with respect
to any property or assets acquired with the proceeds of such indebtedness (even though the rights and remedies of the seller or bank under
such agreement in the event of default are limited to repossession or sale of such property), (F) all monetary obligations under
any leasing or similar arrangement which, in connection with GAAP, consistently applied for the periods covered thereby, is classified
as a finance lease, (G) all indebtedness referred to in clauses (A) through (F) above secured by (or for which the holder
of such Indebtedness has an existing right, contingent or otherwise, to be secured by) any Lien upon or in any property or assets (including
accounts and contract rights) owned by any Person, even though the Person which owns such assets or property has not assumed or become
liable for the payment of such indebtedness, and (H) all Contingent Obligations in respect of indebtedness or obligations of others
of the kinds referred to in clauses (A) through (G) above; and (y) &ldquo;<B>Contingent Obligation</B>&rdquo; means, as
to any Person, any direct or indirect liability, contingent or otherwise, of that Person with respect to any Indebtedness, lease, dividend
or other obligation of another Person if the primary purpose or intent of the Person incurring such liability, or the primary effect thereof,
is to provide assurance to the obligee of such liability that such liability will be paid or discharged, or that any agreements relating
thereto will be complied with, or that the holders of such liability will be protected (in whole or in part) against loss with respect
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(t) <U>Litigation</U>.
There is no material action, suit, arbitration, proceeding, inquiry or investigation before or by the Principal Market, any court, public
board, other Governmental Entity, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against
or affecting the Company or any of its Subsidiaries, the Common Stock or any of the Company&rsquo;s or its Subsidiaries&rsquo; officers
or directors, whether of a civil or criminal nature or otherwise, in their capacities as such, except as disclosed in the SEC Documents.
To its knowledge, no director, officer or employee of the Company or any of its subsidiaries has willfully violated 18 U.S.C. &sect;1519
or engaged in spoliation in reasonable anticipation of litigation. Without limitation of the foregoing, there has not been, and to the
knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving the Company, any of its Subsidiaries
or any current or former director or officer of the Company or any of its Subsidiaries relating to the Company. Neither the Company nor
any of its Subsidiaries is subject to any order, writ, judgment, injunction, decree, determination or award of any Governmental Entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(u) <U>Insurance</U>.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries
are engaged. Neither the Company nor any such Subsidiary has been refused any insurance coverage sought or applied for, and neither the
Company nor any such Subsidiary has any reason to believe that it will be unable to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that
would not have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(v) <U>Employee Matters;
Benefit Plans</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and its Subsidiaries have complied in all material respects with all applicable laws relating to wages, hours, equal opportunity, collective bargaining, workers&rsquo; compensation insurance and the payment of social security and other taxes. The Company is not aware that any officer, key employee or group of employees intends to terminate his, her or their employment with the Company or its Subsidiaries, as the case may be, nor does the Company have a present intention, or know of a present intention of its Subsidiaries, to terminate the employment of any officer or key employee. There are no pending or, to the knowledge of the Company, threatened employment discrimination charges or complaints against or involving the Company or its Subsidiaries before any federal, state, or local board, department, commission or agency, or unfair labor practice charges or complaints, disputes or grievances affecting the Company or its Subsidiaries.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships with their employees are good.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and its Subsidiaries are in compliance in all material respects with the applicable provisions of the Employee Retirement Income Security Act of 1974, as amended (&ldquo;<B>ERISA</B>&rdquo;). No benefit plan of the Company or any Subsidiary (a) is subject to the provisions of Section&nbsp;412 of the Code or Part&nbsp;3 of Subtitle B of Title I of ERISA, (b) is subject to Title IV of ERISA, (c) is a &ldquo;multiemployer plan&rdquo; (within the meaning of Section&nbsp;3(37) of ERISA). Since inception, neither the Company, its Subsidiaries, nor any business or entity treated as a single employer with the Company or its Subsidiaries for purposes of Title IV of ERISA contributed to or was obliged to contribute to a pension plan that was at any time subject to Title IV of ERISA.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(w) <U>Assets; Title</U>.
The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable
title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and
clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with
the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal,
state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither
delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by
them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in material compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(x) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<B>Intellectual Property Rights</B>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(y) <U>Environmental
Laws</U>. The Company and its Subsidiaries (A) are in compliance with any and all Environmental Laws (as defined below), (B) have
received all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses
and (C) are in compliance with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses
(A), (B) and (C), the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse
Effect. The term &ldquo;<B>Environmental Laws</B>&rdquo; means all federal, state, local or foreign laws relating to pollution or protection
of human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface
strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<B>Hazardous Materials</B>&rdquo;) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous
Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(z) <U>Subsidiary Rights</U>.
The Company or one of its Subsidiaries has the unrestricted right to vote, and (subject to limitations imposed by applicable law) to receive
dividends and distributions on, all capital securities of its Subsidiaries as owned by the Company or such Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(aa) <U>Tax Status</U>. Except
for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect, the
Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income
and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes
and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and
declarations and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods
subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed
to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such
claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(bb) <U>Internal Accounting
and Disclosure Controls</U>. Other than as disclosed in the SEC Reports, the Company and each of its Subsidiaries maintains internal control
over financial reporting (as such term is defined in Rule&nbsp;13a-15(f) under the 1934 Act) that is effective to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with GAAP, including that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with management&rsquo;s
general or specific authorization and (iv) the recorded accountability for assets and liabilities is compared with the existing assets
and liabilities at reasonable intervals and appropriate action is taken with respect to any difference. Other than as disclosed in the
SEC Reports, the Company maintains disclosure controls and procedures (as such term is defined in Rule&nbsp;13a-15(e) under the 1934
Act) that are effective in ensuring that information required to be disclosed by the Company in the reports that it files or submits under
the 1934 Act is recorded, processed, summarized and reported, within the time periods specified in the rules&nbsp;and forms of the SEC,
including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in
the reports that it files or submits under the 1934 Act is accumulated and communicated to the Company&rsquo;s management, including its
principal executive officer or officers and its principal financial officer or officers, as appropriate, to allow timely decisions regarding
required disclosure. Since January&nbsp;1, 2024, other than as disclosed in the SEC Reports, neither the Company nor any of its Subsidiaries
has received any notice or correspondence from any accountant, Governmental Entity or other Person relating to any material weakness or
significant deficiency in any part of the internal controls over financial reporting of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(cc) <U>Off Balance Sheet
Arrangements</U>. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated
or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that
otherwise could be reasonably likely to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(dd) <U>Investment Company
Status</U>. The Company is not, and upon consummation of the sale of the Securities will not be, an &ldquo;investment company,&rdquo;
an affiliate of an &ldquo;investment company,&rdquo; a company controlled by an &ldquo;investment company&rdquo; or an &ldquo;affiliated
person&rdquo; of, or &ldquo;promoter&rdquo; or &ldquo;principal underwriter&rdquo; for, an &ldquo;investment company&rdquo; as such terms
are defined in the Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(ee) <U>Acknowledgement Regarding
Buyers&rsquo; Trading Activity</U>. It is understood and acknowledged by the Company that (i) following the public disclosure of
the transactions contemplated by the Transaction Documents, in accordance with the terms thereof, none of the Buyers have been asked by
the Company or any of its Subsidiaries to agree, nor has any Buyer agreed with the Company or any of its Subsidiaries, to desist from
effecting any transactions in or with respect to (including, without limitation, purchasing or selling, long and/or short) any securities
of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold any of the Securities for
any specified term; (ii) any Buyer, and counterparties in &ldquo;derivative&rdquo; transactions to which any such Buyer is a party,
directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock which was established prior to such Buyer&rsquo;s
knowledge of the transactions contemplated by the Transaction Documents; (iii) each Buyer shall not be deemed to have any affiliation
with or control over any arm&rsquo;s length counterparty in any &ldquo;derivative&rdquo; transaction; and (iv) each Buyer may rely
on the Company&rsquo;s obligation to timely deliver shares of Common Stock upon conversion, exercise or exchange, as applicable, of the
Securities as and when required pursuant to the Transaction Documents for purposes of effecting trading in the Common Stock of the Company.
The Company further understands and acknowledges that following the public disclosure of the transactions contemplated by the Transaction
Documents pursuant to the 8-K Filing (as defined below) one or more Buyers may engage in hedging and/or trading activities (including,
without limitation, the location and/or reservation of borrowable shares of Common Stock) at various times during the period that the
Securities are outstanding, including, without limitation, during the periods that the value and/or number of the Warrant Shares or Conversion
Shares, as applicable, deliverable with respect to the Securities are being determined and such hedging and/or trading activities (including,
without limitation, the location and/or reservation of borrowable shares of Common Stock), if any, can reduce the value of the existing
stockholders&rsquo; equity interest in the Company both at and after the time the hedging and/or trading activities are being conducted.
The Company acknowledges that such aforementioned hedging and/or trading activities do not constitute a breach of this Agreement, the
Certificate of Designations, the Warrants or any other Transaction Document or any of the documents executed in connection herewith or
therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(ff) <U>Manipulation of Price</U>.
Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person acting on their behalf has, directly
or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation of the price of any security
of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased,
or paid any compensation for soliciting purchases of, any of the Securities (other than the Placement Agent), (iii) paid or agreed
to pay to any Person any compensation for soliciting another to purchase any other securities of the Company or any of its Subsidiaries
or (iv) paid or agreed to pay any Person for research services with respect to any securities of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(gg) <U>U.S. Real Property
Holding Corporation</U>. Neither the Company nor any of its Subsidiaries is, or has ever been a U.S. real property holding corporation
within the meaning of Section&nbsp;897 of the Code, and the Company and each Subsidiary shall so certify upon any Buyer&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(hh) <U>Registration Eligibility</U>.
Except for rights pursuant to the Registration Rights Agreement, no Person has any right to cause the Company or any Subsidiary to effect
the registration under the 1933 Act of any securities of the Company or any Subsidiary. The Company is eligible to register the Registrable
Securities (as defined in the Registration Rights Agreement) for resale by the Buyers using Form&nbsp;S-3 promulgated under the 1933 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(ii) <U>Transfer Taxes</U>.
On the Closing Date, all stock transfer or other taxes (other than income or similar taxes) which are required to be paid in connection
with the issuance, sale and transfer of the Securities to be sold to each Buyer hereunder will be, or will have been, fully paid or provided
for by the Company, and all laws imposing such taxes will be or will have been complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(jj) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries is subject to the Bank Holding Company Act of 1956, as amended (the &ldquo;<B>BHCA</B>&rdquo;)
and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<B>Federal Reserve</B>&rdquo;). Neither the Company
nor any of its Subsidiaries or affiliates owns or controls, directly or indirectly, five percent (5%) or more of the outstanding shares
of any class of voting securities or twenty-five percent (25%) or more of the total equity of a bank or any entity that is subject to
the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or affiliates exercises a controlling
influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(kk) <U>Shell Company Status</U>.
The Company is not, and has never been, an issuer identified in, or subject to, Rule&nbsp;144(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(ll) <U>Illegal or Unauthorized
Payments; Political Contributions</U>. Neither the Company nor any of its Subsidiaries nor, to the best of the Company&rsquo;s knowledge
(after reasonable inquiry of its officers and directors), any of the officers, directors, employees, agents or other representatives of
the Company or any of its Subsidiaries or any other business entity or enterprise with which the Company or any Subsidiary is or has been
affiliated or associated, has, directly or indirectly, made or authorized any payment, contribution or gift of money, property, or services,
whether or not in contravention of applicable law, (i) as a kickback or bribe to any Person or (ii) to any political organization,
or the holder of or any aspirant to any elective or appointive public office except for personal political contributions not involving
the direct or indirect use of funds of the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(mm) <U>Money Laundering</U>.
The Company and its Subsidiaries are in compliance with, and have not previously violated, the USA Patriot Act of 2001 and all other applicable
U.S. and non-U.S. anti-money laundering laws and regulations, including, without limitation, the laws, regulations and Executive Orders
and sanctions programs administered by the U.S. Office of Foreign Assets Control, including, but not limited, to (i) Executive Order
13224 of September&nbsp;23, 2001 entitled, &ldquo;Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to
Commit, or Support Terrorism&rdquo; (66 Fed. Reg. 49079 (2001)) and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter
V.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(nn) <U>Stock Option Plans</U>.
Each stock option granted by the Company was granted (i) in accordance with the terms of the applicable stock option plan of the
Company and (ii) with an exercise price at least equal to the fair market value of the shares of Common Stock on the date such stock
option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option plan
has been backdated. The Company has not knowingly granted, and there is no and has been no policy or practice of the Company to knowingly
grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement
of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(oo) <U>No Disagreements
with Accountants and Lawyers</U>. There are no material disagreements of any kind presently existing, or reasonably anticipated by the
Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is
current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of
its obligations under any of the Transaction Documents. In addition, on or prior to the date hereof, the Company had discussions with
its accountants about its financial statements previously filed with the SEC. Based on those discussions, the Company has no reason to
believe that it will need to restate any such financial statements or any part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(pp) <U>No Disqualification
Events</U>. With respect to Securities to be offered and sold hereunder in reliance on Rule&nbsp;506(b) under the 1933 Act (&ldquo;<B>Regulation
D Securities</B>&rdquo;), none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other
officer of the Company participating in the offering contemplated hereby, any beneficial owner of 20% or more of the Company&rsquo;s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule&nbsp;405 under the
1933 Act) connected with the Company in any capacity at the time of sale (each, an &ldquo;<B>Issuer Covered Person</B>&rdquo; and, together,
 &ldquo;<B>Issuer Covered Persons</B>&rdquo;) is subject to any of the &ldquo;<B>Bad Actor</B>&rdquo; disqualifications described in Rule&nbsp;506(d)(1)(i) to
(viii) under the 1933 Act (a &ldquo;<B>Disqualification Event</B>&rdquo;), except for a Disqualification Event covered by Rule&nbsp;506(d)(2) or
(d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event.
The Company has complied, to the extent applicable, with its disclosure obligations under Rule&nbsp;506(e), and has furnished to the Buyers
a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(qq) <U>Other Covered Persons</U>.
The Company is not aware of any Person (other than the Placement Agent) that has been or will be paid (directly or indirectly) remuneration
for solicitation of Buyers or potential purchasers in connection with the sale of any Regulation D Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(rr) <U>No Additional Agreements</U>.
The Company does not have any agreement or understanding with any Buyer with respect to the transactions contemplated by the Transaction
Documents other than as specified in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(ss) <U>Public Utility Holding
Act</U>. None of the Company nor any of its Subsidiaries is a &ldquo;holding company,&rdquo; or an &ldquo;affiliate&rdquo; of a &ldquo;holding
company,&rdquo; as such terms are defined in the Public Utility Holding Act of 2005.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(tt) <U>Federal Power Act</U>.
None of the Company nor any of its Subsidiaries is subject to regulation as a &ldquo;public utility&rdquo; under the Federal Power Act,
as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(uu) <U>Cybersecurity</U>.
The Company and its Subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware, software,
websites, applications, and databases (collectively, &ldquo;<B>IT Systems</B>&rdquo;) are adequate for, and operate and perform in all
material respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted,
free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants that would reasonably be
expected to have a Material Adverse Effect on the Company&rsquo;s business. The Company and its Subsidiaries have implemented and maintained
commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to maintain and protect
their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and data, including
 &ldquo;Personal Data,&rdquo; used in connection with their businesses. &ldquo;<B>Personal Data</B>&rdquo; means (i) a natural person&rsquo;s
name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver&rsquo;s
license number, passport number, credit card number, bank information, or customer or account number; (ii) any information which
would qualify as &ldquo;personally identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii) &ldquo;personal
data&rdquo; as defined by the European Union General Data Protection Regulation (&ldquo;<B>GDPR</B>&rdquo;) (EU 2016/679); (iv) any
information which would qualify as &ldquo;protected health information&rdquo; under the Health Insurance Portability and Accountability
Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (collectively, &ldquo;<B>HIPAA</B>&rdquo;);
and (v) any other piece of information that allows the identification of such natural person, or his or her family, or permits the
collection or analysis of any data related to an identified person&rsquo;s health or sexual orientation. Since January&nbsp;1, 2021, there
have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without
material cost or liability or the duty to notify any other person or such, nor any incidents under internal review or investigations relating
to the same except in each case, where such would not, either individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect. The Company and its Subsidiaries are presently in compliance with all applicable laws or statutes and all judgments,
orders, rules&nbsp;and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal
Data from unauthorized use, access, misappropriation or modification except in each case, where such would not, either individually or
in the aggregate, reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(vv) <U>Compliance with Data
Privacy Laws</U>. The Company and its Subsidiaries are in compliance with all applicable state and federal data privacy and security laws
and regulations, including without limitation HIPAA, and the Company and its Subsidiaries have taken commercially reasonable actions to
prepare to comply with, and since May&nbsp;25, 2018, have been and currently are in compliance with, the GDPR (EU 2016/679) (collectively,
the &ldquo;Privacy Laws&rdquo;) except in each case, where such would not, either individually or in the aggregate, reasonably be expected
to result in a Material Adverse Effect. To ensure compliance with the Privacy Laws, the Company and its Subsidiaries have in place, comply
with, and take appropriate steps reasonably designed to ensure compliance in all material respects with their policies and procedures
relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the &ldquo;<B>Policies</B>&rdquo;).
The Company and its Subsidiaries have made all disclosures to users or customers required by applicable laws and regulatory rules&nbsp;or
requirements, and none of such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in
violation of any applicable laws and regulatory rules&nbsp;or requirements in any material respect. The Company further certifies that
neither it nor any Subsidiary: (i) has received notice of any actual or potential liability under or relating to, or actual or potential
violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected to result in any
such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective
action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement that imposes any obligation or liability
under any Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(ww)&#8239;<U>Disclosure</U>.
The Company confirms that neither it nor any other Person acting on its behalf has provided any of the Buyers or their agents or counsel
with any information that constitutes or could reasonably be expected to constitute material, non-public information concerning the Company
or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the other Transaction Documents.
The Company understands and confirms that each of the Buyers will rely on the foregoing representations in effecting transactions in securities
of the Company. All disclosure provided to the Buyers regarding the Company and its Subsidiaries, their businesses and the transactions
contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the Company or any of its Subsidiaries is
true and correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements made therein, in the light of the circumstances under which they were made, not misleading. Each press release issued
by the Company or any of its Subsidiaries during the twelve (12) months preceding the date of this Agreement did not at the time of release
contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to
make the statements therein, in the light of the circumstances under which they are made, not misleading. Other than with respect to the
transactions contemplated by this Agreement and the other Transaction Documents, no event or circumstance has occurred or information
exists with respect to the Company or any of its Subsidiaries or its or their business, properties, liabilities, prospects, operations
(including results thereof) or conditions (financial or otherwise), which, under applicable law, rule&nbsp;or regulation, requires public
disclosure at or before the date hereof or announcement by the Company but which has not been so publicly disclosed. The Company acknowledges
and agrees that no Buyer makes or has made any representations or warranties with respect to the transactions contemplated hereby other
than those specifically set forth in Section&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>4. COVENANTS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a)&#8239;&#8239;<U>Best
Efforts</U>. Each Buyer shall use its best efforts to timely satisfy each of the covenants hereunder and conditions to be satisfied by
it as provided in Section&nbsp;6 of this Agreement. The Company shall use its best efforts to timely satisfy each of the covenants hereunder
and conditions to be satisfied by it as provided in Section&nbsp;7 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b)&#8239;&#8239;<U>Form&nbsp;D
and Blue Sky</U>. The Company shall file a Form&nbsp;D with respect to the Securities as required under Regulation D and to provide a
copy thereof to each Buyer promptly after such filing. The Company shall, on or before the Closing Date, take such action as the Company
shall reasonably determine is necessary in order to obtain an exemption for, or to, qualify the Securities for sale to the Buyers at the
Closing pursuant to this Agreement under applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States (or to
obtain an exemption from such qualification), and shall provide evidence of any such action so taken to the Buyers on or prior to the
Closing Date. Without limiting any other obligation of the Company under this Agreement, the Company shall timely make all filings and
reports relating to the offer and sale of the Securities required under all applicable securities laws (including, without limitation,
all applicable federal securities laws and all applicable &ldquo;Blue Sky&rdquo; laws), and the Company shall comply with all applicable
federal, foreign, state and local laws, statutes, rules, regulations and the like relating to the offering and sale of the Securities
to the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c)&#8239;&#8239;<U>Reporting
Status</U>. From the date hereof until the date on which the Buyers shall have sold all of the Registrable Securities (the &ldquo;<B>Reporting
Period</B>&rdquo;), the Company shall timely file all reports required to be filed with the SEC pursuant to the 1934 Act, and the Company
shall not terminate its status as an issuer required to file reports under the 1934 Act even if the 1934 Act or the rules&nbsp;and regulations
thereunder would no longer require or otherwise permit such termination. The Company shall take all actions necessary to maintain its
eligibility to register the Registrable Securities for resale by the Buyers on Form&nbsp;S-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d)&#8239;&#8239;<U>Use of
Proceeds</U>. The Company shall use the proceeds from the sale of the Securities for general corporate purposes, but not, directly or
indirectly, for (i) the satisfaction of any indebtedness of the Company or any of its Subsidiaries outstanding on the date hereof
or (ii) the settlement of any litigation outstanding on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e)&#8239;&#8239;<U>Financial
Information</U>. The Company agrees to send the following to each Investor (as defined in the Registration Rights Agreement) during the
Reporting Period (i) unless the following are filed with the SEC through EDGAR and are available to the public through the EDGAR
system, within one (1) Business Day after the filing thereof with the SEC, a copy of its Annual Report on Form&nbsp;10-K, Quarterly
Reports on Form&nbsp;10-Q, any other interim reports or any consolidated balance sheets, income statements, stockholders&rsquo; equity
statements and/or cash flow statements for any period other than any annual report, any Current Reports on Form&nbsp;8-K and any registration
statements (other than on Form&nbsp;S-8) or amendments filed pursuant to the 1933 Act, (ii) unless the following are either filed
with the SEC through EDGAR or are otherwise widely disseminated via a recognized news release service (such as PR Newswire), on the same
day as the release thereof, e-mail copies of all press releases issued by the Company or any of its Subsidiaries and (iii) unless
the following are filed with the SEC through EDGAR, copies of any notices and other information made available or given to the stockholders
of the Company, as applicable, generally, contemporaneously with the making available or giving thereof to the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f)&#8239;&#8239;<U>Listing</U>.
The Company shall promptly secure the listing or designation for quotation (as the case may be) of all of the Registrable Securities upon
each national securities exchange and automated quotation system, if any, upon which the Common Stock is then listed or designated for
quotation (as the case may be) (subject to official notice of issuance) and shall maintain such listing or designation for quotation (as
the case may be) of all Registrable Securities from time to time issuable under the terms of the Transaction Documents on such national
securities exchange or automated quotation system. The Company shall maintain the Common Stock&rsquo;s listing or authorization for quotation
(as the case may be) on the Principal Market, The New York Stock Exchange, the NYSE American, the Nasdaq Global Market or the Nasdaq Global
Select Market (each, an &ldquo;<B>Eligible Market</B>&rdquo;). Neither the Company nor any of its Subsidiaries shall take any action which
could be reasonably expected to result in the delisting or suspension of the Common Stock on the Principal Market. The Company shall pay
all fees and expenses in connection with satisfying its obligations under this Section&nbsp;4(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g)&#8239;&#8239;<U>Fees</U>.
The Company shall reimburse the lead Buyer a non-accountable amount of $50,000 for all costs and expenses incurred by it or its affiliates
in connection with the structuring, documentation, negotiation and closing of the transactions contemplated by the Transaction Documents
(including, without limitation, as applicable, all reasonable legal fees of outside counsel and disbursements of Haynes and Boone, LLP
(&ldquo;<B>Buyer Counsel</B>&rdquo;), counsel to the lead Buyer, any other reasonable fees and expenses in connection with the structuring,
documentation, negotiation and closing of the transactions contemplated by the Transaction Documents and due diligence and regulatory
filings in connection therewith) (the &ldquo;<B>Transaction Expenses</B>&rdquo;) and shall be withheld by the lead Buyer from its Purchase
Price at the Closing. The Company shall be responsible for the payment of any placement agent&rsquo;s fees, financial advisory fees, transfer
agent fees, DTC (as defined below) fees or broker&rsquo;s commissions (other than for Persons engaged by any Buyer) relating to or arising
out of the transactions contemplated hereby (including, without limitation, any fees or commissions payable to the Placement Agent). The
Company shall pay, and the Company shall hold each Buyer harmless against, any liability, loss or expense (including, without limitation,
reasonable attorneys&rsquo; fees and out-of-pocket expenses) arising in connection with any claim relating to any such payment. Except
as otherwise set forth in the Transaction Documents, each party to this Agreement shall bear its own expenses in connection with the sale
of the Securities to the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(h)&#8239;&#8239;<U>Pledge
of Securities</U>. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and agrees that the
Securities may be pledged by a Buyer in connection with a bona fide margin agreement or other loan or financing arrangement that is secured
by the Securities. The pledge of Securities shall not be deemed to be a transfer, sale or assignment of the Securities hereunder, and
no Buyer effecting a pledge of Securities shall be required to provide the Company with any notice thereof or otherwise make any delivery
to the Company pursuant to this Agreement or any other Transaction Document, including, without limitation, Section&nbsp;2(g) hereof;
provided that a Buyer and its pledgee shall be required to comply with the provisions of Section&nbsp;2(g) hereof in order to effect
a sale, transfer or assignment of Securities to such pledgee. The Company hereby agrees to execute and deliver such documentation as a
pledgee of the Securities may reasonably request in connection with a pledge of the Securities to such pledgee by a Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(i)&#8239;&#8239;&#8239;<U>Disclosure
of Transactions and Other Material Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Disclosure of Transaction</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">. The Company shall, no later than 9:30 a.m., New York time, on the Business Day following the date of this Agreement, file a Current Report on Form&nbsp;8-K describing all the material terms of the transactions contemplated by the Transaction Documents in the form required by the 1934 Act and attaching all the material Transaction Documents (including, without limitation, this Agreement (and all schedules to this Agreement, to the extent material), the form of Certificate of Designations, the form of the Warrant and the form of the Registration Rights Agreement) (including the attachments thereto, the &ldquo;<B>8-K Filing</B>&rdquo;). From and after the filing of the 8-K Filing, the Company shall have disclosed all material, non-public information (if any) provided to any of the Buyers by the Company or any of its Subsidiaries or any of their respective officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and any of the Buyers or any of their affiliates, on the other hand, shall terminate.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Limitations on Disclosure</U></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective officers, directors, employees and agents not to, provide any Buyer with any material, non-public information regarding the Company or any of its Subsidiaries from and after the date hereof without the express prior written consent of such Buyer (which may be granted or withheld in such Buyer&rsquo;s sole discretion). In the event of a breach of any of the foregoing covenants, including, without limitation, Section&nbsp;4(o) of this Agreement, or any of the covenants or agreements contained in any other Transaction Document, by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees and agents (as determined in the reasonable good faith judgment of such Buyer), in addition to any other remedy provided herein or in the Transaction Documents, such Buyer shall have the right to make a public disclosure, in the form of a press release, public advertisement or otherwise, of such breach or such material, non-public information, as applicable, without the prior approval by the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees or agents. No Buyer shall have any liability to the Company, any of its Subsidiaries, or any of its or their respective officers, directors, employees, affiliates, stockholders or agents, for any such disclosure. To the extent that the Company, directly or indirectly, delivers any material, non-public information to a Buyer without such Buyer&rsquo;s consent, the Company hereby covenants and agrees that such Buyer shall not have any duty of confidentiality with respect to, or a duty not to trade on the basis of, such material, non-public information. Subject to the foregoing, neither the Company, its Subsidiaries nor any Buyer shall issue any press releases or any other public statements with respect to the transactions contemplated hereby; provided, however, the Company shall be entitled, without the prior approval of any Buyer, to make any press release or other public disclosure with respect to such transactions (i) in substantial conformity with the 8-K Filing and contemporaneously therewith and (ii) as is required by applicable law and regulations (provided that in the case of clause (i) each Buyer shall be consulted by the Company in connection with any such press release or other public disclosure prior to its release). Without the prior written consent of the applicable Buyer (which may be granted or withheld in such Buyer&rsquo;s sole discretion), the Company shall not (and shall cause each of its Subsidiaries and affiliates to not) disclose the name of such Buyer in any filing, announcement, release or otherwise. Notwithstanding anything contained in this Agreement to the contrary and without implication that the contrary would otherwise be true, the Company expressly acknowledges and agrees that no Buyer shall have (unless expressly agreed to by a particular Buyer after the date hereof in a written definitive and binding agreement executed by the Company and such particular Buyer (it being understood and agreed that no Buyer may bind any other Buyer with respect thereto)), any duty of confidentiality with respect to, or a duty not to trade on the basis of, any material, non-public information regarding the Company and/or any of its Subsidiaries.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(j)&#8239;&#8239;&#8239;<U>Additional Registration
Statements</U>. From the date hereof until the Applicable Date (as defined below) and at any time thereafter while any Registration Statement
is not effective or the prospectus contained therein is not available for use or any Current Public Information Failure (as defined in
the Registration Rights Agreement) exists, the Company shall not file a registration statement or an offering statement under the 1933
Act relating to securities that are not the Registrable Securities (other than a registration statement on Form S-8 or such supplements
or amendments to registration statements that are outstanding and have been declared effective by the SEC as of the date hereof (solely
to the extent necessary to keep such registration statements effective and available and not with respect to any Subsequent Placement)).
 &ldquo;<B>Applicable Date</B>&rdquo; means the earlier of (x) the first date on which the resale by the Buyers of all the Registrable
Securities required to be filed on the initial Registration Statement (as defined in the Registration Rights Agreement) pursuant to the
Registration Rights Agreement is declared effective by the SEC (and each prospectus contained therein is available for use on such date)
or (y) the first date on which all of the Registrable Securities are eligible to be resold by the Buyers pursuant to Rule 144 (or, if
a Current Public Information Failure has occurred and is continuing, such later date after which the Company has cured such Current Public
Information Failure).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-size: 10pt">(k)&#8239;&#8239;<U>Additional
Issuance of Securities</U>. So long as any Buyer beneficially owns any Preferred Shares or Warrants, the Company will not, without the
prior written consent of the Required Holders, directly or indirectly, issue any other securities that would cause a breach or default
under the Certificate of Designations or the Warrants. The Company agrees that unless Stockholder Approval (as defined herein) is obtained,
the Company shall not affect any Dilutive Issuance (as defined in the Certificate of Designations). The Company further agrees that for
the period commencing on the date hereof and ending on the date immediately following the 90<SUP>th</SUP> day after the Applicable Date
(provided that such period shall be extended by the number of calendar days during such period and any extension thereof contemplated
by this proviso on which any Registration Statement is not effective or any prospectus contained therein is not available for use or
any Current Public Information Failure exists) (the &ldquo;<B>Restricted Period</B>&rdquo;), neither the Company nor any of its Subsidiaries
shall directly or indirectly issue, offer, sell, grant any option or right to purchase, or otherwise dispose of (or announce any issuance,
offer, sale, grant of any option or right to purchase or other disposition of) any equity security or any equity-linked or related security
(including, without limitation, any &ldquo;equity security&rdquo; (as that term is defined under Rule 405 promulgated under the 1933
Act), any Convertible Securities (as defined below), any preferred stock or any purchase rights) (any such issuance, offer, sale, grant,
disposition or announcement (whether occurring during the Restricted Period or at any time thereafter), is referred to as a &ldquo;<B>Subsequent
Placement</B>&rdquo;). Notwithstanding the foregoing, this Section 4(k) shall not apply in respect of the issuance of (i) shares of Common
Stock issued or issuable to directors, officers, employees or other service providers of the Company in their capacity as such pursuant
to an Approved Stock Plan (as defined below); provided that (1) all such issuances (taking into account the shares of Common Stock issuable
upon exercise of such awards) after the date hereof pursuant to this clause (i) do not, in the aggregate, exceed more than 10.0% of the
sum of (1) the shares of Common Stock issued and outstanding immediately prior to the date hereof, (2) the shares of Common Stock issuable
upon conversion in full of the Preferred Shares (assuming for purposes hereof that (x) the Preferred Shares are convertible at the Conversion
Price (as defined in the Certificate of Designations) as of the Closing Date, and (y) any such conversion shall not take into account
any limitations on the conversion of the Preferred Shares as set forth herein) issued and outstanding as of the Closing Date, and (3)
the shares of Common Stock issuable upon conversion in full of the Series D Preferred Stock (assuming for purposes hereof that (x) the
shares of Series D Preferred Stock are convertible at the Conversion Price (as defined in the certificate of designations of the Series
D Convertible Preferred Stock of the Company (&ldquo;Series D Certificate of Designations&rdquo;)) as of the Closing Date, and (y) any
such conversion shall not take into account any limitations on the conversion of the shares of the Series D Preferred Stock set forth
in the Series D Certificate of Designations) issued and outstanding as of the Closing Date, and (B) the exercise price of any such options
is not lowered, none of such options are amended to increase the number of shares issuable thereunder and none of the terms or conditions
of any such options are otherwise materially changed in any manner that adversely affects any of the Buyers, (ii) shares of Common Stock
issued or issuable upon the conversion or exercise of Convertible Securities (other than shares of Common Stock issued or issuable pursuant
to an Approved Stock Plan that are covered by clause (i) above) issued prior to the date hereof, provided that the conversion, exercise
or other method of issuance (as the case may be) of any such Convertible Security is made solely pursuant to the conversion, exercise
or other method of issuance (as the case may be) provisions of such Convertible Security that were in effect on the date immediately
prior to the date of this Agreement, the conversion, exercise or issuance price of any such Convertible Securities (other than standard
options to purchase shares of Common Stock issued pursuant to an Approved Stock Plan that are covered by clause (i) above) is not lowered,
none of such Convertible Securities are amended to increase the number of shares issuable thereunder and none of the terms or conditions
of any such Convertible Securities (other than those issued pursuant to an Approved Stock Plan that are covered by clause (i) above)
are otherwise materially changed in any manner that materially adversely affects any of the Buyers, (iii) the Preferred Shares, (iv)
the Conversion Shares, (v) the Warrant Shares and any other securities issued or issuable pursuant to this Agreement or any of the Transaction
Documents, including, without limitation, any shares of Common Stock issued or issuable pursuant to Section 9 of the Certificate of Designations,
(vi) securities issued as consideration for the acquisition of another entity by the Company by merger, purchase of substantially all
of the assets or other reorganization or bona fide joint venture agreement, provided that such issuance is approved by the majority of
the disinterested directors of the Company and provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined
in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the Restricted Period and such issuance does not, in the aggregate, exceed more than 5% of the shares of Common Stock issued and
outstanding immediately prior to the date hereof (each of the foregoing in clauses (i) through (vi), collectively the &ldquo;<B>Excluded
Securities</B>&rdquo;) and (vii) provided the Equity Conditions (as defined in the Certificate of Designations) are then satisfied and
the closing price of the Common Stock on the Trading Market equals or exceeds 200% of the initial Conversion Price (as defined in the
Certificate of Designations) for three consecutive Trading Days, sales of shares of Common Stock or Convertible Securities at a per share
purchase price in excess of 160% of the initial Conversion Price (as defined in the Certificate of Designations) (as adjusted for stock
splits, stock dividends, stock combinations, recapitalizations and similar events); provided, however, that if 90% of the aggregate Stated
Value (as defined in the Certificate of Designations) of the Preferred Shares has been paid in full to the Buyers or otherwise converted
to Common Stock, then the Company may sell shares of Common Stock at a per share purchase price in excess of 130% of the Initial Conversion
Price. &ldquo;<B>Approved Stock Plan</B>&rdquo; means any employee benefit plan which has been approved by the board of directors of
the Company prior to or subsequent to the date hereof pursuant to which shares of Common Stock or other awards convertible, exercisable
for or exchangeable for shares of Common Stock may be issued to any employee, officer, director or other service provider for services
provided to the Company and/or a Subsidiary in their capacity as such.</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(l)&#8239;&#8239;&#8239;<U>Reservation
of Shares</U>. So long as any of the Preferred Shares or Warrants remain outstanding, the Company shall take all action necessary to at
all times have authorized, and reserved for the purpose of issuance, no less than the sum of (i) 150% of the maximum number of shares
of Common Stock issuable upon conversion of all the Preferred Shares then outstanding (assuming for purposes hereof that (x) the
Preferred Shares are convertible at the Floor Price (as defined in the Certificate of Designations) then in effect and (y) any such
conversion shall not take into account any limitations on the conversion of the Preferred Shares set forth in the Certificate of Designations),
and (ii) the maximum number of Warrant Shares issuable upon exercise of all the Warrants then outstanding (without regard to any
limitations on the exercise of the Warrants set forth therein) (collectively, the &ldquo;<B>Required Reserve Amount</B>&rdquo;); provided
that at no time shall the number of shares of Common Stock reserved pursuant to this Section&nbsp;4(l) be reduced other than proportionally
in connection with any conversion, exercise and/or redemption, as applicable of Preferred Shares and Warrants. If at any time the number
of shares of Common Stock authorized and reserved for issuance is not sufficient to meet the Required Reserve Amount, the Company will
promptly take all corporate action necessary to authorize and reserve a sufficient number of shares, including, without limitation, calling
a special meeting of stockholders to authorize additional shares to meet the Company&rsquo;s obligations pursuant to the Transaction Documents,
in the case of an insufficient number of authorized shares, obtain stockholder approval of an increase in such authorized number of shares,
and voting the management shares of the Company in favor of an increase in the authorized shares of the Company to ensure that the number
of authorized shares is sufficient to meet the Required Reserve Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(m)&#8239;&#8239;<U>Conduct
of Business</U>. The business of the Company and its Subsidiaries shall not be conducted in violation of any law, ordinance or regulation
of any Governmental Entity, except where such violations would not reasonably be expected to result, either individually or in the aggregate,
in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(n) [Reserved]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(o)&#8239;&#8239;<U>Participation
Right</U>. At any time after the Closing Date and until the later of (x) Preferred Shares are no longer outstanding and (y) the
Maturity Date (as defined in the Certificate of Designations), neither the Company nor any of its Subsidiaries shall, directly or indirectly,
effect any Subsequent Placement unless the Company shall have first complied with this Section&nbsp;4(o). The Company acknowledges and
agrees that the right set forth in this Section&nbsp;4(o) is a right granted by the Company, separately, to each Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At least five (5) Trading Days prior to any proposed or intended Subsequent Placement, the Company shall deliver to each Buyer a written notice (each such notice, a &ldquo;Pre-Notice&rdquo;), which Pre-Notice shall not contain any information (including, without limitation, material, non-public information) other than: (A) if the proposed Offer Notice (as defined below) constitutes or contains material, non-public information, a statement asking whether the Investor is willing to accept material non-public information or (B) if the proposed Offer Notice does not constitute or contain material, non-public information, (x) a statement that the Company proposes or intends to effect a Subsequent Placement, (y) a statement that the statement in clause (x) above does not constitute material, non-public information and (z) a statement informing such Buyer that it is entitled to receive an Offer Notice (as defined below) with respect to such Subsequent Placement upon its written request. Upon the written request of a Buyer within three (3) Trading Days after the Company&rsquo;s delivery to such Buyer of such Pre-Notice, and only upon a written request by such Buyer, the Company shall promptly, but no later than one (1) Trading Day after such request, deliver to such Buyer an irrevocable written notice (the &ldquo;Offer Notice&rdquo;) of any proposed or intended issuance or sale or exchange (the &ldquo;Offer&rdquo;) of the securities being offered (the &ldquo;Offered Securities&rdquo;) in a Subsequent Placement, which Offer Notice shall (A) identify and describe the Offered Securities, (B) describe the price and other terms upon which they are to be issued, sold or exchanged, and the number or amount of the Offered Securities to be issued, sold or exchanged, (C) identify the Persons (if known) to which or with which the Offered Securities are to be offered, issued, sold or exchanged and (D) offer to issue and sell to or exchange with such Buyer in accordance with the terms of the Offer such Buyer&rsquo;s pro rata portion of 50% of the Offered Securities, provided that the number of Offered Securities which such Buyer shall have the right to subscribe for under this Section&nbsp;4(o) shall be (x) based on such Buyer&rsquo;s pro rata portion of the aggregate stated value of the Preferred Shares purchased hereunder by all Buyers (the &ldquo;Basic Amount&rdquo;), and (y) with respect to each Buyer that elects to purchase its Basic Amount, any additional portion of the Offered Securities attributable to the Basic Amounts of other Buyers as such Buyer shall indicate it will purchase or acquire should the other Buyers subscribe for less than their Basic Amounts (the &ldquo;Undersubscription Amount&rdquo;), which process shall be repeated until each Buyer shall have an opportunity to subscribe for any remaining Undersubscription Amount.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To accept an Offer, in whole or in part, such Buyer must deliver a written notice to the Company prior to the end of the fifth (5th) Business Day after such Buyer&rsquo;s receipt of the Offer Notice (the &ldquo;<B>Offer Period</B>&rdquo;), setting forth the portion of such Buyer&rsquo;s Basic Amount that such Buyer elects to purchase and, if such Buyer shall elect to purchase all of its Basic Amount, the Undersubscription Amount, if any, that such Buyer elects to purchase (in either case, the &ldquo;<B>Notice of Acceptance</B>&rdquo;). If the Basic Amounts subscribed for by all Buyers are less than the total of all of the Basic Amounts, then each Buyer who has set forth an Undersubscription Amount in its Notice of Acceptance shall be entitled to purchase, in addition to the Basic Amounts subscribed for, the Undersubscription Amount it has subscribed for; provided, however, if the Undersubscription Amounts subscribed for exceed the difference between the total of all the Basic Amounts and the Basic Amounts subscribed for (the &ldquo;<B>Available Undersubscription Amount</B>&rdquo;), each Buyer who has subscribed for any Undersubscription Amount shall be entitled to purchase only that portion of the Available Undersubscription Amount as the Basic Amount of such Buyer bears to the total Basic Amounts of all Buyers that have subscribed for Undersubscription Amounts, subject to rounding by the Company to the extent it deems reasonably necessary. Notwithstanding the foregoing, if the Company desires to modify or amend the terms and conditions of the Offer prior to the expiration of the Offer Period, the Company may deliver to each Buyer a new Offer Notice and the Offer Period shall expire on the fifth (5th) Business Day after such Buyer&rsquo;s receipt of such new Offer Notice.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company shall have five (5) Business Days from the expiration of the Offer Period above (A) to offer, issue, sell or exchange all or any part of such Offered Securities as to which a Notice of Acceptance has not been given by a Buyer (the &ldquo;<B>Refused Securities</B>&rdquo;) pursuant to a definitive agreement(s) (the &ldquo;<B>Subsequent Placement Agreement</B>&rdquo;), but only to the offerees described in the Offer Notice (if so described therein) and only upon terms and conditions (including, without limitation, unit prices and interest rates) that are not more favorable to the acquiring Person or Persons or less favorable to the Company than those set forth in the Offer Notice and (B) to publicly announce (x) the execution of such Subsequent Placement Agreement, and (y) either (I) the consummation of the transactions contemplated by such Subsequent Placement Agreement or (II) the termination of such Subsequent Placement Agreement, which shall be filed with the SEC on a Current Report on Form&nbsp;8-K with such Subsequent Placement Agreement and any documents contemplated therein filed as exhibits thereto.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event the Company shall propose to sell less than all the Refused Securities (any such sale to be in the manner and on the terms specified in Section&nbsp;4(o)(iii) above), then each Buyer may, at its sole option and in its sole discretion, withdraw its Notice of Acceptance or reduce the number or amount of the Offered Securities specified in its Notice of Acceptance to an amount that shall be not less than the number or amount of the Offered Securities that such Buyer elected to purchase pursuant to Section&nbsp;4(o)(ii) above multiplied by a fraction, (i) the numerator of which shall be the number or amount of Offered Securities the Company actually proposes to issue, sell or exchange (including Offered Securities to be issued or sold to Buyers pursuant to this Section&nbsp;4(o) prior to such reduction) and (ii) the denominator of which shall be the original amount of the Offered Securities. In the event that any Buyer so elects to reduce the number or amount of Offered Securities specified in its Notice of Acceptance, the Company may not issue, sell or exchange more than the reduced number or amount of the Offered Securities unless and until such securities have again been offered to the Buyers in accordance with Section&nbsp;4(o)(i) above.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the closing of the issuance, sale or exchange of all or less than all of the Refused Securities, such Buyer shall acquire from the Company, and the Company shall issue to such Buyer, the number or amount of Offered Securities specified in its Notice of Acceptance, as reduced pursuant to Section&nbsp;4(o)(iv) above if such Buyer has so elected, upon the terms and conditions specified in the Offer. The purchase by such Buyer of any Offered Securities is subject in all cases to the preparation, execution and delivery by the Company and such Buyer of a separate purchase agreement relating to such Offered Securities reasonably satisfactory in form and substance to such Buyer and its counsel.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any Offered Securities not acquired by a Buyer or other Persons in accordance with this Section&nbsp;4(o) may not be issued, sold or exchanged until they are again offered to such Buyer under the procedures specified in this Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company and each Buyer agree that if any Buyer elects to participate in the Offer, (x) neither the Subsequent Placement Agreement with respect to such Offer nor any other transaction documents related thereto (collectively, the &ldquo;<B>Subsequent Placement Documents</B>&rdquo;) shall include any term or provision whereby such Buyer shall be required to agree to any restrictions on trading as to any securities of the Company or be required to consent to any amendment to or termination of, or grant any waiver, release or the like under or in connection with, any agreement previously entered into with the Company or any instrument received from the Company, and (y) any registration rights set forth in such Subsequent Placement Documents shall be similar in all material respects to the registration rights contained in the Registration Rights Agreement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="white-space: nowrap; font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding anything to the contrary in this Section&nbsp;4(o) and unless otherwise agreed to by such Buyer, the Company shall either confirm in writing to such Buyer that the transaction with respect to the Subsequent Placement has been abandoned or shall publicly disclose its intention to issue the Offered Securities, in either case, in such a manner such that such Buyer will not be in possession of any material, non-public information, by the fifth (5th) Business Day following delivery of the Offer Notice. If by such fifth (5th) Business Day, no public disclosure regarding a transaction with respect to the Offered Securities has been made, and no notice regarding the abandonment of such transaction has been received by such Buyer, such transaction shall be deemed to have been abandoned and such Buyer shall not be in possession of any material, non-public information with respect to the Company or any of its Subsidiaries. Should the Company decide to pursue such transaction with respect to the Offered Securities, the Company shall provide such Buyer with another Offer Notice and such Buyer will again have the right of participation set forth in this Section&nbsp;4(o). The Company shall not be permitted to deliver more than one such Offer Notice to such Buyer in any sixty (60) day period, except as expressly contemplated by the last sentence of Section&nbsp;4(o)(ii).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The restrictions contained in this Section&nbsp;4(o) shall not apply in connection with the issuance of any Excluded Securities.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(p)&#8239;&#8239;<U>Dilutive
Issuances</U>. For so long as any Preferred Shares or Warrants remain outstanding, the Company shall not, in any manner, enter into or
affect any Dilutive Issuance (as defined in the Certificate of Designations) if the effect of such Dilutive Issuance is to cause the Company
to be required to issue upon conversion of any Preferred Shares or exercise of any Warrant any shares of Common Stock in excess of that
number of shares of Common Stock which the Company may issue upon conversion of the Preferred Shares and exercise of the Warrants without
breaching the Company&rsquo;s obligations under the rules&nbsp;or regulations of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(q)&#8239;&#8239;<U>Restriction
of Redemption and Cash Dividends</U>. So long as any Preferred Shares are outstanding, except as provided in the Certificate of Designations,
the Company shall not, directly or indirectly, redeem, or declare or pay any cash dividend or distribution on, any securities of the Company
without the prior express written consent of the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(r)&#8239;&#8239;&#8239;<U>Corporate
Existence</U>. So long as any Buyer beneficially owns any Preferred Shares or Warrants, the Company shall not be party to any Fundamental
Transaction (as defined in the Certificate of Designations) unless the Company is in compliance with the applicable provisions governing
Fundamental Transactions set forth in the Certificate of Designations and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(s)&#8239;&#8239;<U>Stock
Splits</U>. Until the Preferred Shares are no longer outstanding, the Company shall not effect any stock combination, reverse stock split
or other similar transaction (or make any public announcement or disclosure with respect to any of the foregoing) without the prior written
consent of the Required Holders (as defined below); provided, however, that the Company may effect a stock combination, reverse stock
split or other similar transaction if necessary to comply with the requirements of the Principal Market without the prior written consent
of the Required Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(t)&#8239;&#8239;&#8239;<U>Conversion
and Exercise Procedures</U>. Each of the form of Exercise Notice (as defined in the Warrants) included in the Warrants and the form of
Conversion Notice (as defined in the Certificate of Designations) included in the Certificate of Designations set forth the totality of
the procedures required of the Buyers in order to exercise the Warrants or convert the Preferred Shares. Except as provided in Section&nbsp;5(d),
no additional legal opinion, other information or instructions shall be required of the Buyers to exercise their Warrants or convert their
Preferred Shares. The Company shall honor exercises of the Warrants and conversions of the Preferred Shares and shall deliver the Conversion
Shares and Warrant Shares in accordance with the terms, conditions and time periods set forth in the Certificate of Designations and Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(u)&#8239;&#8239;<U>Regulation
M</U>. The Company will not take any action prohibited by Regulation M under the 1934 Act, in connection with the distribution of the
Securities contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(v)&#8239;&#8239;<U>General
Solicitation</U>. None of the Company, any of its affiliates (as defined in Rule&nbsp;501(b) under the 1933 Act) or any person acting
on behalf of the Company or such affiliate will solicit any offer to buy or offer or sell the Securities by means of any form of general
solicitation or general advertising within the meaning of Regulation D, including: (i) any advertisement, article, notice or other
communication published in any newspaper, magazine or similar medium or broadcast over television or radio; and (ii) any seminar
or meeting whose attendees have been invited by any general solicitation or general advertising.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(w)&#8239;<U>Stockholder
Approval</U>. The Company shall provide each stockholder entitled to vote at a special meeting of stockholders of the Company (the &ldquo;<B>Stockholder
Meeting</B>&rdquo;), which shall be held no later than December 31, 2025 (the &ldquo;<B>Stockholder Meeting Deadline</B>&rdquo;), a proxy
statement, in a form reasonably acceptable to the Buyers, at the expense of the Company, soliciting each such stockholder&rsquo;s affirmative
vote at the Stockholder Meeting for approval of resolutions (&ldquo;<B>Stockholder Resolutions</B>&rdquo;) providing for the issuance
of the Securities in compliance with the rules and regulations of the Principal Market (the &ldquo;<B>Stockholder Approval</B>&rdquo;,
and the date the Stockholder Approval is obtained, the &ldquo;<B>Stockholder Approval Date</B>&rdquo;), and the Company shall use its
reasonable best efforts to solicit its stockholders&rsquo; approval of such Stockholder Resolutions and to cause the Board of Directors
of the Company to recommend to the stockholders that they approve such Stockholder Resolutions. The Company shall be obligated to seek
to obtain the Stockholder Approval by the Stockholder Meeting Deadline. If, despite the Company's reasonable best efforts the Stockholder
Approval is not obtained on or prior to the Stockholder Meeting Deadline, the Company shall cause an additional Stockholder Meeting to
be held within 75 days. If, despite the Company's reasonable best efforts the Stockholder Approval is not obtained after such subsequent
stockholder meetings, the Company shall cause an additional Stockholder Meeting to be held semi-annually thereafter until such Stockholder
Approval is obtained. Notwithstanding the above, the Company shall not be required to hold a Stockholder Meeting or seek Stockholder Approval
any time following the time when the Preferred Shares are no longer outstanding if upon full exercise of the Warrants, the shares of Common
Stock issued pursuant to the Preferred Shares and Warrants would not exceed the Exchange Cap (as defined in the Certificate of Designations).</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(x)&#8239;&#8239;&#8239;<U>Integration</U>.
None of the Company, any of its affiliates (as defined in Rule&nbsp;501(b) under the 1933 Act), or any person acting on behalf of
the Company or such affiliate will sell, offer for sale, or solicit offers to buy or otherwise negotiate in respect of any security (as
defined in the 1933 Act) which will be integrated with the sale of the Securities in a manner which would require the registration of
the Securities under the 1933 Act, and the Company will take all action that is appropriate or necessary to assure that its offerings
of other securities will not be integrated for purposes of the 1933 Act or the rules&nbsp;and regulations of the Principal Market, with
the issuance of Securities contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(y)&#8239;&#8239;<U>Notice
of Disqualification Events</U>. The Company will notify the Buyers in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event
relating to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(z)&#8239;&#8239;&#8239;<U>Books
and Records</U>. The Company will keep proper books of record and account, in which full and correct entries shall be made of all financial
transactions and the asset and business of the Company and its Subsidiaries in accordance with GAAP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(aa) <U>Closing Documents</U>.
On or prior to twenty (20) calendar days after the Closing Date, the Company agrees to deliver, or cause to be delivered, to each Buyer
and Buyer Counsel a complete closing set of the executed Transaction Documents (which may be delivered in electronic format), Securities
and any other document required to be delivered to any party pursuant to Section&nbsp;7 hereof or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>5.&#8239; &#8239;REGISTER; TRANSFER AGENT INSTRUCTIONS;
LEGEND.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a)&#8239;&#8239;<U>Register</U>.
The Company shall maintain at its principal executive offices (or such other office or agency of the Company as it may designate by notice
to each holder of Securities), a register for the Preferred Shares and the Warrants in which the Company shall record the name and address
of the Person in whose name the Preferred Shares and the Warrants have been issued (including the name and address of each transferee),
the principal amount of the Preferred Shares held by such Person, the number of Conversion Shares issuable pursuant to the terms of the
Preferred Shares and the number of Warrant Shares issuable upon exercise of the Warrants held by such Person. The Company shall keep the
register open and available at all times during business hours for inspection of any Buyer or its legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b)&#8239;&#8239;<U>Transfer
Agent Instructions</U>. On or prior to the Closing Date, the Company shall issue irrevocable instructions to its transfer agent and any
subsequent transfer agent (as applicable, the &ldquo;<B>Transfer Agent</B>&rdquo;) in a form acceptable to each of the Buyers (the &ldquo;<B>Irrevocable
Transfer Agent Instructions</B>&rdquo;) to issue certificates or credit shares (to the extent unrestricted shares are issued) to the applicable
balance accounts at The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;), registered in the name of each Buyer or its respective nominee(s),
for the Conversion Shares and the Warrant Shares in such amounts as specified from time to time by each Buyer to the Company upon conversion
of the Preferred Shares or the exercise of the Warrants (as the case may be). The Company represents and warrants that no instruction
other than the Irrevocable Transfer Agent Instructions referred to in this Section&nbsp;5(b), and stop transfer instructions to give effect
to Section&nbsp;2(g) hereof, will be given by the Company to its transfer agent with respect to the Securities, and that the Securities
shall otherwise be freely transferable on the books and records of the Company, as applicable, to the extent provided in this Agreement
and the other Transaction Documents. If a Buyer effects a sale, assignment or transfer of the Securities in accordance with Section&nbsp;2(g),
the Company shall permit the transfer and shall promptly instruct its transfer agent to issue one or more certificates or credit shares
to the applicable balance accounts at DTC in such name and in such denominations as specified by such Buyer to effect such sale, transfer
or assignment. In the event that such sale, assignment or transfer involves Conversion Shares or Warrant Shares sold, assigned or transferred
pursuant to an effective registration statement or in compliance with Rule&nbsp;144, the transfer agent shall issue such shares to such
Buyer, assignee or transferee (as the case may be) without any restrictive legend in accordance with Section&nbsp;5(d) below. The
Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to a Buyer. Accordingly, the Company
acknowledges that the remedy at law for a breach of its obligations under this Section&nbsp;5(b) will be inadequate and agrees, in
the event of a breach or threatened breach by the Company of the provisions of this Section&nbsp;5(b), that a Buyer shall be entitled,
in addition to all other available remedies, to an order and/or injunction restraining any breach and requiring immediate issuance and
transfer, without the necessity of showing economic loss and without any bond or other security being required. The Company shall cause
its counsel to issue the legal opinion referred to in the Irrevocable Transfer Agent Instructions to the Company&rsquo;s transfer agent
on each Effective Date (as defined in the Registration Rights Agreement). Any fees (with respect to the transfer agent, counsel to the
Company or otherwise) associated with the issuance of such opinion or the removal of any legends on any of the Securities shall be borne
by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c)&#8239;&#8239;<U>Legends</U>.
Each Buyer understands that the Securities have been issued (or will be issued in the case of the Shares) pursuant to an exemption from
registration or qualification under the 1933 Act and applicable state securities laws, and except as set forth below, the Securities shall
bear any legend as required by the &ldquo;blue sky&rdquo; laws of any state and a restrictive legend in substantially the following form
(and a stop-transfer order may be placed against transfer of such stock certificates):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">[NEITHER THE ISSUANCE AND SALE OF THE SECURITIES
REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE [CONVERTIBLE][EXERCISABLE] HAVE BEEN][THE SECURITIES
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN] REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES
LAWS. THE SECURITIES MAY&nbsp;NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL TO THE HOLDER
(IF REQUESTED BY THE COMPANY),&nbsp;IN A FORM&nbsp;REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER SAID
ACT OR (II) UNLESS SOLD OR ELIGIBLE TO BE SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE
SECURITIES MAY&nbsp;BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d)&#8239;&#8239;<U>Removal
of Legends</U>. Certificates evidencing the Shares shall not be required to contain the legend set forth in Section&nbsp;5(c) above
or any other legend (i) while a registration statement (including a Registration Statement) covering the resale of such Shares is
effective under the 1933 Act, (ii) following any sale of such Shares pursuant to Rule&nbsp;144 (assuming the transferor is not an
affiliate of the Company), (iii) if such Shares are eligible to be sold, assigned or transferred under Rule&nbsp;144 (provided that
a Buyer provides the Company with reasonable assurances that such Shares are eligible for sale, assignment or transfer under Rule&nbsp;144
which shall not include an opinion of Buyer&rsquo;s counsel), (iv) in connection with a sale, assignment or other transfer (other
than under Rule&nbsp;144), provided that such Buyer provides the Company with an opinion of counsel to such Buyer, in a generally acceptable
form, to the effect that such sale, assignment or transfer of the Shares may be made without registration under the applicable requirements
of the 1933 Act or (v) if such legend is not required under applicable requirements of the 1933 Act (including, without limitation,
controlling judicial interpretations and pronouncements issued by the SEC). If a legend is not required pursuant to the foregoing, the
Company shall no later than one (1) Trading Day (or such earlier date as required pursuant to the 1934 Act or other applicable law,
rule&nbsp;or regulation for the settlement of a trade initiated on the date such Buyer delivers such legended certificate representing
such Shares to the Company) following the delivery by a Buyer to the Company or the transfer agent (with notice to the Company) of a legended
certificate representing such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary
to affect the reissuance and/or transfer, if applicable), together with any other deliveries from such Buyer as may be required above
in this Section&nbsp;5(d) or as reasonably required by the Company&rsquo;s transfer agent, as directed by such Buyer, either: (A) provided
that the Company&rsquo;s transfer agent is participating in the DTC Fast Automated Securities Transfer Program (&ldquo;<B>FAST</B>&rdquo;),
credit the aggregate number of shares of Common Stock to which such Buyer shall be entitled to such Buyer&rsquo;s or its designee&rsquo;s
balance account with DTC through its Deposit/Withdrawal at Custodian system or (B) if the Company&rsquo;s transfer agent is not participating
in FAST, issue and deliver (via reputable overnight courier) to such Buyer, a certificate representing such Shares that is free from all
restrictive and other legends, registered in the name of such Buyer or its designee (the date by which such credit is so required to be
made to the balance account of such Buyer&rsquo;s or such Buyer&rsquo;s designee with DTC or such certificate is required to be delivered
to such Buyer pursuant to the foregoing is referred to herein as the &ldquo;<B>Required Delivery Date</B>&rdquo;, and the date such shares
of Common Stock are actually delivered without restrictive legend to such Buyer or such Buyer&rsquo;s designee with DTC, as applicable,
the &ldquo;<B>Share Delivery Date</B>&rdquo;). The Company shall be responsible for any transfer agent fees or DTC fees with respect to
any issuance of Securities or the removal of any legends with respect to any Securities in accordance herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e)&#8239;&#8239;<U>Failure
to Timely Deliver; Buy-In</U>. If the Company fails, for any reason or for no reason, to issue and deliver (or cause to be delivered)
to a Buyer (or its designee) by the Required Delivery Date, either (I) if the Transfer Agent is not participating in FAST, a certificate
for the number of Shares to which such Buyer is entitled and register such Shares on the Company&rsquo;s share register or, if the Transfer
Agent is participating in FAST, to credit the balance account of such Buyer or such Buyer&rsquo;s designee with DTC for such number of
Shares submitted for legend removal by such Buyer pursuant to Section&nbsp;5(d) above or (II) if the Registration Statement
covering the resale of the Shares submitted for legend removal by such Buyer pursuant to Section&nbsp;5(d) above (the &ldquo;<B>Unavailable
Shares</B>&rdquo;) is not available for the resale of such Unavailable Shares pursuant to its terms and the Company fails to promptly,
but in no event later than as required pursuant to the Registration Rights Agreement (x) so notify such Buyer and (y) deliver
the Shares electronically without any restrictive legend by crediting such aggregate number of Shares submitted for legend removal by
such Buyer pursuant to Section&nbsp;5(d) above to such Buyer&rsquo;s or its designee&rsquo;s balance account with DTC through its
Deposit/Withdrawal At Custodian system (the event described in the immediately foregoing clause (II) is hereinafter referred as a
 &ldquo;<B>Notice Failure</B>&rdquo; and together with the event described in clause (I) above, a &ldquo;<B>Delivery Failure</B>&rdquo;),
then, in addition to all other remedies available to such Buyer, the Company shall pay in cash to such Buyer on each day after the Share
Delivery Date and during such Delivery Failure an amount equal to 1.5% of the product of (A) the sum of the number of shares of Common
Stock not issued to such Buyer on or prior to the Required Delivery Date and to which such Buyer is entitled, and (B) any trading
price of the Common Stock selected by such Buyer in writing as in effect at any time during the period beginning on the date of the delivery
by such Buyer to the Company of the applicable Shares and ending on the applicable Share Delivery Date. In addition to the foregoing,
if on or prior to the Required Delivery Date either (I) if the Transfer Agent is not participating in FAST, the Company shall fail
to issue and deliver a certificate to a Buyer and register such shares of Common Stock on the Company&rsquo;s share register or, if the
Transfer Agent is participating in FAST, credit the balance account of such Buyer or such Buyer&rsquo;s designee with DTC for the number
of shares of Common Stock to which such Buyer submitted for legend removal by such Buyer pursuant to Section&nbsp;5(d) above (ii) below
or (II) a Notice Failure occurs, and if on or after such Trading Day such Buyer purchases (in an open market transaction or otherwise)
shares of Common Stock to deliver in satisfaction of a sale by such Buyer of shares of Common Stock submitted for legend removal by such
Buyer pursuant to Section&nbsp;5(d) above that such Buyer is entitled to receive from the Company (a &ldquo;<B>Buy-In</B>&rdquo;),
then the Company shall, within two (2) Trading Days after such Buyer&rsquo;s request and in such Buyer&rsquo;s discretion, either
(i) pay cash to such Buyer in an amount equal to such Buyer&rsquo;s total purchase price (including brokerage commissions and other
out-of-pocket expenses, if any, for the shares of Common Stock so purchased) (the &ldquo;<B>Buy-In Price</B>&rdquo;), at which point the
Company&rsquo;s obligation to so deliver such certificate or credit such Buyer&rsquo;s balance account shall terminate and such shares
shall be cancelled, or (ii) promptly honor its obligation to so deliver to such Buyer a certificate or certificates or credit the
balance account of such Buyer or such Buyer&rsquo;s designee with DTC representing such number of shares of Common Stock that would have
been so delivered if the Company timely complied with its obligations hereunder and pay cash to such Buyer in an amount equal to the excess
(if any) of the Buy-In Price over the product of (A) such number of Shares that the Company was required to deliver to such Buyer
by the Required Delivery Date multiplied by (B) the lowest Closing Sale Price (as defined in the Warrants) of the shares of Common
Stock on any Trading Day during the period commencing on the date of the delivery by such Buyer to the Company of the applicable Shares
and ending on the date of such delivery and payment under this clause (ii). Nothing shall limit such Buyer&rsquo;s right to pursue any
other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or
injunctive relief with respect to the Company&rsquo;s failure to timely deliver certificates representing shares of Common Stock (or to
electronically deliver such shares of Common Stock) as required pursuant to the terms hereof. Notwithstanding anything herein to the contrary,
with respect to any given Notice Failure and/or Delivery Failure, this Section&nbsp;5(e) shall not apply to the applicable Buyer
the extent the Company has already paid such amounts in full to such Buyer with respect to such Notice Failure and/or Delivery Failure,
as applicable, pursuant to the analogous sections of the Certificate of Designations or Warrant, as applicable, held by such Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f)&#8239;&#8239;&#8239;<U>FAST
Compliance.</U> While any Warrants remain outstanding, the Company shall maintain a transfer agent that participates in FAST.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>6.&#8239;&#8239; CONDITIONS TO THE COMPANY&rsquo;S
OBLIGATION TO SELL.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation of the Company
hereunder to issue and sell the Preferred Shares and the related Warrants to each Buyer at the Closing is subject to the satisfaction,
at or before the Closing Date, of each of the following conditions, provided that these conditions are for the Company&rsquo;s sole benefit
and may be waived by the Company at any time in its sole discretion by providing each Buyer with prior written notice thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a)&#8239;&#8239;Such Buyer
shall have executed each of the other Transaction Documents to which it is a party and delivered the same to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b)&#8239;&#8239;Such Buyer
and each other Buyer shall have delivered to the Company the Purchase Price (less, in the case of any Buyer, the amounts withheld pursuant
to Section&nbsp;4(g)) for the Preferred Shares and the related Warrants being purchased by such Buyer at the Closing by wire transfer
of immediately available funds in accordance with the wire instructions provided by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c)&#8239;&#8239;The representations
and warranties of such Buyer shall be true and correct in all material respects as of the date when made and as of the Closing Date as
though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true and
correct as of such specific date), and such Buyer shall have performed, satisfied and complied in all material respects with the covenants,
agreements and conditions required by this Agreement to be performed, satisfied or complied with by such Buyer at or prior to the Closing
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d)&#8239;&#8239;No statute,
rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court
or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>7.&#8239;&#8239; CONDITIONS TO EACH BUYER&rsquo;S
OBLIGATION TO PURCHASE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The obligation of each Buyer
hereunder to purchase its Preferred Shares and its related Warrants at the Closing is subject to the satisfaction, at or before the Closing
Date, of each of the following conditions, provided that these conditions are for each Buyer&rsquo;s sole benefit and may be waived by
such Buyer at any time in its sole discretion by providing the Company with prior written notice thereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a)&#8239;&#8239;The Company
and each Subsidiary (as the case may be) shall have duly executed and delivered to such Buyer each of the Transaction Documents to which
it is a party and the Company shall have duly delivered to such Buyer (A) such aggregate number of Preferred Shares as is set forth
across from such Buyer&rsquo;s name in column (3) of the Schedule of Buyers, and (B) a Warrant initially exercisable for such
aggregate number of Warrant Shares as is set forth across from such Buyer&rsquo;s name in column (4) of the Schedule of Buyers, in
each case, as being purchased by such Buyer at the Closing pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b)&#8239;&#8239;Such Buyer
shall have received the opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C, the Company&rsquo;s counsel, dated as of the Closing
Date, addressed to each Buyer, in the form acceptable to such Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c)&#8239;&#8239;The Company
shall have delivered to such Buyer a copy of the Irrevocable Transfer Agent Instructions, which instructions shall have been delivered
to and acknowledged in writing by the Company&rsquo;s transfer agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d)&#8239;&#8239;The Company
shall have delivered to such Buyer a certificate evidencing the formation and good standing of the Company in its jurisdiction of formation
issued by the Secretary of State (or comparable office) of such jurisdiction of formation as of a date within ten (10) days of the
Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e)&#8239;&#8239;The Company
shall have delivered to such Buyer a certified copy of the Certificate of Incorporation as certified by the Delaware Secretary of State
within ten (10) days of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f)&#8239;&#8239;The Company
shall have delivered to such Buyer a certificate, in the form acceptable to such Buyer, executed by the Secretary of the Company and dated
as of the Closing Date, as to (i) the resolutions consistent with Section&nbsp;3(b) as adopted by the Company&rsquo;s board
of directors in a form reasonably acceptable to such Buyer, (ii) the Certificate of Incorporation of the Company and (iii) the
Bylaws of the Company as in effect at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g)&#8239;&#8239;Each and
every representation and warranty of the Company shall be true and correct as of the date when made and as of the Closing Date as though
originally made at that time (except for representations and warranties that speak as of a specific date, which shall be true and correct
as of such specific date) and the Company shall have performed, satisfied and complied in all respects with the covenants, agreements
and conditions required to be performed, satisfied or complied with by the Company at or prior to the Closing Date. Such Buyer shall have
received a certificate, duly executed by the Chief Executive Officer or Chief Financial Officer of the Company, dated as of the Closing
Date, to the foregoing effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(h)&#8239;&#8239;The Company
shall have delivered to such Buyer a letter from the Company&rsquo;s transfer agent certifying the number of shares of Common Stock outstanding
on the Closing Date immediately prior to the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(i)&#8239;&#8239;&#8239;The
Common Stock (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have
been suspended, as of the Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by
the SEC or the Principal Market have been threatened, as of the Closing Date, either (I) in writing by the SEC or the Principal Market
or (II) by falling below the minimum maintenance requirements of the Principal Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(j)&#8239;&#8239;&#8239;The
Company shall have obtained all governmental, regulatory or third party consents and approvals, if any, necessary for the sale of the
Securities, including without limitation, those required by the Principal Market, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(k)&#8239;&#8239;No statute,
rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by any court
or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(l)&#8239;&#8239;Since the
date of execution of this Agreement, no event or series of events shall have occurred that reasonably would have or result in a Material
Adverse Effect, provided, however, that the definition of &ldquo;<B>Material Adverse Effect</B>&rdquo; for the purpose of this clause
(xiv), will not include any change or effect that results from (A) changes in law or interpretations thereof, or regulatory policy
or interpretation, by any Governmental Entity so long as such change does not have a disproportionate effect on the Company, (B) changes
in applicable accounting rules&nbsp;or principles, including changes in GAAP, so long as such change does not have a disproportionate
effect on the Company, (C) changes in general economic conditions, and events or conditions generally affecting the industries in
which the Company operates, so long as such change does not have a disproportionate effect on the Company, or (D) national or international
hostilities, acts of terror or acts of war.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(m)&#8239;&#8239;The Company
shall have filed a Notification: Listing of Additional Shares form with the Principal Market and shall not have received any objection
thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(n)&#8239;&#8239;Such Buyer
shall have received the wire transfer instructions of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(o)&#8239;&#8239;The Company
and its Subsidiaries shall have delivered to such Buyer such other documents, instruments or certificates relating to the transactions
contemplated by this Agreement as such Buyer or its counsel may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">8. [RESERVED].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>9. TERMINATION.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement may be terminated
(i) by the mutual consent of each of the Company and the Buyers, (ii) if the Closing shall not have occurred by October&nbsp;31,
2025 (provided that no party shall have the right to terminate if they were the proximate cause of the failure to close by such date),
or (iii) with respect to a Buyer, if the Company has breached the terms of this Agreement in a manner that would cause the failure
of the conditions to closing hereunder to be met (and such breach remains uncured after 30 days&rsquo; notice). Upon any termination in
accordance with this Section&nbsp;9 by a Buyer, such party shall have the right to terminate its obligations under this Agreement with
respect to itself at any time on or after the close of business on such date (without liability of such Buyer to any other party); provided,
however, the abandonment of the sale and purchase of the Preferred Shares and Warrants by such Buyer shall be applicable only to such
Buyer providing such written notice, provided further that no such termination by any party shall affect any obligation of the Company
under this Agreement to reimburse such Buyer for the expenses described in Section&nbsp;4(g) above. Nothing contained in this Section&nbsp;9
shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or
the other Transaction Documents or to impair the right of any party to compel specific performance by any other party of its obligations
under this Agreement or the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>10.&#8239;&#8239; MISCELLANEOUS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(a)&#8239;&#8239;Governing
Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or
rule&nbsp;(whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions
other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or under
any of the other Transaction Documents or with any transaction contemplated hereby or thereby, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that
such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper.
Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding
by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any
right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude any Buyer from
bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations
to such Buyer or to enforce a judgment or other court ruling in favor of such Buyer. <B>EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT
IT MAY&nbsp;HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION
DOCUMENT OR IN CONNECTION WITH OR ARISING OUT OF THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY
OR THEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(b)&#8239;&#8239;<U>Counterparts</U>.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any signature
is delivered by facsimile or electronic transmission (including DocuSign and similar) or by an e-mail which contains a portable document
format (.pdf) file of an executed signature page, such signature page&nbsp;shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such signature page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(c)&#8239;&#8239;<U>Headings;
Gender</U>. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation of,
this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine,
neuter, singular and plural forms thereof. The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words
of like import shall be construed broadly as if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo;
 &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo; and words of like import refer to this entire Agreement instead of just the provision in
which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(d)&#8239;&#8239;<U>Severability;
Maximum Payment Amounts</U>. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties
or the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes
as close as possible to that of the prohibited, invalid or unenforceable provision(s). Notwithstanding anything to the contrary contained
in this Agreement or any other Transaction Document (and without implication that the following is required or applicable), it is the
intention of the parties that in no event shall amounts and value paid by the Company and/or any of its Subsidiaries (as the case may
be), or payable to or received by any of the Buyers, under the Transaction Documents (including without limitation, any amounts that would
be characterized as &ldquo;interest&rdquo; under applicable law) exceed amounts permitted under any applicable law. Accordingly, if any
obligation to pay, payment made to any Buyer, or collection by any Buyer pursuant the Transaction Documents is finally judicially determined
to be contrary to any such applicable law, such obligation to pay, payment or collection shall be deemed to have been made by mutual mistake
of such Buyer, the Company and its Subsidiaries and such amount shall be deemed to have been adjusted with retroactive effect to the maximum
amount or rate of interest, as the case may be, as would not be so prohibited by the applicable law. Such adjustment shall be effected,
to the extent necessary, by reducing or refunding, at the option of such Buyer, the amount of interest or any other amounts which would
constitute unlawful amounts required to be paid or actually paid to such Buyer under the Transaction Documents. For greater certainty,
to the extent that any interest, charges, fees, expenses or other amounts required to be paid to or received by such Buyer under any of
the Transaction Documents or related thereto are held to be within the meaning of &ldquo;interest&rdquo; or another applicable term to
otherwise be violative of applicable law, such amounts shall be pro-rated over the period of time to which they relate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(e)&#8239;&#8239;<U>Entire
Agreement; Amendments</U>. This Agreement, the other Transaction Documents and the schedules and exhibits attached hereto and thereto
and the instruments referenced herein and therein supersede all other prior oral or written agreements between the Buyers, the Company,
its Subsidiaries, their affiliates and Persons acting on their behalf, including, without limitation, any transactions by any Buyer with
respect to shares of Common Stock or the Securities, and the other matters contained herein and therein, and this Agreement, the other
Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein contain
the entire understanding of the parties solely with respect to the matters covered herein and therein; provided, however, nothing contained
in this Agreement or any other Transaction Document shall (or shall be deemed to) (i) have any effect on any agreements any Buyer
has entered into with, or any instruments any Buyer has received from, the Company or any of its Subsidiaries prior to the date hereof
with respect to any prior investment made by such Buyer in the Company or (ii) waive, alter, modify or amend in any respect any obligations
of the Company or any of its Subsidiaries, or any rights of or benefits to any Buyer or any other Person, in any agreement entered into
prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Buyer, or any instruments any Buyer received
from the Company and/or any of its Subsidiaries prior to the date hereof, and all such agreements and instruments shall continue in full
force and effect. Except as specifically set forth herein or therein, neither the Company nor any Buyer makes any representation, warranty,
covenant or undertaking with respect to such matters. For clarification purposes, the Recitals are part of this Agreement. No provision
of this Agreement may be amended other than by an instrument in writing signed by the Company and the Required Holders (as defined below),
and any amendment to any provision of this Agreement made in conformity with the provisions of this Section&nbsp;10(e) shall be binding
on all Buyers and holders of Securities, as applicable; provided that no such amendment shall be effective to the extent that it (A) applies
to less than all of the holders of the Securities then outstanding or (B) imposes any obligation or liability on any Buyer without
such Buyer&rsquo;s prior written consent (which may be granted or withheld in such Buyer&rsquo;s sole discretion). No waiver shall be
effective unless it is in writing and signed by an authorized representative of the waiving party, provided that the Required Holders
may waive any provision of this Agreement, and any waiver of any provision of this Agreement made in conformity with the provisions of
this Section&nbsp;10(e) shall be binding on all Buyers and holders of Securities, as applicable, provided that no such waiver shall
be effective to the extent that it (1) applies to less than all of the holders of the Securities then outstanding (unless a party
gives a waiver as to itself only) or (2) imposes any obligation or liability on any Buyer without such Buyer&rsquo;s prior written
consent (which may be granted or withheld in such Buyer&rsquo;s sole discretion). No consideration (other than reimbursement of legal
fees) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction
Documents unless the same consideration also is offered to all of the parties to the Transaction Documents, all holders of the Preferred
Shares or all holders of the Warrants (as the case may be). From the date hereof and while any Preferred Shares or Warrants are outstanding,
the Company shall not be permitted to receive any consideration from a Buyer or a holder of Preferred Shares or Warrants that is not otherwise
contemplated by the Transaction Documents in order to, directly or indirectly, induce the Company or any Subsidiary (i) to treat
such Buyer or holder of Preferred Shares or Warrants in a manner that is more favorable than to other similarly situated Buyers or holders
of Preferred Shares or Warrants, as applicable, or (ii) to treat any Buyer(s) or holder(s) of Preferred Shares or Warrants
in a manner that is less favorable than the Buyer or holder of Preferred Shares or Warrants that is paying such consideration; provided,
however, that the determination of whether a Buyer has been treated more or less favorably than another Buyer shall disregard any securities
of the Company purchased or sold by any Buyer. The Company has not directly or indirectly, made any agreements with any Buyers relating
to the terms or conditions of the transactions contemplated by the Transaction Documents except as set forth in the Transaction Documents.
Without limiting the foregoing, the Company confirms that, except as set forth in this Agreement, no Buyer has made any commitment or
promise or has any other obligation to provide any financing to the Company, any Subsidiary or otherwise. As a material inducement for
each Buyer to enter into this Agreement, the Company expressly acknowledges and agrees that (x) no due diligence or other investigation
or inquiry conducted by a Buyer, any of its advisors or any of its representatives shall affect such Buyer&rsquo;s right to rely on, or
shall modify or qualify in any manner or be an exception to any of, the Company&rsquo;s representations and warranties contained in this
Agreement or any other Transaction Document and (y) unless a provision of this Agreement or any other Transaction Document is expressly
preceded by the phrase &ldquo;except as disclosed in the SEC Documents,&rdquo; nothing contained in any of the SEC Documents shall affect
such Buyer&rsquo;s right to rely on, or shall modify or qualify in any manner or be an exception to any of, Company&rsquo;s representations
and warranties contained in this Agreement or any other Transaction Document. &ldquo;<B>Required Holders</B>&rdquo; means (I) prior
to the Closing Date, each Buyer entitled to purchase, in the aggregate, at least a majority of the number of Preferred Shares at the Closing
and (II) on or after the Closing Date, holders of a majority of the Registrable Securities as of such time (excluding any Registrable
Securities held by the Company or any of its Subsidiaries as of such time) issued or issuable hereunder or pursuant to the Certificate
of Designations and/or the Warrants (or the Buyers, with respect to any waiver or amendment of Section&nbsp;4(o)); provided, however,
that in each case, each of Iroquois Master Fund Ltd. and Iroquois Capital Investment Group, LLC (each, an &ldquo;<B>Iroquois Fund</B>&rdquo;)
shall be among the Required Holders voting for such amendment or waiver, provided further that if an Iroquois Fund no longer beneficially
owns (directly or indirectly) Series&nbsp;E Preferred Stock, its vote shall not be required for any such amendment or waiver.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(f)&#8239;&#8239;&#8239;<U>Notices</U>.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be in
writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent
by electronic mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending
party does not receive an automatically generated message from the recipient&rsquo;s email server that such e-mail could not be delivered
to such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified,
in each case, properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications
shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TAO Synergies Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1185 Avenue of the Americas, 3<SUP>rd</SUP> Floor</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10036</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone: (973) 242-0005</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: rweinstein@synaptogen.com</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy (for informational purposes only) to:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">919 Third Avenue</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10022</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Kenneth R. Koch and Daniel A. Bagliebter</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: <U>KRKoch@mintz.com; DABagliebter@mintz.com</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to the Transfer Agent:</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pacific Stock Transfer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6725 Via Austi Parkway, Suite&nbsp;300</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Las Vegas, Nevada 89119 </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>Telephone: (702) 361-3033</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Angela L. Lamb</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail: alamb@PacificStockTransfer.com</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to a Buyer, to its mailing address and e-mail address set forth on the Schedule of Buyers, with copies to such Buyer&rsquo;s representatives as set forth on the Schedule of Buyers,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with a copy (for informational purposes only) to:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Haynes and Boone, LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">30 Rockefeller Plaza, 26<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10112</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Telephone: (212) 659-7300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Rick Werner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">E-mail: <U>rick.werner@haynesboone.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or to such other mailing address and/or e-mail
address and/or to the attention of such other Person as the recipient party has specified by written notice given to each other party
five (5) days prior to the effectiveness of such change, provided that Buyer Counsel shall only be provided copies of notices sent
to the lead Buyer. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other communication,
(B) mechanically or electronically generated by the sender&rsquo;s e-mail containing the time, date and recipient&rsquo;s e-mail
or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by e-mail or receipt from
an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(g)&#8239;&#8239;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and assigns,
including any purchasers of any of the Preferred Shares and Warrants. The Company shall not assign this Agreement or any rights or obligations
hereunder without the prior written consent of the Required Holders, including, without limitation, by way of a Fundamental Transaction
(as defined in the Warrants) (unless the Company is in compliance with the applicable provisions governing Fundamental Transactions set
forth in the Warrants) or a Fundamental Transaction (as defined in the Certificate of Designations) (unless the Company is in compliance
with the applicable provisions governing Fundamental Transactions set forth in the Certificate of Designations). A Buyer may assign some
or all of its rights hereunder in connection with any transfer of any of its Securities without the consent of the Company, in which event
such assignee shall be deemed to be a Buyer hereunder with respect to such assigned rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(h)&#8239;&#8239;<U>No Third
Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and
assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, other than the Indemnitees referred
to in Section&nbsp;10(k) and the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(i)&#8239;&#8239;&#8239;<U>Survival</U>.
The representations, warranties, agreements and covenants shall survive the Closing. Each Buyer shall be responsible only for its own
representations, warranties, agreements and covenants hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(j)&#8239;&#8239;&#8239;<U>Further
Assurances</U>. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(k)&#8239;&#8239;<U>Indemnification</U>.
In consideration of each Buyer&rsquo;s execution and delivery of the Transaction Documents and acquiring the Securities thereunder and
in addition to all of the Company&rsquo;s other obligations under the Transaction Documents, the Company shall defend, protect, indemnify
and hold harmless each Buyer and each holder of any Securities and all of their stockholders, partners, members, officers, directors,
employees and direct or indirect investors and any of the foregoing Persons&rsquo; agents or other representatives (including, without
limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the &ldquo;<B>Indemnitees</B>&rdquo;)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder is sought),
and including reasonable attorneys&rsquo; fees and disbursements (the &ldquo;<B>Indemnified Liabilities</B>&rdquo;), incurred by any Indemnitee
as a result of, or arising out of, or relating to (i) any misrepresentation or breach of any representation or warranty made by the
Company or any Subsidiary in any of the Transaction Documents, (ii) any breach of any covenant, agreement or obligation of the Company
or any Subsidiary contained in any of the Transaction Documents or (iii) any cause of action, suit, proceeding or claim brought or
made against such Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company or any
Subsidiary) or which otherwise involves such Indemnitee that arises out of or results from (A) the execution, delivery, performance
or enforcement of any of the Transaction Documents, (B) any transaction financed or to be financed in whole or in part, directly
or indirectly, with the proceeds of the issuance of the Securities, (C) any disclosure properly made by such Buyer pursuant to Section&nbsp;4(i),
or (D) the status of such Buyer or holder of the Securities either as an investor in the Company pursuant to the transactions contemplated
by the Transaction Documents or as a party to this Agreement (including, without limitation, as a party in interest or otherwise in any
action or proceeding for injunctive or other equitable relief). To the extent that the foregoing undertaking by the Company may be unenforceable
for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law. Except as otherwise set forth herein, the mechanics and procedures with respect to the rights
and obligations under this Section&nbsp;10(k) shall be the same as those set forth in Section&nbsp;6 of the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(l)&#8239;&#8239;&#8239;<U>Construction</U>.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules&nbsp;of
strict construction will be applied against any party. No specific representation or warranty shall limit the generality or applicability
of a more general representation or warranty. Each and every reference to share prices, shares of Common Stock and any other numbers in
this Agreement that relate to the shares of Common Stock shall be automatically adjusted for any stock splits, stock dividends, stock
combinations, recapitalizations or other similar transactions that occur with respect to the Common Stock after the date of this Agreement.
Notwithstanding anything in this Agreement to the contrary, for the avoidance of doubt, nothing contained herein shall constitute a representation
or warranty against, or a prohibition of, any actions with respect to the borrowing of, arrangement to borrow, identification of the availability
of, and/or securing of, securities of the Company in order for such Buyer (or its broker or other financial representative) to effect
short sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(m)&#8239;<U>Remedies</U>.
Each Buyer and in the event of assignment by Buyer of its rights and obligations hereunder, each holder of Securities, shall have all
rights and remedies set forth in the Transaction Documents and all rights and remedies which such holders have been granted at any time
under any other agreement or contract and all of the rights which such holders have under any law. Any Person having any rights under
any provision of this Agreement shall be entitled to enforce such rights specifically (without posting a bond or other security), to recover
damages by reason of any breach of any provision of this Agreement and to exercise all other rights granted by law. Furthermore, the Company
recognizes that in the event that it or any Subsidiary fails to perform, observe, or discharge any or all of its or such Subsidiary&rsquo;s
(as the case may be) obligations under the Transaction Documents, any remedy at law would inadequate relief to the Buyers. The Company
therefore agrees that the Buyers shall be entitled to specific performance and/or temporary, preliminary and permanent injunctive or other
equitable relief from any court of competent jurisdiction in any such case without the necessity of proving actual damages and without
posting a bond or other security. The remedies provided in this Agreement and the other Transaction Documents shall be cumulative and
in addition to all other remedies available under this Agreement and the other Transaction Documents, at law or in equity (including a
decree of specific performance and/or other injunctive relief).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(n)&#8239;&#8239;<U>Withdrawal
Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents,
whenever any Buyer exercises a right, election, demand or option under a Transaction Document and the Company or any Subsidiary does not
timely perform its related obligations within the periods therein provided, then such Buyer may rescind or withdraw, in its sole discretion
from time to time upon written notice to the Company or such Subsidiary (as the case may be), any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(o)&#8239;&#8239;<U>Payment
Set Aside; Currency</U>. To the extent that the Company makes a payment or payments to any Buyer hereunder or pursuant to any of the other
Transaction Documents or any of the Buyers enforce or exercise their rights hereunder or thereunder, and such payment or payments or the
proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential,
set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver
or any other Person under any law (including, without limitation, any bankruptcy law, foreign, state or federal law, common law or equitable
cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall
be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.
Unless otherwise expressly indicated, all dollar amounts referred to in this Agreement and the other Transaction Documents are in United
States Dollars (&ldquo;<B>U.S. Dollars</B>&rdquo;), and all amounts owing under this Agreement and all other Transaction Documents shall
be paid in U.S. Dollars. All amounts denominated in other currencies (if any) shall be converted into the U.S. Dollar equivalent amount
in accordance with the Exchange Rate on the date of calculation. &ldquo;<B>Exchange Rate</B>&rdquo; means, in relation to any amount of
currency to be converted into U.S. Dollars pursuant to this Agreement, the U.S. Dollar exchange rate as published in the Wall Street Journal
on the relevant date of calculation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(p)&#8239;&#8239;<U>Judgment
Currency</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If for the purpose of obtaining or enforcing judgment against the Company in connection with this Agreement or any other Transaction Document in any court in any jurisdiction it becomes necessary to convert into any other currency (such other currency being hereinafter in this Section&nbsp;10(p) referred to as the &ldquo;<B>Judgment Currency</B>&rdquo;) an amount due in US Dollars under this Agreement, the conversion shall be made at the Exchange Rate prevailing on the Trading Day immediately preceding:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date actual payment of the amount due, in the case of any proceeding in the courts of New York or in the courts of any other jurisdiction that will give effect to such conversion being made on such date: or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date on which the foreign court determines, in the case of any proceeding in the courts of any other jurisdiction (the date as of which such conversion is made pursuant to this Section&nbsp;10(p)(i)(2) being hereinafter referred to as the &ldquo;<B>Judgment Conversion Date</B>&rdquo;).</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If in the case of any proceeding in the court of any jurisdiction referred to in Section&nbsp;10(p)(i)(2) above, there is a change in the Exchange Rate prevailing between the Judgment Conversion Date and the date of actual payment of the amount due, the applicable party shall pay such adjusted amount as may be necessary to ensure that the amount paid in the Judgment Currency, when converted at the Exchange Rate prevailing on the date of payment, will produce the amount of US Dollars which could have been purchased with the amount of Judgment Currency stipulated in the judgment or judicial order at the Exchange Rate prevailing on the Judgment Conversion Date.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any amount due from the Company under this provision shall be due as a separate debt and shall not be affected by judgment being obtained for any other amounts due under or in respect of this Agreement or any other Transaction Document.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">(q)&#8239;&#8239;<U>Independent
Nature of Buyers&rsquo; Obligations and Rights</U>. The obligations of each Buyer under the Transaction Documents are several and not
joint with the obligations of any other Buyer, and no Buyer shall be responsible in any way for the performance of the obligations of
any other Buyer under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by
any Buyer pursuant hereto or thereto, shall be deemed to constitute the Buyers as, and the Company each acknowledge that the Buyers do
not so constitute, a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the
Buyers are in any way acting in concert or as a group or entity, and the Company shall not assert any such claim with respect to such
obligations or the transactions contemplated by the Transaction Documents or any matters, and the Company acknowledges that the Buyers
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or the transactions
contemplated by the Transaction Documents. The decision of each Buyer to purchase Securities pursuant to the Transaction Documents has
been made by such Buyer independently of any other Buyer. Each Buyer acknowledges that no other Buyer has acted as agent for such Buyer
in connection with such Buyer making its investment hereunder and that no other Buyer will be acting as agent of such Buyer in connection
with monitoring such Buyer&rsquo;s investment in the Securities or enforcing its rights under the Transaction Documents. The Company and
each Buyer confirms that each Buyer has independently participated with the Company and its Subsidiaries in the negotiation of the transaction
contemplated hereby with the advice of its own counsel and advisors. Each Buyer shall be entitled to independently protect and enforce
its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents, and it
shall not be necessary for any other Buyer to be joined as an additional party in any proceeding for such purpose. The use of a single
agreement to effectuate the purchase and sale of the Securities contemplated hereby was solely in the control of the Company, not the
action or decision of any Buyer, and was done solely for the convenience of the Company and its Subsidiaries and not because it was required
or requested to do so by any Buyer. It is expressly understood and agreed that each provision contained in this Agreement and in each
other Transaction Document is between the Company, each Subsidiary and a Buyer, solely, and not between the Company, its Subsidiaries
and the Buyers collectively and not between and among the Buyers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>signature pages&nbsp;follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>IN WITNESS WHEREOF,</B></FONT>
each Buyer and the Company have caused their respective signature page&nbsp;to this Agreement to be duly executed as of the date first
written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>COMPANY:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TAO SYNERGIES INC.</B></FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 5%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font-size: 10pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joshua Silverman</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Chairman</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>IN WITNESS WHEREOF,</B></FONT>
each Buyer and the Company have caused their respective signature page&nbsp;to this Agreement to be duly executed as of the date first
written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUYER:</B></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee ID Number:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>tm2528153d1_ex10-2.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>REGISTRATION RIGHTS
AGREEMENT</B> (this &ldquo;<B>Agreement</B>&rdquo;), dated as of October 13, 2025, is by and among TAO Synergies Inc., a Delaware corporation
(the &ldquo;<B>Company</B>&rdquo;), and the undersigned buyers (each, a &ldquo;<B>Buyer</B>,&rdquo; and collectively, the &ldquo;<B>Buyers</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>RECITALS</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A.&#8239;&#8239;&#8239;&#8239;In
connection with the Securities Purchase Agreement by and among the parties hereto, dated as of October 13, 2025 (the &ldquo;<B>Securities
Purchase Agreement</B>&rdquo;), the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement,
to issue and sell to each Buyer (i) the Preferred Shares (as defined in the Securities Purchase Agreement) which will be convertible into
Conversion Shares (as defined in the Securities Purchase Agreement) in accordance with the terms of the Certificate of Designations (as
defined in the Securities Purchase Agreement) and (ii) the Warrants (as defined in the Securities Purchase Agreement) which will be exercisable
to purchase Warrant Shares (as defined in the Securities Purchase Agreement) in accordance with the terms of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B.&#8239;&#8239;&#8239;&#8239;To
induce the Buyers to consummate the transactions contemplated by the Securities Purchase Agreement, the Company has agreed to provide
certain registration rights under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor
statute (collectively, the &ldquo;<B>1933 Act</B>&rdquo;), and applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>AGREEMENT</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>NOW,
THEREFORE,</B></FONT> in consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and each of the Buyers hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Definitions.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used herein
and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement. As used in this Agreement,
the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &#8239;&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
 &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239; &ldquo;<B>Closing
Date</B>&rdquo; shall have the meaning set forth in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c) &#8239;&ldquo;<B>Effective
Date</B>&rdquo; means the date that the applicable Registration Statement has been declared effective by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(d) &#8239;&ldquo;<B>Effectiveness
Deadline</B>&rdquo; means (i)&nbsp;with respect to the initial Registration Statement required to be filed pursuant to Section&nbsp;2(a),
the earlier of the (A)&nbsp;60<SUP>th</SUP></FONT> (or if a full review by the SEC, the 90th) calendar day after the Closing Date and
(B)&nbsp;2nd Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that such Registration
Statement will not be reviewed or will not be subject to further review and (ii)&nbsp;with respect to any additional Registration Statements
which may be required hereunder, the earlier of (I)&nbsp;the 30th calendar day following the date on which an additional Registration
Statement is required to be filed hereunder (or, in the event of a &ldquo;full review&rdquo; by the SEC, the 60th calendar day following
the date such additional Registration Statement is required to be filed hereunder) and (II)&nbsp;2nd Business Day after the date the Company
is notified (orally or in writing, whichever is earlier) by the SEC that such Registration Statement will not be reviewed or will not
be subject to further review, provided, further, if such Effectiveness Deadline falls on a day that is not a Trading Day, then the Effectiveness
Deadline shall be the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e) &#8239;&ldquo;<B>Filing
Deadline</B>&rdquo; means (i)&nbsp;with respect to the initial Registration Statement required to be filed pursuant to Section&nbsp;2(a),
the 30th calendar day after the date of this Agreement and (ii)&nbsp;with respect to any additional Registration Statements that may be
required to be filed by the Company pursuant to this Agreement, the date on which the Company was required to file such additional Registration
Statement pursuant to the terms of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f) &#8239;&ldquo;<B>Investor</B>&rdquo;
means a Buyer or any transferee or assignee of any Registrable Securities, Preferred Shares or Warrants, as applicable, to whom a Buyer
assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance with Section&nbsp;9
and any transferee or assignee thereof to whom a transferee or assignee of any Registrable Securities, Preferred Shares or Warrants, as
applicable, assigns its rights under this Agreement and who agrees to become bound by the provisions of this Agreement in accordance with
Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&#8239; &ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization
or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&#8239; &ldquo;<B>register</B>,&rdquo;
 &ldquo;<B>registered</B>,&rdquo; and &ldquo;<B>registration</B>&rdquo; refer to a registration effected by preparing and filing one or
more Registration Statements in compliance with the 1933 Act and pursuant to Rule&nbsp;415 and the declaration of effectiveness of such
Registration Statement(s)&nbsp;by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239; &ldquo;<B>Registrable
Securities</B>&rdquo; means (i)&nbsp;the Conversion Shares, (ii)&nbsp;the Warrant Shares and (iii)&nbsp;any capital stock of the Company
issued or issuable with respect to the Conversion Shares, the Warrant Shares, the Preferred Shares or the Warrants, including, without
limitation, (1)&nbsp;as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2)&nbsp;any
capital stock of the Company into which the shares of Common Stock (as defined in the Securities Purchase Agreement) are converted or
exchanged and capital stock of a Successor Entity (as defined in the Warrants) into which the shares of Common Stock are converted or
exchanged, in each case, without regard to any limitations on conversion of the Preferred Shares or exercise of the Warrants; provided,
however, that any such Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain
the effectiveness of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a)&nbsp;a Registration
Statement with respect to the sale of such Registrable Securities is declared effective by the SEC under the 1933 Act and such Registrable
Securities have been disposed of by the Investor in accordance with such effective Registration Statement, (b)&nbsp;such Registrable Securities
have been previously sold in accordance with Rule&nbsp;144, or (c)&nbsp;such securities become eligible for resale without volume or manner-of-sale
restrictions and without current public information pursuant to Rule&nbsp;144, including paragraph (i)&nbsp;of Rule&nbsp;144, as set forth
in a written opinion letter to such effect, addressed, delivered and acceptable to the Company&rsquo;s transfer agent and the affected
Investors (assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend
upon which, such securities were issued or are issuable, were at no time held by any Affiliate of the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j) &#8239;&ldquo;<B>Registration
Statement</B>&rdquo; means a registration statement or registration statements of the Company filed under the 1933 Act covering Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k) &#8239;&ldquo;<B>Required
Holders</B>&rdquo; shall have the meaning as set forth in the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&#8239; &ldquo;<B>Required
Registration Amount</B>&rdquo; means, as of any time of determination, the sum of (i)&nbsp;150% of the maximum number of Conversion Shares
issuable upon conversion of the Preferred Shares (assuming for purposes hereof that (x)&nbsp;the Preferred Shares are convertible at the
Floor Price (as defined in the Certificate of Designations), (y)&nbsp;dividends on the Preferred Shares shall accrue through the 18-month
anniversary of the Closing Date and will be converted into shares of Common Stock at the Floor Price and (z)&nbsp;any such conversion
shall not take into account any limitations on the conversion of the Preferred Shares set forth in the Certificate of Designations) and
(ii)&nbsp;150% of the maximum number of Warrant Shares issuable upon exercise of the Warrants (without taking into account any limitations
on the exercise of the Warrants set forth therein), all subject to adjustment as provided in Section&nbsp;2(d)&nbsp;and/or Section&nbsp;2(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&#8239; &ldquo;<B>Rule&nbsp;144</B>&rdquo;
means Rule&nbsp;144 promulgated by the SEC under the 1933 Act, as such rule&nbsp;may be amended from time to time, or any other similar
or successor rule&nbsp;or regulation of the SEC that may at any time permit the Investors to sell securities of the Company to the public
without registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&#8239; &ldquo;<B>Rule&nbsp;415</B>&rdquo;
means Rule&nbsp;415 promulgated by the SEC under the 1933 Act, as such rule&nbsp;may be amended from time to time, or any other similar
or successor rule&nbsp;or regulation of the SEC providing for offering securities on a continuous or delayed basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&#8239; &ldquo;<B>SEC</B>&rdquo;
means the United States Securities and Exchange Commission or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Mandatory Registration</U>.
The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline, file with the SEC an initial Registration
Statement on Form&nbsp;S-3 covering the resale of all of the Registrable Securities, provided that such initial Registration Statement
shall register for resale at least the number of shares of Common Stock equal to the Required Registration Amount as of the date such
Registration Statement is initially filed with the SEC; provided further that if Form&nbsp;S-3 is unavailable for such a registration,
the Company shall use such other form as is required by Section&nbsp;2(c). Such initial Registration Statement, and each other Registration
Statement required to be filed pursuant to the terms of this Agreement, shall contain (except if otherwise directed by the Required Holders)
the &ldquo;<U>Selling Stockholders</U>&rdquo; and &ldquo;<U>Plan of Distribution</U>&rdquo; sections in substantially the form attached
hereto as <B>Exhibit&nbsp;A</B> and <B>Exhibit&nbsp;B</B>, respectively. The Company shall use its best efforts to have such initial Registration
Statement, and each other Registration Statement required to be filed pursuant to the terms of this Agreement, declared effective by the
SEC as soon as practicable, but in no event later than the applicable Effectiveness Deadline for such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Legal Counsel</U>.
Subject to Section&nbsp;5 hereof, Haynes and Boone, LLP, counsel solely to the lead investor (&ldquo;<B>Legal Counsel</B>&rdquo;), shall
be provided a copy of any registration, solely on behalf of the lead investor, pursuant to this Section&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Ineligibility
to Use Form&nbsp;S-3</U>. In the event that Form&nbsp;S-3 is not available for the registration of the resale of Registrable Securities
hereunder, the Company shall (i)&nbsp;register the resale of the Registrable Securities on Form&nbsp;S-1 or another appropriate form reasonably
acceptable to the Required Holders and (ii)&nbsp;undertake to register the resale of the Registrable Securities on Form&nbsp;S-3 as soon
as such form is available, provided that the Company shall maintain the effectiveness of all Registration Statements then in effect until
such time as a Registration Statement on Form&nbsp;S-3 covering the resale of all the Registrable Securities has been declared effective
by the SEC and the prospectus contained therein is available for use.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Sufficient Number
of Shares Registered</U>. In the event the number of shares available under any Registration Statement is insufficient to cover all of
the Registrable Securities required to be covered by such Registration Statement or an Investor&rsquo;s allocated portion of the Registrable
Securities pursuant to Section&nbsp;2(h), the Company shall amend such Registration Statement (if permissible), or file with the SEC a
new Registration Statement (on the short form available therefor, if applicable), or both, so as to cover at least the Required Registration
Amount as of the Trading Day immediately preceding the date of the filing of such amendment or new Registration Statement, in each case,
as soon as practicable, but in any event not later than fifteen (15) days after the necessity therefor arises (but taking account of any
Staff position with respect to the date on which the Staff will permit such amendment to the Registration Statement and/or such new Registration
Statement (as the case may be) to be filed with the SEC). The Company shall use its best efforts to cause such amendment to such Registration
Statement and/or such new Registration Statement (as the case may be) to become effective as soon as practicable following the filing
thereof with the SEC, but in no event later than the applicable Effectiveness Deadline for such Registration Statement. For purposes of
the foregoing provision, the number of shares available under a Registration Statement shall be deemed &ldquo;insufficient to cover all
of the Registrable Securities&rdquo; if at any time the number of shares of Common Stock available for resale under the applicable Registration
Statement is less than the product determined by multiplying (i)&nbsp;the Required Registration Amount as of such time by (ii)&nbsp;0.90.
The calculation set forth in the foregoing sentence shall be made without regard to any limitations on conversion of the Preferred Shares
or exercise of the Warrants (and such calculation shall assume (A)&nbsp;that the Preferred Shares are then convertible in full into shares
of Common Stock at the Floor Price (as defined in the Certificate of Designations) and (B)&nbsp;the Warrants are then exercisable in full
into shares of Common Stock at the then prevailing Exercise Price (as defined in the Warrants)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Effect of Failure
to File and Obtain and Maintain Effectiveness of any Registration Statement</U>. If (i)&nbsp;a Registration Statement covering the resale
of all of the Registrable Securities required to be covered thereby (disregarding any reduction pursuant to Section&nbsp;2(f)) and required
to be filed by the Company pursuant to this Agreement is (A)&nbsp;not filed with the SEC on or before the Filing Deadline for such Registration
Statement (a &ldquo;<B>Filing Failure</B>&rdquo;) (it being understood that if the Company files a Registration Statement without affording
each Investor the opportunity to review and comment on the same as required by Section&nbsp;3(c)&nbsp;hereof, the Company shall be deemed
to not have satisfied this clause (i)(A)&nbsp;and such event shall be deemed to be a Filing Failure) or (B)&nbsp;not declared effective
by the SEC on or before the Effectiveness Deadline for such Registration Statement (an &ldquo;<B>Effectiveness Failure</B>&rdquo;) (it
being understood that if on the Business Day immediately following the Effective Date for such Registration Statement the Company shall
not have filed a &ldquo;final&rdquo; prospectus for such Registration Statement with the SEC under Rule&nbsp;424(b)&nbsp;in accordance
with Section&nbsp;3(b)&nbsp;(whether or not such a prospectus is technically required by such rule), the Company shall be deemed to not
have satisfied this clause (i)(B)&nbsp;and such event shall be deemed to be an Effectiveness Failure), (ii)&nbsp;other than during an
Allowable Grace Period (as defined below), on any day after the Effective Date of a Registration Statement sales of all of the Registrable
Securities required to be included on such Registration Statement (disregarding any reduction pursuant to Section&nbsp;2(f)) cannot be
made pursuant to such Registration Statement (including, without limitation, because of a failure to keep such Registration Statement
effective, a failure to disclose such information as is necessary for sales to be made pursuant to such Registration Statement, a suspension
or delisting of (or a failure to timely list) the Common Stock on the Principal Market (as defined in the Securities Purchase Agreement)
or any other limitations imposed by the Principal Market, or a failure to register a sufficient number of shares of Common Stock or by
reason of a stop order) or the prospectus contained therein is not available for use for any reason (a &ldquo;<B>Maintenance Failure</B>&rdquo;),
or (iii)&nbsp;if a Registration Statement is not effective for any reason or the prospectus contained therein is not available for use
for any reason, and either (x)&nbsp;the Company fails for any reason to satisfy the requirements of Rule&nbsp;144(c)(1), including, without
limitation, the failure to satisfy the current public information requirement under Rule&nbsp;144(c)&nbsp;or (y)&nbsp;the Company has
ever been an issuer described in Rule&nbsp;144(i)(1)(i)&nbsp;or becomes such an issuer in the future, and the Company shall fail to satisfy
any condition set forth in Rule&nbsp;144(i)(2)&nbsp;(a &ldquo;<B>Current Public Information Failure</B>&rdquo;) as a result of which any
of the Investors are unable to sell Registrable Securities without restriction under Rule&nbsp;144 (including, without limitation, volume
restrictions), then, as partial relief for the damages to any holder by reason of any such delay in, or reduction of, its ability to sell
the underlying shares of Common Stock (which remedy shall not be exclusive of any other remedies available at law or in equity, including,
without limitation, specific performance), the Company shall pay to each holder of Registrable Securities relating to such Registration
Statement an amount in cash equal to two percent (2%) of such Investor&rsquo;s respective Purchase Price (as defined in the Securities
Purchase Agreement) on the Closing Date (1)&nbsp;on the date of such Filing Failure, Effectiveness Failure, Maintenance Failure or Current
Public Information Failure, as applicable, and (2)&nbsp;on every thirty (30) day anniversary of (I)&nbsp;a Filing Failure until such Filing
Failure is cured; (II)&nbsp;an Effectiveness Failure until such Effectiveness Failure is cured; (III)&nbsp;a Maintenance Failure until
such Maintenance Failure is cured; and (IV)&nbsp;a Current Public Information Failure until the earlier of (i)&nbsp;the date such Current
Public Information Failure is cured and (ii)&nbsp;such time that such public information is no longer required pursuant to Rule&nbsp;144
(in each case, prorated for periods totaling less than thirty (30) days). The payments to which a holder of Registrable Securities shall
be entitled pursuant to this Section&nbsp;2(e)&nbsp;are referred to herein as &ldquo;<B>Registration Delay Payments</B>.&rdquo; Following
the initial Registration Delay Payment for any particular event or failure (which shall be paid on the date of such event or failure,
as set forth above), without limiting the foregoing, if an event or failure giving rise to the Registration Delay Payments is cured prior
to any thirty (30) day anniversary of such event or failure, then such Registration Delay Payment shall be made on the third (3rd) Business
Day after such cure. In the event the Company fails to make Registration Delay Payments in a timely manner in accordance with the foregoing,
such Registration Delay Payments shall bear interest at the rate of one and one half percent (1.5%) per month (prorated for partial months)
until paid in full. Notwithstanding the foregoing, no Registration Delay Payments shall be owed to an Investor (other than with respect
to a Maintenance Failure resulting from a suspension or delisting of (or a failure to timely list) the Common Stock on the Principal Market)
with respect to any period during which all of such Investor&rsquo;s Registrable Securities may be sold by such Investor without restriction
under Rule&nbsp;144 (including, without limitation, volume restrictions) and without the need for current public information required
by Rule&nbsp;144(c)(1)&nbsp;(or Rule&nbsp;144(i)(2), if applicable).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Offering</U>.
Notwithstanding anything to the contrary contained in this Agreement, but subject to the payment of the Registration Delay Payments pursuant
to Section&nbsp;2(e), in the event the staff of the SEC (the &ldquo;<B>Staff</B>&rdquo;) or the SEC seeks to characterize any offering
pursuant to a Registration Statement filed pursuant to this Agreement as constituting an offering of securities by, or on behalf of, the
Company, or in any other manner, such that the Staff or the SEC do not permit such Registration Statement to become effective and used
for resales in a manner that does not constitute such an offering and that permits the continuous resale at the market by the Investors
participating therein (or as otherwise may be acceptable to each Investor) without being named therein as an &ldquo;underwriter,&rdquo;
then the Company shall reduce the number of shares to be included in such Registration Statement by all Investors until such time as the
Staff and the SEC shall so permit such Registration Statement to become effective as aforesaid. In making such reduction, the Company
shall reduce the number of shares to be included by all Investors on a pro rata basis (based upon the number of Registrable Securities
otherwise required to be included for each Investor) unless the inclusion of shares by a particular Investor or a particular set of Investors
are resulting in the Staff or the SEC&rsquo;s &ldquo;by or on behalf of the Company&rdquo; offering position, in which event the shares
held by such Investor or set of Investors shall be the only shares subject to reduction (and if by a set of Investors on a pro rata basis
by such Investors or on such other basis as would result in the exclusion of the least number of shares by all such Investors); provided,
that, with respect to such pro rata portion allocated to any Investor, such Investor may elect the allocation of such pro rata portion
among the Registrable Securities of such Investor. In addition, in the event that the Staff or the SEC requires any Investor seeking to
sell securities under a Registration Statement filed pursuant to this Agreement to be specifically identified as an &ldquo;underwriter&rdquo;
in order to permit such Registration Statement to become effective, and such Investor does not consent to being so named as an underwriter
in such Registration Statement, then, in each such case, the Company shall reduce the total number of Registrable Securities to be registered
on behalf of such Investor, until such time as the Staff or the SEC does not require such identification or until such Investor accepts
such identification and the manner thereof. Any reduction pursuant to this paragraph will first reduce all Registrable Securities other
than those issued pursuant to the Securities Purchase Agreement. In the event of any reduction in Registrable Securities pursuant to this
paragraph, an affected Investor shall have the right to require, upon delivery of a written request to the Company signed by such Investor,
the Company to file a registration statement within twenty (20) days of such request (subject to any restrictions imposed by Rule&nbsp;415
or required by the Staff or the SEC) for resale by such Investor in a manner acceptable to such Investor, and the Company shall following
such request cause to be and keep effective such registration statement in the same manner as otherwise contemplated in this Agreement
for registration statements hereunder, in each case until such time as: (i)&nbsp;all Registrable Securities held by such Investor have
been registered and sold pursuant to an effective Registration Statement in a manner acceptable to such Investor or (ii)&nbsp;all Registrable
Securities may be resold by such Investor without restriction (including, without limitation, volume limitations) pursuant to Rule&nbsp;144
(taking account of any Staff position with respect to &ldquo;affiliate&rdquo; status) and without the need for current public information
required by Rule&nbsp;144(c)(1)&nbsp;(or Rule&nbsp;144(i)(2), if applicable) or (iii)&nbsp;such Investor agrees to be named as an underwriter
in any such Registration Statement in a manner acceptable to such Investor as to all Registrable Securities held by such Investor and
that have not theretofore been included in a Registration Statement under this Agreement (it being understood that the special demand
right under this sentence may be exercised by an Investor multiple times and with respect to limited amounts of Registrable Securities
in order to permit the resale thereof by such Investor as contemplated above).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Piggyback Registrations</U>.
Without limiting any obligation of the Company hereunder or under the Securities Purchase Agreement, if there is not an effective Registration
Statement covering all of the Registrable Securities or the prospectus contained therein is not available for use and the Company shall
determine to prepare and file with the SEC a registration statement or offering statement relating to an offering for its own account
or the account of others under the 1933 Act of any of its equity securities (other than on Form&nbsp;S-4 or Form&nbsp;S-8 (each as promulgated
under the 1933 Act) or their then equivalents relating to equity securities to be issued solely in connection with any acquisition of
any entity or business or equity securities issuable in connection with the Company&rsquo;s share option or other employee benefit plans),
then the Company shall deliver to each Investor a written notice of such determination and, if within fifteen (15) days after the date
of the delivery of such notice, any such Investor shall so request in writing, the Company shall include in such registration statement
or offering statement all or any part of such Registrable Securities such Investor requests to be registered; provided, however, the Company
shall not be required to register any Registrable Securities pursuant to this Section&nbsp;2(g)&nbsp;that are eligible for resale pursuant
to Rule&nbsp;144 without restriction (including, without limitation, volume restrictions) and without the need for current public information
required by Rule&nbsp;144(c)(1)&nbsp;(or Rule&nbsp;144(i)(2), if applicable) or that are the subject of a then-effective Registration
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Allocation of
Registrable Securities</U>. The initial number of Registrable Securities included in any Registration Statement and any increase in the
number of Registrable Securities included therein shall be allocated pro rata among the Investors based on the number of Registrable Securities
held by each Investor at the time such Registration Statement covering such initial number of Registrable Securities or increase thereof
is declared effective by the SEC. In the event that an Investor sells or otherwise transfers any of such Investor&rsquo;s Registrable
Securities, each transferee or assignee (as the case may be) that becomes an Investor shall be allocated a pro rata portion of the then-remaining
number of Registrable Securities included in such Registration Statement for such transferor or assignee (as the case may be). Any shares
of Common Stock included in a Registration Statement and which remain allocated to any Person which ceases to hold any Registrable Securities
covered by such Registration Statement shall be allocated to the remaining Investors, pro rata based on the number of Registrable Securities
then held by such Investors which are covered by such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>No Inclusion of
Other Securities</U>. The Company shall in no event include any securities other than Registrable Securities on any Registration Statement
filed in accordance herewith without the prior written consent of the Required Holders. Until the Applicable Date (as defined in the Securities
Purchase Agreement), the Company shall not enter into any agreement providing any registration rights to any of its security holders,
except as otherwise permitted under the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">3.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Related
Obligations.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company shall use its
best efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition thereof, and,
pursuant thereto, the Company shall have the following obligations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The Company shall
promptly prepare and file with the SEC a Registration Statement with respect to all the Registrable Securities (but in no event later
than the applicable Filing Deadline) and use its best efforts to cause such Registration Statement to become effective as soon as practicable
after such filing (but in no event later than the Effectiveness Deadline). Subject to Allowable Grace Periods, the Company shall keep
each Registration Statement effective (and the prospectus contained therein available for use) pursuant to Rule&nbsp;415 for resales by
the Investors on a delayed or continuous basis at then-prevailing market prices (and not fixed prices) at all times until the earlier
of (i)&nbsp;the date as of which all of the Investors may sell all of the Registrable Securities required to be covered by such Registration
Statement (disregarding any reduction pursuant to Section&nbsp;2(f)) without restriction pursuant to Rule&nbsp;144 (including, without
limitation, volume restrictions) and without the need for current public information required by Rule&nbsp;144(c)(1)&nbsp;(or Rule&nbsp;144(i)(2),
if applicable) or (ii)&nbsp;the date on which the Investors shall have sold all of the Registrable Securities covered by such Registration
Statement (the &ldquo;<B>Registration Period</B>&rdquo;). Notwithstanding anything to the contrary contained in this Agreement, the Company
shall ensure that, when filed and at all times while effective, each Registration Statement (including, without limitation, all amendments
and supplements thereto) and the prospectus (including, without limitation, all amendments and supplements thereto) used in connection
with such Registration Statement (1)&nbsp;shall not contain any untrue statement of a material fact or omit to state a material fact required
to be stated therein, or necessary to make the statements therein (in the case of prospectuses, in the light of the circumstances in which
they were made) not misleading and (2)&nbsp;will disclose (whether directly or through incorporation by reference to other SEC filings
to the extent permitted) all material information regarding the Company and its securities. The Company shall submit to the SEC, within
one (1)&nbsp;Business Day after the date that the Company learns that no review of a particular Registration Statement will be made by
the Staff or that the Staff has no further comments on a particular Registration Statement (as the case may be), a request for acceleration
of effectiveness of such Registration Statement to a time and date not later than two (2)&nbsp;Business Days after the submission of such
request. The Company shall respond in writing to comments made by the SEC in respect of a Registration Statement as soon as practicable,
but in no event later than fifteen (15) days after the receipt of comments by or notice from the SEC that an amendment is required in
order for a Registration Statement to be declared effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Subject to Section&nbsp;3(r)&nbsp;of
this Agreement, the Company shall prepare and file with the SEC such amendments (including, without limitation, post-effective amendments)
and supplements to each Registration Statement and the prospectus used in connection with each such Registration Statement, which prospectus
is to be filed pursuant to Rule&nbsp;424 promulgated under the 1933 Act, as may be necessary to keep each such Registration Statement
effective at all times during the Registration Period for such Registration Statement, and, during such period, comply with the provisions
of the 1933 Act with respect to the disposition of all Registrable Securities of the Company required to be covered by such Registration
Statement until such time as all of such Registrable Securities shall have been disposed of in accordance with the intended methods of
disposition by the seller or sellers thereof as set forth in such Registration Statement; provided, however, by 8:30 a.m.&nbsp;(New York
time) on the Business Day immediately following each Effective Date, the Company shall file with the SEC in accordance with Rule&nbsp;424(b)&nbsp;under
the 1933 Act the final prospectus to be used in connection with sales pursuant to the applicable Registration Statement (whether or not
such a prospectus is technically required by such rule). In the case of amendments and supplements to any Registration Statement which
are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this Section&nbsp;3(b)) by reason of the
Company filing a Current Report on Form&nbsp;8-K, an Annual Report on Form&nbsp;10-K, a Quarterly Report on Form&nbsp;10-Q or any analogous
report under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>1934 Act</B>&rdquo;), the Company shall, if permitted under
the applicable rules&nbsp;and regulations of the SEC, have incorporated such report by reference into such Registration Statement, if
applicable, or shall file such amendments or supplements with the SEC on the same day on which the 1934 Act report is filed which created
the requirement for the Company to amend or supplement such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;The Company shall
(A)&nbsp;permit each Investor to review and comment upon (i)&nbsp;each Registration Statement at least five (5)&nbsp;days prior to its
filing with the SEC and (ii)&nbsp;all amendments and supplements to each Registration Statement (including, without limitation, the prospectus
contained therein) (except for Annual Reports on Form&nbsp;10-K, Quarterly Reports on Form&nbsp;10-Q, Current Reports on Form&nbsp;8-K,
and any similar or successor reports) within a reasonable number of days prior to their filing with the SEC, and (B)&nbsp;not file any
Registration Statement or amendment or supplement thereto in a form to which such Investor reasonably objects; <U>provided</U>, that the
Company shall not have any obligation to modify any information if the Company reasonably expects that so doing would cause (i)&nbsp;the
Registration Statement to contain an untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein not misleading or (ii)&nbsp;any prospectus contained therein to contain an untrue statement
of a material fact or to omit to state a material fact necessary in order to make the statements made, in light of the circumstances under
which they were made, not misleading. The Company shall promptly furnish to each Investor, without charge, (i)&nbsp;copies of any correspondence
from the SEC or the Staff to the Company or its representatives relating to each Registration Statement, provided that such correspondence
shall not contain any material, non-public information regarding the Company or any of its Subsidiaries (as defined in the Securities
Purchase Agreement), (ii)&nbsp;after the same is prepared and filed with the SEC, one (1)&nbsp;copy of each Registration Statement and
any amendment(s)&nbsp;and supplement(s)&nbsp;thereto, including, without limitation, financial statements and schedules, all documents
incorporated therein by reference, if requested by an Investor, and all exhibits and (iii)&nbsp;upon the effectiveness of each Registration
Statement, one (1)&nbsp;copy of the prospectus included in such Registration Statement and all amendments and supplements thereto. The
Company shall reasonably cooperate with each Investor in performing the Company&rsquo;s obligations pursuant to this Section&nbsp;3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;The Company shall
promptly furnish to each Investor whose Registrable Securities are included in any Registration Statement, without charge, (i)&nbsp;after
the same is prepared and filed with the SEC, at least one (1)&nbsp;copy of each Registration Statement and any amendment(s)&nbsp;and supplement(s)&nbsp;thereto,
including, without limitation, financial statements and schedules, all documents incorporated therein by reference, if requested by an
Investor, all exhibits and each preliminary prospectus, provided, that any such item which is available on the EDGAR system (or successor
thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The Company shall
use its best efforts to (i)&nbsp;register and qualify, unless an exemption from registration and qualification applies, the resale by
Investors of the Registrable Securities covered by a Registration Statement under such other securities or &ldquo;blue sky&rdquo; laws
of all applicable jurisdictions in the United States, (ii)&nbsp;prepare and file in those jurisdictions, such amendments (including, without
limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain the effectiveness
thereof during the Registration Period, (iii)&nbsp;take such other actions as may be necessary to maintain such registrations and qualifications
in effect at all times during the Registration Period, and (iv)&nbsp;take all other actions reasonably necessary or advisable to qualify
the Registrable Securities for sale in such jurisdictions; provided, however, the Company shall not be required in connection therewith
or as a condition thereto to (x)&nbsp;qualify to do business in any jurisdiction where it would not otherwise be required to qualify but
for this Section&nbsp;3(e), (y)&nbsp;subject itself to general taxation in any such jurisdiction, or (z)&nbsp;file a general consent to
service of process in any such jurisdiction. The Company shall promptly notify Legal Counsel, legal counsel for each other Investor and
each Investor who holds Registrable Securities of the receipt by the Company of any notification with respect to the suspension of the
registration or qualification of any of the Registrable Securities for sale under the securities or &ldquo;blue sky&rdquo; laws of any
jurisdiction in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;The Company shall
notify each Investor in writing of the happening of any event, as promptly as practicable after becoming aware of such event, as a result
of which the prospectus included in a Registration Statement, as then in effect, may include an untrue statement of a material fact or
omission to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading (provided that in no event shall such notice contain any material, non-public information regarding
the Company or any of its Subsidiaries), and, subject to Section&nbsp;3(r), promptly prepare a supplement or amendment to such Registration
Statement and such prospectus contained therein to correct such untrue statement or omission and deliver ten (10)&nbsp;copies of such
supplement or amendment to each Investor (or such other number of copies as such Investor may reasonably request). The Company shall also
promptly notify each Investor in writing (i)&nbsp;when a prospectus or any prospectus supplement or post-effective amendment has been
filed, when a Registration Statement or any post-effective amendment has become effective (notification of such effectiveness shall be
delivered to each Investor by e-mail on the same day of such effectiveness and by overnight mail), and when the Company receives written
notice from the SEC that a Registration Statement or any post-effective amendment will be reviewed by the SEC, (ii)&nbsp;of any request
by the SEC for amendments or supplements to a Registration Statement or related prospectus or related information, (iii)&nbsp;of the Company&rsquo;s
reasonable determination that a post-effective amendment to a Registration Statement would be appropriate; and (iv)&nbsp;of the receipt
of any request by the SEC or any other federal or state governmental authority for any additional information relating to the Registration
Statement or any amendment or supplement thereto or any related prospectus. The Company shall respond as promptly as practicable to any
comments received from the SEC with respect to each Registration Statement or any amendment thereto (it being understood and agreed that
the Company&rsquo;s response to any such comments shall be delivered to the SEC no later than fifteen (15) Business Days after the receipt
thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;The Company shall
(i)&nbsp;use its best efforts to prevent the issuance of any stop order or other suspension of effectiveness of each Registration Statement
or the use of any prospectus contained therein, or the suspension of the qualification, or the loss of an exemption from qualification,
of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is issued, to obtain the withdrawal
of such order or suspension at the earliest possible moment and (ii)&nbsp;notify each Investor who holds Registrable Securities of the
issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding for such
purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;If any Investor may
be required under applicable securities law to be described in any Registration Statement as an underwriter and such Investor consents
to so being named an underwriter, at the request of any Investor, the Company shall furnish to such Investor, on the date of the effectiveness
of such Registration Statement and thereafter from time to time on such dates as an Investor may reasonably request (i)&nbsp;a letter,
dated such date, from the Company&rsquo;s independent certified public accountants in form and substance as is customarily given by independent
certified public accountants to underwriters in an underwritten public offering, addressed to the Investors, and (ii)&nbsp;an opinion,
dated as of such date, of counsel representing the Company for purposes of such Registration Statement, in form, scope and substance as
is customarily given in an underwritten public offering, addressed to the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;If any Investor may
be required under applicable securities law to be described in any Registration Statement as an underwriter and such Investor consents
to so being named an underwriter, upon the written request of such Investor, the Company shall make available for inspection by (i)&nbsp;such
Investor, (ii)&nbsp;legal counsel for such Investor and (iii)&nbsp;one (1)&nbsp;firm of accountants or other agents retained by such Investor
(collectively, the &ldquo;<B>Inspectors</B>&rdquo;), all pertinent financial and other records, and pertinent corporate documents and
properties of the Company (collectively, the &ldquo;<B>Records</B>&rdquo;), as shall be reasonably deemed necessary by each Inspector,
and cause the Company&rsquo;s officers, directors and employees to supply all information which any Inspector may reasonably request;
provided, however, each Inspector shall agree in writing to hold in strict confidence and not to make any disclosure (except to such Investor)
or use of any Record or other information which the Company&rsquo;s board of directors determines in good faith to be confidential, and
of which determination the Inspectors are so notified, unless (1)&nbsp;the disclosure of such Records is necessary to avoid or correct
a misstatement or omission in any Registration Statement or is otherwise required under the 1933 Act, (2)&nbsp;the release of such Records
is ordered pursuant to a final, non-appealable subpoena or order from a court or government body of competent jurisdiction, or (3)&nbsp;the
information in such Records has been made generally available to the public other than by disclosure in violation of this Agreement or
any other Transaction Document (as defined in the Securities Purchase Agreement). Such Investor agrees that it shall, upon learning that
disclosure of such Records is sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt
notice to the Company and allow the Company, at its expense, to undertake appropriate action to prevent disclosure of, or to obtain a
protective order for, the Records deemed confidential. Nothing herein (or in any other confidentiality agreement between the Company and
such Investor, if any) shall be deemed to limit any Investor&rsquo;s ability to sell Registrable Securities in a manner which is otherwise
consistent with applicable laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;The Company shall
hold in confidence and not make any disclosure of information concerning an Investor provided to the Company unless (i)&nbsp;disclosure
of such information is necessary to comply with federal or state securities laws, (ii)&nbsp;the disclosure of such information is necessary
to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in such Registration
Statement pursuant to the 1933 Act, (iii)&nbsp;the release of such information is ordered pursuant to a subpoena or other final, non-appealable
order from a court or governmental body of competent jurisdiction, or (iv)&nbsp;such information has been made generally available to
the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company agrees that it shall,
upon learning that disclosure of such information concerning an Investor is sought in or by a court or governmental body of competent
jurisdiction or through other means, give prompt written notice to such Investor and allow such Investor, at such Investor&rsquo;s expense,
to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;Without limiting
any obligation of the Company under the Securities Purchase Agreement, the Company shall use its best efforts either to (i)&nbsp;cause
all of the Registrable Securities covered by each Registration Statement to be listed on each securities exchange on which securities
of the same class or series issued by the Company are then listed, if any, if the listing of such Registrable Securities is then permitted
under the rules&nbsp;of such exchange, (ii)&nbsp;secure designation and quotation of all of the Registrable Securities covered by each
Registration Statement on an Eligible Market (as defined in the Securities Purchase Agreement), or (iii)&nbsp;if, despite the Company&rsquo;s
best efforts to satisfy the preceding clauses (i)&nbsp;or (ii)&nbsp;the Company is unsuccessful in satisfying the preceding clauses (i)&nbsp;or
(ii), without limiting the generality of the foregoing, to use its best efforts to arrange for at least two market makers to register
with the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;) as such with respect to such Registrable Securities. In
addition, the Company shall cooperate with each Investor and any broker or dealer through which any such Investor proposes to sell its
Registrable Securities in effecting a filing with FINRA pursuant to FINRA Rule&nbsp;5110 as requested by such Investor. The Company shall
pay all fees and expenses in connection with satisfying its obligations under this Section&nbsp;3(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;The Company shall
cooperate with the Investors who hold Registrable Securities being offered and, to the extent applicable, facilitate the timely preparation
and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities to be offered pursuant to a
Registration Statement and enable such certificates to be in such denominations or amounts (as the case may be) as the Investors may reasonably
request from time to time and registered in such names as the Investors may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;If requested by an
Investor, the Company shall as soon as practicable after receipt of notice from such Investor and subject to Section&nbsp;3(r)&nbsp;hereof,
(i)&nbsp;incorporate in a prospectus supplement or post-effective amendment such information as an Investor reasonably requests to be
included therein relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect
to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of the offering
of the Registrable Securities to be sold in such offering; (ii)&nbsp;make all required filings of such prospectus supplement or post-effective
amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and (iii)&nbsp;supplement
or make amendments to any Registration Statement or prospectus contained therein if reasonably requested by an Investor holding any Registrable
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;The Company shall
use its best efforts to cause the Registrable Securities covered by a Registration Statement to be registered with or approved by such
other United States governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;The Company shall
make generally available to its security holders as soon as practical, but not later than ninety (90) days after the close of the period
covered thereby, an earnings statement (in form complying with, and in the manner provided by, the provisions of Rule&nbsp;158 under the
1933 Act) covering a twelve-month period beginning not later than the first day of the Company&rsquo;s fiscal quarter next following the
applicable Effective Date of each Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;The Company shall
otherwise use its best efforts to comply with all applicable rules&nbsp;and regulations of the SEC in connection with any registration
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;Within one (1)&nbsp;Business
Day after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company shall deliver, and
shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities (with copies to the Investors
whose Registrable Securities are included in such Registration Statement) confirmation that such Registration Statement has been declared
effective by the SEC in the form acceptable to the Transfer Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;Notwithstanding anything
to the contrary herein (but subject to the last sentence of this Section&nbsp;3(r)), at any time after the Effective Date of a particular
Registration Statement, the Company may delay the disclosure of material, non-public information concerning the Company or any of its
Subsidiaries the disclosure of which at the time is not, in the good faith opinion of the board of directors of the Company, in the best
interest of the Company and, in the opinion of counsel to the Company, otherwise required (a &ldquo;<B>Grace Period</B>&rdquo;), provided
that the Company shall promptly notify the Investors in writing of the (i)&nbsp;existence of material, non-public information giving rise
to a Grace Period (provided that in each such notice the Company shall not disclose the content of such material, non-public information
to any of the Investors) and the date on which such Grace Period will begin and (ii)&nbsp;date on which such Grace Period ends, provided
further that (I)&nbsp;no Grace Period shall exceed ten (10)&nbsp;consecutive days and during any three hundred sixty five (365) day period
all such Grace Periods shall not exceed an aggregate of thirty (30) days, (II)&nbsp;the first day of any Grace Period must be at least
five (5)&nbsp;Trading Days after the last day of any prior Grace Period and (III)&nbsp;no Grace Period may exist during the sixty (60)
Trading Day period immediately following the Effective Date of such Registration Statement (provided that such sixty (60) Trading Day
period shall be extended by the number of Trading Days during such period and any extension thereof contemplated by this proviso during
which such Registration Statement is not effective or the prospectus contained therein is not available for use) (each, an &ldquo;<B>Allowable
Grace Period</B>&rdquo;). For purposes of determining the length of a Grace Period above, such Grace Period shall begin on and include
the date the Investors receive the notice referred to in clause (i)&nbsp;above and shall end on and include the later of the date the
Investors receive the notice referred to in clause (ii)&nbsp;above and the date referred to in such notice. The provisions of Section&nbsp;3(g)&nbsp;hereof
shall not be applicable during the period of any Allowable Grace Period. Upon expiration of each Grace Period, the Company shall again
be bound by the first sentence of Section&nbsp;3(f)&nbsp;with respect to the information giving rise thereto unless such material, non-public
information is no longer applicable. Notwithstanding anything to the contrary contained in this Section&nbsp;3(r), the Company shall cause
its transfer agent to deliver unlegended shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities
Purchase Agreement in connection with any sale of Registrable Securities with respect to which such Investor has entered into a contract
for sale, and delivered a copy of the prospectus included as part of the particular Registration Statement to the extent applicable, prior
to such Investor&rsquo;s receipt of the notice of a Grace Period and for which the Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;The Company shall
take all other reasonable actions necessary to expedite and facilitate disposition by each Investors of its Registrable Securities pursuant
to each Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;Neither the Company
nor any Subsidiary or affiliate thereof shall identify any Investor as an underwriter in any public disclosure or filing with the SEC,
the Principal Market or any Eligible Market and any Buyer being deemed an underwriter by the SEC shall not relieve the Company of any
obligations it has under this Agreement or any other Transaction Document (as defined in the Securities Purchase Agreement); provided,
however, that the foregoing shall not prohibit the Company from including the disclosure found in the &ldquo;Plan of Distribution&rdquo;
section attached hereto as Exhibit&nbsp;A in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;Neither the Company
nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company or any of its Subsidiaries, on or after the date
of this Agreement, enter into any agreement with respect to its securities, that would have the effect of impairing the rights granted
to the Buyers in this Agreement or otherwise conflicts with the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Obligations
of the Investors.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;At least five (5)&nbsp;Business
Days prior to the first anticipated filing date of each Registration Statement, the Company shall notify each Investor in writing of the
information the Company requires from each such Investor with respect to such Registration Statement. It shall be a condition precedent
to the obligations of the Company to complete the registration pursuant to this Agreement with respect to the Registrable Securities of
a particular Investor that such Investor shall furnish to the Company such information regarding itself, the Registrable Securities held
by it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably required to effect and maintain
the effectiveness of the registration of such Registrable Securities and shall execute such documents in connection with such registration
as the Company may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Each Investor, by
such Investor&rsquo;s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of each Registration Statement hereunder, unless such Investor has notified the Company
in writing of such Investor&rsquo;s election to exclude all of such Investor&rsquo;s Registrable Securities from such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Each Investor agrees
that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section&nbsp;3(g)&nbsp;or the
first sentence of 3(f), such Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration
Statement(s)&nbsp;covering such Registrable Securities until such Investor&rsquo;s receipt of the copies of the supplemented or amended
prospectus contemplated by Section&nbsp;3(g)&nbsp;or the first sentence of Section&nbsp;3(f)&nbsp;or receipt of notice that no supplement
or amendment is required. Notwithstanding anything to the contrary in this Section&nbsp;4(c), the Company shall cause its transfer agent
to deliver unlegended shares of Common Stock to a transferee of an Investor in accordance with the terms of the Securities Purchase Agreement
in connection with any sale of Registrable Securities with respect to which such Investor has entered into a contract for sale prior to
the Investor&rsquo;s receipt of a notice from the Company of the happening of any event of the kind described in Section&nbsp;3(g)&nbsp;or
the first sentence of Section&nbsp;3(f)&nbsp;and for which such Investor has not yet settled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Expenses
of Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All reasonable expenses, other
than underwriting discounts and commissions, incurred in connection with registrations, filings or qualifications pursuant to Sections
2 and 3, including, without limitation, all registration, listing and qualifications fees, printers and accounting fees, FINRA filing
fees (if any) and fees and disbursements of counsel for the Company shall be paid by the Company. In no event shall the Company be responsible
for any broker or similar commissions of any Investor or, except to the extent expressly provided for in the Transaction Documents, any
legal fees or other costs of the Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Indemnification.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;To the fullest extent
permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend each Investor and each of its directors, officers,
stockholders, members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent role
of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person, if any, who controls such
Investor within the meaning of the 1933 Act or the 1934 Act and each of the directors, officers, stockholders, members, partners, employees,
agents, advisors, representatives (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
the lack of such title or any other title) of such controlling Persons (each, an &ldquo;<B>Indemnified Person</B>&rdquo;), against any
losses, obligations, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges, costs (including, without limitation,
court costs, reasonable attorneys&rsquo; fees and costs of defense and investigation), amounts paid in settlement or expenses, joint or
several, (collectively, &ldquo;<B>Claims</B>&rdquo;) incurred in investigating, preparing or defending any action, claim, suit, inquiry,
proceeding, investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory
agency, body or the SEC, whether pending or threatened, whether or not an Indemnified Person is or may be a party thereto (&ldquo;<B>Indemnified
Damages</B>&rdquo;), to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened,
in respect thereof) arise out of or are based upon: (i)&nbsp;any untrue statement or alleged untrue statement of a material fact in a
Registration Statement or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering
under the securities or other &ldquo;blue sky&rdquo; laws of any jurisdiction in which Registrable Securities are offered (&ldquo;<B>Blue
Sky Filing</B>&rdquo;), or the omission or alleged omission to state a material fact required to be stated therein or necessary to make
the statements therein not misleading, (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in any
preliminary prospectus if used prior to the effective date of such Registration Statement, or contained in the final prospectus (as amended
or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to
state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the statements
therein were made, not misleading or (iii)&nbsp;any violation or alleged violation by the Company of the 1933 Act, the 1934 Act, any other
law, including, without limitation, any state securities law, or any rule&nbsp;or regulation thereunder relating to the offer or sale
of the Registrable Securities pursuant to a Registration Statement or (iv)&nbsp;any violation of this Agreement (the matters in the foregoing
clauses (i)&nbsp;through (iv)&nbsp;being, collectively, &ldquo;<B>Violations</B>&rdquo;). Subject to Section&nbsp;6(c), the Company shall
reimburse the Indemnified Persons, promptly as such expenses are incurred and are due and payable, for any legal fees or other reasonable
expenses incurred by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained
herein, the indemnification agreement contained in this Section&nbsp;6(a): (i)&nbsp;shall not apply to a Claim by an Indemnified Person
arising out of or based upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the
Company by such Indemnified Person for such Indemnified Person expressly for use in connection with the preparation of such Registration
Statement or any such amendment thereof or supplement thereto, if such prospectus was timely made available by the Company pursuant to
Section&nbsp;3(d); and (ii)&nbsp;shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the
prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the transfer of any
of the Registrable Securities by any of the Investors pursuant to Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;In connection with
any Registration Statement in which an Investor is participating, such Investor agrees to severally and not jointly indemnify, hold harmless
and defend, to the same extent and in the same manner as is set forth in Section&nbsp;6(a), the Company, each of its directors, each of
its officers who signs the Registration Statement and each Person, if any, who controls the Company within the meaning of the 1933 Act
or the 1934 Act (each, an &ldquo;<B>Indemnified Party</B>&rdquo;), against any Claim or Indemnified Damages to which any of them may become
subject, under the 1933 Act, the 1934 Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or are based upon any
Violation, in each case, to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity with written
information furnished to the Company by such Investor expressly for use in connection with such Registration Statement; and, subject to
Section&nbsp;6(c)&nbsp;and the below provisos in this Section&nbsp;6(b), such Investor will reimburse an Indemnified Party any legal or
other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such Claim; provided, however,
the indemnity agreement contained in this Section&nbsp;6(b)&nbsp;and the agreement with respect to contribution contained in Section&nbsp;7
shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of such Investor,
which consent shall not be unreasonably withheld or delayed, provided further that such Investor shall be liable under this Section&nbsp;6(b)&nbsp;for
only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to such Investor as a result of the applicable
sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in full force and effect regardless
of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of any of the Registrable Securities
by any of the Investors pursuant to Section&nbsp;9.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Promptly after receipt
by an Indemnified Person or Indemnified Party (as the case may be) under this Section&nbsp;6 of notice of the commencement of any action
or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified
Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section&nbsp;6,
deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate
in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control
of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party
(as the case may be); provided, however, an Indemnified Person or Indemnified Party (as the case may be) shall have the right to retain
its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i)&nbsp;the indemnifying party has
agreed in writing to pay such fees and expenses; (ii)&nbsp;the indemnifying party shall have failed promptly to assume the defense of
such Claim and to employ counsel reasonably satisfactory to such Indemnified Person or Indemnified Party (as the case may be) in any such
Claim; or (iii)&nbsp;the named parties to any such Claim (including, without limitation, any impleaded parties) include both such Indemnified
Person or Indemnified Party (as the case may be) and the indemnifying party, and such Indemnified Person or such Indemnified Party (as
the case may be) shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Person or such Indemnified Party and the indemnifying party (in which case, if such Indemnified Person or such Indemnified
Party (as the case may be) notifies the indemnifying party in writing that it elects to employ separate counsel at the expense of the
indemnifying party, then the indemnifying party shall not have the right to assume the defense thereof and such counsel shall be at the
expense of the indemnifying party, provided further that in the case of clause (iii)&nbsp;above the indemnifying party shall not be responsible
for the reasonable fees and expenses of more than one (1)&nbsp;separate legal counsel for such Indemnified Person or Indemnified Party
(as the case may be). The Indemnified Party or Indemnified Person (as the case may be) shall reasonably cooperate with the indemnifying
party in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying
party all information reasonably available to the Indemnified Party or Indemnified Person (as the case may be) which relates to such action
or Claim. The indemnifying party shall keep the Indemnified Party or Indemnified Person (as the case may be) reasonably apprised at all
times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any
settlement of any action, claim or proceeding effected without its prior written consent; provided, however, the indemnifying party shall
not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the Indemnified
Party or Indemnified Person (as the case may be), consent to entry of any judgment or enter into any settlement or other compromise which
does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified Person
(as the case may be) of a release from all liability in respect to such Claim or litigation, and such settlement shall not include any
admission as to fault on the part of the Indemnified Party. Following indemnification as provided for hereunder, the indemnifying party
shall be subrogated to all rights of the Indemnified Party or Indemnified Person (as the case may be) with respect to all third parties,
firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying
party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party of any liability to the
Indemnified Person or Indemnified Party (as the case may be) under this Section&nbsp;6, except to the extent that the indemnifying party
is materially and adversely prejudiced in its ability to defend such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;The indemnification
required by this Section&nbsp;6 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or Indemnified Damages are incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;The indemnity and
contribution agreements contained herein shall be in addition to (i)&nbsp;any cause of action or similar right of the Indemnified Party
or Indemnified Person against the indemnifying party or others, and (ii)&nbsp;any liabilities the indemnifying party may be subject to
pursuant to the law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Contribution.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under Section&nbsp;6 to the fullest extent permitted by law; provided, however:
(i)&nbsp;no contribution shall be made under circumstances where the maker would not have been liable for indemnification under the fault
standards set forth in Section&nbsp;6 of this Agreement, (ii)&nbsp;no Person involved in the sale of Registrable Securities which Person
is guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the 1933 Act) in connection with such sale
shall be entitled to contribution from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent misrepresentation;
and (iii)&nbsp;contribution by any seller of Registrable Securities shall be limited in amount to the amount of net proceeds received
by such seller from the applicable sale of such Registrable Securities pursuant to such Registration Statement. Notwithstanding the provisions
of this Section&nbsp;7, no Investor shall be required to contribute, in the aggregate, any amount in excess of the amount by which the
net proceeds actually received by such Investor from the applicable sale of the Registrable Securities subject to the Claim exceeds the
amount of any damages that such Investor has otherwise been required to pay, or would otherwise be required to pay under Section&nbsp;6(b),
by reason of such untrue or alleged untrue statement or omission or alleged omission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Reports
Under the 1934 Act.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">With a view to making available
to the Investors the benefits of Rule&nbsp;144, the Company agrees to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;make and keep public
information available, as those terms are understood and defined in Rule&nbsp;144;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;file with the SEC
in a timely manner all reports and other documents required of the Company under the 1933 Act and the 1934 Act so long as the Company
remains subject to such requirements (it being understood and agreed that nothing herein shall limit any obligations of the Company under
the Securities Purchase Agreement) and the filing of such reports and other documents is required for the applicable provisions of Rule&nbsp;144;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;furnish to each Investor
so long as such Investor owns Registrable Securities, promptly upon request, (i)&nbsp;a written statement by the Company, if true, that
it has complied with the reporting, submission and posting requirements of Rule&nbsp;144, the 1933 Act and the 1934 Act, (ii)&nbsp;a copy
of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the SEC
if such reports are not publicly available via EDGAR, and (iii)&nbsp;such other information as may be reasonably requested to permit the
Investors to sell such securities pursuant to Rule&nbsp;144 without registration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Assignment
of Registration Rights.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All or any portion of the
rights under this Agreement shall be automatically assignable by each Investor to any transferee or assignee (as the case may be) of all
or any portion of such Investor&rsquo;s Registrable Securities, Preferred Shares or Warrants if: (i)&nbsp;such Investor agrees in writing
with such transferee or assignee (as the case may be) to assign all or any portion of such rights, and a copy of such agreement is furnished
to the Company within a reasonable time after such transfer or assignment (as the case may be); (ii)&nbsp;the Company is, within a reasonable
time after such transfer or assignment (as the case may be), furnished with written notice of (a)&nbsp;the name and address of such transferee
or assignee (as the case may be), and (b)&nbsp;the securities with respect to which such registration rights are being transferred or
assigned (as the case may be); (iii)&nbsp;immediately following such transfer or assignment (as the case may be) the further disposition
of such securities by such transferee or assignee (as the case may be) is restricted under the 1933 Act or applicable state securities
laws if so required; (iv)&nbsp;at or before the time the Company receives the written notice contemplated by clause (ii)&nbsp;of this
sentence such transferee or assignee (as the case may be) agrees in writing with the Company to be bound by all of the provisions contained
herein; (v)&nbsp;such transfer or assignment (as the case may be) shall have been made in accordance with the applicable requirements
of the Securities Purchase Agreement, the Certificate of Designations and the Warrants (as the case may be); and (vi)&nbsp;such transfer
or assignment (as the case may be) shall have been conducted in accordance with all applicable federal and state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10.  &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Amendment
of Registration Rights.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Provisions of this Agreement
may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively),
only with the written consent of the Company and the Required Holders; provided that any such amendment or waiver that complies with the
foregoing, but that disproportionately, materially and adversely affects the rights and obligations of any Investor relative to the comparable
rights and obligations of the other Investors shall require the prior written consent of such adversely affected Investor. Any amendment
or waiver effected in accordance with this Section&nbsp;10 shall be binding upon each Investor and the Company, provided that no such
amendment shall be effective to the extent that it (1)&nbsp;applies to less than all of the holders of Registrable Securities or (2)&nbsp;imposes
any obligation or liability on any Investor without such Investor&rsquo;s prior written consent (which may be granted or withheld in such
Investor&rsquo;s sole discretion). No waiver shall be effective unless it is in writing and signed by an authorized representative of
the waiving party. No consideration shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision
of this Agreement unless the same consideration (other than the reimbursement of legal fees) also is offered to all of the parties to
this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">11.  &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Miscellaneous.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;Solely for purposes
of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns, or is deemed to own, of record
such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons with respect
to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from such record
owner of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;Any notices, consents,
waivers or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed
to have been delivered: (i)&nbsp;upon receipt, when delivered personally; (ii)&nbsp;upon receipt, when sent by electronic mail (provided
that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party does not receive
an automatically generated message from the recipient&rsquo;s email server that such e-mail could not be delivered to such recipient);
or (iii)&nbsp;one (1)&nbsp;Business Day after deposit with an overnight courier service with next day delivery specified, in each case,
properly addressed to the party to receive the same. The mailing addresses and e-mail addresses for such communications shall be:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">TAO Synergies Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">1185 Avenue of the Americas, 3rd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, NY 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Telephone: (973) 242-0005</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">E-Mail: rweinstein@synaptogen.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy (for informational purposes only) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">919 Third Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Kenneth R. Koch and Daniel A. Bagliebter</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">E-Mail: <U>KRKoch@mintz.com;</U> &#8239;<U>DABagliebter@mintz.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If to the Transfer Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pacific Stock Transfer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6725 Via Austi Parkway, Suite&nbsp;300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Las Vegas, Nevada 89119</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Telephone: (702) 361-3033</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Attention: Angela L. Lamb</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">E-Mail: alamb@PacificStockTransfer.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to Legal Counsel:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Haynes and Boone, LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">30 Rockefeller Plaza, 26th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">New York, New York 10112</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Telephone: (212) 659-7300</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Attention: Rick Werner</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">E-mail: rick.werner@haynesboone.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If to a Buyer, to its mailing address and/or email
address set forth on the Schedule of Buyers attached to the Securities Purchase Agreement, with copies to such Buyer&rsquo;s representatives
as set forth on the Schedule of Buyers, or to such other mailing address and/or email address and/or to the attention of such other Person
as the recipient party has specified by written notice given to each other party five (5)&nbsp;days prior to the effectiveness of such
change, provided that Legal Counsel shall only be provided notices sent to the lead investor. Written confirmation of receipt (A)&nbsp;given
by the recipient of such notice, consent, waiver or other communication, (B)&nbsp;mechanically or electronically generated by the sender&rsquo;s
e-mail containing the time, date and recipient&rsquo;s e-mail or (C)&nbsp;provided by a courier or overnight courier service shall be
rebuttable evidence of personal service, receipt by e-mail or receipt from a nationally recognized overnight delivery service in accordance
with clause (i), (ii)&nbsp;or (iii)&nbsp;above, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Failure of any party
to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or remedy, shall not operate
as a waiver thereof. The Company and each Investor acknowledge and agree that irreparable damage would occur in the event that any of
the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. It is accordingly
agreed that each party hereto shall be entitled to an injunction or injunctions to prevent or cure breaches of the provisions of this
Agreement by any other party hereto and to enforce specifically the terms and provisions hereof (without the necessity of showing economic
loss and without any bond or other security being required), this being in addition to any other remedy to which any party may be entitled
by law or equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;All questions concerning
the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws of the State of New
York, without giving effect to any choice of law or conflict of law provision or rule&nbsp;(whether of the State of New York or any other
jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each party hereby irrevocably
submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY&nbsp;HAVE
TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF
THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;If any provision
of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction, the
provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that it
would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Agreement so long as this Agreement as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s)&nbsp;in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s)&nbsp;with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;This Agreement, the
other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein
constitute the entire agreement among the parties hereto and thereto solely with respect to the subject matter hereof and thereof. There
are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein and therein. This Agreement,
the other Transaction Documents, the schedules and exhibits attached hereto and thereto and the instruments referenced herein and therein
supersede all prior agreements and understandings among the parties hereto solely with respect to the subject matter hereof and thereof;
provided, however, nothing contained in this Agreement or any other Transaction Document shall (or shall be deemed to) (i)&nbsp;have any
effect on any agreements any Investor has entered into with the Company or any of its Subsidiaries prior to the date hereof with respect
to any prior investment made by such Investor in the Company, (ii)&nbsp;waive, alter, modify or amend in any respect any obligations of
the Company or any of its Subsidiaries or any rights of or benefits to any Investor or any other Person in any agreement entered into
prior to the date hereof between or among the Company and/or any of its Subsidiaries and any Investor and all such agreements shall continue
in full force and effect or (iii)&nbsp;limit any obligations of the Company under any of the other Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;Subject to compliance
with Section&nbsp;9 (if applicable), this Agreement shall inure to the benefit of and be binding upon the permitted successors and assigns
of each of the parties hereto. This Agreement is not for the benefit of, nor may any provision hereof be enforced by, any Person, other
than the parties hereto, their respective permitted successors and assigns and the Persons referred to in Sections 6 and 7 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;The headings in this
Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless the context clearly
indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural forms thereof.
The terms &ldquo;including,&rdquo; &ldquo;includes,&rdquo; &ldquo;include&rdquo; and words of like import shall be construed broadly as
if followed by the words &ldquo;without limitation.&rdquo; The terms &ldquo;herein,&rdquo; &ldquo;hereunder,&rdquo; &ldquo;hereof&rdquo;
and words of like import refer to this entire Agreement instead of just the provision in which they are found.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;This Agreement may
be executed in two or more identical counterparts, each of which shall be deemed an original, but all of which shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In
the event that any signature is delivered by facsimile transmission or by an email which contains a portable document format (.pdf) file
of an executed signature page, such signature page&nbsp;shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such signature page&nbsp;were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;Each party shall
do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements,
certificates, instruments and documents as any other party may reasonably request in order to carry out the intent and accomplish the
purposes of this Agreement and the consummation of the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;The language used
in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules&nbsp;of strict construction
will be applied against any party. Notwithstanding anything to the contrary set forth in Section&nbsp;10, terms used in this Agreement
but defined in the other Transaction Documents shall have the meanings ascribed to such terms on the Closing Date in such other Transaction
Documents unless otherwise consented to in writing by each Investor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;All consents and
other determinations required to be made by the Investors pursuant to this Agreement shall be made, unless otherwise specified in this
Agreement, by the Required Holders, determined as if all of the outstanding Preferred Shares then held by the Investors have been converted
for Registrable Securities without regard to any limitations on conversion of the Preferred Shares and the outstanding Warrants then held
by Investors have been exercised for Registrable Securities without regard to any limitations on exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;This Agreement is
intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor
may any provision hereof be enforced by, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;The obligations of
each Investor under this Agreement and the other Transaction Documents are several and not joint with the obligations of any other Investor,
and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under this Agreement or any
other Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Investor pursuant
hereto or thereto, shall be deemed to constitute the Investors as, and the Company acknowledges that the Investors do not so constitute,
a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Investors are in
any way acting in concert or as a group or entity with respect to such obligations or the transactions contemplated by the Transaction
Documents or any matters, and the Company acknowledges that the Investors are not acting in concert or as a group, and the Company shall
not assert any such claim, with respect to such obligations or the transactions contemplated by this Agreement or any of the other the
Transaction Documents. Each Investor shall be entitled to independently protect and enforce its rights, including, without limitation,
the rights arising out of this Agreement or out of any other Transaction Documents, and it shall not be necessary for any other Investor
to be joined as an additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations
of the Company contained herein was solely in the control of the Company, not the action or decision of any Investor, and was done solely
for the convenience of the Company and not because it was required or requested to do so by any Investor. It is expressly understood and
agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and an Investor,
solely, and not between the Company and the Investors collectively and not between and among Investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>signature page&nbsp;follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>IN WITNESS WHEREOF</B></FONT>,
each Buyer and the Company have caused their respective signature page&nbsp;to this Registration Rights Agreement to be duly executed
as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>TAO SYNERGIES INC.</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 47%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Joshua Silverman</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Executive Chairman</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>IN WITNESS WHEREOF</B></FONT>,
each Buyer and the Company have caused their respective signature page&nbsp;to this Registration Rights Agreement to be duly executed
as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUYER:</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>[&bull;]</B></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 47%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of common stock
being offered by the selling stockholders are those issuable to the selling stockholders upon conversion of the preferred shares and exercise
of the warrants. For additional information regarding the issuance of the preferred shares and the warrants, see &ldquo;Private Placement
of Preferred Shares and Warrants&rdquo; above. We are registering the shares of common stock in order to permit the selling stockholders
to offer the shares for resale from time to time. Except for the ownership of the preferred shares and the warrants issued pursuant to
the Securities Purchase Agreement, the selling stockholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling stockholders and other information regarding the beneficial ownership (as determined under Section&nbsp;13(d)&nbsp;of the Securities
Exchange Act of 1934, as amended, and the rules&nbsp;and regulations thereunder) of the shares of common stock held by each of the selling
stockholders. The second column lists the number of shares of common stock beneficially owned by the selling stockholders, based on their
respective ownership of shares of common stock, preferred shares and warrants, as of ________, 2025, assuming conversion of the preferred
shares and exercise of the warrants held by each such selling stockholder on that date but taking account of any limitations on conversion
and exercise set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of common stock being offered by this prospectus by the selling stockholders and does not take in account any limitations on (i)&nbsp;conversion
of the preferred shares set forth therein or (ii)&nbsp;exercise of the warrants set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the holders of the preferred shares and the warrants, this prospectus generally covers the resale
of the sum of (i)&nbsp;the maximum number of shares of common stock issued or issuable pursuant to the preferred shares and (ii)&nbsp;the
maximum number of shares of common stock issued or issuable upon exercise of the warrants, in each case, determined as if the outstanding
preferred shares and warrants were converted or exercised (as the case may be) in full (without regard to any limitations on conversion
or exercise contained therein solely for the purpose of such calculation) at the floor price or exercise price (as the case may be) calculated
as of the trading day immediately preceding the date this registration statement was initially filed with the SEC. Because the conversion
price of the preferred shares and the exercise price of the warrants may be adjusted, the number of shares that will actually be issued
may be more or less than the number of shares being offered by this prospectus. The fourth column assumes the sale of all of the shares
offered by the selling stockholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the Certificate
of Designations and the warrants, a selling stockholder may not convert the preferred shares or exercise the warrants to the extent (but
only to the extent) such selling stockholder or any of its affiliates would beneficially own a number of shares of our shares of common
stock which would exceed [4.99][9.99]% of the outstanding shares of the Company. The number of shares in the second column reflects these
limitations. The selling stockholders may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: bottom; width: 25%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Name of Selling Stockholder</U></B></P></TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Number of shares of<BR>
Common Stock<BR>
Owned <BR>
Prior to Offering</U></B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Maximum Number of shares of<BR>
Common Stock to be Sold Pursuant<BR>
to<BR>
this Prospectus</U></B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Number of shares of<BR>
Common Stock of<BR>
Owned <BR>
After Offering</U></B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>
[LEAD INVESTOR] (1)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[OTHER BUYERS]</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top">(1) [</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXHIBIT&nbsp;B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are registering the shares
of common stock issuable upon conversion of the preferred shares and exercise of the warrants to permit the resale of these shares of
common stock by the holders of the preferred shares and warrants from time to time after the date of this prospectus. We will not receive
any of the proceeds from the sale by the selling stockholders of the shares of common stock, although we will receive the exercise price
of any warrants not exercised by the selling stockholders on a cashless exercise basis. We will bear all fees and expenses incident to
our obligation to register the shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders may
sell all or a portion of the shares of common stock held by them and offered hereby from time to time directly or through one or more
underwriters, broker-dealers or agents. If the shares of common stock are sold through underwriters or broker-dealers, the selling stockholders
will be responsible for underwriting discounts or commissions or agent&rsquo;s commissions. The shares of common stock may be sold in
one or more transactions at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time
of sale or at negotiated prices. These sales may be effected in transactions, which may involve crosses or block transactions, pursuant
to one or more of the following methods:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">on any national securities exchange or quotation service on which the securities
may be listed or quoted at the time of sale;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">in the over-the-counter market;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">in transactions otherwise than on these exchanges or systems or in the over-the-counter
market;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">through the writing or settlement of options, whether such options are listed
on an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">ordinary brokerage transactions and transactions in which the broker-dealer
solicits purchasers;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">block trades in which the broker-dealer will attempt to sell the shares as agent
but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">purchases by a broker-dealer as principal and resale by the broker-dealer for
its account;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">an exchange distribution in accordance with the rules&nbsp;of the applicable
exchange;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">privately negotiated transactions;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">short sales made after the date the Registration Statement is declared effective
by the SEC;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">broker-dealers may agree with a selling security holder to sell a specified
number of such shares at a stipulated price per share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">a combination of any such methods of sale; and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT><FONT STYLE="font-family: Symbol"></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">any other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders may
also sell shares of common stock under Rule&nbsp;144 promulgated under the Securities Act of 1933, as amended, if available, rather than
under this prospectus. In addition, the selling stockholders may transfer the shares of common stock by other means not described in this
prospectus. If the selling stockholders effect such transactions by selling shares of common stock to or through underwriters, broker-dealers
or agents, such underwriters, broker-dealers or agents may receive commissions in the form of discounts, concessions or commissions from
the selling stockholders or commissions from purchasers of the shares of common stock for whom they may act as agent or to whom they may
sell as principal (which discounts, concessions or commissions as to particular underwriters, broker-dealers or agents may be in excess
of those customary in the types of transactions involved). In connection with sales of the shares of common stock or otherwise, the selling
stockholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the shares of common
stock in the course of hedging in positions they assume. The selling stockholders may also sell shares of common stock short and deliver
shares of common stock covered by this prospectus to close out short positions and to return borrowed shares in connection with such short
sales. The selling stockholders may also loan or pledge shares of common stock to broker-dealers that in turn may sell such shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders may
pledge or grant a security interest in some or all of the preferred shares, warrants or shares of common stock owned by them and, if they
default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock
from time to time pursuant to this prospectus or any amendment to this prospectus under Rule&nbsp;424(b)(3)&nbsp;or other applicable provision
of the Securities Act amending, if necessary, the list of selling stockholders to include the pledgee, transferee or other successors
in interest as selling stockholders under this prospectus. The selling stockholders also may transfer and donate the shares of common
stock in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial
owners for purposes of this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent required by
the Securities Act and the rules&nbsp;and regulations thereunder, the selling stockholders and any broker-dealer participating in the
distribution of the shares of common stock may be deemed to be &ldquo;underwriters&rdquo; within the meaning of the Securities Act, and
any commission paid, or any discounts or concessions allowed to, any such broker-dealer may be deemed to be underwriting commissions or
discounts under the Securities Act. At the time a particular offering of the shares of common stock is made, a prospectus supplement,
if required, will be distributed, which will set forth the aggregate amount of shares of common stock being offered and the terms of the
offering, including the name or names of any broker-dealers or agents, any discounts, commissions and other terms constituting compensation
from the selling stockholders and any discounts, commissions or concessions allowed or re-allowed or paid to broker-dealers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the securities laws
of some states, the shares of common stock may be sold in such states only through registered or licensed brokers or dealers. In addition,
in some states the shares of common stock may not be sold unless such shares have been registered or qualified for sale in such state
or an exemption from registration or qualification is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There can be no assurance
that any selling stockholder will sell any or all of the shares of common stock registered pursuant to the registration statement, of
which this prospectus forms a part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selling stockholders and
any other person participating in such distribution will be subject to applicable provisions of the Securities Exchange Act of 1934, as
amended, and the rules&nbsp;and regulations thereunder, including, without limitation, to the extent applicable, Regulation M of the Exchange
Act, which may limit the timing of purchases and sales of any of the shares of common stock by the selling stockholders and any other
participating person. To the extent applicable, Regulation M may also restrict the ability of any person engaged in the distribution of
the shares of common stock to engage in market-making activities with respect to the common stock. All of the foregoing may affect the
marketability of the common stock and the ability of any person or entity to engage in market-making activities with respect to the common
stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will pay all expenses of
the registration of the shares of common stock pursuant to the registration rights agreement, estimated to be $[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
] in total, including, without limitation, Securities and Exchange Commission filing fees and expenses of compliance with state securities
or &ldquo;blue sky&rdquo; laws; provided, however, a selling stockholder will pay all underwriting discounts and selling commissions,
if any. We will indemnify the selling stockholders against liabilities, including some liabilities under the Securities Act in accordance
with the registration rights agreements or the selling stockholders will be entitled to contribution. We may be indemnified by the selling
stockholders against civil liabilities, including liabilities under the Securities Act that may arise from any written information furnished
to us by the selling stockholder specifically for use in this prospectus, in accordance with the related registration rights agreements
or we may be entitled to contribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Once sold under the registration
statement, of which this prospectus forms a part, the shares of common stock will be freely tradable in the hands of persons other than
our affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>tm2528153d1_ex10-3.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT>Execution
Version</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GP NURMENKARI INC<BR>
</B>22 Elizabeth Street<BR>
Norwalk, CT 06854<BR>
TEL: 212-400-6993 FAX: 212-247-1059<BR>
Member: FINRA&nbsp;&amp; SIPC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September&nbsp;25<SUP>th</SUP>, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I><U>STRICTLY CONFIDENTIAL</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TAO Synergies Inc.,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">46-1585656</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1185 Avenue of the Americas, 3rd Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York, 10036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">This
letter (the &ldquo;<I>Agreement</I>&rdquo;) constitutes our understanding with respect to the engagement of GP Nurmenkari Inc (&ldquo;<I>GPN</I>&rdquo;),
registered broker dealer and member of the Financial Industry Regulatory Authority (&ldquo;<I>FINRA</I>&rdquo;) and SIPC, and TAO Synergies
Inc., a publicly traded corporation duly organized under the laws of the State of Delaware (the &ldquo;<I>Company</I>&rdquo;), to act
as a non-exclusive placement agent (the &ldquo;<I>Placement Agent</I>&rdquo;) in connection with a </FONT>private placement of convertible
preferred stock and warrants to purchase common stock of the Company (, the &ldquo;<I>Offering</I>&rdquo;). The Offering is currently
anticipated to be an offering of shares of convertible preferred stock of the Company and warrants to purchase shares of common stock
of the Company (collectively, the &ldquo;<I>Securities</I>&rdquo;). The Company intends to raise up to Ten Million Dollars ($10,000,000)
(the &ldquo;<I>Maximum Offering Amount</I>&rdquo;) through the sale of the Securities. The Company reserves the right to increase the
Maximum Offering Amount at its sole discretion. Nothing herein implies that the Placement Agent would have the power or authority to bind
the Company or an obligation of the Company to issue any Securities or proceed with any proposed transaction. The Offering will be made
pursuant to the exemptions afforded by Section&nbsp;4(a)(2)&nbsp;of the Securities Act of 1933, as amended (the &ldquo;<I>Act</I>&rdquo;),
and Regulation D promulgated thereunder and applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt"><B>A.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>A<FONT STYLE="font-size: 10pt">PPOINTMENT
OF </FONT>GPN.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During the Term of this Agreement,
the Company hereby engages the Placement Agent to serve as a non-exclusive placement agent in connection with the Offering and the Placement
Agent hereby accepts such engagement on a &ldquo;reasonable best efforts&rdquo; basis upon the terms and conditions set forth herein.
GPN may offer the Securities through other broker-dealers who are FINRA members (collectively, the &ldquo;<I>Sub Agents</I>&rdquo;) and
may re-allow all or a portion of GPN&rsquo;s Broker Fees (as defined in Section&nbsp;B(a)&nbsp;and 3(b)&nbsp;below) it receives to such
other Sub Agents or pay a finders or consultant fee as allowed by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that GPN&rsquo;s engagement hereunder is not an agreement or commitment, express or implied, by GPN or any of its
affiliates to underwrite or purchase any securities or otherwise provide financing. The proposed Offering is to be made directly by
the Company to the investors pursuant to agreements entered between the investors and the Company. Purchases of Securities may be
made by the Placement Agent and its officers, directors, employees and affiliates and by the officers, directors, employees and
affiliates of the Company (collectively, the &ldquo;<I>Affiliates</I>&rdquo;) for the Offering and such purchases will be made by
the Affiliates based solely upon the same information that is provided to the investors in the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">B.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><B>F<FONT STYLE="font-size: 10pt">EES&nbsp;</FONT>&amp;
E<FONT STYLE="font-size: 10pt">XPENSES</FONT></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt"><B><I>(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</I></B></FONT><B><I>C<FONT STYLE="font-size: 10pt">ASH
</FONT>P<FONT STYLE="font-size: 10pt">ORTION</FONT></I>. </B>The Company hereby agrees to pay the Placement Agent (or the designees authorized
by such Placement Agent), as a condition to the applicable Closing(s)&nbsp;of the Offering, as compensation for their services hereunder,
a cash fee equal to Eight Percent (8.0%) of the gross proceeds from any sale of Securities in the Offering, including any cash proceeds
realized by the Company from the exercise of the Series&nbsp;E Warrants, payable in cash by wire transfer at the time of such Closing
(the &ldquo;<I>Placement Agent Fee</I>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B><I>(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;WARRANTS.
</I></B>The Company shall issue to the Placement Agent or its designees, as determined by Placement Agent, after the final closing of
the offering, warrants equal to Four Percent (4%) of the aggregate number of shares of common stock (or common stock equivalents) issuable
in such closing. The Warrants shall (i)&nbsp;be exercisable commencing on the date of issuance, at the Purchase Price, (ii)&nbsp;expire
five years after the date of issuance, and (iii)&nbsp;include the most favorable anti-dilution protection provisions contained in the
Company&rsquo;s current securities or included in any security issued during the term of the Warrants, include a cashless exercise provision,
customary registration rights, shall be non-redeemable, and shall otherwise be on terms and conditions satisfactory to Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt"><B><I>(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</I></B></FONT><B><I>E<FONT STYLE="font-size: 10pt">XPENSES</FONT>.
</I></B>In addition to the Broker Fee payable pursuant to Section&nbsp;B(a)&nbsp;and (b), the Company hereby agrees to pay GPN&rsquo;s
due diligence fees with the engagement hereunder in the amount of Ten Thousand Dollars ($10,000) (the &ldquo;<I>GPN DD Fee</I>&rdquo;).
Regardless of whether the Offering is consummated and if there is no Closing, the GPN DD Fee will be due and payable within five (5)&nbsp;days
of written request to the Company by wire transfer. The GPN DD Fee is separate and apart from the Placement Agent Fee and is in addition
to the reimbursement of fees and expenses set forth in Appendix I relating to indemnification and contribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">C.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><B>T<FONT STYLE="font-size: 10pt">ERM
AND </FONT>T<FONT STYLE="font-size: 10pt">ERMINATION OF </FONT>E<FONT STYLE="font-size: 10pt">NGAGEMENT</FONT></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth below,
the term of this Agreement begins on the date of this Agreement and shall end automatically upon the earlier to occur of (i)&nbsp;the
Closing of the Offering, (ii)&nbsp;the date of termination of the Offering or (iii)&nbsp;October&nbsp;15, 2025 (the &ldquo;<I>Term</I>&rdquo;).
Notwithstanding the Term of this Agreement, this Agreement may be earlier terminated immediately by the Company or the Placement Agent
in the event of either the Company&rsquo;s or the Placement Agent&rsquo;s failure to perform any of its material obligations hereunder
or fraud, illegal or willful misconduct or gross negligence. Notwithstanding any such expiration or termination, the terms of this Agreement
other than Paragraphs A, D, and E shall all remain in full force and effect and be binding on the parties hereto, including the exculpation,
indemnification and contribution obligations of the Company, the confidentiality obligations, and the right of the Placement Agent to
receive any earned but unpaid Placement Agent Fee hereunder and the right of the Placement Agent to receive reimbursement for the GPN
Legal Fee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">D.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><B>S<FONT STYLE="font-size: 10pt">UBSCRIPTION
AND </FONT>C<FONT STYLE="font-size: 10pt">LOSING </FONT>P<FONT STYLE="font-size: 10pt">ROCEDURES</FONT></B>. The Company shall cause
to be delivered to the Placement Agent copies of any offering documents (the &ldquo;<I>Offering Documents</I>&rdquo;) related to the
Offering and hereby consents to the use of such copies for the purposes permitted by the Securities Act and applicable securities
laws and in accordance with the terms and conditions of this Agreement, and hereby authorizes the Placement Agent and its agents and
employees to use the Offering Documents in connection with the sale of the Securities during the Term, and no person nor entity is
or will be authorized to give any information or make any representations other than those contained in the Offering Documents or to
use any offering materials other than the Offering Documents in connection with the sale of the Securities, unless the Company first
provides the Placement Agent with notification of such information, representations or offering materials. Each prospective investor
will be required to complete and execute the Offering Documents. The Offering will be made to no more than 5 institutional
accredited investors and the Company agrees to not accept any subscription funds until all of the closing conditions to the Offering
have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">E.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><B>R<FONT STYLE="font-size: 10pt">EPRESENTATIONS</FONT>,
W<FONT STYLE="font-size: 10pt">ARRANTIES AND </FONT>C<FONT STYLE="font-size: 10pt">OVENANTS</FONT></B>. The Company represents and warrants
to, and agrees with, the Placement Agent that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company represents and warrants that it has all requisite power and authority to enter into and carry out the terms and provisions of
this Agreement. The execution, delivery and performance of this Agreement and the Offering of Securities will not violate or conflict
with any provision of the charter or bylaws of the Company or, except as would not have a material adverse effect or has been otherwise
disclosed to the Placement Agent, any agreement or other instrument to which the Company is a party or by which it or any of its properties
is bound. Any necessary approvals, governmental and private, will be obtained by the Company prior to any Closing, except as may be waived
or obtained or filed following any Closing and except where the failure to obtain any such approval would not have a material adverse
effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Securities will be offered and sold by the Company in compliance with the requirements for the exemption from registration pursuant to
Section&nbsp;5 of the Securities Act (including any applicable exemption therefrom), and with all other securities laws and regulations.
The Company will file appropriate notices with the Securities and Exchange Commission and with other applicable securities authorities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
information in any investor presentation materials, memorandum or other offering documents furnished to investors in the Offering by the
Company is true and correct in all material respects and does not contain any untrue statement of a material fact or omit to state a material
fact required to be stated or necessary to make the statements therein not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company hereby permits the Placement Agent to rely on the representations and warranties made or given by the Company to any acquirer
of Securities in any agreement, certificate or otherwise in connection with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Company shall timely make or cause to be made any necessary state &ldquo;blue sky&rdquo; applications in Connecticut and other states
and jurisdictions as shall be required by law or requested by GPN in order to qualify the Common Stock for sale; provided, however, that
the Company shall not be required to qualify to do business in any such jurisdiction. It shall be the Company&rsquo;s obligation to bear
all blue-sky counsel fees and expenses. The Company shall provide copies of all such blue-sky filings to GPN.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">F.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><B>I<FONT STYLE="font-size: 10pt">NDEMNIFICATION
AND </FONT>C<FONT STYLE="font-size: 10pt">ONTRIBUTION</FONT></B>. The Company agrees to indemnify GPN and its controlling persons, representatives
and agents in accordance with the indemnification provisions set forth in <U>Appendix I</U>. These provisions will apply regardless of
whether any Offering is consummated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">G.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><B>L<FONT STYLE="font-size: 10pt">IMITATION
OF </FONT>E<FONT STYLE="font-size: 10pt">NGAGEMENT TO THE </FONT>C<FONT STYLE="font-size: 10pt">OMPANY</FONT></B>. The Company acknowledges
that GPN has been retained only by the Company, that GPN is providing services hereunder as an independent contractor (and not in any
fiduciary or agency capacity) and that the Company&rsquo;s engagement of GPN is not deemed to be on behalf of, and is not intended to
confer rights upon, any shareholder, owner or partner of the Company or any other person not a party hereto as against GPN or any of its
affiliates, or any of their respective officers, directors, controlling persons (within the meaning of Section&nbsp;15 of the Securities
Act or Section&nbsp;20 of the Securities Exchange Act of 1934, as amended (the &ldquo;<FONT STYLE="font-size: 10pt"><I>Exchange Act</I></FONT>&rdquo;),
employees or agents. Unless otherwise expressly agreed in writing by GPN, no one other than the Company is authorized to rely upon this
Agreement or any other statements or conduct of GPN, and no one other than the Company is intended to be a beneficiary of this Agreement.
The Company acknowledges that any recommendation or advice, written or oral, given by GPN to the Company in connection with GPN&rsquo;s
engagement is intended solely for the benefit and use of the Company&rsquo;s management and directors in considering a possible Offering,
and any such recommendation or advice is not on behalf of, and shall not confer any rights or remedies upon, any other person or be used
or relied upon for any other purpose. GPN shall not have the authority to make any commitment binding on the Company. The Company, in
its sole discretion, shall have the right to reject any investor introduced to it by GPN, or its respective designees or affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>H.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>L<FONT STYLE="font-size: 10pt">IMITATION
OF </FONT>P<FONT STYLE="font-size: 10pt">LACEMENT </FONT>A<FONT STYLE="font-size: 10pt">GENT</FONT>&rsquo;<FONT STYLE="font-size: 10pt">S
</FONT>L<FONT STYLE="font-size: 10pt">IABILITY TO THE </FONT>C<FONT STYLE="font-size: 10pt">OMPANY</FONT></B>. GPN shall not have any
liability to the Company for any Losses attributable to the gross negligence, intentional misrepresentation or willful misconduct of another
Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>I.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>G<FONT STYLE="font-size: 10pt">OVERNING
</FONT>L<FONT STYLE="font-size: 10pt">AW</FONT></B>. This Agreement shall be deemed to have been made and delivered in New York City and
shall be governed as to validity, interpretation, construction, effect and in all other respects by the internal laws of the State of
New York applicable to contracts to be wholly performed in said state.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>J.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>I<FONT STYLE="font-size: 10pt">NFORMATION</FONT>;
R<FONT STYLE="font-size: 10pt">ELIANCE</FONT></B>. The Company shall furnish, or cause to be furnished, to the Placement Agent all information
reasonably requested by the Placement Agent for the purpose of rendering services hereunder and shall further make available to the Placement
Agent all such information to the same extent and on the same terms as such information is available to the Company and potential lenders
and investors (all such information being the &ldquo;<FONT STYLE="font-size: 10pt"><I>Information</I></FONT>&rdquo;). The Company shall
notify the Placement Agent if it becomes aware of any material adverse change, or development that may lead to a material adverse change,
in the business, properties, operations or financial condition or prospects of the Company or any other material Information to the extent
needed to allow the Company and the Placement agent to assess whether any disclosure to investors, a delay of the date of the Closing,
or other any other appropriate step is required. In addition, the Company agrees to make available to the Placement Agent upon request
from time to time the officers, directors, accountants, counsel and other advisors of the Company. The Company recognizes and confirms
that the Placement Agent (a)&nbsp;will use and rely on the Information and Offering Documents and on information available from generally
recognized public sources in performing the services contemplated by this Agreement without having independently verified the same; (b)&nbsp;will
not assume responsibility for the accuracy or completeness of the Offering Documents or the Information and such other information, except
for any written information furnished to the Company by the Placement Agent specifically for inclusion in the Offering Documents; and
(c)&nbsp;will not make an appraisal of any of the assets or liabilities of the Company. Upon reasonable request, the Company will meet
with the Placement Agent or its representatives to discuss all information relevant for disclosure in the Offering Documents and will
cooperate in any investigation undertaken by the Placement Agent thereof, including any document included therein. At each Closing, at
the request of the Placement Agent, the Company shall deliver copies of such officer&rsquo;s certificates, in form and substance reasonably
satisfactory to the Placement Agent and its counsel as is customary for such Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>K.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>U<FONT STYLE="font-size: 10pt">SE
OF </FONT>I<FONT STYLE="font-size: 10pt">NFORMATION</FONT></B>. The Company authorizes the Placement Agent to transmit to the prospective
investors of Securities the Company&rsquo;s power point presentation prepared by the Company (the &ldquo;<FONT STYLE="font-size: 10pt"><I>Presentation
Materials</I></FONT>&rdquo;). The Company represents and warrants that the Presentation Materials (i)&nbsp;will be prepared by the management
of the Company; and (ii)&nbsp;will not contain any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not misleading. The Company will advise the Placement Agent promptly if it
becomes aware of the occurrence of any event or any other change known to the Company which results in the Presentation Materials containing
an untrue statement of a material fact or omitting to state a material fact required to be stated therein or necessary to make the statements
therein or previously made, in light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, if
any Placement Agent elects to not transmit Presentation Materials to prospective investors, such Placement Agent shall direct qualified
prospective investors to an electronic data room in which the Company makes available the Presentation Materials for review by qualified
prospective investors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>L.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>A<FONT STYLE="font-size: 10pt">NNOUNCEMENT
OF </FONT>T<FONT STYLE="font-size: 10pt">RANSACTION</FONT>. </B>The Company and the Placement Agent acknowledge and agree that GPN may,
subsequent to the Closing of the Offering and to the extent GPN receives a Placement Agent Fee for Securities sold in the Offering, make
public its involvement with the Company provided that any such public announcement or other public disclosure (other than customary tombstone
presentations or other investment banking presentation materials containing only publicly available information) shall be approved by
the Company, which approval shall not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>M.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>A<FONT STYLE="font-size: 10pt">DVICE
TO THE </FONT>B<FONT STYLE="font-size: 10pt">OARD</FONT></B>. The Company acknowledges that any advice given by the Placement Agent to
the Company is solely for the benefit and use of the Company&rsquo;s board of directors and officers, who will make all decisions regarding
whether and how to pursue any opportunity or transaction. The Company&rsquo;s board of directors and senior management may consider the
Placement Agent&rsquo;s advice but will base their decisions on the advice of legal, tax and other business advisors and other factors
which they consider appropriate. Accordingly, as an independent contractor, GPN will not assume the responsibilities of a fiduciary to
the Company or its stockholders in connection with the performance of its services. Any advice provided may not be used, reproduced, disseminated,
quoted or referred to without the Placement Agent&rsquo;s prior written consent. GPN does not provide accounting, tax, or legal advice.
GPN is not responsible for the success of any Offering. The Company is a sophisticated business enterprise that has retained the Placement
Agent for the limited purposes set forth in this Agreement. The parties acknowledge and agree that their respective rights and obligations
are contractual in nature. Each party disclaims an intention to impose fiduciary obligations on the other by virtue of the engagement
contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>N.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>E<FONT STYLE="font-size: 10pt">NTIRE
</FONT>A<FONT STYLE="font-size: 10pt">GREEMENT</FONT></B>. This Agreement was drafted by the Company and the Placement Agent&rsquo;s respective
counsels and constitutes the entire Agreement between the parties and supersedes and cancels any and all prior or contemporaneous arrangements,
understandings and agreements, written or oral, between them relating to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>O.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>A<FONT STYLE="font-size: 10pt">MENDMENT</FONT></B>.
This Agreement may not be modified except in writing signed by each of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>P.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>N<FONT STYLE="font-size: 10pt">O
</FONT>P<FONT STYLE="font-size: 10pt">ARTNERSHIP</FONT></B>. The Company is a sophisticated business enterprise that has retained the
Placement Agent for the limited purposes set forth in this Agreement. The parties acknowledge and agree that their respective rights and
obligations are contractual in nature. Each party disclaims an intention to impose fiduciary obligations on the other by virtue of the
engagement contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>Q.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>N<FONT STYLE="font-size: 10pt">OTICE</FONT></B>.
All notices and other communications required hereunder shall be in writing and shall be deemed effectively given to a party by (a)&nbsp;personal
delivery; (b)&nbsp;upon deposit with the United States Post Office, by certified mail, return receipt requested, first- class mail, postage
prepaid; (c)&nbsp;delivered by hand or by messenger or overnight courier, addressee signature required, to the addresses below or at such
other address and/or to such other persons as shall have been furnished by the parties;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left"><FONT STYLE="font-size: 10pt">If to the Company:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 70%; text-align: left"><FONT STYLE="font-size: 10pt">TAO Synergies Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">1185 Avenue of the Americas
    3rd Floor</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">New York, NY 10036</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">If to GP Nurmenkari Inc.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">GPN Nurmenkari Inc.,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Attn: Compliance</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">22 Elizabeth Street, Suite
    1J</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Norwalk, CT 06854</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 10pt">Email: Compliance@GPnurmenkari.com</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>R.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>S<FONT STYLE="font-size: 10pt">EVERABILITY</FONT></B>.
If any term, provision, covenant or restriction herein is held by a court of competent jurisdiction to be invalid, void or unenforceable
or against public policy, the remainder of the terms, provisions and restrictions contained herein will remain in full force and effect
and will in no way be affected, impaired or invalidated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>S.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>G<FONT STYLE="font-size: 10pt">OVERNING
</FONT>L<FONT STYLE="font-size: 10pt">AW AND </FONT>J<FONT STYLE="font-size: 10pt">URISDICTION</FONT></B>. This Agreement shall be deemed
to have been made and delivered in New York City and shall be governed as to validity, interpretation, construction, effect and in all
other respects by the internal laws of the State of New York without regard to principles of conflicts of law thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THE PARTIES HERETO AGREE
TO SUBMIT ALL CONTROVERSIES TO THE EXCLUSIVE JURISDICTION OF FINRA ARBITRATION IN ACCORDANCE WITH THE PROVISIONS SET FORTH BELOW AND UNDERSTAND
THAT (A)&nbsp;ARBITRATION IS FINAL AND BINDING ON THE PARTIES, (B)&nbsp;THE PARTIES ARE WAIVING THEIR RIGHTS TO SEEK REMEDIES IN COURT,&nbsp;INCLUDING
THE RIGHT TO A JURY TRIAL, (C)&nbsp;PRE-ARBITRATION DISCOVERY IS GENERALLY MORE LIMITED AND DIFFERENT FROM COURT PROCEEDINGS, (D)&nbsp;THE
ARBITRATOR&rsquo;S AWARD IS NOT REQUIRED TO INCLUDE FACTUAL FINDINGS OR LEGAL REASONING AND ANY PARTY&rsquo;S RIGHT TO APPEAL OR TO SEEK
MODIFICATION OF RULES BY ARBITRATORS IS STRICTLY LIMITED, (E)&nbsp;THE PANEL OF FINRA ARBITRATORS WILL TYPICALLY INCLUDE A MINORITY OF
ARBITRATORS WHO WERE OR ARE AFFILIATED WITH THE SECURITIES INDUSTRY, AND (F)&nbsp;ALL CONTROVERSIES WHICH MAY&nbsp;ARISE BETWEEN THE PARTIES
CONCERNING THIS AGREEMENT SHALL BE DETERMINED BY ARBITRATION PURSUANT TO THE RULES THEN PERTAINING TO FINRA. ALL QUESTIONS CONCERNING
THE CONSTRUCTION, VALIDITY, ENFORCEMENT AND INTERPRETATION OF THIS AGREEMENT SHALL BE GOVERNED BY ANDCONSTRUED AND ENFORCED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK. JUDGMENT ON ANY AWARD OF ANY SUCH ARBITRATION MAY&nbsp;BE ENTERED IN THE SUPREME COURT OF THE
STATE OF NEW YORK OR IN ANY OTHER COURT HAVING JURISDICTION OVER THE PERSON OR PERSONS AGAINST WHOM SUCH AWARD IS RENDERED. THE PARTIES
AGREE THAT THE DETERMINATION OF THE ARBITRATORS SHALL BE BINDING AND CONCLUSIVE UPON THEM. THE PREVAILING PARTY, AS DETERMINED BY SUCH
ARBITRATORS,&nbsp;IN A LEGAL PROCEEDING SHALL BE ENTITLED TO COLLECT ANY COSTS, DISBURSEMENTS AND REASONABLE ATTORNEY&rsquo;S FEES FROM
THE OTHER PARTY. PRIOR TO FILING AN ARBITRATION, THE PARTIES HEREBY AGREE THAT THEY WILL ATTEMPT TO RESOLVE THEIR DIFFERENCES FIRST BY
SUBMITTING THE MATTER FOR RESOLUTION TO A MEDIATOR, ACCEPTABLE TO ALL PARTIES, AND WHOSE EXPENSES WILL BE BORNE EQUALLY BY ALL PARTIES.
THE MEDIATION WILL BE HELD IN THE COUNTY OF NEW YORK, STATE OF NEW YORK, ON AN EXPEDITED BASIS. IF THE PARTIES CANNOT SUCCESSFULLY RESOLVE
THEIR DIFFERENCES THROUGH MEDIATION, THE MATTER WILL BE RESOLVED BY ARBITRATION. THE ARBITRATION SHALL TAKE PLACE IN THE COUNTY OF NEW
YORK, THE STATE OF NEW YORK, ON AN EXPEDITED BASIS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>T.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>O<FONT STYLE="font-size: 10pt">THER
</FONT>I<FONT STYLE="font-size: 10pt">NVESTMENT </FONT>B<FONT STYLE="font-size: 10pt">ANKING </FONT>S<FONT STYLE="font-size: 10pt">ERVICES</FONT></B>.
The Company acknowledges that GPN and its affiliates are securities firms engaged in securities trading and brokerage activities and providing
investment banking and financial advisory services. In the ordinary course of business, the Placement Agent and its affiliates, registered
representatives and employees may at any time hold long or short positions, and may trade or otherwise effect transactions, for their
own account or the accounts of customers, in the Company&rsquo;s debt or equity securities, the Company&rsquo;s affiliates or other entities
that may be involved in the transactions contemplated by this Agreement. In addition, the Placement Agent and its affiliates may from
time to time perform various investment banking and financial advisory services for other clients and customers who may have conflicting
interests with respect to the Company or an Offering. The Company also acknowledges that the Placement Agent and its affiliates have no
obligation to use in connection with this engagement or to furnish to the Company, confidential information obtained from other companies.
Furthermore, the Company acknowledges the Placement Agent may have fiduciary or other relationships whereby the Placement Agent or its
affiliates may exercise voting power over securities of various persons, which securities may from time to time include securities of
the Company or others with interests in respect of any Offering. The Company acknowledges that the Placement Agent or such affiliates
may exercise such powers and otherwise perform their functions in connection with such fiduciary or other relationships without regard
to the defined relationship to the Company hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B>U.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>M<FONT STYLE="font-size: 10pt">ISCELLANEOUS</FONT></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>This
Agreement shall be binding upon and inure to the benefit of the Placement Agent and the Company and their respective assigns, successors,
and legal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>This
Agreement may be executed in counterparts (including facsimile or in pdf format counterparts), each of which shall be deemed an original
but all of which together shall constitute one and the same instrument.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notwithstanding
anything herein to the contrary, in the event that the Placement Agent determines that any of the terms provided for hereunder shall not
comply with a FINRA rule, including but not limited to FINRA Rule&nbsp;5110, then the Company shall agree to amend this Agreement in writing
upon the request of the Placement Agent to comply with any such rules; provided that any such amendments shall not provide for terms that
are less favorable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt"><B>V.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>C<FONT STYLE="font-size: 10pt">ONFIDENTIALITY</FONT>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
Placement Agent will maintain the confidentiality of the Information and, unless and until such Information shall have been made publicly
available by the Company or by others without breach of a confidentiality agreement, shall disclose the Information only as provided for
herein, authorized by the Company or as required by law or by request of a governmental authority, FINRA or court of competent jurisdiction.
In the event the Placement Agent is legally required to make disclosure of any of the Information, the Placement Agent will give prompt
notice to the Company prior to such disclosure, to the extent the Placement Agent can practically do so.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>The
foregoing paragraph shall not apply to information that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i) </FONT>at
the time of disclosure by the Company, is or thereafter becomes, generally available to the public or within the industries in which
the Company conducts business, other than as a result of a breach by the Placement Agent of its obligations under this Agreement;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii) </FONT>prior
to or at the time of disclosure by the Company, was already in the possession of, the Placement Agent or any of its affiliates, or
could have been developed by them from information then lawfully in their possession, by the application of other information or
techniques in their possession, generally available to the public; at the time of disclosure by the Company thereafter, is obtained
by the Placement Agent or any of its affiliates from a third party who the Placement Agent reasonably believes to be in possession
of the information not in violation of any contractual, legal or fiduciary obligation to the Company with respect to that
information; or is independently developed by the Placement Agent or its affiliates. The exclusions set forth in sub-section
(b)&nbsp;above shall not apply to pro forma financial information of the Company, which pro forma Information shall in all events be
subject to sub- section (a)&nbsp;above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;Nothing in this
Agreement shall be construed to limit the ability of the Placement Agent or its affiliates to pursue, investigate, analyze, invest
in, or engage in investment banking, financial advisory or any other business relationship with entities other than the Company,
notwithstanding that such entities may be engaged in a business which is similar to or competitive with the business of the Company,
and notwithstanding that such entities may have actual or potential operations, products, services, plans, ideas, customers or
supplies similar or identical to the Company&rsquo;s, or may have been identified by the Company as potential merger or acquisition
targets or potential candidates for some other business combination, cooperation or relationship. The Company expressly acknowledges
and agrees that it does not claim any proprietary interest in the identity of any other entity in its industry or otherwise, and
that the identity of any such entity is not confidential information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt"><B>W.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</B></FONT><B>N<FONT STYLE="font-size: 10pt">O
</FONT>D<FONT STYLE="font-size: 10pt">ISQUALIFICATION </FONT>E<FONT STYLE="font-size: 10pt">VENTS</FONT>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(a) The Company represents and warrants the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(i) </FONT>None
of Company, any director, executive officer, other officer of the Company participating in the Offering, any beneficial owner of 20%
or more of the Company&rsquo;s outstanding voting equity securities, calculated on the basis of voting power, nor any promoter (as
that term is defined in Rule&nbsp;405 under the Securities Act) connected with the Company in any capacity at the time of sale
(each, an &ldquo;<I>Issuer Covered Person</I>&rdquo; and, together, &ldquo;<I>Issuer Covered Persons</I>&rdquo;) is subject to any
Disqualification Event (as defined below), except for a Disqualification Event covered by Rule&nbsp;506(d)(2)&nbsp;or (d)(3)&nbsp;or
has been involved in any matter which would be a Disqualification Event except for the fact that it occurred before
September&nbsp;23, 2013. The Company has exercised reasonable care to determine whether any Covered Person is subject to a
Disqualification Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule&nbsp;506(e),
and has furnished to the Placement Agent a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii) </FONT>The
Company will promptly notify GPN in writing if the Company becomes aware of (A)&nbsp;any Disqualification Event relating to any
Issuer Covered Person and (B)&nbsp;any event that would, with the passage of time, become a Disqualification Event relating to any
Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii)
T</FONT>he Company is aware that other persons (other that any Issuer Covered Persons and the Placement Agent Covered Person (as
defined below) will be paid (directly or indirectly) remuneration for solicitation of investors in connection with the sale of any
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(b) The Placement Agent represents and warrants the
following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) No Disqualification
Events. Neither it, nor to its knowledge any of its directors, executive officers, general partners, managing members or other officers
participating in the Offering (each, a &ldquo;<I>Placement Agent Covered Person</I>&rdquo; and, together, &ldquo;<I>Placement Agent Covered
Persons</I>&rdquo;), is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications currently described in Rule</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">506(d)(1)(i)&nbsp;to
(viii)&nbsp;under the Securities Act (a &ldquo;<I>Disqualification Event</I></FONT>&rdquo;) or has been involved in any matter which would
be a Disqualification Event except for the fact that it occurred before September&nbsp;23, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(ii) </FONT>Other
Covered Persons. The Placement Agent is aware that other persons (other than any Issuer Covered Person or Placement Agent Covered
Person) will be paid (directly or indirectly) remuneration for solicitation of investors in connection with the sale of any
Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">(iii) </FONT>Notice
of Disqualification Events. The Placement Agent will notify the Company promptly in writing upon the Placement Agent learning of
(A)&nbsp;any Disqualification Event relating to any Placement Agent Covered Person not previously disclosed to the Company in
accordance with the provisions of this Section&nbsp;and (B)&nbsp;any event that would, with the passage of time, become a
Disqualification Event relating to any Placement Agent Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page&nbsp;Follows]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In acknowledgment that the
foregoing correctly sets forth the understanding reached by the Placement Agent and the Company, please sign in the space provided below,
whereupon this letter shall constitute a binding Agreement as of the date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>This Agreement contains a pre-dispute arbitration provision
in Paragraph S.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">TAO Synergies Inc.,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-size: 10pt">/s/
Joshua Silverman</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Joshua Silverman</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Executive Chairman</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">GP NURMENKARI INC</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Albert Pezone</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Name: Albert Pezone</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>APPENDIX I</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEMNIFICATION AND CONTRIBUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company agrees to indemnify
and hold harmless the Placement Agent, its affiliates, officers, directors, employees, agents and controlling persons (each an &ldquo;<I>Indemnified
Person</I>&rdquo;) from and against any and all losses, claims, damages, liabilities and expenses, to which any such Indemnified Person
may become subject arising out of or in connection with the transactions contemplated in the Agreement to which this <U>Appendix I</U>
is attached (the &ldquo;<I>Agreement</I>&rdquo;), insofar as such loss, claim, damage, liability or expense arises out of or is based
upon any untrue statement of a material fact or omission to state a material fact in Offering Documents required to be stated therein
or necessary to make the statements therein not misleading in any litigation, investigation or proceeding (collectively, the &ldquo;<I>Proceedings</I>&rdquo;),
regardless of whether any of such Indemnified Person is a party to the Agreement, and to reimburse such Indemnified Persons for any reasonable
and documented legal or other expenses as they are incurred in connection with investigating, responding to or defending against in any
Proceeding, provided that the foregoing indemnification will not, as to any Indemnified Person, apply to losses, claims, damages, liabilities
or expenses to the extent that they are finally judicially determined to have resulted primarily and directly from the fraud, gross negligence
or willful misconduct of an Indemnified Person; and provided, further, that the foregoing indemnification will not apply to any loss,
claim, damage, liability or expense arising out of or based upon any written information furnished to the Company by the Placement Agent
specifically for inclusion in the Offering Documents; provided further that the Company shall only have the obligation to reimburse an
Indemnified Person if such Indemnified Person provides to the Company a written undertaking of such Indemnified Person to repay to the
Company the amount so advanced to the extent that any such reimbursement is so held to have been improper in a final judgment by a court
of competent jurisdiction, and if the court of competent jurisdiction holds that such reimbursement was improper, such Indemnified Person
shall promptly return any amount advanced to it by the Company. The Company also agrees that no Indemnified Person shall have any liability
(whether direct or indirect, in contract, tort or otherwise) to the Company its affiliates, officers, directors employees, agents, creditors
or stockholders, directly or indirectly, for or in connection with the Agreement, any transactions contemplated in the Agreement, or the
Placement Agent&rsquo;s role or services in connection with the Agreement, except to the extent that any liability for losses, claims,
demands, damages, liabilities or expenses incurred by the Company are finally judicially determined to have resulted primarily from the
fraud, gross negligence or willful misconduct of such Indemnified Person or have resulted from any written information furnished to the
Company by the Placements Agent specifically for inclusion in the Offering Documents. The Company will be liable to pay the legal fees,
expenses and costs incurred by GPN&rsquo;s legal team related to any lawsuit but will not be obligated to pay the legal fees of a sub
dealer brought in by GPN if named in the lawsuit, unless agreed to by the Company. If the Company engages additional Placement Agents
in addition to GPN, then the Company will be liable for those Placement Agents&rsquo; legal fees, expenses and costs separate and apart
to the legal fees, expenses and costs incurred by and due GPN&rsquo;s legal team.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If for any reason the
foregoing indemnification is unavailable to any Indemnified Person or insufficient to hold it harmless, then the Company and the
Placement Agent in accordance with the contributions provisions herein, shall contribute to the amount paid or payable by such
Indemnified Person as a result of such loss, claim, damage, liability or expense in such proportion as is appropriate to reflect not
only the relative benefits received by the Company on the one hand and GPN on the other hand, but also the relative fault of the
Company and GPN, as well as any relevant equitable considerations; provided that, in no event, will the aggregate contribution of
GPN hereunder exceed the amount of fees actually received by GPN pursuant to this Agreement and in no event will the aggregate
contribution of the Company hereunder exceed the amount of proceeds received by the Company through the sale of Securities in the
Offering to investors first contacted by GPN. Notwithstanding the foregoing, no person found guilty of fraudulent misrepresentation
(within the meaning of Section&nbsp;11(f)&nbsp;of the Securities Act) shall be entitled to contribution from any person who was not
guilty of such fraudulent misrepresentation. The indemnity, reimbursement and contribution obligations of the Company under this
Agreement will bind and inure to the benefit of any successors, assigns, heirs and personal representatives of the Company and any
Indemnified Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Promptly after receipt by
an Indemnified Person of notice of the commencement of any Proceedings, that Indemnified Person will, if a claim is to be made under this
indemnity agreement against the Company in respect of the Proceedings, notify the Company in writing of the commencement of the Proceedings;
provided that (i)&nbsp;the omission so to notify the Company will not relieve the Company from any liability that the Company may have
under this indemnity agreement except to the extent the Company has been materially prejudiced by such omission, and (ii)&nbsp;the omission
to so notify the Company will not relieve the Company from any liability that the Company may have to an Indemnified Person otherwise
than on account of this indemnity agreement. In case any Proceedings are brought against any Indemnified Person and it notifies the Company
of the commencement of the Proceedings, the Company will be entitled to participate in the Proceedings and, to the extent that it may
elect by written notice delivered to the Indemnified Person, to assume the defense of the Proceedings with counsel reasonably satisfactory
to the Indemnified Person; provided that, if the defendants in any Proceedings include both the Indemnified Person and the Company and
the Indemnified Person concludes that there may be legal defenses available to the Indemnified Person that are different from or in addition
to those available to the Company, the Indemnified Person has the right to select separate counsel to assert those legal defenses and
to otherwise participate in the defense of the Proceedings on its behalf at its sole expense. Upon receipt of notice from the Company
to the Indemnified Person of its election to assume the defense of the Proceedings, the Company will not be liable to the Indemnified
Person for expenses incurred by the Indemnified Person in connection with the defense of the Proceedings (other than reasonable costs
of investigation) unless the Company authorizes, in writing, the employment of counsel for the Indemnified Person and expressly agrees
in writing to be liable for the reasonable expenses of such legal counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will not be liable
for any settlement of any Proceedings effected without its written consent (which consent must not be unreasonably withheld), but if settled
with the Company&rsquo;s written consent or if a final judgment for the plaintiff in any such Proceedings is delivered, the Company agrees
to indemnify and hold harmless each Indemnified Person from and against any and all losses, claims, damages, liabilities and expenses
by reason of such settlement or judgment. The Company may not, without the prior written consent of an Indemnified Person (which consent
shall not be unreasonably withheld), effect any settlement of any pending or threatened Proceedings in respect of which indemnity could
have been sought under this indemnity agreement by such Indemnified Person unless the settlement includes an unconditional release of
the Indemnified Person, in form and substance reasonably satisfactory to the Indemnified Person, from all liability on claims that are
the subject matter of such Proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s reimbursement,
indemnity and contribution obligations hereunder will be in addition to any liability that it may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Capitalized terms used but not defined in this
<U>Appendix I</U> have the meanings assigned to such terms in the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>tm2528153d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TAO Synergies Announces $11 Million Private
Placement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Financing supported by existing stockholders,
TAO Strategy Advisor James Altucher, and new investor DCG</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NEW YORK,&nbsp;Oct. 13, 2025&nbsp;-- TAO Synergies Inc. (Nasdaq:&nbsp;<B>TAOX</B>)
(the &ldquo;Company&rdquo;), a&nbsp;digital asset&nbsp;treasury company focused on Bittensor (TAO), the premier&nbsp;cryptotoken&nbsp;for&nbsp;decentralized&nbsp;artificial
intelligence (DeAI), today announced that it has entered into a securities purchase agreement with existing investors, James Altucher
and a new investor, DCG, for a $11 million financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;TAO Synergies&rsquo; latest financing further supports its continuing
strategic investments not only in TAO tokens, but also in potential opportunities to earn revenue and accrue additional TAO within the
Bittensor ecosystem,&rdquo; said James Altucher. &ldquo;We are pleased to welcome our new strategic investor DCG, a leader in the&nbsp;cryptocurrency&nbsp;and
blockchain industry and a major investor and incubator in the Bittensor ecosystem. We have strong conviction in Bittensor&rsquo;s vision
for&nbsp;decentralized&nbsp;intelligence and believe its network model will be a key driver of innovation and value creation in the years
ahead.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The financing involves the sale of 11,000 shares of the Company&rsquo;s
newly issued Series E convertible preferred stock (&ldquo;preferred stock&rdquo;), with a stated value of $1,000 per share which is convertible
into shares of the Company&rsquo;s common stock, and associated five-year common stock purchase warrants, in a private placement priced
above the five-day trailing average price. The shares of Series E preferred stock have a conversion price of $8.00 per share. The warrants
have an exercise price of&nbsp;$8.00&nbsp;per common share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">The transaction is expected to close on or about October 15, 2025,
subject to the satisfaction of customary closing conditions.</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The securities described
above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Act&rdquo;) and
Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants sold in the offering, have not
been registered under the Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United
States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only
to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements
with the SEC covering the resale of the unregistered securities to be issued in the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This press release shall
not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities
in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under
the securities laws of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About TAO Synergies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">TAO Synergies Inc. is the first pure-play
public company focused on the convergence between&nbsp;cryptocurrency&nbsp;and artificial intelligence.&nbsp; The Company&rsquo;s
differentiated&nbsp;cryptocurrency&nbsp;treasury strategy is centered exclusively on the acquisition of TAO, the native
cryptocurrency of&nbsp;<U>Bittensor</U>, a&nbsp;decentralized&nbsp;blockchain network for machine learning and AI. TAO Synergies
Inc. seeks to stake TAO for revenue generation and capital appreciation, a strategy that underscores its mission to create
significant value for shareholders. Visit <U>The Tao Daily</U>, a comprehensive media, news, and insight platform dedicated to
Bittensor (TAO) and the TAO ecosystem, and <U>taosynergies.com</U> for more information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Such forward-looking statements are subject to risks and uncertainties and
other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may
differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. These and other
factors are identified and described in more detail in the Company&rsquo;s filings with the Securities and Exchange Commission. The Company
does not undertake to update these forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contact<BR>
</B>800-811-5591<BR>
<U>ir@taosynergies.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>snpx-20251013.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaCN+bOdzZR+eYkxtmB4bZnaPyUiirp6uC1p9NiG8RYM -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:snpx="http://synaptogen.com/20251013" elementFormDefault="qualified" targetNamespace="http://synaptogen.com/20251013">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://synaptogen.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="snpx-20251013_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="snpx-20251013_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>snpx-20251013_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>snpx-20251013_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="snpx-20251013.xsd#Cover" roleURI="http://synaptogen.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://synaptogen.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Oct. 13, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 13,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TAO Synergies Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001571934<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">48-1585656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1185
    Avenue of the Americas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">3rd
    Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10036<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">242-0005<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TAOX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2528153d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synaptogen.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>snpx-20251013.xsd</File>
    <File>snpx-20251013_lab.xml</File>
    <File>snpx-20251013_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2528153d1_8k.htm">tm2528153d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2528153d1_8k.htm": {
   "nsprefix": "snpx",
   "nsuri": "http://synaptogen.com/20251013",
   "dts": {
    "schema": {
     "local": [
      "snpx-20251013.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "snpx-20251013_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "snpx-20251013_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2528153d1_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://synaptogen.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-10-13",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2528153d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-10-13",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2528153d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://synaptogen.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-25-098909-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-098909-xbrl.zip
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M%B9>WRL94^JF3_3V; ,D1, *H"%!S$]?A +G<8%,4[>92,9/X[D5K>\RD[_
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MA^O#?.>%Y]@]6 =W< P*#[2>D\WRD[V/K>-OS8!=-%?!\K&X<1JF%\+O$6#
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M@-]!Q&T5;\O8';C& \BPTPB<,UZ>VH_A6-4=T@A7XX!CI<_00V[ $7 T%E$
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MGC#^()?0&2TV70-7+_U:N]G#WUY5C8"KT'RW:>@P 9W#BRS*;6@$X<T[:PS
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M"L2]1:<^1/L,]IT'H4XGS^T#02Y6M*Z8.B1)&Z+,.:KAA=(5SA$BFDB@.9@
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MP4XGG#(#ETCB#%)4+XEOQ*5^U.[/<5F2+SYE2>Y>EJ32P,BSIE[!?NX[4V?
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M3XPF(:,)^[7_C?%QY3EDF7YFYFY '2FAXO/=O*O LVFU=,U)Y)#^)$"D[&5
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M-TA/U8^7[.RUWKF'W8 OBCJ]-RL1[,K'Q;$ZO(=!!)%7$2&"QA! '$M;A/C
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MRM1?2/4XHRJ[_;S7$C*Y'><U3/K5OLWHGRDV@]L\M]@C"@NO7?=@V+>D<)J
M1],RK;N6/SHJ+P&17V!4! [6YK>3@#CH<I,5SDAQ9>1';"B<YWBB0XEDYU;F
MBMV;OKK'?,ICLR6-Q[3;:@^R[:)LO=8=9V'E8:%-<5P_:(5.L=!#U[K4V" +
M5-HE8A=O06KVS88OUC9AZ)-+QZC@.-6^[Y72J[HKU$OX9?\XDVA35\ANZUU1
M2AK9$5' '4AF"!N_%'YWS4' N1A1XC VQ.8EH1;Y08*&8,2X&ZM!3B*N&<?)
M+G98T]ZDD*#+AMZ(=&S027U/=89-T>+FD"B^C[@)I]0XD2*>YNV0&=^]=!1*
MC>JK3,<W,K8M69S 3RTI9@0NW%N\%=()J5,_* PW3Q<:FJ44*WW0Z(*>=5R+
ME1Z((YK'0-I(^.+#K)M.2.$'01AYLJ=J<R5IWN/S!&Q5'7,\?<2!M>/2W0\?
M?,IW_Y[Y[G]GM+2C:&G(XH [GMLZ/5/KXX.*2]EO5^5YO+&/A#F_F;6?_6IC
MG_3&;V-/26;"U((HC#B=0?;OP4UI0J2AZ#B"^]D"7?E<S"#!1^/33C!5ZKI&
M'GSFL&!O7F)]MJ^$$%Y]XEX:+3!BQT^WP:_V;8AGZT.<&W:T]A<\YSP#X83F
M8TL4.0<A"WY]$^RWJ Z,5L#4D!*?-#^T"XI0<(*/*&CAQBKCBX#I\:L/VGD'
MWHI0V65+I="@+7PLW'$_:AW6J'TGN?]<2Z*0E>/H<ILTPP_V")2W^28[ 0O:
M6Q=V^,;&T(T@&6E#\X-!U^7.]R=!OIZ"^%R,-,%T"VBZMKG&**;40R"XF$C,
M[:ZF&*GX;\R;A7L6/MTP"PF91QJL=[U<MRW7;WG<A\U\)N+$R /G \7R^GSX
M2BR\[="*YC=/],]!=L59T%2*T ':L;'CSJ[,H=OLL>=]L9=G!Y8V:477N\*T
M&2.DF:+>9FUMTM=/8FZJP98[#O[+R(;,3$S6R88=ZQ)$:(!A!N*LT8Y,84<4
MHSYR@F3'BR@ZA7U-T5UT,ZR3G\/O=JT@"1)WQ*.J>5Y[TZXQ][6^4DK>C53F
M*0V@Q:R0(CX;[EE8$Q#M4N"L+29-#L6T.N+(C*I=RG<@^A=3'S8]+=)31HY^
MD0I[9@%EZX%(A.TJ42DME;68O2WO(>D3PXHN-::=2V<$Y_ $V4?0WT34"EZN
MG7'(44&HA/>YNG*]9D &,K'QJV/Y.?JY3A;*WB92$_RA:@9N.;>IG":44EX-
M5T@LB^ZF[X7;_ 4O!$H((H&S.T!&0'X[G%"!6:?ZK7@)&V\./+EI+NX!U?.B
MX;8!O6O@"I^M$76TJE"*F5[?(C)@_-\GA%]$<0SWV*$L9F(S!A#1>\_A@:SK
M^>0@7,0C)+TW16>59BZPV-B$R(@@AI@K<6DM_9?;HLS^)=3V[GDSVF0_5K!!
M*)'5.-:JQ,8+,'[, "O<V:(P96?-"%GF.NVR^LBS>!N*6I'DX77=.7R=G%8W
M!.4%4)6 VU,"QAC,27<8'AP$ :W\,%-'6:?H=6AAJ: DS]5:QV&LJ)&.9)ZY
M_GV%LO.8E?]>5E[B63>S,(,\')C5RJ*'D9)!A(3.<.$*0P.<GZ$=&MT8] I%
M[Q8ETAA#(T<VOQ* >K2E;9E'!@1_*C>N5B*Q*J*$=\5K+=/&.8M(+R?)Z2I_
MS)OH@LN-7'LYAJY0<3GE,XG^G'8.I24U&D6#++T\<G?.?(<Z_YD&5"EQ2VBU
M#E--%VBU-$)43(:Y#V6:K)/T+]";N/X*KB3$T26;OG9C(V#Z4 26$6M;LY;)
M(Q-VIBV9,^K '&F4CS[V<BLWO2<W_4?0QWI$M,FDHT'P;,'"=-#MT-0IVGG5
M:]S0\S.@[D#-*MX$(DQU'W-$15)<?8*50_VA70O_I'87"TQF%>U2HK[I<C-0
MMZM[AE8C@-*2^;S$RE;)?!\#- <1@P8,-4?AK< 96#H>B8JFT3A%'S.2^(MO
M&9%69X8&XI#,OFTPPW!!CA":>P$'ND(#JR9>QTA,5=I>5LH5A0D!#TM^-/,+
M[I*&AANRM"4AX+ZV>E]PI+.!#E17>%X9[.'JWA_^E<K>G]W/_@P*N'_R\,N'
M7].<&!+*#LNE>?E)$SEP)B9_<,.I6%V[?1\1([DK^LN8"TFHMI5A1R+(TJQG
MWY9R)ZHWFS&@J>7]'QT:7^C$[4VB[9?OC2[1>6*7)FM<L8>'";=^D8Y./\;\
M*_*3T2B>:S:<BF49U P_EL(B2!249VF>%:97P?]B:$7:7=)XKP6)6J3K4C]B
MD7UDN/SAIW#YW2L/VTF@7$RK1)?GO>Q4!*C$'TN/"?HG&S_82>*B)L2=Y[A'
M0P9].+&(U-)A0ZEQ:4[PVM\K#;20X&B\E!K!U<5%F8B]*9&Y]M?8MCMN=8'^
M#16L2-.7_C+(K#KNW#YZ[Z%4PQ<66;\_<9#BER).-/ M=IUP3%4Z[^RTXK;J
MT+L@<6G\VP&=E:^MV/<\!F<D6=XKCS#P!-4@J&&'X4L[9S0QPD)3T64M807W
M5?G+MFH=DQ1753M'WUU%=3 FA,1;AA:62(E\?Q[F(H.![,J0[A!M=?BJXV;4
MT\GUL3GNCU<*W^K87G$U@-HU\+88#'PRG3SE:HWL#2(SZ#1_(A3Y?X=0));;
MB:X65\9Y/= <,"R-)\96:WU=PUG&[ 9&Q7,LR,-2SBV2ZNQJ"50H)U VAXW$
M$"@PKQKPMEKG6E")8=VIP:SBQO4=--&@AOND**K<1[C[XI>XI;12O!,=D&EL
M(:5K[\N;@'+IHFUVU+S95S$Q!SY7VXFM5V*)6IXQ9:UX,?R#C<L 1';LWLJT
MS!:F#3IYB"CSO?4D,DWQ!K3UV>T:?#_B#-K7H-BO'[@K.W8NDYT?Y244H-N'
M^K+F>>C;L8](X^4XC *"P1NI2-.+<<">_-#W2,VN>OF4DBV7)=%\4D:6)FW=
M((F5^/1+[!_9&X9%%^5&%K8%QZ=V-?6M6!=S"F8*X6!RP!A(Z[8[::AV <.Y
M8A#]J./^[R<(^23"/SKBFE>-[#;939DPQQ]UW! & #NY=M(HBO_*]:94,[J!
M)7T>IXH\ B"!-<-[*UO&0DU& &.BQE<'%W 8*P+:%;TMA6:.3/F5:;5AB!=2
M@CDRF#^,D#L"'J15GLTD1LC#M):..ZU4;? ZOB=TU9KI0O%\T33+3U+DWR)%
M/C(Q<M 49-?=$B[M-P<I/>_-00]8US/NO)&W92_<3(3!W3@4JR-E>OCU7QX'
M@%K3@?GL[<OS@"24V >D"EW@Y,EHH7%^3XI9%-Z3%+L9<M L"ZN5W5V79!&^
M@5,MG;3H\MV< 0)/\:]W],^7^$\:;YZ=S.-'RC7_8R]:"%9)7G<#4K22$\Q0
M>4T0GN"<2Z0"DX7"I!)U^/KB+S-W]YD2PN/_;-E.3(BS/&$:JH2SC8]*H0\5
M+ 4ES3%UOW;:HSV.5685X9@&T\*IYVJ^$^72,)$G9_>6&@/@"UC**@,[;0:N
MEBC"NME]RW#':=BNN9\H9>"?\-N/1/4HLC_P#E&%9-PS#+-B'!NB.83MN(+C
MW56(]5?6!V+P\4 #!0W O3=TE\3MIA-W/[S#D/LGO(O613NYM)_^)/EJ8;O>
M;(44Z51VOUB71:O >\10>$0C;EQ$^M*GE)'BD@I#3%ZXC+5O:!= 8Q@ .?@=
M,?5@8:VTJ\<;[+I26V(NXVY<]/G@WE$9;G))A>-#WR*!L5 W":NWA03).-6Y
M0;*$?02(D*'SE=0\2$HTK02"DD#?I?QZWZ)<V[M@7X4:$P\]R29;W%S"3NFY
M]INCF^MPL@V@^K)<:_4\(1V.FS#,L.$/YS>T+ANY Q6#YYPDY- H!<:QP?*"
MRRT8?1@T:SOF857M=[97QG<E4/F+Y!?ZD@SC';($O)'U2O-")J624)[YDG;8
M"CMJA8@"! ,,Z'_S/]1*$4PE(3Q1^-A_A]? UF?(:6:OR^J"YH#_Z##QQR3\
M5QQFH>KM[0T/"!N#+9AZQX>E*O/:?I<:Z%Y8BC^=^,AWXYK6,,!MUY4CF,FQ
M#ATDL4HNN@YRZ&]+C-&9>C).,[ON'3 ;C08*T0T\T!?@)*3^[H.:++OPF:Z[
M%*[&-AYYBX$;EN[S--JT0UMVG/A.+[:YLPD"\C#W#8[Y]2B=L<0B!8V<"7 -
MVP+/8:0P:(8/1>!N_B4%"5W,C7YH?Z8FWG63G3R:93>@B3K?-,8WDJY,C2^H
M\7U9IY&Y&6L*3C[T@5[4#!@4J)/?1MBKC?81LKWKA+N>*>@*KXMJ$RR!RTGY
M^(5#3>U="X%?<"1PA5"RTC4VF4["7FH.J>B )%']8]/N"6P<5269#L*XE!P+
M)<%Y[GDK3B5Z_>&+I!GY9')P_,ZD+PF0&<#QFH S,BUJY9F'^R5+8Q8"\!OH
MBHNY@R_2$0J<@7F]FC\D'A>,3EPAFK"ON*,765G.."J8KX7%5DH\5H/60J:M
M$/5\OEU'LCU5/G_83.&1>(U'G_ :=P^O<<.)W_JJ:AL!&$TG/U)=<<J8&G)Q
M8I7/(/(SH-H.'I#A_1/L:5P)Q,V&O!9FCPX[>AF;R-<V$H%?L39U^BP/U,XV
M(:;$((YK3L;($2J]&7E5&"277 OTG4M"G!)A/XO>PKV$0#)H]"R:O%,90_44
M,3Z=P'Q+P12/*(^,+19H,+H;D6OSTLJL6%X=(_*&(FTZL17^5!-HXFV#61X
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MY 4YP9S<\727FV@&.#VH50'>/KU-ORU\K-1U*7F)4G?#:'Q[M:']*9B(#D1
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MG.9VZ#6/="[V#6(>]KO3Y+]="'=>Q:'K/3[/'\F-&M_2O_O&)78=0^HX("+
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MQ): 1E?,^L15B;3 &#N#^FS L8.9"+(R?@>B*-#IAS)EWE\?"-O=,5R<7%'
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MFS"*P!5"_B'4WIX8K706Z6,T?"^<EW73DF\UP*42U"AYD@AW,&?E+C>.??#
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MMPGU?&+%#YD>+ +!O!B*WCP+96I6C9P7R$4D>H@,((T--8?O1^+9&@+KE(U
M1B2$A[+8N4$1&U:6=ZR&'!BH&<F9DU8Z@2A%UN+@[7C8-LO(Y;G;Z=DH*V/-
M9$)N NZF%A-?MF<UC;@A+?W2ODY]Q02\KK*])T&XO[9[$YY&L)( ?LC6>$?G
MM72*L6#RX9+24I <!9V44$BTL;$>23P7X6H]%S$):)-2/5]6[XLE>*" <576
MM>92.#?F+*POJ\F7"[=[12-(;'6?&33[/NW0L>&5OMQM6F3OTL(#F,,H!@MK
M^ HNG!!M@NQ+@DB#0,+TF+;":J9&O[U"L70AL2D<DX:)2F)?&C<:P>^FJ WA
M#L.5UJ8"@K4-"Z6C888[FK=&G.XRP*7X-!*Q'93=' 57) :LQX-:-7=-_*2*
M<12 1A6.%%=0Q"\%LMT%[9C%N\V91]L2N6#@PN"A[)G>-#U?#(W9MK"BB=NX
M=)#:S</8;'(7M2RW0[O/5M.FI'5P7P3S":LHJFL0#M(>> H"E<:\%B^;)]EE
M"'(EL542;4N*@.U&&TRI=M/)-I84M0B%II0\G;M<^/&\Z3-JY]-> O$/@.<,
M="-2ZM#MP_1P4M)B4J)1_CKL<5CG$KC'Z.GK2\,#-9[ 'C8W!N(UF9YV-W=<
MC"!] ?.B/IT1K"]B$?B\'Z17J#T &U[<(9BL8^[3&4W8&N!>/A]?#R5$>)G3
MMW</S<_=G<B1#N1F^J>]M;X^!1.H&ZZ-/)<+"2AG(IJ0"[1/O"=Q")QZZ2*+
MB#.HL4_53V8ZBS;S6;LUBZ\M29&&^J+\T082R'RZ+/(QP$&4X[#ILF10NE!,
M):F?MYR'NS)A.UZ\TOD\GU87U0IJB85MF>7M&N!QWZC5ZO<+>LFI6>CNIA9N
M%8N>= +@@(-!Y@2UE>U#!#K[F<K0/ '9MIQM'O^AU3T(2L1PBM?BWMSA-=XR
M??/-0_KF\TW?(.K+U_OAQ8":V\,CA':):HQ9%9WN[KQY_NKH)149NZ^<#E^]
MNA?@+R@P(#5L;/6P.G-WQYNH02Q%L><[T3X0=:PPP*(!3I( 48OQ5V(L^E=C
M#UB/&Q0$UH;1$0]^22DJ@1VHA(A%"K$\BT5<U.B^5Q<!R\729Q9:H9T*H72!
M7XM[P+G\Z#H7DF0K(6T<S\D^1'"&)WAW%W[A8;+-PJ >#=EXI!*,+(W/K8]D
M6\RA4^-.,$<*M#XI/I;=WS7-]SZ,1<4M.0-:F0@@@]K6^2PNK[O#"NIW0;?8
MM47O)%<L)EO2A0L> ((%+BU<=XFHL*,&;&[]N/],87+(;!"[$4XVVEUBW;7A
M);[:N^CU-J,VM60+=?9JQ"5RW")9 V50B"SJ\0(F08K()!I74*K2P9.##PG0
M,U3 ?#9=JK^KK?'LTE2XD<U-QXL!3ICK,54YZ-:L"! 388W1J"32=_$D$ 5"
MW'+$NKUDFGMJ\?-^@ 7E!*1:<%@OH)N^=+-%?X]^Q>8IBN8][E&<8$EQ,)$L
MF@=%7!?.SN*7YM[I':,*BD@F9(:07J<IYGXU@I\**DN\3'@;V:'&PES4B"57
M0FADJ7/E]*!"?G^.<.%N>R07K113HO[":E@+>L+E),FA(/N5C7&UKEX''-3N
M#F:1[LG5B+N0CBMLY7&*BTO7^Z9FO6\1\I88@*%02A\@@!EJWH JF.. <4>W
MF9!39(IL^ ^(OZZFQ*10 <L*EWHS=0T4JQ+7XDNL8&7*S"&D#&ZH6V.V*# ,
M\.MJ6=;CTL C"S]5+>&+>C6;J;%H(F$!F&D .\SBT.AKM_N*EO.9'0'T(KY9
M[T4,!P<_9L_?_3(\Z7(BWKX[.?AQ<#J\SXZ$A44-_ C-R\"I2FIY0@V+M/SM
M?(:LRV4@R?-I?08_U:3+D*4\AJ"ZYK8>0Q"C_T]U&4Q9L[%K%17Y)@UI9&W=
ME;,+U,.(7(0@O&E/RGJ_ ^!C8L>C'3WSK^]ZHR9I4O5;[4M3XWV0CE0 .%H"
M-$[4.*.G$QL'L(%PNIK-L[VGFE@YA3:@%975*2&55+TH\A4U5DUI^0 73POS
M*)>=&G2$FA4-.;OEB+]:.V+ 5\(]@ZW'\.^M?(0P &V-H<]-77V,BVB.*)<2
M,.:=[^]\7<Z;W_K9J^*J=(,ZJ"[=_[YP)[)T8WLYK:[J]W3RWU:+HNIG;_</
M@AARW-+:1TLX8="+L&;P6[HE7MJJ[YF Z[Q_L?V4 Z;RK\N%#Y/MU4+MM2VQ
MJL2S2?#E>I,T[-<AE'P%6!O;>K>M>NWNRX;%;L%';)C);T6(!9[-&-;[HJH
MV9.3CQ&@-EL4@7'OOJ)/<#HK[!D&=Z0!#0JE 8BHL\>>'D/M$81W3SW:SD>K
MNTSN.Y<1N2.S]_A1CR#Y!3G:^O#WY03$K2$??0*@*=E<WBCO>30?5<M%M=0E
M][_B+3UTUO0UF*OMO:5,=,>V9/=Q5^(DZ>^ZE]OIH+ZW,U.7+,@>@!T*ZA#S
MXHEM0'O&/1TJY2@>ZLD>P4&'^E.IIP_BJT\!F1)2X>-JT;3BE+XV#/@A,2PZ
M%H+(;2A,[62Q+&SC04U,G-! 4!X\OQ%@K^!+4<&T69S[<CPOHN,Y9 Q-9])B
MW408J[2ARM99ZHZX?EQ@-:.X*@23_LV!59F(7))$8'6=[[5U8'5=/#7SX51R
M0%/QU%M&3Z,\XCHT_?WL-!4TACYRMMHC017ZN_*R2ZC)&FI(\@VJ=JRGI#^]
M$,(B_Z<(37N#\=[JU:;;>X>OZY;E('][* ?Y?,M!NJ3OY>\V#J9%@^PS4?E]
M%RH%7=$;)7S95(UL"K,0(K@EIFTR,R4\[O#%N]5.E>E:MS,NFS<5H(.>5R#*
M*43=&&Y+6(]":P:83N.(.J0G9;PMUG&)B_F"2UL>OG** U!Z^AWJM&\@FC+-
M>4>OH$/$U<Q=XX"B>QH#O;2F>#&WD:YYNO?@/>9X]W!MEU;+HU_S&M_L<P[-
MMH1HA6U ^/59.2]GJQE5%()F':61L^+'WI=C_.OZ8QQ;+IZDVWUR81)ZFF,$
M)A?<BG(YYB@TN 6:]17F>-//XBE/M;/%MX'O[EB.#M]%DRH+;Y#_*H96:A.7
MTHOORQ:^?\C__J?D?[N.P#0.J)=SRL#M[DC[!V^[.+XVK=#W2 ,@RPGU#'Z"
MI+7!]8?VR*5D)(TS[ON3,G2[ZM64ZFK<G:/:D-V=P1C [@HF%/#IS7YV65T7
M5U2RQ4XU=N"4,ES?OB9/R\*'V5YXD2',>*S3I=:6W9V]#^55K^^YDCWXI3NL
MQ#1?+0,02)H.9X= G=/7,!:@K2LA,F(C/$4>,! $XP+XL&_P-H2_Z,MU25V2
MNLJF%;5K4Y\=C7)<%;7J?0AREC4PQU9+>"#&;&D.8<=P'XT&G@'Q;_C6#&YN
M0ZH*3PA-;B#(T&DH@\TZ -UK_V-'*BBQ[:$>!(O-X)V>@<-FRS$'2R<675MU
MA@WD)V'1LJWK;M&J;IB_5D!1K0<,++S00O#1\^K: ;!(#GL9]8H /!4?!_E@
M=\<ILJ:<"C'5B.V08@G(MM"1S)]<Y_<FOS3;TO.9E(C'@^T]0A;P7?;*V<Z<
M>Q@P+H!;5T[V8N10(RA)0SHTHGWF$8\!UGF@XL!KW53W9<WG'Y&'#<I7P\1<
M&)FY+XM4;2K\:+%A;^&G&T):(4=&R0JK.5,9%C8;>B;UV.(AN-[0Y F**$5N
M!2B- I,,M2D1,FE1WV4'9\L V;</ ;)_1X#LO'*6X$<\]6_[V3^!-^/DI^'A
MO^[VZ7O^P[?[V=GPY/71,195WJ="RD!N<-F@(C.,"2&#?:K9"M!'Q;V/:QIM
M8@W^+=51>XRX;T,\D?I5-\.]Z,VHJ<Z+)><0'SN7]LFC)\\B>'UP8"C68&0O
M9B>E-]V#2]"KG<M2<&FF>]*'$DK8&<!0:C)]$_AH"HZ$%&U1W3S%E3!AV.JE
MUOJ@<"6@M9E(Z5B7&O+J8-G1<7*[.B?4-X%_8'Q%/S;%BC?6+@]7FK^U[A50
MZ0L@)I9R?Z;'HX9;(!1T:PX6#P*J/'V$>7B.&G-)9V\_>[=@C -9SQ*9QZ'D
M+VY2B;O#OS58Y'T:PM9;UDU^Z!<-7HLHQK(-[E?%=!)4MUH\'URW*7N(2K]=
MS?TF$Q@Z!9GR<S#';Z*>$FZ<)T6.L^E][_U:,./5L77^P;E;^VHN,/$:YT(H
M!JE*UG!CHC#9MQP%Y8,:7#:.7#6GUOL W$<+>/''8;FNJ3:>K);-I9R\.9LM
M=K_95;6[Q^CK9"YW-G0F]PTQ@\K9^0K<>3,M\>,%_R8$LFNU;A$ZD0>M8,X4
M0Z0;GD8#*C.&D3!XT;2 7?#3(WQLP [6(R  J9X>TQQFB4<IUF.")]//O6(<
MA'4]A91!*=T2EDMS03C^16]%CIC9PAES230,WC!S3.'GT:WJV![>A764PY^9
MYD,%_OA1W$7Q^NCT8/CJU>!X^.;=Z;W0Z!V5ZQ1BP@3>J_SZ^^P?)NR*_P($
MFS*?[F<#=S_0&9"PZHA^J-%8\?WZV94;RQBA6XJY.W<C]CL0?,L&NA*70"GX
M.*'@@[8<%)EFMA:'2@+=/V"I?JF6[SU$S$5YY3/\(IQ'EQ4C)'*LS@U\XN1D
M(Q_I#<7KZ+D^]JXO"5"SZ\590*]DH]=U+ZVW64);X6CY X-'M-C86^_?S[ X
MARXT*'M@+];"VAM&?E.JD.+#:.K4G%.S<<$DJB+E+IP48XRR8>0>P+><GF"<
M0/1]60WZY7]>$60JE&;G\TN@\YA[E+)\C/PQ0=0> F6KIC 62K6,*(4$=AW^
M@E\AO/<MFK K0^9AL?<"'YF7B\8(_TD!Q,0J8L\,QQ>)07EW!RQ5.%YU[5QT
M0LF"Y2X;#-:5@CU9C8J"($SP($[S<D;GHO2@DLXFKJB4*6HHBC>)7@'!1]@7
MBI5S&T_WF^$UY[@[/$R(W@*K^+Q$C/UJN9K1(G#@W?UEY>&BUC_8Z:0EQ$B%
M5+3S(-(2ZEPAQ7#%=Q*?6&M#:"WM+/(Y=4[ #[@J2E:A>VB(".:,VBGQEV'E
M*L?C-0K#[3%,24+U_08<&TVBFK&JDFK1GX;,$$7QO%BBH80L(1%'%=)D>D,9
M$RY^QRJ$[5,I@X9!G1+V"V%T\3)=YS>$Q:46-2ZCOHR_QG[& @R\AL-'3BC=
MXL40DZ90.>U<X1,J;,HAW^LY(*&1^5F279&_QYAMPT0CP+)"^ZG<IF$=>5K8
MDO4SG;8C[0G<PCHF]2#SBI66.RY.6%V$W&5XWR0["@!4^56U#!V!_<R9%-AX
M^79P<O9+]N/P9/C\E^SHY&3XTYL#I)/\>7#T$Q!;'O^2G1R]_/%L=^?HS%,Q
M(B?HV9L^,IP.7IX,AT0H"1R0Q&#I_I3]X]W)+]G9R='@E1)I#@[_\>X0>$69
M"A.>?WAT^O8=$(VZ41!7I/LR_0?\F:@;D>!S@'R/NSN';P[>(66C^V*""A((
M0$^.3H'?\<V[,R)?/3JE<<+/^NGG9O:Q\ W[-_>.L^'KMZ\&P,U)Z[6[0Y."
M_[Y/!EC<[O3W=S\<0)K-F45.# DO<SKTH@63#(#J3MX,>DJA&Z,!,#D,X\JC
M^@3'/8GK5K$P>XQQ:"!-DY ,HI#D5J9YK\CY$Y*_ I,!2W3MJTQ- ),B.KE1
M>#70:FCT:AN_@!C.:)9<*6X7"G>A (.^$/,$K-X9U4[ 32E!JX!ZI.092-4"
MK8))<.H>1X(7?IDOD8H+_:&L^!*4!"\5"SELG:R65%8ND7GB!W3CV]M?C"<]
M3$&11O;;H\/&D"['-\(/Z0C2^HZPX,F]#.UF'.!YR>TS+?^9%I03^*#?H!\&
M6!>QW.6\<$^<Q"\$5%X>6\_GOG##6=)!NI2]]EK)!5,CQD 98!ISU;6JIKM[
M/;?+$#Q]]) AN'\EM'&CHI.V/Q98PEA_O[OS$JHBE\1_ ][,)?\IX9=*?[W:
MRV2K862N8)!1$[G&+#-<U8SK/@PC8<L'1K3KH+4W>S<'0"-QK6%NSF, %DLP
M?<8"2MPP>'B?92VQ;ZXQ":6\!0/V>3T",\;]>E) Y>,<2L3FA9,2$))UZ[!R
M(I+"5M,5^( PJ=K;HF<:VN*2'(_3*N4WP1_<AJ8_M\05U^XB$;_9M'P/!<0@
M@$/=!7T78W!D\O'TAN4582;X8 $^1E[3K@[<EU>VYD!K)P/UC!L>HS:: ZU&
M:PI9- ,\*-K$#>K:'2@;Y*\;=_C@5W"B)17!H8B@(N6&SZ(;S1T6NK^7.OL4
M0N4<9'7;\#K_@)6Y;QFE>$!07DI=A=%/'[II)U%J+1]4IR; WW>7A*+:VB=3
MSDD=8\B!70)B!L+4!3D"G26+_6@+303(O_.\,*/J=[ZQ=9.=XB;250@[6&!=
MO!2 9:U8NA1?H!>[!W@+PSS?$PWR"#"H$PPBS'?X:;%SBPB_7L+YAY#-0FDE
MA#-8%P WA56)DH7*V;ICZ3^%LK05.>7%!VCKJC7P!YR17!=(E5FT%6JP8&EW
M4*.""+&$ R'X+1Q]<4^"[!#'"V25S$DB^ZB_8>$T-:?3WZNQ<EWBJ;YXS+T9
M6BH8TL(&^BF755Y1$F0DQ8584S@JP8^'XC&3& MGARE*&@/XU2,$Z')C_BVP
M+ADFINX\KQ O99[S!?O7_ )2"+*66%$)IQ3]8RC7@Z#'),>\W+RXJ( -67*4
MRV+A#*8B6MPU%R)81^8;IZ_:O]#&2]G=1(W[&6*CUYSP<_^QJ.I:^-UQXGZ[
M;C>6->#;$>JV#Z1XIN @S^+#&ZG )J5N1;&5,Q])UN"=AQ&RK*;5,J0\IN C
M%@?KQ8CO!4D10T'&:3Z&4X21N+59%031'7<.$M0VAVM;Y5$Q, Z$_GMH,2WR
M&^GGI3->","I"?U*'8%G4D^'@??6]PK@0'DZ_N1C&L+)$+@P3J#\1IV%:KM
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MJCR+(N+%=Q94=?OI1.YD>:7T)%%<&?J?\<$%E=)PTBJ?2^D!_,:,*53%\,^
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M^?QB!6&ZE>(41$3MB<AN8W\X@@W0I*,!6F+$!+:L&16>O$0RRN85$#5*0S$
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M+^P#NE)_(G^%FXL.B\)E^:(;_T=_0X/;C?X=IL4O0J)SH6.1"T$WE^Q4#A7
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M(P;OH5(MR^;I$U9I>KCCKE)=.I;K3YY.@S]O\O=8PD[#B)IN&(I!4I/ 6IL
M/#&UP2;UF7/_H;W!N&&&*;)58S2N=G?@GM;VJ7WN?(%^U,MR@>QB>5U7SI[@
MG%U&.PGU6ZME$5Z_]U@4,,DN@*2,HI7NL3?4HHY,JUBG7-2KV<+'&#"]*C-9
M!CL+"T>VKQLB-)IK;T_K%?'\ ZPD^*6O5<+FMQ1*S.Y.<%Z8#NGC6%)Y868
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MV"K.HX9 'Q]E-%_ $&J$!8J_Q%MAU3G=3M*%8<*6(QRLVE8-KCP:L939(N,
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MDF022)[&* -![C Z#96,ZI#='7J"_#5^\R7,-_,:,Y?_8O^(_@C#K6#^8$;
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M;E$14(!^!)9$5\+MHW&0]T@IMP%!?QWK;F1%1@K#0 YX/UCSD+ 8I.G6EC1
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M#,B+;4:?U9>%I)M\6&_/A ]LAIH/3%+8LKE']1H-$9!Y=S+[--[DOL1W(HI
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M5]5];U%KT^\X)AE^WXF*+9W;5#Q$^; <W;ZNDAELV0J=V(12RZ<NHH:W;M:
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M'$G9(E37ZS4)_&I:L%"U;K9/:88B3=6]&LS^P=[OC_O(6WUOBZI[L?S0=0F
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M@$M1%9T&5]L$L3_\#C=RO7!&L*^TA-T:Q_!8.W 4.[V%29R-6,2N5>]V)O'
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MTL&DIEP&RY+O"O[3[1Q*>FF)&?2])5@_.7THI9V3H75\C86?)ORKM*K4<.Z
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MI@CM,MR;QG8+S9>U$D+*N4R\M^7BDKBB?Z,P</&V!F-Q%.)RE>]<,B&=*%!
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M2Z&"\R-V;2_-'R5BE9Z!1(II$EB\;Q8IK#G/NVQ>OD/<!%XTC$=VU&I/^MO
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MS?/B'B?$YS[D!5PI^]?^WM[S^]S4O6/321CAB899I-X 04GC>9S]^G 7[)/
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M9#+SEIF@(QSUY1O>BCR25'Y(%44^Q06+4_#.. =ZOZLZ\ !P8F"PZ,0!Z0O
M! PO4)<Y["K#:7&+=+Z4LQ$8#I6/15JHV5+@09(2:')CP+:0% /-=0@($)%
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M&H?1PX[)O"^4C;Z81"B&#S;#K$UU*= ](F;XNG+L")(<I!R1N(6FAZQ.TD4
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M8,+:.9":0KG80$CA]+,\Q9P4E5]G;,!$\U]F*]9XY2AN1,0R[L3*V LYNH8
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MPN6')D;PED1Y5QX4YPEZ +(Z/^50=3BM95J90,<UIR>0IH2C,+L+L'6ED&T
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M$U[KA0E)4T&]H(;U8"4D;T$>M#>L2W3P]:=5S8@^>P',3AQ^(O?1L"8R>^E
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MS%]U-N3@\DD41[F&4<V7.\GIEZ!I4<.2F'$P8WVOZGLX@21@;.Q3=LQ:^YE
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M@GZ-5\4;6Q\Q*HC^_^'M9 &\HOR\)6!A@L (V9!$JSUP.3NEQ(2;FM7>K-5
MM^ZNR?;TX+&A9_=PDOC]9,,30(M,[+,OU?F+S.RR./N*_W3N4ZXB&?P$SNN0
MNDN-\=#FCK4/J/73$\6F?/D-W$>39"5(]@+? 1^?#J;RL+7LBGSL"N>V(C8J
M8W3XWE/$,B% GV<?$;A__\/]!P]<C@#DJRVJ.4Z"_)+*I 1-.G A\3+.U/<@
MU)AM%,2N3RSS+V;M:MJXY&-7SQ0B)1A$CP30&Q5O/[[@X4KT.&925\NV9Q=M
MJ#]BV3@N'O_E[_'X3R(>?S?38N9-BY_JV56U;F;J98:^\)NK.K(9#OJ[&/WS
MN&U_1#AC_MG=RVXA7P@2VGJ8LHC&H4N6CMRS$=M-?)HYNTY9[9Q))E>1;RF6
M=7%V<U63,KMNJJ+&)''7PL8C4L-CGFZ:OH9G+ B(,JL;6!+V:AW(Y.'#/SWZ
M8[&YO[I?TL+^O>W>DO]+(0AW75*R>M9N=JS]P9' $B?$P')@"D%5@6 YM/A9
M[V%%*4S6^^GT*O,,)W'="MSS >04 VAX->#%T1>P;K!-4JO(;WB.&X2K-VY:
M9L*5ZK]H) P=39>>P2*OQ"DFP!!?F#C*FQ;-(_YS$%?UIZ7*F.HYHYDP4Q7J
MPQZLHY(^$^U_3XD?JO;")!M?=Q38AQUN+[DXK(5WK3$<XAVQONZN<:=0%MPO
MPZES1*)KX!"!W61*'!!HV-"H\5I%?!^&-^2B/ 28B(^( 11&V 5WL!C.[=:A
M.",K ,8 \UZM78D!1XF'"@&^69<TAU>C)%G5,_8#'&FXYAEGN!@*6II^Z+9L
M<5:$8ASJU69)YF4B#%\^ +=N<A\3-?!5OLA8:@EB<O;P^V<O?GYC%=F]'O:'
MM1G<8J]_>?E##^8^_O?[+_"S/P2A^2(T2<2P.CUQ9QF#$HEPYT(:9.FLF@&]
MLEA98.IG]G;=WBSK^:5"U;#N#4L7'?+.[7O%(14&]ZD2BI!M@=[#V %\:(TW
M"E6(A?4TK[;+6M*C7W_-^=&B7BP8]<*^@\M8=?4E0@AE"%0@MZ*$9DY;%/N5
MA=,65 9DEI3FDJQJ+MQN4W$N,:/!G*+BD$IX&L* 2ZCJN6 L6'G%H*SAVAJV
ME!F'N7H194''%&\0QX%?@S4]P]3/R&Q&2J\\.J=9[Y'K?@CDU-K.9%&PI*YE
M1E8<KZI>\4CSG/#26:<QUU6W;-2=H&]IRCRJVWSXQZ^^+L[1I7 &OG%_E]4-
M*"TG8W037FZ7O+Q23H@1]6%9J^Q7N(=S7",,^)I$M'ELXOTL1%D?"MS8T>?W
M9A++#.O-IZJTG];5? E.<B@\9I$US A^/4\ZS51%\H*P4UL)AN*!QN+3>@->
MT-!VB$L TRG)0EILV)LG=D2G)\^P?N)\"V8[K2%H3LP;8VF.>_O+KKWLJI5]
MS+/SUV_"F<U@TT%ST6+Y=.'!4!E6>4@)ICFV:8 ^V1!S58=GWLT:4^9#+V#7
MNG:_GU9+CH#"R<*8 QZKTQ-8&%CSKMU>7M'79%&_0!C^O*MNX*Z%77D"R]O.
M&SC?_:X'M5;B6YQ=T63#M8*W2;8.U[!TB&J\+\ 1[+URX^F4+BH_]U8E6I.@
MZK<#":NW(V!"'9Q&9RU5\SG!_+&2"*[<!O.;!&C+BC29L<:@*$634QY3=/>Z
M6M71"..%+MV!/6+WBV3S]5R8W7=IA3VU7.[FX[AHQK"P-HVS=\&V76%&G8,8
M-N2])R@KQJ5L>E]<$DZYDP3^_G$R=,*94"5?NHDM@#$<6(F6#9P-)3AFMC1[
MW0K ?&E>/6KD<G[,7)^9]0EJV-T"T=4^T :W-VO-3>2D,KIZSR*QF* =#+[+
MGETA(#E_ZG';OKUWL1XZQ*? :QM&PE?TZ@,I,3#XYI-):@/OV14\H&Y/[L--
MC<L#DL!^&/^KS\)UG0MU* T0>Q?CU8@">\?[NJ/,$X@B*".IU<#ZHAIG[\#+
MG:V)VV?CM2IHP:UX'X\_KJ++<3( 6^'T:= Q"BR*3> Q#W#^JN+Q=H=28*+%
MHD+,%?-RV\VNT,P_AR-$-_O$&4MZ'")7^.L_/7A GC#O]9ESAY\@J -]XHG.
MT]KHS6H%]Q-7, 6U&PYA+GECDYR$\T>WF;<GDCV#AWC$0>Z:RIA.!"M'$]'
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M=M)%S%1@T '#;?N(XUAW@[_7AL()$=:D!<Z7H&S75,\<=BO^R&=_=^2[FW'
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MMJD#_U.8)E&T!&TG,_1*NL,$#S$OE8#3WF$D/>>DRX0MOD/HN0&YH9KU2[B
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MHWP"5JB]VV+9LH(/3%N92F^K\PT'(FE5-E!QD,)IAW9/Q_I;YR#/Z;2]:OJ
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MC"ON/=.V\4&FI=?A9:VV2)2#*2MR/72>\8GB_?./YY2!$KBS>I58T^F))\7
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MT.OW(?$'$YI.$\[68E##I!Q+4UO@,=^>5H"FHP1NV[7TWZVHR,:WY,4L3&#
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M]-="'.ZL_?%*R9'9VR]_S]Y^$MG;NQWZM_L.?;^EM,[8);>E_L1(14"'-.8
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ML]#*(FO/39A#TG:^&7P,,C13]S&W-:7/VZ#^T6N!U5E/O%MIP0\I1M.%S$Z
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MJ0HG( A#N>!8:LDB'KMEB\&0E>%$VU0H:'#KM 2:(\R-KF@ZCJ2Y>Y7IX$"
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M_<RD!1EZ)VLI'$>9P0>K60#H&7&KKXT7%T.'BET&*+!$6]8N/5G%N-0R!M2
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MX<'ML+V%F(OPVQT&^@F9C<GA4"U2%Y/Y>$8I-TRL#:HY#/)(*;NX*?HH'V5
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M.!5M<9HIIJ#SL*BV*7))68*F9HB;W!6&Y@:@:_>('_PM1*NJF,\WN9.(<6Y
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M78$VF%PJ-=,:4NRYRI$X3?AR)LY:X3Y#__-&]+)K!,">A&'OG6)*&2)>/32
M>PI1Y&[RNE'X3>/8B&-3]Y+FB6%:,XY:=O0Q!XU503!]&MC]VGR"A1.<D.??
M@DN8!OR]J86]T&)0#!D(5R>"HVN/5U#\&@9(W8Y.,(MOAAH9&Q7=U;9OK)+7
M86\(A(CE(Z! ,X6WT 3L<P/:,R'OVP@!F<7TJO86V9X ]W=JU6Y'9?5<+FQ5
MXN< S0TV)%I/#O%K(4^)G2I)LU'%*9+-ZE29=RQ[B^8[7AQ3"S%W@\3%=C0S
M@3BW)A=8=X&X:UB8BSWO0V;R'!358#ZI9TQ%WIF['?@QHEF3)OD'**.HT64N
M/3TL->^!"L#S5\BA1T0LS,B,N;. <6_X.L*+>H!N>>KMGQHS4-:PVP@9N&G)
M@, /4%-?>^M_R:9S=X=S76R:'+A+?:S_^F4^EH]P?]\X+=7/*_F36T)6Q.,<
MROR3NSRK4A^ &!65NPYE"*@]@5,=3FKSO8_W'G^[$5MPNV +HD3,[JC=6'K-
M[W;WB%\S07K-U,"+^PA,JRQ^&7#!XXU8W ^MQ3UV/R(%1_'3]O)"E%43$50_
M(S@J%(D\_?W\6/AY.>=_FM7#[._)RW'9=S[2.668)?73_@*';LDLQIQ7D,'8
MB*6_:R^]4ZKN@M!+/&+X1?H?D7%C&H=:,7TE)=MXP[#?CUOY,(_&\&T%0/2;
M%KXZK&[:WEH&\,*M+4,&GP_[ PGP?^D3()(:[X+R%;@8]C5<%N)N-:M]-?R:
MLVQS92>&>X=A"WJM92NF?E(\_7%^F0>7LFT7%29'2%(@O:/)6R%?Y4YH9CNW
M"_HR*NZAO#-U,LE*\TK9LK!(E;4A>HVA6C:?T7MNXB+W(B*SL&V3F4_6D9#(
M$]H"@O0F?'1:YZ:SUS.E!&V(,./?O$3J*.0C\I>L*GXX5[+!)!NVO26QWIY/
M4E(?+">E*2D +? \7W)[>%%ZG.4692T*,R0G\!&K>NZD -/A=-'QSH'[$'F*
MM5#IEXKE#H_E*BQ@6+TMDYW'+#U#$ ,80#F0.,<BH6AM*9$TP,D4DG'(ELVG
M XY!A)FDGAN*L!)"UW M[5M^P%C@WYZ=7Y79%?99@W.SPX#A5/Y#!]KYF$K'
M8%ZALZ-:I39]+L!6^;D*;[3[4PZ8D10QP?-*!*D9+17**50^5WX0H!/>YXS\
MCR_&#CGINZZEWX'R;(J!D2DAO4!%-]< ZJA>M(.LR<@-GLA@QN4M94><1P<M
M5#Q]@/[$X!9.@(OA:7]8_%NOLJ1'C2-%N;CETD^0;+JFSVUE)2DJ.M?+%4%(
MXVL"NQX!8X6K9^G1U]0.9G/!GG1[R34H=9AI"H%<+<& ;W$S,>\@;-U %0_0
M6\P\$2AMR3!FVOQGR\"/2N=SPNX^;_0L=BP0<VIT@8K1+A%8.HW=QAA8T:V@
M8ML8'^0#N:DS#)F%9?=O8@PE\[J>8MGZ08_FX[%: 3=%R:'/%N*N!1=SZ_-)
MRV,@;/^URP-1G.!]WAP"6T7#]-Y8J1O6BA<K0NWO]9)5EQC#4QYHD:KD6U#5
MGT/#-.]7V$]O%FUOQ>RB5;3-M.0J_. RHS8SUN,I@3S4;%T(WG9'9T:0OJ:[
M"*+O"DQ ]24 3M!W.J2<0E!?]M/3]LXG4'(\Q%G*-*<82!T%MK!:SA"2+^O:
MW<H"ZT7E.52W#/.</N*)%E-DLL=5M; !OGYETM!/Z:+R=/^SHK*L)YFV?CNC
M3GJCP"8F6(,:RI> #096<,:,XY=T45&R!:Y66H E]N^:MPIW9!&J?2-SB&=>
M[W\\\O#&-&JX5? 18E_>!7,A?^26#$BE&&W6D&]O!=")P>]K\P!89L.4KH_)
MAG"@/5-*I1]AQJJ%-*[#Y?'P,'K:B3\H;\!L,("%()<LD</"=IG%KJ   :&K
MM2"\V'4I1UF!R'P<VT'P@O>YY<X(2BZZA@"7X(>&K'3 Z"R0&43F$Z&I\N98
M]4S#*'XMQ^[-R4]N_-BV)W%^^4/FTVO+S.OG)F#/?(3+G:P#U0W)@6^#I*Y8
M&0.-/_]0$*M*7WLH!.V@8?QK2==9SASQ!TJ%UP5\ E-5P#FA;5N,H-Y,BA%J
M+[XQ1G,"*&!\/[6H, ^@&&],XPK)J)J%.P%4VP)#\J/LI+;ULN1B]:4(>"8[
MMQ!$HUL'KF5:+Y3G8>L;)#69.T7%Y66.#SN^X80^%'%[6AV_+-=974M=*01J
M2_7!R#]%P"\$O[ ='*U78 .MF[>M-5EF]HMD*!-;>XN@O6E6U*-L8(6PO7J8
M%04>!-->C*7U9*I@S$#LG)&I=HY$I\B\;SFZ#SA(NF(IV).OI6 ;5@KVC^4Q
M[^TMUDH=*>P8_E\'S#@733?,N7;T,@GQ[!B3#TI\U>#0.NC(:^('')6?6N.D
M% H&V&0J%H]V*A=2BVAK,U"<L\R6N)"&)R45Z6=:@/-(ZOC0%T#S;7'DFY:D
M 7FGZ#5]82YM4 1'T[\=-/LN>HOS$Z&I4_ISLYNR&$KL?5C.^]3(9 J[!?5K
M^9,I(K.]%?C.OG11I[<(V]&(.51Y.,';V=_O!'(4N4>D!4%-X3SS"*[;G6>S
MJ]ZJ:(Y\.%:8:!#[U]<E"]\&ZZ(D(5 %O> -&W%F^OW@S'P 502&6ZSJQ!3.
M=MDPE)5:$3K08P8.?>>L.-980R+^=L/*1NGUJ($5A#(BH,^=J($--RP1],;$
M@S=BI&;(U#-(=]YK-)N"V^(.M/1B2'K,+<\L>T_6,):P#!@=>+G=AW$VF\*A
M$CDIWO$(>BUP1^@/;W@34C[E]HJ:R[0Y5I':4B& ]*F6_;U=#_%:SR>HX_9[
MRX;/IJ2S&''WT9R/XE9$1Y]"=F?U%3)!0'%%NG)B.U#$.L'A!,!R4F*$V_BA
MUY%0J_*@S$EQO!NJWDH*+_$"*B*0&2_/ICXQ%:A=JG:BTFT?[E1G!EK+0]F*
M!$KAX<MSACB45B"U8T>3A<-^\DD;J+@"H,S<[X\24P-GATU%^+[X7LOQ?1%^
MPR'?8>VF3VX\37*V:\F*GV;78S]%>@9>>CBG;<GR5E^HI4NQ0$QE67JT[9S0
M_N>*JU]E/^/MK?921UJJED_PX\3\!>V_*&G(WA8#!;JR^EK:G]%4S#%&/VTI
M=0HY>0)V@5K&ERB>OBR$GJ*9I_"%4<&3]01Q$Y<)=];1X<&;?019@JY .,)M
M)QKPG4YS*=>G8"V$$]"VK6VWZ(OY'79.1@1Z82]9C_"6EEPOVGMIQ:0*;DM[
M$LY-@4I09["N<;*"I4!+@\==TZ+F]B7CP8?]EER%H8W1F'%;VN*33A;-&<-*
M_Y1)-\Y ,"IHQ8@UOY+\SECK>C?*'\O6HO6XW"2V5BL]P,F(T+IT]D0N6FW;
M%]1KG/0U-@A Y?ZY4MFE?TC=KZ6 DA7US\,6V&5:$1NR/T(M<BW)1]E(G<:;
M%;M%S;R+N3$MEJ7JG)5_36"(B%TA7(:3<EA@#*JL? \C%3=V>S -W1#MBP]4
M@TG4)9!?'!9CQDOWI&5=+<[K:1<)CMRLL7W>0.#'2NYFV6K;+$]%D;U[65@X
MT8"1958JN>^%VHB R&!@ R*FZZFC/2X(!?YY?_?IMQA[I5Y$PH"CO*-;.28J
MA[UL=0*D$IQM5J'W?&SNL??->8BOJ6Z.XYL2VVR88&=S)Y;/OGWR3'Z,?^#_
MYHIX$F)Y(]M:YX:.^D!8U#D^N<#(<Z-I6WGWO2K/6^V$6ER0&09+#!2MC7?1
M0EZ,P%U@4NXA=_ZMF/YZ^C7]M6'IK^$P4&'Q"J]87->SVWG..E_HT@TR:8OJ
MJW)^>86,-%)>E3:H-TP+?3&UF)M0AD=@119*)O7-)9!@ +GB;EY$-0UQ?=6.
MQ];><!(,G^*A*P.X2&FZ/R<]LKUUC+B1*6&7R@B<E3>&W L80*DB27,[Y%TP
M.\3]*1F'<#P6GAX@P"&3,O.!2RC-RROQ)=SC<ZUT!E#$&+ZJ@'N[@:!I-IT%
MB[[@*N#>O4=[C^%99UKYF)P_^F\DX;.MSKP<R3%C9Q+SK"F,AA(G7*0,\B8+
M?TN%7\'76^4Q5H^7%:4W&;+5VUK^:U2R7F$C_]VRL</+,<V:J3<!58M3)E+Q
MJ&_ >YAHK^Q@D%_/?#5/#"Z5:$T-J]XS?U/;V%+<=DP]P=I:O[/P7D :-UK4
M)^O)")S8=:R,74G<)$]Q2\<,LZ.K_%:R++3(;I>Z5AD" WA2S72I9D:2^/BH
MEBO:G!U^B[RQ[OFA[*XWP;L5IM<I0\YZR9U=D8<<,WBH6\P["T[JD^&C)Z8<
M33AO>H$(KBEQI45D]K6ZSGOR'>6$.*..MR<H4UM(>VB,];2<=7HISK43F/K:
M7>QN$7$<@ZM\0GH47*-+-BA;D,VM74>P1A9Y2A@WM5GBX7WE6FODR-3CMZ1Y
ME'UD=1V_M+1WG2F/535\Y(XYY7+W24]8I"U:W[7*@IV]8.&@G^'C-,:" T6"
MMZZ\;6_=OPZ)3;GK+!L2+:=?_E5G68ZR'JT\!.W+ ^SXN]:=FMI.K7NU_K:W
M5C3_N@X2&@H1.6H>W>BF-<\S&@S]G$J(<3^--]U4RLN-J*[M[%XM-E A'D.+
M98#'4W.GD(U))>ED74(P3.X:?^?0/9-K9WR5#XD-&U=W%;U"Y !$T$C6-0XE
M=M;2Y:H[$<V=QO7V\D<P T^;OM2;UF$0]M8);%T2"8][V2H*5^4AB5/,:R,#
M4_!TY H[K+A/?&/2^4)T!KS"PNIGHZFC=YP)V4GQU-*@[DI7A7"=+A]!3$&G
M@8+.!$?#0/G>TQYU5RK1G9)33:5IHV^DS>LYE"05S*Y*ZB@^3R"EES@I=N?/
MD7VCOBHKS%!/E-A&>U.,4>'KNSG0Y*-OK3$A2$)%A4_P05%U;H^88)D$\"2[
MON#QL#6'TOGZR4Y_F*E84>W#<"SD "MXV.[*5U<IKR4 N%5SL1;LLL+?![-Y
M)<D;3=V4#'9T@UJI9(_/_TT&84#VBMKPI'LZGP&E[,-/M:D-^P,J$<UB<CU&
M1=@<C]=ND@.ATGOX/<@.0=H%J9#(F*1CX ,.>IH/G :'DX-,$U5%H';A3Z#_
M$7N4B $Z]E3?AH7]OR-NCD.)@.E!-\%TYH>G[84S:'V77D2JD^O:J <<25T]
M]);G-O3V\N#@;23.]LZM*B8GT20RO&(2:>!*&<8V@+CW.*_I@J:5'C,F2+X9
MJ,JC4;!JP'D;6;9,OG,)7U!>"L&<@RX_)[7SFHRT%8ECJ05^@7GWS"2[[V^Q
M5UZ;?]F>7%[VDO_+O7/#__> Q6S%-,>SKVF.#4MS7%U9K6&1=B/*@TM0&"/7
M-'^ :32<8S],V(P*MW=A'HK=&$X0*F=\0LGT-+]+PRY,C^);LS&:DF^(;%#4
MH0PUIF15HT$N)1T:]- *+TX)W"6FTGUI<S(OA\!W(-ZPI@*"J@I&@OBXJRAZ
M$WDV.<*8T4*;&4?A;(4'$X!D=U RX0Q$-.M0_6(5$H4^Q.H? +<.+HKQ24.C
MXQJ\K>L*+(D!5&RH]0K[4N7%I ^/$*M#NK'MAE'GI^D$&N>S&9O& S>T8@91
MJBH'$I(2N$;1SP@RPMZT@:3548=D!& ZSBF";<4GIDX<^N['<RGNB3[7F]WV
MH75IGDL(T-&67W*L+-69E[14$T\^T(;QFYWCKB,Q0&0C@BBO"BR6-5"B4@ &
M0#+,LL8B *"?;EM@_[ 0Q=,=D$G)K;SNS!4  03RCL8RN_9H;\<ZM^RAX<EP
M'';8H-?(A[4Q2<V4=K"?"8[6)7V]*BZON.<:,(B&!2=7T(?*QV-RYX [EN=.
M??(:O Q04+":>Y3-QU2+AF>72N^ ^L4C7U2\8CQ"F1=(]D]^,YQR<VH(J<VL
M,/@M&#/MG!$F$XHALSZ-B<E'FJB :+^^9D#D<0GWT+YG2:##W+1?=LF@EL61
MYJ":/BC[]=EL<D_]RD&M'SG\#&GEQH?TP(KOPD4OLO[V<D'\$Z3^8J@N%)!N
MG'B)./KW4<F\\WUGEQF$[(;0@P,25;G;+@6&<(@$CO,A?$B8Z:DE<P)569NH
MN#OU\TF_$D\9'CX%CNS<1,:PWM;] JO3.HZ*A:BC[26QAYF!:N6CT(L>/7P&
M*E=]\"TS\UB\?3@&$/O4XR7H^80,?#OE#BVOBO1Y@CLC=Z@/X0+FNS2P7^5>
MO4?.-Q?S_6P/D:</2-[8*WRJ<\02.","914<N))Y*#6.\KZ &R(NF4E;,%]:
MP7S IO;JMIF6!U@#;99CYF0.B9*WLJMG*%,K=.;:^!0&4AHH/JDIJ  ,'U+;
M;J><:9=/:RH_@')?S&F!_0$,3J"SR!B99CAOMK42^C#X)X!3N3-?29&8?,:_
M+-TK"[CL;DOW4SR)"+I07Q77T+,THPN<_H/'!VKC^H[_&ZZX&[H2@2R"AYUJ
MY,[]9XP8_1\R'IJ'4Q15/K/V26%6WA\G<Z\9+$$NN*;;SLR6=+4[81LAGG_\
M$;H.-SG5"\:B#M.[I)6L=SMJM66M;6DS^13ECBYWST@QT,944N'$0$]99ZLD
MN=)G7&:0"L^&-Z3:*[T442,7_;F$_(QK(RWCH8V'";Q8!9+VR_FBHP;]2,GH
MR.JB\!73^0-0PY=H&(JQ?[6(,HV>LQ%B]?Y]0ZP:S+-<E(,<LQ$T_S81K18A
MP;T'"E'Z2QML10.AL_4RR7220F 1^]GVU@MA6C[:*":+\=CNPZO"'86AZ=Z/
MXEUSW2!&Y,%FABZ7>,7'*)*I\#N-I]G_<^Q?CEC,=<G%]V!N%I2AFE^K0V$2
M,))B\C!UX3'EU(,!'UI29!B4%7I7.GPSJ?[VW4J$UFB9(X'.1LC)9&+EY+6;
MXJ/?D!V(H,)B<N(IC T>.L>0/:Q*U*<BN#KEE5;SW7E^;+!JH!FL5*F0S_\.
MUS890&YW%,0L&ZIW+4P%@EV#L%3.A*_F'L9L61L/E7PHY\,9DPQ.@]X/:I F
M9A[)$6.OG31+:^V(3]ZB#SE,?A6E/XOVVD>;;L'ASC L;Q.Z6CAAX;RI8^TU
MN#UPTVX,/L=TZD3T?_WU\9/OGW\1T?@U",C+\/"9G8OP:,+Q(Y*39/\)THY\
M9UNIKLI;JO]H28%D+96I6SN)B4>64&L$+)7@D!1Q3]1Q*SB(RIF^3-3HVK8[
MFE=PJM<:$I^9\EK--1E(TPDB9@3^$#J.@N@2G#YR<+'MI706)#:TIS'LNQC
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M,AX8ZV=CC)W65WD^8V_1P+0UOOU?\ZQR5B)8<&<YE$/"8W^"NMW]O4?_E8P
MWMT;MN?'A_#YP?S2+42R_U0&AB9J, N3:O1+\:K(J:U\/M7/YS.J12.M106B
MFC8"  I,7MWT5+Q,%>>H^>R4,4>"H4CRK %-WA&NP/!_?ED,I$O AKZ65J-
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M9YY['7@C?'"Z(^X;I!-:*;:@0[1YTN-%C JZY>.S_ERSCL*;197N7N)685P
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M->)@I189HN ND\JUVRS3VPK;SIC@:L%#CGV)8<G>>=A4;#+!=XY)P(9Y (;
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MK3(<0X*IT]/;55965_F:A>=%0Q2Y 'RCI*<C7]E(O;N'-6M2'#9MYQ/C0C2
MPFY4&J%1A)OQXM56_:XVRR5/<"EDYD5-:%MS:H0!UV.5W5"P?YY9+$W!5&!)
M2^[ )94*6#(%>7 O%6WZU%P] Z=<1G5=YE/V%,_$N,/H+R<^EG>@]8O-$ON/
MS-F!=D# *QYC@@8,;/UO7^Y_\\W?__8-_O\_A)5S;])?\NO--58/X^ FN"=>
M6V?44W-U5MJS-G FW?N.=;?KLBH"0EL9[+M[0#!J&H!G=;MJ )(;YFNG+7.
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MFC2!.X2&+41#.]2P?Z7#!0W+6IO*W,5_;8:G8>[3K-8YC\4:?'#X/;F'&.L
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M8(>Y3XB:?&V:YM4!!26,.'G17#6).&^Y;+L<=\==HU+!>#&EQ:])OI%-42R
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MKM<9A6;_ 6Q3S5D!2"1.(3NBN&8 /??.:>9=CM8WJG 0SSF66XBRDG 6#&9
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M[+C)8440L#1L641VZ&>V*0$[LZR#3/8-"RIKPD=-<T869O02U"*VLFE*%9#
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MDD\W4P)"_F%PGG%V%9:ROQ1(!XQB*\$EJKI8+"B5NQ!46!K).1]ZLYAHTJ'
M#6@+-(!#L,D(YROA2[RF7V,^D#RQ5M;>Y7WZI12TN <J_C'?Y+:C?QA$.ZS*
M'Y]?C(Y/^KVC\<OCDV.%#_02?6Z>ZAJ9<$$%-2Z91=9U$!EU'YL:\V\_,<*W
MER&[',;3;YX_1WQYE<?H]W##5<BG(S9O\0<,:L9X"@X'@?,N/%3I4DH'*S89
M2#%_:GS;GC[SR/?E;N0S(X@4';_\CZ;C3--QY)#2S]'"B]#3M<X1UK<(Z1 K
MNXG<U+3*AJ:#TL/%]=Q)41,4N#+]?(T/.\8S/1LT\+]U98N/*U??K8-DBWG,
M<V*#+XU[GC VR8Q0)A"-;\G-A1SO31EMGX,FC+GGRH+#^%\[%%6<.M*RZV8(
M.ZN49QDTS%*TWM/JB@#LEZS7S'1F^KL&Q[<Q&JPR3PT0^\=<W7,?3I][G&Y
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M5$WE&MI(%']4[]F5>36K X62<Q..9!<;E!M]YQ4FL?SD=COU/U!+ P04
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M,#(U,3 Q,U]P<F4N>&UL4$L! A0#%     @ B3%.6P;MPB@5(P  +,   !(
M             ( !%18  '1M,C4R.#$U,V0Q7SAK+FAT;5!+ 0(4 Q0    (
M (DQ3EMH:N"[T],  .3^ P 6              "  5HY  !T;3(U,C@Q-3-D
M,5]E>#$P+3$N:'1M4$L! A0#%     @ B3%.6U( 9]*=<@  "UH" !8
M         ( !80T! '1M,C4R.#$U,V0Q7V5X,3 M,BYH=&U02P$"% ,4
M" "),4Y;8N<A2\PZ  #<'P$ %@              @ $R@ $ =&TR-3(X,34S
M9#%?97@Q,"TS+FAT;5!+ 0(4 Q0    ( (DQ3EL5X=PP_M(  /(^!  5
M          "  3*[ 0!T;3(U,C@Q-3-D,5]E>#,M,2YH=&U02P$"% ,4
M" "),4Y;[0YE_U9Z   J: ( %0              @ %CC@( =&TR-3(X,34S
M9#%?97@T+3$N:'1M4$L! A0#%     @ B3%.6P ^!+6J"0  SA\  !8
M         ( ![ @# '1M,C4R.#$U,V0Q7V5X.3DM,2YH=&U02P4&      H
,"@"; @  RA(#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm2528153d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="snpx-20251013.xsd" xlink:type="simple"/>
    <context id="AsOf2025-10-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001571934</identifier>
        </entity>
        <period>
            <startDate>2025-10-13</startDate>
            <endDate>2025-10-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-10-13" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-10-13" id="Fact000004">0001571934</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-10-13" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-10-13" id="Fact000010">2025-10-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-10-13" id="Fact000011">TAO Synergies Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-10-13" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-10-13" id="Fact000013">001-40458</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-10-13" id="Fact000014">48-1585656</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-10-13" id="Fact000015">1185     Avenue of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-10-13" id="Fact000016">3rd     Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-10-13" id="Fact000017">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-10-13" id="Fact000018">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-10-13" id="Fact000019">10036</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-10-13" id="Fact000020">973</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-10-13" id="Fact000021">242-0005</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-10-13" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-10-13" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-10-13" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-10-13" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-10-13" id="Fact000026">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-10-13" id="Fact000027">TAOX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-10-13" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-10-13" id="Fact000029">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-10-13" id="Fact000030">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
